|
|
|
Scientific Literature, 2005
-
't Hart BA, Heije K. Broad spectrum immune monitoring in immune-mediated inflammatory disorders.
Drug Discov. Today 10: 1348-1351 (2005).
-
A SE, Moses PD, George R. Ocular manifestations of Behcet's disease.
Indian Pediatr. 42: 942-945 (2005).
*
-
Aanpreung P, Laohapansang M, Ruangtrakool R, Kimhan J. Neonatal cholestasis in Thai infants.
J. Med. Assoc. Thai. 88 Suppl. 8: S9-S15 (2005).
-
Abad C, Juarranz Y, Martinez C, Arranz A, Rosignoli F, Garcia-Gomez M, Leceta J, Gomariz RP. cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.
Inflamm. Bowel Dis. 11: 674-684 (2005).
*
-
Abadia-Molina AC, Mizoguchi A, Faubion WA, De Jong YP, Rietdijk ST, Comiskey M, Clarke K, Bhan AK, Terhorst C. In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta.
Gastroenterology 128: 1268-1277 (2005).
*
-
Abanmi A, Al Harthi F, Al Agla R, Khan HA, Tariq M. Study of alanine-73 and aspartate-9 of HLA-C locus in Saudi psoriasis patients, using sequence-specific primers (PCR-SSP).
J. Biochem. Mol. Biol. 38: 350-353 (2005).
*
-
Abanmi A, Al Harthi F, Al Agla R, Khan HA, Tariq M. Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia.
Int. J. Dermatol. 44: 82-83 (2005).
*
-
Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, Radha V, Deepa R, Mohan V. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.
Diabetes 54: 1207-1213 (2005).
*
-
Abbadie C. Chemokines, chemokine receptors and pain.
Trends Immunol. 26: 529-534 (2005).
*
-
Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F, Fong S, van Lookeren Campagne M, Godowski P, Williams PM, Chan AC, Clark HF. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.
Genes Immun. 6: 319-331 (2005).
*
-
Abbott DW, Polk DB. NODing off and Ramping up.
Inflamm. Bowel Dis. 11: 860-861 (2005).
*
-
Abdel Razek AA, Abu Zeid MM, Bilal M, Abdel Wahab NM. Virtual CT colonoscopy versus conventional colonoscopy: a prospective study.
Hepatogastroenterology 52: 1698-1702 (2005).
-
Abdelrazeq AS, Lund JN, Leveson SH. Implications of pouchitis on the functional results following stapled restorative proctocolectomy.
Dis. Colon Rectum 48: 1700-1707 (2005).
*
-
Abdelrazeq AS, Wilson TR, Leitch DL, Lund JN, Leveson SH. Ileitis in ulcerative colitis: is it a backwash?
Dis. Colon Rectum 48: 2038-2046 (2005).
*
-
Abdul-Aziz K, Faizal AA. Serological diagnosis of autoimmune hepatobiliary diseases.
Saudi Med. J. 26: 1875-1881 (2005).
-
Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S. Effect of linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Int. Immunopharmacol. 5: 231-239 (2005).
-
Abdullah MA. Epidemiology of type I diabetes mellitus among Arab children.
Saudi Med. J. 26: 911-917 (2005).
-
Abe D, Sakaki T, Kusudo T, Kittaka A, Saito N, Suhara Y, Fujishima T, Takayama H, Hamamoto H, Kamakura M, Ohta M, Inouye K. Metabolism of 2alpha-propoxy-1alpha-,25-dihydroxyvitamin D3 and 2alpha-(3-hydroxypropoxy)-1alpha,25-dihydroxyvitamin D3 by human CYP27A1 and CYP24A1.
Drug Metab. Dispos. 33: 778-784 (2005).
*
-
Abe R. Regulation of immune response by T cell co-signaling.
Nihon Rinsho Meneki Gakkai Kaishi 28: 21-32 (2005).
-
Abe S, Hanawa H, Hayashi M, Yoshida T, Komura S, Watanabe R, Lie H, Chang H, Kato K, Kodama M, Maruyama H, Nakazawa M, Miyazaki J, Aizawa Y. Prevention of experimental autoimmune myocarditis by hydrodynamics-based naked plasmid DNA encoding CTLA4-Ig gene delivery.
J. Card. Fail. 11: 557-564 (2005).
-
Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, Depierre JW, Hassan M. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice.
Clin. Exp. Immunol. 141: 238-247 (2005).
*
-
Abenavoli L, Leggio L, Ferrulli A, Vonghia L, Gasbarrini G, Addolorato G. Association between psoriasis and coeliac disease.
Br. J. Dermatol. 152: 1393-1394 (2005).
*
-
Aberra F. Synergy in a synbiotic?
Inflamm. Bowel Dis. 11: 1024-1025 (2005).
*
-
Aberra FN, Brensinger CM, Bilker WB, Lichtenstein GR, Lewis JD. Antibiotic use and the risk of flare of inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 3: 459-465 (2005).
*
-
Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease.
Inflamm. Bowel Dis. 11: 685-695 (2005).
*
-
Aberra FN, Lichtenstein GR. Review article: monitoring of immunomodulators in inflammatory bowel disease.
Aliment. Pharmacol. Ther. 21: 307-319 (2005).
*
-
Abir F, Alva S, Kaminski DL, Longo WE. The role of arachidonic acid regulatory enzymes in colorectal disease.
Dis. Colon Rectum 48: 1471-1483 (2005).
*
-
Abo T, Kawamura T, Watanabe H. Immunologic states of autoimmune diseases.
Immunol. Res. 33: 23-34 (2005).
*
-
Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, Koni PA, Gurish MF. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.
Blood 105: 4308-4313 (2005).
*
-
Abouljoud M, Yoshida A, Kim D, Jerius J, Arenas J, Raoufi M, Brown K, Moonka D. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Transplant. Proc. 37: 1248-1250 (2005).
*
-
Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models.
Trends Immunol. 26: 587-595 (2005).
*
-
Abraham E. Alterations in cell signaling in sepsis.
Clin. Infect. Dis. 41 Suppl. 7: S459-S464 (2005).
*
-
Abraham NS, El-Serag HB, Johnson ML, Hartman C, Richardson P, Ray WA, Smalley W. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs.
Gastroenterology 129: 1171-1178 (2005).
*
-
Abrahamsson A, Gafvels M, Reihner E, Bjorkhem I, Einarsson C, Eggertsen G. Polymorphism in the coding part of the sterol 12alpha-hydroxylase gene does not explain the marked differences in the ratio of cholic acid and chenodeoxycholic acid in human bile.
Scand. J. Clin. Lab. Invest. 65: 595-600 (2005).
*
-
Abrahamsson A, Gustafsson U, Ellis E, Nilsson LM, Sahlin S, Bjorkhem I, Einarsson C. Feedback regulation of bile acid synthesis in human liver: importance of HNF-4alpha for regulation of CYP7A1.
Biochem. Biophys. Res. Commun. 330: 395-399 (2005).
*
-
Abrahamsson A, Krapivner S, Gustafsson U, Muhrbeck O, Eggertsen G, Johansson I, Persson I, Angelin B, Ingelman-Sundberg M, Bjorkhem I, Einarsson C, Hooft FM. Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration.
Atherosclerosis 182: 37-45 (2005).
-
Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension.
Clin. Liver Dis. 9: 685-713 (2005).
-
Abramovits W, Cockerell C, Stevenson LC, Goldstein AM, Ehrig T, Menter A. PsEma - a hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczema.
Skinmed. 4: 275-281 (2005).
-
Abramovits W, Stevenson LC. Atopic profiles, familial histories, and coexisting conditions associated with hand eczema.
Skinmed. 4: 204-210 (2005).
-
Abrams B. Long-term sleep apnea as a pathogenic factor for cell-mediated autoimmune disease.
Med. Hypotheses 65: 1024-1027 (2005).
-
Abreu MT. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 210-211 (2005).
*
-
Abreu MT. Nod2 in normal and abnormal intestinal immune function.
Gastroenterology 129: 1302-1304 (2005).
*
-
Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease.
J. Immunol. 174: 4453-4460 (2005).
*
-
Abt PL, Abdullah I, Korenda K, Frank A, Peterman H, Stephenson GR, Markmann JF, Shaked A, Olthoff KM. Appendicitis among liver transplant recipients.
Liver Transpl. 11: 1282-1284 (2005).
*
-
Abu J, Batuwangala M, Herbert K, Symonds P. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer.
Lancet Oncol. 6: 712-720 (2005).
-
Abu-Elmagd KM, Balan V. Recurrent primary sclerosing cholangitis: from an academic illusion to a clinical reality.
Liver Transpl. 11: 1326-1328 (2005).
*
-
Abu-Sa'da O, Barbar M, Al-Harbi N, Taha D. Arthrogryposis, renal tubular acidosis and cholestasis (ARC) syndrome: two new cases and review.
Clin. Dysmorphol. 14: 191-196 (2005).
-
Acamovic T, Brooker JD. Biochemistry of plant secondary metabolites and their effects in animals.
Proc. Nutr. Soc. 64: 403-412 (2005).
*
-
Aceituno M, Panes J. Pathogenesis and immunotherapy in inflammatory bowel disease: lessons from animal models.
Gastroenterol. Hepatol. 28: 576-590 (2005).
-
Aceto G, Cristina Curia M, Veschi S, De Lellis L, Mammarella S, Catalano T, Stuppia L, Palka G, Valanzano R, Tonelli F, Casale V, Stigliano V, Cetta F, Battista P, Mariani-Costantini R, Cama A. Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli.
Hum. Mutat. 26: 394 (2005).
*
-
Acevedo Ribo M, Moreno Planas JM, Sanz Moreno C, Rubio Gonzalez EE, Rubio Gonzalez E, Boullosa Grana E, Sanchez-Turrion V, Sanz Guajardo D, Cuervas-Mons V. Therapy of intractable pruritus with MARS.
Transplant. Proc. 37: 1480-1481 (2005).
*
-
Acevedo-Suarez CA, Hulbert C, Woodward EJ, Thomas JW. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
J. Immunol. 174: 827-833 (2005).
*
-
Achiam MP, Chabanova E, Logager VB, Thomsen HS, Nielsen OH. MR colonography: a new diagnostic tool.
Ugeskr. Laeger. 167: 4279-4284 (2005).
-
Achiron A, Miron S. Intravenous immunoglobulin and multiple sclerosis.
Clin. Rev. Allergy Immunol. 29: 247-254 (2005).
-
Achkar JP, Al-Haddad M, Lashner B, Remzi FH, Brzezinski A, Shen B, Khandwala F, Fazio V. Differentiating risk factors for acute and chronic pouchitis.
Clin. Gastroenterol. Hepatol. 3: 60-66 (2005).
*
-
Achneck HE, Pradhan SK, Kavic SM, Longo WE. Primary signet-ring cell carcinoma mimicking segmental Crohn's colitis.
Dig. Liver Dis. 37: 537-541 (2005).
-
Achneck HE, Wong IY, Kim PJ, Fernandes MA, Walther Z, Seymour NE, Jain D. Ileostomy adenocarcinomas in the setting of ulcerative colitis.
J. Clin. Gastroenterol. 39: 396-400 (2005).
-
Actis GC, Ottobrelli A, Baldi S, Scappaticci E, Modena V, Fusaro E, Mengozzi G, Rizzetto M. Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
Mt. Sinai J. Med. 72: 136-140 (2005).
*
-
Adachi R, Honma Y, Masuno H, Kawana K, Shimomura I, Yamada S, Makishima M. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
J. Lipid Res. 46: 46-57 (2005).
*
-
Adachi T, Togashi H, Suzuki A, Kasai S, Ito J, Sugahara K, Kawata S. NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells.
Hepatology 41: 1272-1281 (2005).
*
-
Adachi Y, Kobayashi Y. Hepatic uptake of bilirubin re-visited.
Hepatol. Res. 31: 193-194 (2005).
-
Adam R, Lucidi V, Karam V. Liver transplantation in Europe: is there a room for improvement?
J. Hepatol. 42: 33-40 (2005).
*
-
Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, Hagerty D, Townsend R, Hollenbaugh D, Pearson TC, Larsen CP. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.
J. Immunol. 174: 542-550 (2005).
*
-
Adams DD, Knight JG, Manning P, Smith G. An informative case of Graves' disease with implications for schizophrenia.
J. Clin. Lab. Immunol. 53: 13-25 (2005).
-
Adams DH, Afford SC. Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection.
Semin. Liver Dis. 25: 281-297 (2005).
-
Adams DH, Eksteen B, Grant A, Miles A, Lalor T. The molecular regulation of lymphocyte homing between the liver and gut.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 54 (2005). *
-
Adams EJ, Chien YH, Garcia KC. Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22.
Science 308: 227-231 (2005).
*
-
Adams J, Kiss E, Arroyo AB, Bonrouhi M, Sun Q, Li Z, Gretz N, Schnitger A, Zouboulis CC, Wiesel M, Wagner J, Nelson PJ, Grone HJ. 13-cis Retinoic acid inhibits development and progression of chronic allograft nephropathy.
Am. J. Pathol. 167: 285-298 (2005).
*
-
Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease.
CMAJ 172: 899-905 (2005).
*
-
Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
Clin. Chem. 51: 1867-1873 (2005).
*
-
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Gastroenterology 129: 113-121 (2005).
*
-
Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
J. Hepatol. 42: 132-138 (2005).
*
-
Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation.
Arthritis Res. Ther. 7: R196-R207 (2005).
*
-
Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases.
COPD 2: 445-455 (2005).
-
Addo A, Le J, Li W, Aksentijevich I, Balow J Jr, Lee A, Gregersen PK, Kastner DL, Remmers EF. Analysis of CARD15/NOD2 haplotypes fails to identify common variants associated with rheumatoid arthritis susceptibility.
Scand. J. Rheumatol. 34: 198-203 (2005).
*
-
Adelman B, Sandrock A, Panzara MA. Natalizumab and progressive multifocal leukoencephalopathy.
N. Engl. J. Med. 353: 432-433 (2005).
*
-
Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Anto M, Capasso R, Zappia V, Ruggiero G. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Hepatology 41: 995-1003 (2005).
*
-
Adjers K, Karjalainen J, Pessi T, Eklund C, Hurme M. Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females.
Int. Arch. Allergy Immunol. 138: 251-256 (2005).
-
Adkins B. Neonatal T cell function.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S5-S7 (2005).
*
-
Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA, Qureshi W, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Faigel DO; Standards of Practice Committee of American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas.
Gastrointest. Endosc. 62: 1-8 (2005).
*
-
Adler G. The posttranslational modification of thyrotropin receptor and thyroid diseases.
Endokrynol. Pol. 56: 72-77 (2005).
-
Adler M, De Gendt E, Vereerstraeten P, Degre D, Bourgeois N, Boon N, Gelin M, Ickx B, Donckier V. Value of the MELD score for the assessment of pre- and post-liver transplantation survival.
Transplant. Proc. 37: 2863-2864 (2005).
*
-
Adler SN, Jacob H. Occult inflammatory small-bowel disease: not so occult anymore.
Scand. J. Gastroenterol. 40: 360-364 (2005).
*
-
Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists.
Cell. Immunol. 233: 115-124 (2005).
*
-
Adriaansen J, Tas SW, Klarenbeek PL, Bakker AC, Apparailly F, Firestein GS, Jorgensen C, Vervoordeldonk MJ, Tak PP. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
Ann. Rheum. Dis. 64: 1677-1684 (2005).
*
-
Adsay NV, Basturk O, Thirabanjasak D. Diagnostic features and differential diagnosis of autoimmune pancreatitis.
Semin. Diagn. Pathol. 22: 309-317 (2005).
-
Afdhal N. Can serum markers be used to reliably detect liver fibrosis?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 132-133 (2005).
*
-
Afzal NA, Davies S, Paintin M, Arnaud-Battandier F, Walker-Smith JA, Murch S, Heuschkel R, Fell J. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved.
Dig. Dis. Sci. 50: 1471-1475 (2005).
*
-
Agabiti E, Loganathan A, Rimmer M, Eames RA, Cullen PT. Cancer of ileostomy: a late complication of colectomy for ulcerative colitis.
Acta Chir. Belg. 105: 99-101 (2005).
-
Agardh D, Dahlbom I, Daniels T, Lorinc E, Ivarsson SA, Lernmark A, Hansson T. Autoantibodies against soluble and immobilized human recombinant tissue transglutaminase in children with celiac disease.
J. Pediatr. Gastroenterol. Nutr. 41: 322-327 (2005).
*
-
Agardh D, Roth B, Lernmark A, Stenberg P. Calcium activation of tissue transglutaminase in radioligand binding and enzyme-linked autoantibody immunoassays in childhood celiac disease.
Clin. Chim. Acta 358: 95-103 (2005).
*
-
Agarwal N, Sharma BC. Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH).
Hepatol. Res. 33: 92-96 (2005).
-
Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases.
J. Gastroenterol. Hepatol. 20: 1691-1695 (2005).
*
-
Agostini C, Cabrelle A, Calabrese F, Bortoli M, Scquizzato E, Carraro S, Miorin M, Beghe B, Trentin L, Zambello R, Facco M, Semenzato G. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis.
Am. J. Respir. Crit. Care Med. 172: 1290-1298 (2005).
*
-
Agrawal A, Durrani S, Leiper K, Ellis A, Morris AI, Rhodes JM. Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease.
Clin. Gastroenterol. Hepatol. 3: 1215-1220 (2005).
-
Agrawal C, Raghav SK, Gupta B, Das RH, Chaturvedi VP, Goswami K, Das HR. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients.
Arch. Med. Res. 36: 555-559 (2005).
-
Agrawal J, Syngal S. Colon cancer screening strategies.
Curr. Opin. Gastroenterol. 21: 59-63 (2005).
-
Agrawal YP. Low dose naltrexone therapy in multiple sclerosis.
Med. Hypotheses 64: 721-724 (2005).
*
-
Agret F, Cosnes J, Hassani Z, Gornet JM, Gendre JP, Lemann M, Beaugerie L. Impact of pregnancy on the clinical activity of Crohn's disease.
Aliment. Pharmacol. Ther. 21: 509-513 (2005).
*
-
Aguiar M, Masse R, Gibbs BF. Regulation of cytochrome P450 by posttranslational modification.
Drug Metab. Rev. 37: 379-404 (2005).
-
Aguilar-Bernier M, Bassas-Vila J, Sanz-Munoz C, Miranda-Romero A. Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis.
Br. J. Dermatol. 152: 808-809 (2005).
*
-
Aguilar-Martinez P, Schved JF, Brissot P. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities.
Am. J. Gastroenterol. 100: 1185-1194 (2005).
*
-
Aguillon G JC, Cruzat C A, Contreras-Levicoy J, Dotte G A, Pesce R B, Aravena MO, Salazar A L, Catalan M D, Abello C P, Aguirre D A, Llanos M C, Cuchacovich TM. Emergent therapies for rheumatoid arthritis.
Rev. Med. Chil. 133: 969-976 (2005).
-
Aharoni R, Kayhan B, Arnon R. Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis.
Inflamm. Bowel Dis. 11: 106-115 (2005).
*
-
Ahmad M, Afzal S, Roshan E, Mubarik A, Bano S, Khan SA, Hashmi SN. Usefulness of needle biopsy in the diagnosis of paediatric liver disorders.
J. Pak. Med. Assoc. 55: 24-28 (2005).
-
Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T, Neville M, Kanawati C, Fortune F, Celik A, Stanford M, Jewell DP, Marshall SE. CARD15 polymorphisms in Behcet's disease.
Scand. J. Rheumatol. 34: 233-237 (2005).
-
Ahmadi K, McCruden AB. Macrophage may responses to androgen via its receptor.
Med. Sci. Monit. 12: BR15-BR20 (2005).
*
-
Ahmadi S, Powell FC. Pyoderma gangrenosum: uncommon presentations.
Clin. Dermatol. 23: 612-620 (2005).
-
Ahmed FE. Molecular markers that predict response to colon cancer therapy.
Expert Rev. Mol. Diagn. 5: 353-375 (2005).
-
Ahmed KA, Thompson JW, Joyner RE, Stocks RM. Airway obstruction secondary to tracheobronchial involvement of asymptomatic undiagnosed Crohn's disease in a pediatric patient.
Int. J. Pediatr. Otorhinolaryngol. 69: 1003-1005 (2005).
-
Ahn D, Crawley S, Hokari R, Kato S, Yang S, Li J, Kim Y. TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation.
Cell. Physiol. Biochem. 15: 29-40 (2005).
*
-
Ahn ER, Lander G, Bidot CJ, Jy W, Ahn YS. Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy.
Am. J. Hematol. 78: 127-129 (2005).
*
-
Ahn J, Flamm SL, Flamm SL. Autoimmune hepatitis.
Curr. Treat. Options Gastroenterol. 8: 481-492 (2005).
-
Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals.
Ann. N. Y. Acad. Sci. 1056: 218-233 (2005).
*
-
Ahn LB, Huang CS, Forse RA, Hess DT, Andrews C, Farraye FA. Crohn's disease after gastric bypass surgery for morbid obesity: is there an association?
Inflamm. Bowel Dis. 11: 622-624 (2005).
*
-
Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells.
Nat. Biotechnol. 23: 983-987 (2005).
*
-
Ahrens ET, Morel PA. In vivo imaging of autoimmune disease in model systems.
Curr. Top. Dev. Biol. 70C: 215-238 (2005).
-
Aittoniemi J, Soranummi H, Rovio AT, Hurme M, Pessi T, Nieminen M, Karjalainen J. Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.
Clin. Exp. Immunol. 142: 120-124 (2005).
*
-
Aizawa Y, Sutoh S, Matsuoka M, Negishi M, Torii A, Miyakawa Y, Sugisaka H, Nakamura M, Toda G. Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease.
Tissue Antigens 65: 88-92 (2005).
*
-
Ajaj W, Lauenstein TC, Langhorst J, Kuehle C, Goyen M, Zoepf T, Ruehm SG, Gerken G, Debatin JF, Goehde SC. Small bowel hydro-MR imaging for optimized ileocecal distension in Crohn's disease: should an additional rectal enema filling be performed?
J. Magn. Reson. Imaging 22: 92-100 (2005).
-
Ajaj WM, Lauenstein TC, Pelster G, Gerken G, Ruehm SG, Debatin JF, Goehde SC. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity.
Gut 54: 257-263 (2005).
*
-
Ajib R, Janbazian L, Rahal E, Matar GM, Zaynoun S, Kibbi AG, Abdelnoor AM. HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus.
J. Biomed. Biotechnol. 2005: 310-315 (2005).
*
-
Ajioka Y, Nishikura K, Watanabe G. Pathomorphology of ulcerative colitis.
Nippon Rinsho 63: 763-769 (2005).
-
Ajith C, Gupta S, Bhansali A, Radotra BD, Kanwar AJ, Kumar B. Alopecia areata associated with idiopathic primary hypophysitis.
Clin. Exp. Dermatol. 30: 250-252 (2005).
*
-
Ajonuma LC, Tsang LL, Zhang GH, Wong CH, Lau MC, Ho LS, Rowlands DK, Zhou CX, Ng CP, Chen J, Xu PH, Zhu JX, Chung YW, Chan HC. Estrogen-induced abnormally high CFTR expression results in ovarian hyperstimulation syndrome.
Mol. Endocrinol. 19: 3038-3044 (2005).
*
-
Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, Sidobre S, Kronenberg M, Hogaboam CM, Swain MG. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
J. Immunol. 174: 8027-8037 (2005).
*
-
Ak DG, Kahraman H, Dursun E, Duman BS, Erensoy N, Alagol F, Tanakol R, Yilmazer S. Polymorphisms at the ligand binding site of the vitamin D receptor gene and osteomalacia.
Dis. Markers 21: 191-197 (2005).
-
Akadegawa K, Ishikawa S, Sato T, Suzuki J, Yurino H, Kitabatake M, Ito T, Kuriyama T, Matsushima K. Breakdown of mucosal immunity in the gut and resultant systemic sensitization by oral antigens in a murine model for systemic lupus erythematosus.
J. Immunol. 174: 5499-5506 (2005).
*
-
Akamatsu N, Sugawara Y, Kaneko J, Kishi Y, Makuuchi M. Risk factors of cytomegalovirus infection after living donor liver transplantation.
Hepatogastroenterology 52: 197-199 (2005).
-
Akamatsu N, Sugawara Y, Nakajima J, Kishi Y, Kaneko J, Makuuchi M. Cryptococcosis after living donor liver transplantation: report of three cases.
Transpl. Infect. Dis. 7: 26-29 (2005).
*
-
Akamatsu S, Tsukazaki H, Inoue K, Nishio Y. A case of lupus cystitis diagnosed from urinary symptoms as the sole initial complaint.
Hinyokika. Kiyo. 51: 685-687 (2005).
-
Akasaka Y, Abe K, Sato T, Inoue H. Regulation of neurokinin-1 receptor messenger RNA expression in synovial fibroblasts of patients with rheumatoid arthritis.
Neuropeptides 39: 467-474 (2005).
*
-
Akashi M, Takumi T. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1.
Nat. Struct. Mol. Biol. 12: 441-448 (2005).
*
-
Akashi S, Sho M, Kashizuka H, Hamada K, Ikeda N, Kuzumoto Y, Tsurui Y, Nomi T, Mizuno T, Kanehiro H, Hisanaga M, Ko S, Nakajima Y. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Transplantation 80: 378-384 (2005).
-
Akbar A, Ghosh S. Anisakiasis - a neglected diagnosis in the West.
Dig. Liver Dis. 37: 7-9 (2005).
*
-
Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival.
Proc. Natl. Acad. Sci. U.S.A. 102: 10858-10863 (2005).
*
-
Akbayir N, Calis AB, Alkim C, Sokmen HM, Erdem L, Ozbal A, Bolukbas F, Akbayir N. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation.
Dig. Dis. Sci. 50: 1938-1945 (2005).
*
-
Akca T, Colak T, Caglikulekci M, Ocal K, Aydin S. Intestinal perforation in Wegener's granulomatosis: a case report.
Ulus. Travma. Derg. 11: 348-351 (2005).
*
-
Akcam M, Artan R, Yilmaz A, Cig H, Aksoy NH. Abdominal tuberculosis in adolescents. Difficulties in diagnosis.
Saudi Med. J. 26: 122-126 (2005).
-
Akcay A, Ozdemir FN, Sezer S, Micozkadioglu H, Arat Z, Atac FB, Verdi H, Sahin F, Haberal M. Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients.
Perit. Dial. Int. 25 Suppl. 3: S52-S55 (2005).
-
Akerman L, Mimouni D, David M. Intravenous immunoglobulin for treatment of pemphigus.
Clin. Rev. Allergy Immunol. 29: 289-294 (2005).
-
Akesson LS, Duffy DL, Phelps SC, Thompson PJ, Kedda MA. A polymorphism in the promoter region of the human interleukin-16 gene is not associated with asthma or atopy in an Australian population.
Clin. Exp. Allergy 35: 327-331 (2005).
*
-
Akgun E, Caliskan C, Celik HA, Ozutemiz AO, Tuncyurek M, Aydin HH. Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats.
J. Int. Med. Res. 33: 196-206 (2005).
-
Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population.
Arch. Dermatol. Res. 297: 94-98 (2005).
*
-
Akiba Y, Jung M, Ouk S, Kaunitz JD. A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G753-G759 (2005).
*
-
Akiho H, Lovato P, Deng Y, Ceponis PJ, Blennerhassett P, Collins SM. Interleukin-4 and -13-induced hypercontractility of human intestinal muscle cells: implication for motility changes in Crohn's disease.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G609-G615 (2005).
*
-
Akimoto T, Kobayashi S, Tamura N, Ohsawa T, Kawano T, Tanaka M, Hashimoto H. Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus.
Angiology 56: 601-609 (2005).
-
Akisu C, Delibas SB, Ozkoc S. Evaluation of three different ELISA kits for the diagnosis of trichinellosis.
Mikrobiyol. Bul. 39: 325-331 (2005).
-
Akiyama M, Sugiyama-Nakagiri Y, Sakai K, McMillan JR, Goto M, Arita K, Tsuji-Abe Y, Tabata N, Matsuoka K, Sasaki R, Sawamura D, Shimizu H. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer.
J. Clin. Invest. 115: 1777-1784 (2005).
*
-
Akiyama T, Maeda S, Yamane S, Ogino K, Kasai M, Kajiura F, Matsumoto M, Inoue JI. Dependence of self-tolerance on TRAF6-directed development of thymic stroma.
Science 308: 248-251 (2005).
*
-
Akiyama TE, Meinke PT, Berger JP. PPAR ligands: potential therapies for metabolic syndrome.
Curr. Diab. Rep. 5: 45-52 (2005).
-
Akkurt MO, Bektaser B, Ocguder A, Oguz T, Solak S. An unusual complication of familial Mediterranean fever: protracted arthritis with bilateral coxarthrosis and intraosseous amyloidosis of femoral head.
Mod. Rheumatol. 15: 358-360 (2005).
-
Akman C, Korman U, Ogut G, Kurugoglu S, Urger E, Ulus S, Esen G, Tasci I. A combination of small bowel imaging methods: conventional enteroclysis with complementary magnetic resonance enteroclysis.
Clin. Radiol. 60: 778-786 (2005).
*
-
Aksoy DY, Gurlek A, Ringkananont U, Weiss RE, Refetoff S. Resistance to thyroid hormone associated with autoimmune thyroid disease in a Turkish family.
J. Endocrinol. Invest. 28: 379-383 (2005).
-
Al Dahouk S, Hagen RM, Nockler K, Tomaso H, Wittig M, Scholz HC, Vergnaud G, Neubauer H. Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin.
Chemotherapy 51: 352-356 (2005).
-
Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Dig. Liver Dis. 37: 282-297 (2005).
-
Al Moutaery A. Proglumide attenuates experimental colitis in rats.
Exp. Toxicol. Pathol. 56: 327-332 (2005).
-
Al-Abdulhadi SA, Helms PJ, Main M, Smith O, Christie G. Preferential transmission and association of the -403 G --> A promoter RANTES polymorphism with atopic asthma.
Genes Immun. 6: 24-30 (2005).
*
-
Al-Alem U, Li C, Forey N, Relouzat F, Fondaneche MC, Tavtigian SV, Wang ZQ, Latour S, Yin L. Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap.
Blood 106: 2069-2075 (2005).
*
-
Al-Ali AK, Al-Muhana FA, Larbi EB, Abdulmohsen MF, Al-Sultan AI, Al-Maden MS, Al-Ateeq SA. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia.
Saudi Med. J. 26: 1886-1888 (2005).
-
Al-Bahrani AZ, Ammori BJ. Clinical laboratory assessment of acute pancreatitis.
Clin. Chim. Acta 362: 26-48 (2005).
*
-
Al-Bishri J, le Riche N, Pope JE. Refractory polyarteritis nodosa successfully treated with infliximab.
J. Rheumatol. 32: 1371-1373 (2005).
-
Al-Haddad S, Riddell RH. The role of eosinophils in inflammatory bowel disease.
Gut 54: 1674-1675 (2005).
*
-
Al-Hasani H, Joost HG. Nutrition-/diet-induced changes in gene expression in white adipose tissue.
Best Pract. Res. Clin. Endocrinol. Metab. 19: 589-603 (2005).
-
Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, Al-Ola K, Motala AA, Almawi WY. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.
J. Clin. Endocrinol. Metab. 90: 5104-5109 (2005).
*
-
Al-Otaibi LM, Porter SR, Poate TW. Behcet's disease: a review.
J. Dent. Res. 84: 209-222 (2005).
*
-
Al-Za'abi AM, Ghazarian D, Greenberg GR, Shaw JC. Eruptive tufted angiomas in a patient with Crohn's disease.
J. Clin. Pathol. 58: 214-216 (2005).
*
-
Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis.
Hepatology 41: 668-670 (2005).
*
-
Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder.
Ann. Intern. Med. 142: 289-298 (2005).
*
-
Alain S, Ducancelle A, Saussure P, Bouhnik Y, Lavergne A, Pors MJ, Mazeron MC. Cytomegalovirus infection in patients with active inflammatory bowel disease.
J. Clin. Virol. 33: 180-182 (2005).
-
Alaish SM, Torres M, Ferlito M, Sun CC, De Maio A. The severity of cholestatic injury is modulated by the genetic background.
Shock 24: 412-416 (2005).
*
-
Alarcon-Riquelme ME. The genetics of shared autoimmunity.
Autoimmunity 38: 205-208 (2005).
-
Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
Arthritis Rheum. 52: 1138-1147 (2005).
*
-
Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.
Gut 54: 987-993 (2005).
*
-
Albarran B, Goncalves L, Salmen S, Borges L, Fields H, Soyano A, Montes H, Berrueta L. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B.
APMIS 113: 526-535 (2005).
*
-
Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann MM, Haefeli WE, Weiss J. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Biochem. Pharmacol. 70: 949-958 (2005).
*
-
Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, Samartín S, Sanderson IR, Van Loo J, Vas Dias FW, Watzl B. Markers to measure immunomodulation in human nutrition intervention studies.
Br. J. Nutr. 94: 452-481 (2005).
*
-
Albert DA, Albert AN, Vernace M, Sebastian JK, Hsia EC. Analysis of a cluster of cases of Wegener granulomatosis.
J. Clin. Rheumatol. 11: 188-193 (2005).
-
Albert JG, Martiny F, Krummenerl A, Stock K, Lesske J, Gobel CM, Lotterer E, Nietsch HH, Behrmann C, Fleig WE. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis.
Gut 54: 1721-1727 (2005).
*
-
Albert NM. We are what we eat: women and diet for cardiovascular health.
J. Cardiovasc. Nurs. 20: 451-460 (2005).
-
Alberts DS, Martinez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
J. Natl. Cancer Inst. 97: 846-853 (2005).
*
-
Albillos A, Banares R, Gonzalez M, Catalina MV, Molinero LM. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
J. Hepatol. 43: 990-996 (2005).
*
-
Alcantara Torres M, Rodriguez Merlo R, Repiso Ortega A, de Lucas Veguillas A, Valle Munoz J, Sanchez Simon R, Martinez Potenciano J. DNA aneuploidy in colorectal adenomas. Role in the adenoma-carcinoma sequence.
Rev. Esp. Enferm. Dig. 97: 7-15 (2005).
-
Alcazar Navarrete B, Quiles Ruiz-Rico N, Gonzalez Vargas F, Cabrera Torres L. Bronchiectasis following colectomy in a patient with ulcerative colitis and factor V Leiden mutation.
Arch. Bronconeumol. 41: 230-232 (2005).
*
-
Alderuccio F, Murphy K, Biondo M, Field J, Toh BH. Reversing the autoimmune condition: experience with experimental autoimmune gastritis.
Int. Rev. Immunol. 24: 135-155 (2005).
-
Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3.
Hum. Mol. Genet. 14: 2045-2052 (2005).
*
-
Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, Vizzutti F, Anania FA, Milani S, Rombouts K, Laffi G, Pinzani M, Marra F. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.
Hepatology 42: 1339-1348 (2005).
*
-
Aleksandra Nielsen A, Nederby Nielsen J, Schmedes A, Brandslund I, Hey H. Saliva interleukin-6 in patients with inflammatory bowel disease.
Scand. J. Gastroenterol. 40: 1444-1448 (2005).
*
-
Aleksandrova EN, Novikov AA, Nasonov EL. Soluble CD40 ligand in autoimmune diseases and atherosclerosis.
Ter. Arkh. 77: 91-95 (2005).
-
Alemany Bonastre R, Barquinero Manez J, Ramon y Cajal Agueras S. Gene therapy: current situation and expectations.
Rev. Clin. Esp. 205: 178-188 (2005).
-
Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R, Perez-Vieitez MC, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F. Autoimmune diseases and multiple sclerosis.
Rev. Neurol. 40: 594-597 (2005).
-
Alenezi B, Lamoureux E, Alpert L, Szilagyi A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
Dig. Dis. Sci. 50: 196-200 (2005).
*
-
Alenmyr L, Matheu V, Uller L, Greiff L, Malm-Erjefalt M, Ljunggren HG, Persson CG, Korsgren M. Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance.
Scand. J. Immunol. 62: 437-444 (2005).
*
-
Aleryani SL, Cluette-Brown JE, Khan ZA, Hasaba H, Lopez de Heredia L, Laposata M. Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction.
Clin. Chim. Acta 359: 141-149 (2005).
*
-
Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Clin. Exp. Immunol. 140: 173-180 (2005).
*
-
Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jimenez W, Arroyo V, Rodes J, Gines P. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
Hepatology 41: 1282-1289 (2005).
*
-
Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.
Clin. Exp. Rheumatol. 23: S100-S108 (2005).
-
Alexander J, Kowdley KV. Hereditary hemochromatosis: genetics, pathogenesis, and clinical management.
Ann. Hepatol. 4: 240-247 (2005).
*
-
Alexander JS, Ando T. Density-dependent control of MAdCAM-1 and chronic inflammation. Focus on "Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells".
Am. J. Physiol. Cell Physiol. 288: C243-C244 (2005).
*
-
Alexander S, Dowling D. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine.
Intern. Med. J. 35: 570-571 (2005).
*
-
Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies.
J. Cutan. Med. Surg. 9: 296-302 (2005).
*
-
Alexopoulou L, Kontoyiannis D. Intestinal epithelial barrier and mucosal immunity. Contribution of microbial-associated molecules in innate mucosal responses.
Cell. Mol. Life Sci. 62: 1349-1358 (2005).
*
-
Alfadhli A, McDonald J, Feagan B. Methotrexate for induction of remission in refractory Crohn's disease.
Cochrane Database Syst. Rev. 1: CD003459 (2005).
*
-
Ali FE, Al-Busairi WA, Esbaita EY, Al-Bustan MA. Chronic perforation of the sigmoid colon by foreign body.
Curr. Surg. 62: 419-422 (2005).
-
Ali FR, Larche M. Peptide-based immunotherapy: a novel strategy for allergic disease.
Expert Rev. Vaccines 4: 881-889 (2005).
-
Ali M, Manolios N. Proteomics in rheumatology: a new direction for old diseases.
Semin. Arthritis Rheum. 35: 67-76 (2005).
*
-
Ali MY, Grimm CF, Ritter M, Mohr L, Allgaier HP, Weth R, Bocher WO, Endrulat K, Blum HE, Geissler M. Activation of dendritic cells by local ablation of hepatocellular carcinoma.
J. Hepatol. 43: 817-822 (2005).
*
-
Alia P, Mana J, Capdevila O, Alvarez A, Navarro MA. Association between ACE gene I/D polymorphism and clinical presentation and prognosis of sarcoidosis.
Scand. J. Clin. Lab. Invest. 65: 691-698 (2005).
*
-
Aliagaoglu C, Pirim I, Atasoy M, Egerci N, Aktas A. Association between alopecia areata and HLA class I and II in Turkey.
J. Dermatol. 32: 711-714 (2005).
-
Aliberti J. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.
Nat. Rev. Immunol. 5: 162-170 (2005).
*
-
Alio JL, Artola A, Belda JI, Perez-Santonja JJ, Munoz G, Javaloy J, Rodriguez-Prats JL, Galal A. LASIK in patients with rheumatic diseases. A pilot study.
Ophthalmology 112: 1948-1954 (2005).
*
-
Alizadeh K, Hyman N. Venous thromboembolism prophylaxis in colorectal surgery.
Surg. Technol. Int. 14: 165-170 (2005).
-
Alkari B, Shaath NM, El-Dhuwaib Y, Aboutwerat A, Warnes TW, Chalmers N, Ammori BJ. Transjugular intrahepatic porto-systemic shunt and variceal embolisation in the management of bleeding stomal varices.
Int. J. Colorectal Dis. 20: 457-462 (2005).
*
-
Alkhateeb A, Fain PR, Spritz RA. Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo.
J. Invest. Dermatol. 125: 388-391 (2005).
*
-
Alkhoury F, Malo MS, Mozumder M, Mostafa G, Hodin RA. Differential regulation of intestinal alkaline phosphatase gene expression by Cdx1 and Cdx2.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G285-G290 (2005).
*
-
Alkofer BJ, Chiche L, Khayat A, Deshayes JP, Lepage A, Saloux E, Reznik Y. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature.
Transplant. Proc. 37: 2250-2252 (2005).
*
-
Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders.
Semin. Liver Dis. 25: 461-472 (2005).
-
Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.
J. Clin. Invest. 115: 3276-3284 (2005).
*
-
Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury.
Nat. Rev. Immunol. 5: 629-640 (2005).
*
-
Allegretti M, Moriconi A, Beccari AR, Di Bitondo R, Bizzarri C, Bertini R, Colotta F. Targeting C5a: recent advances in drug discovery.
Curr. Med. Chem. 12: 217-236 (2005).
-
Allen M, Ameen H, Veal C, Evans J, Ramrakha-Jones VS, Marsland AM, Burden AD, Griffiths CE, Trembath R, Barker JW. The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis.
J. Invest. Dermatol. 124: 103-106 (2005).
*
-
Allen SD, Rawale SV, Whitacre CC, Kaumaya PT. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
J. Pept. Res. 65: 591-604 (2005).
*
-
Allorge D, Hamdan R, Broly F, Libersa C, Colombel JF. ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
Gut 54: 565 (2005).
*
-
Almada L, Bellarosa C, Giraudi P, Mamprin M, Mediavilla M, Guibert E, Tiribelli C, Rodriguez J. The urea cycle enzymes activity and its gene expression in rat hepatocytes are not affected by cold storage in University of Wisconsin solution.
Ann. Hepatol. 4: 224-227 (2005).
-
Alnaqdy A, Al-Maskari M. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease.
Med. Princ. Pract. 14: 209-212 (2005).
-
Alon R, Feigelson SW, Manevich E, Rose DM, Schmitz J, Overby DR, Winter E, Grabovsky V, Shinder V, Matthews BD, Sokolovsky-Eisenberg M, Ingber DE, Benoit M, Ginsberg MH. Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the alpha4-cytoplasmic domain.
J. Cell Biol. 171: 1073-1084 (2005).
*
-
Alonso EM. Acute liver failure in children: the role of defects in fatty acid oxidation.
Hepatology 41: 696-699 (2005).
*
-
Alpdogan O, van den Brink MR. IL-7 and IL-15: therapeutic cytokines for immunodeficiency.
Trends Immunol. 26: 56-64 (2005).
*
-
Alpers DH. What is new in vitamin B(12)?
Curr. Opin. Gastroenterol. 21: 183-186 (2005).
-
Alpini G, Glaser S, Baiocchi L, Francis H, Xia X, Lesage G. Secretin activation of the apical Na(+)-dependent bile acid transporter is associated with cholehepatic shunting in rats.
Hepatology 41: 1037-1045 (2005).
*
-
Alpy F, Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals.
J. Cell. Sci. 118: 2791-2801 (2005).
*
-
Alrefai WA, Sarwar Z, Tyagi S, Saksena S, Dudeja PK, Gill RK. Cholesterol modulates human intestinal sodium-dependent bile acid transporter.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G978-G985 (2005).
*
-
Altarescu G, Elstein D. Coexistence of Fabry disease and Crohn's disease: a case report.
Inflamm. Bowel Dis. 11: 87-88 (2005).
*
-
Alteheld B, Evans ME, Gu LH, Ganapathy V, Leibach FH, Jones DP, Ziegler TR. Alanylglutamine dipeptide and growth hormone maintain PepT1-mediated transport in oxidatively stressed Caco-2 cells.
J. Nutr. 135: 19-26 (2005).
*
-
Altermann E, Russell WM, Azcarate-Peril MA, Barrangou R, Buck BL, McAuliffe O, Souther N, Dobson A, Duong T, Callanan M, Lick S, Hamrick A, Cano R, Klaenhammer TR. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM.
Proc. Natl. Acad. Sci. U.S.A. 102: 3906-3912 (2005).
*
-
Altimari A, Gruppioni E, Fiorentino M, Petraroli R, Pinna AD, Petropulacos K, Ridolfi L, Costa AN, Grigioni WF, Grigioni AD. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation.
Diagn. Mol. Pathol. 14: 34-38 (2005).
-
Altmann D. Evaluating the evidence for multiple sclerosis as an autoimmune disease.
Arch. Neurol. 62: 688 (2005).
*
-
Altschuler EL, Kast RE. Bupropion for fatigue and as a tumor necrosis factor-alpha lowering agent in primary biliary cirrhosis.
Med. Hypotheses 64: 118-119 (2005).
-
Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P; International HapMap Consortium. A haplotype map of the human genome.
Nature 437: 1299-1320 (2005).
*
-
Altshuler D, Clark AG. Genetics. Harvesting medical information from the human family tree.
Science 307: 1052-1053 (2005).
*
-
Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E, Guidez F, De Simone M, Schiavone EM, Grimwade D, Zelent A, de The H, Gronemeyer H. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase a-mediated desubordination of retinoid X receptor.
Cancer Res. 65: 8754-8765 (2005).
*
-
Alvarado J, Taylor P, Castillo JR, Thomas LE. Interferon gamma bound to extracellular matrix changes the hyporesponsiveness to LPS in crypt but not villous intestinal epithelial cells.
Immunol. Lett. 99: 109-112 (2005).
-
Alvarado-Guerri R, Cabrera CM, Garrido F, Lopez-Nevot MA. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population.
Hum. Immunol. 66: 921-930 (2005).
-
Alvarez BV, Vilas GL, Casey JR. Metabolon disruption: a mechanism that regulates bicarbonate transport.
EMBO J. 24: 2499-2511 (2005).
*
-
Alvarez JI. Inhibition of Toll-like receptor immune responses by microbial pathogens.
Front. Biosci. 10: 582-587 (2005).
-
Alvarez L, Jara P, Hierro L, Sanchez-Sabate E, Martinez-Fernandez P, Lopez-Santamaria M. Molecular basis of cholestatic diseases of surgical interest.
Semin. Pediatr. Surg. 14: 200-205 (2005).
-
Alvarez Lobo M. Capsule endoscopy and inflammatory bowel disease.
Gastroenterol. Hepatol. 28: 289-91 (2005).
-
Alvarez-Blanco M, Fernandez-Mere LA, Martinez-Rodriguez E. Crohns disease of the appendix.
Cir. Esp. 78: 333-335 (2005).
-
Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, Lacy AM, Pique JM, Yague J, Panes J. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.
Ann. Surg. 242: 693-700 (2005).
*
-
Alvaro D, Metalli VD, Alpini G, Onori P, Franchitto A, Barbaro B, Glaser SS, Francis H, Cantafora A, Blotta I, Attili AF, Gaudio E. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis.
J. Hepatol. 43: 875-883 (2005).
*
-
Alves A, Panis Y. Laparoscopic ileal pouch-anal anastomosis.
Ann. Chir. 130: 421-425 (2005).
-
Alves A, Panis Y, Bouhnik Y, Marceau C, Rouach Y, Lavergne-Slove A, Vicaut E, Valleur P. Factors that predict conversion in 69 consecutive patients undergoing laparoscopic ileocecal resection for Crohn's disease: a prospective study.
Dis. Colon Rectum 48: 2302-2308 (2005).
*
-
Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K; Association Francaise de Chirurgie. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study.
Arch. Surg. 140: 278-283 (2005).
*
-
Alwayn IP, Andersson C, Zauscher B, Gura K, Nose V, Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.
Transplantation 79: 606-608 (2005).
-
Alwayn IP, Gura K, Nose V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
Pediatr. Res. 57: 445-452 (2005).
*
-
Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.
Am. J. Ther. 12: 481-490 (2005).
-
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
J. Autoimmun. 25: S40-S45 (2005).
-
Amadi B, Mwiya M, Chomba E, Thomson M, Chintu C, Kelly P, Walker-Smith J. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition.
J. Trop. Pediatr. 51: 5-10 (2005).
*
-
Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Matsuura E, Coppel RL, Gershwin ME. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.
J. Immunol. 174: 5874-5883 (2005).
*
-
Amano Y, Kushiyama Y, Ishihara S, Yuki T, Miyaoka Y, Yoshino N, Ishimura N, Fujishiro H, Adachi K, Maruyama R, Rumi MA, Kinoshita Y. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus.
Am. J. Gastroenterol. 100: 21-26 (2005).
*
-
Amaral MD. Processing of CFTR: traversing the cellular maze - how much CFTR needs to go through to avoid cystic fibrosis?
Pediatr. Pulmonol. 39: 479-491 (2005).
*
-
Amarapurkar AD, Sangle NA. Histological spectrum of liver in HIV - autopsy study.
Ann. Hepatol. 4: 47-51 (2005).
-
Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD, Fromm M. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells.
Cell Tissue Res. 321: 89-96 (2005).
-
Ambrogini E, Toraldo G, Marcocci C. Post-menopausal osteoporosis: is it an autoimmune disease?
J. Endocrinol. Invest. 28: S43-S47 (2005).
-
Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
Diabetes Res. Clin. Pract. 67: 175-179 (2005).
-
Ameen C, Edvardsson U, Ljungberg A, Asp L, Akerblad P, Tuneld A, Olofsson SO, Linden D, Oscarsson J. Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver.
J. Biol. Chem. 280: 1224-1229 (2005).
*
-
Ameen M, Allen MH, Fisher SA, Lewis CM, Cuthbert A, Kondeatis E, Vaughan RW, Murakami H, Nakagawa H, Barker JN. Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.
Clin. Exp. Dermatol. 30: 414-418 (2005).
*
-
American Academy of Family Physicians. Information from your family doctor. Rheumatoid arthritis: what you should know.
Am. Fam. Physician 72: 1049-1050 (2005).
-
American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain; North American Society for Pediatric Gastroenterology Hepatology, and Nutrition. Chronic abdominal pain in children.
Pediatrics 115: e370-e381 (2005).
*
-
Amin RH, Schlissel MS. NF-kappa B comes home.
Immunity 22: 401-402 (2005).
*
-
Amital H, Heilweil M, Ulmansky R, Szafer F, Bar-Tana R, Morel L, Foster MH, Mostoslavsky G, Eilat D, Pizov G, Naparstek Y. Treatment with a laminin-derived peptide suppresses lupus nephritis.
J. Immunol. 175: 5516-5523 (2005).
*
-
Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices.
J. Hepatol. 42: 820-825 (2005).
*
-
Amlie-Lefond C, Paz DA, Connelly MP, Huffnagle GB, Dunn KS, Whelan NT, Whelan HT. Innate immunity for biodefense: a strategy whose time has come.
J. Allergy Clin. Immunol. 116: 1334-1342 (2005).
*
-
Amoli MM, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
J. Rheumatol. 32: 74-76 (2005).
-
Amoli MM, Salway F, Ollier WE, Gonzalez-Gay MA. MCP-1 gene haplotype association in biopsy proven giant cell arteritis.
J. Rheumatol. 32: 507-510 (2005).
-
Amos MD, Bridges AJ. Standards for autoantibody testing; addressing future needs for autoimmune disease and cancer diagnosis.
Cancer Biomark. 1: 221-227 (2005).
-
Amoura Z, Dode C, Hue S, Caillat-Zucman S, Bahram S, Delpech M, Grateau G, Wechsler B, Piette JC. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behcet's disease.
Arthritis Rheum. 52: 608-611 (2005).
*
-
Amre D. Gene-environment interactions in the etiopathogenesis of inflammatory bowel disease.
J. Pediatr. Gastroenterol. Nutr. 40: S39 (2005).
*
-
Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, Ramasawmy R, Brun M, Dulphy N, Krishnamoorthy R, Toubert A, Charron D, Abbadi MC, Tamouza R. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism.
Hum. Immunol. 66: 1057-1061 (2005).
-
An JK, Blomenkamp K, Lindblad D, Teckman JH. Quantitative isolation of 1AT mutant Z protein polymers from human and mouse livers and the effect of heat.
Hepatology 41: 160-167 (2005).
*
-
An MM, Fan KX, Zhang JD, Li HJ, Song SC, Liu BG, Gao PH, Zhou Q, Jiang YY. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
Pharmacol. Res. 52: 234-244 (2005).
*
-
Anand PK, Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages.
FEMS Microbiol. Lett. 250: 137-144 (2005).
*
-
Anand SS, Mumtaz MM, Mehendale HM. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats.
Arch. Toxicol. 79: 671-682 (2005).
*
-
Anania FA. Adiponectin and alcoholic fatty liver: is it, after all, about what you eat?
Hepatology 42: 530-532 (2005).
*
-
Anaya JM, Mantilla RD, Correa PA. Immunogenetics of primary Sjogren's syndrome in Colombians.
Semin. Arthritis Rheum. 34: 735-743 (2005).
*
-
Anaya JM, Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia.
Isr. Med. Assoc. J. 7: 740-741 (2005).
*
-
Anders HJ. A Toll for lupus.
Lupus 14: 417-422 (2005).
-
Anders HJ, Zecher D, Pawar RD, Patole PS. Molecular mechanisms of autoimmunity triggered by microbial infection.
Arthritis Res. Ther. 7: 215-224 (2005).
*
-
Andersen J, Kehlet H. Fast track open ileo-colic resections for Crohn's disease.
Colorectal Dis. 7: 394-397 (2005).
*
-
Andersen-Nissen E, Smith KD, Strobe KL, Rassoulian Barrett SL, Cookson BT, Logan SM, Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria.
Proc. Natl. Acad. Sci. U.S.A. 102: 9247-9252 (2005).
*
-
Anderson CD, Pierce J, Nicoud I, Belous A, Knox CD, Chari RS. Modulation of mitochondrial calcium management attenuates hepatic warm ischemia-reperfusion injury.
Liver Transpl. 11: 663-668 (2005).
*
-
Anderson GJ, Frazer DM. Hepatic iron metabolism.
Semin. Liver Dis. 25: 420-432 (2005).
-
Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation.
Annu. Rev. Immunol. 23: 447-485 (2005).
*
-
Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance.
Immunity 23: 227-239 (2005).
*
-
Anderson PO, Sundstedt A, Yazici Z, Minaee S, O'Neill EJ, Woolf R, Nicolson K, Whitley N, Li L, Li S, Wraith DC, Wang P. IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells.
J. Immunol. 174: 310-319 (2005).
*
-
Anderson RP. Coeliac disease.
Aust. Fam. Physician 34: 239-242 (2005).
*
-
Anderson RP, van Heel DA, Tye-Din JA, Barnardo M, Salio M, Jewell DP, Hill AV. T cells in peripheral blood after gluten challenge in coeliac disease.
Gut 54: 1217-1223 (2005).
*
-
Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype.
Genes Immun. 6: 481-492 (2005).
*
-
Andersson A, Holmdahl R. A genetic basis for shared autoimmunity in mouse models.
Autoimmunity 38: 209-217 (2005).
-
Andersson HA, Passeri MF, Barry MA. Rad23 as a reciprocal agent for stimulating or repressing immune responses.
Hum. Gene Ther. 16: 634-641 (2005).
-
Andersson S, Gustafsson N, Warner M, Gustafsson JA. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice.
Proc. Natl. Acad. Sci. U.S.A. 102: 3857-3862 (2005).
*
-
Ando T, Jordan P, Wang Y, Itoh M, Joh T, Sasaki M, Elrod JW, Carpenter A, Jennings MH, Minagar A, Alexander JS. MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro.
Inflamm. Bowel Dis. 11: 258-264 (2005).
*
-
Andoh A, Fujiyama Y. Cytoapheresis for IBD.
Nippon Rinsho 63: 836-842 (2005).
-
Andoh A, Hirashima M, Maeda H, Hata K, Inatomi O, Tsujikawa T, Sasaki M, Takahashi K, Fujiyama Y. Serum selenoprotein-P levels in patients with inflammatory bowel disease.
Nutrition 21: 574-579 (2005).
*
-
Andoh A, Tsujikawa T, Hata K, Araki Y, Kitoh K, Sasaki M, Yoshida T, Fujiyama Y. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease.
Am. J. Gastroenterol. 100: 2042-2048 (2005).
*
-
Andoh A, Tsujikawa T, Inatomi O, Deguchi Y, Hata K, Kitoh K, Sasaki M, Mitsuyama K, Fujiyama Y. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
Ther. Apher. Dial. 9: 123-127 (2005).
*
-
Andoh A, Tsujikawa T, Inatomi O, Deguchi Y, Sasaki M, Obata H, Mitsuyama K, Fujiyama Y. Leukocytapheresis therapy modulates circulating T cell subsets in patients with ulcerative colitis.
Ther. Apher. Dial. 9: 270-276 (2005).
*
-
Andoh A, Yasui H, Inatomi O, Zhang Z, Deguchi Y, Hata K, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y. Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts.
J. Gastroenterol. 40: 802-810 (2005).
*
-
Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.
Gastroenterology 129: 969-984 (2005).
*
-
Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4 (TLR4).
Blood 106: 2417-2423 (2005).
*
-
Andrade CF, Waddell TK, Keshavjee S, Liu M. Innate immunity and organ transplantation: the potential role of Toll-like receptors.
Am. J. Transplant. 5: 969-975 (2005).
*
-
Andre J. Artificial nails and psoriasis.
J. Cosmet. Dermatol. 4: 103-106 (2005).
-
Andreakos E, Sacre S, Foxwell BM, Feldmann M. The Toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis.
Front. Biosci. 10: 2478-2488 (2005).
-
Andren M, Johanneson B, Alarcon-Riquelme ME, Kleinau S. IgG Fc receptor polymorphisms and association with autoimmune disease.
Eur. J. Immunol. 35: 3020-3029 (2005).
*
-
Andres A, Toso C, Morel P, Demuylder-Mischler S, Bosco D, Baertschiger R, Pernin N, Bucher P, Majno PE, Buhler LH, Berney T. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
Transplant. Proc. 37: 1326-1327 (2005).
*
-
Andres D, Bautista M, Cascales M. Attenuation of cyclosporine A toxicity by sublethal heat shock. Role of catalase.
Biochem. Pharmacol. 69: 493-501 (2005).
*
-
Andresen L, Jorgensen VL, Perner A, Hansen A, Eugen-Olsen J, Rask-Madsen J. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.
Gut 54: 503-509 (2005).
*
-
Andrews NC. Molecular control of iron metabolism.
Best Pract. Res. Clin. Haematol. 18: 159-169 (2005).
-
Andrews NW. Membrane repair and immunological danger.
EMBO Rep. 6: 826-830 (2005).
*
-
Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
Science 307: 223-227 (2005).
*
-
Andriulli A, Annese V, Caruso N, Pilotto A, Accadia L, Niro AG, Quitadamo M, Merla A, Fiorella S, Leandro G. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
Am. J. Gastroenterol. 100: 207-219 (2005).
*
-
Angele MK, Loehe F, Faist E. Immunomodulation during sepsis in organ transplanted children.
Minerva Pediatr. 57: 259-268 (2005).
-
Angelin B. Telling the liver (not) to make bile acids: a new voice from the gut?
Cell. Metab. 2: 209-210 (2005).
*
-
Angelova-Fischer I, Tsankov N. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
Acta Dermatovenerol. Alp. Panonica Adriat. 14: 115-119 (2005).
*
-
Angerio AD, Bufalino D, Bresnick M, Bell C, Brill S. Inflammatory bowel disease and endothelin-1: a review.
Crit. Care Nurs. Q. 28: 208-213 (2005).
-
Angotti C. Arthritis and skin disease.
Skinmed. 4: 293-297 (2005).
-
Anisfeld AM, Kast-Woelbern HR, Lee H, Zhang Y, Lee FY, Edwards PA. Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling.
J. Lipid Res. 46: 458-468 (2005).
*
-
Anjiki N, Hoshino R, Ohnishi Y, Hioki K, Irie Y, Ishige A, Watanabe K. A kampo formula Juzen-taiho-to induces expression of metallothioneins in mice.
Phytother. Res. 19: 915-917 (2005).
*
-
Anjos SM, Shao W, Marchand L, Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism.
Genes Immun. 6: 305-311 (2005).
*
-
Anlauf M, Perren A, Meyer CL, Schmid S, Saremaslani P, Kruse ML, Weihe E, Komminoth P, Heitz PU, Kloppel G. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.
Gastroenterology 128: 1187-1198 (2005).
*
-
Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, Johansson-Lindbom B, Agace WW, Parker CM, Powrie F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis.
J. Exp. Med. 202: 1051-1061 (2005).
*
-
Annese V, Latiano A, Rossi L, Lombardi G, Dallapiccola B, Serafini S, Damonte G, Andriulli A, Magnani M. Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients - a pilot uncontrolled study.
Am. J. Gastroenterol. 100: 1370-1375 (2005).
*
-
Annese V, Lombardi G, Perri F, D'Inca R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - an IG-IBD study.
Am. J. Gastroenterol. 100: 84-92 (2005).
*
-
Annese V, Piepoli A, Latiano A, Lombardi G, Napolitano G, Caruso N, Cocchiara E, Accadia L, Perri F, Andriulli A. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
Dis. Colon Rectum 48: 57-64 (2005).
-
Anolik JH, Aringer M. New treatments for SLE: cell-depleting and anti-cytokine therapies.
Best Pract. Res. Clin. Rheumatol. 19: 859-878 (2005).
-
Antar KA, Keiser HD, Peeva E. Relapsing arterial aneurysms in juvenile Behcet's disease.
Clin. Rheumatol. 24: 72-75 (2005).
*
-
Antia R, Ganusov VV, Ahmed R. The role of models in understanding CD8+ T-cell memory.
Nat. Rev. Immunol. 5: 101-111 (2005).
*
-
Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
Eur. J. Clin. Pharmacol. 61: 409-416 (2005).
*
-
Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Arthritis Rheum. 52: 1227-1236 (2005).
*
-
Antoniades CG, Wendon J, Vergani D. Paralysed monocytes in acute on chronic liver disease.
J. Hepatol. 42: 163-165 (2005).
*
-
Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, Cardelli M, Galeazzi R, Giovagnetti S, Perna GP, Franceschi C. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers.
Coron. Artery Dis. 16: 489-493 (2005).
-
Antonijevic IA. Depressive disorders - is it time to endorse different pathophysiologies?
Psychoneuroendocrinology 31: 1-15 (2005).
*
-
Antonioli DA. Pediatric inflammatory bowel disease.
Pediatr. Dev. Pathol. 8: 2-19 (2005).
*
-
Anuradha S, Radha V, Deepa R, Hansen T, Carstensen B, Pedersen O, Mohan V. A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians.
Diabetes Care 28: 2430-2435 (2005).
*
-
Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility.
Science 308: 1466-1469 (2005).
*
-
Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME. Transforming growth factor beta (TGF-beta) and autoimmunity.
Autoimmun. Rev. 4: 450-459 (2005).
-
Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME. NOD mice and autoimmunity.
Autoimmun. Rev. 4: 373-379 (2005).
-
Aoki CA, Bowlus CL, Gershwin ME. The immunobiology of primary sclerosing cholangitis.
Autoimmun. Rev. 4: 137-143 (2005).
-
Aoki S, Nakazawa T, Ohara H, Sano H, Nakao H, Joh T, Murase T, Eimoto T, Itoh M. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera.
Histopathology 47: 147-158 (2005).
*
-
Aoki T. Genetic disorders of copper transport - diagnosis and new treatment for the patients of Wilson's disease.
No To Hattatsu 37: 99-109 (2005).
-
Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, Ferrandez A, Bautista D, Perez-Mateo M, Mery S, Sastre J. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis.
Gut 54: 703-709 (2005).
*
-
Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
J. Clin. Virol. 34: 310-314 (2005).
-
Apostolov E, Al-Soud WA, Nilsson I, Kornilovska I, Usenko V, Lyzogubov V, Gaydar Y, Wadstrom T, Ljungh A. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods.
Scand. J. Gastroenterol. 40: 96-102 (2005).
-
Appel LJ. Dietary approaches to reduce blood pressure.
J. Anim. Physiol. Anim. Nutr. (Berl.) 89: 433 (2005).
*
-
Appenzeller S, Li LM, Costallat LT, Cendes F. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Brain 128: 2933-2940 (2005).
*
-
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis.
Toxicol. Appl. Pharmacol. 207: 25-38 (2005).
*
-
Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, Kirimlioglu V, Yilmaz S. Protective effect of resveratrol against oxidative stress in cholestasis.
J. Surg. Res. 127: 112-117 (2005).
*
-
Aragona P, Stilo A, Ferreri F, Mobrici M. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients.
Eye 19: 535-539 (2005).
-
Arai K, Koganei K, Kimura H, Akatani M, Kitoh F, Sugita A, Fukushima T. Incidence and outcome of complications following restorative proctocolectomy.
Am. J. Surg. 190: 39-42 (2005).
*
-
Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R, Totsuka T, Takeda K, Akira S, Watanabe M. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
J. Gastroenterol. 40: 16-23 (2005).
*
-
Araki E, Igata M, Motoshima H, Tsuruzoe K. Polymorphisms of PPARs and metabolic disorders.
Nippon Rinsho 63: 617-622 (2005).
-
Araki O, Ying H, Furuya F, Zhu X, Cheng SY. Thyroid hormone receptor beta mutants: dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Proc. Natl. Acad. Sci. U.S.A. 102: 16251-16256 (2005).
*
-
Araki Y, Sakaguchi C, Ishizuka I, Sasaki M, Tsujikawa T, Koyama S, Furukawa A, Fujiyama Y. Budd-Chiari syndrome: a case with a combination of hepatic vein and superior vena cava occlusion.
World J. Gastroenterol. 11: 3797-3799 (2005).
*
-
Aranyi T, Ratajewski M, Bardoczy V, Pulaski L, Bors A, Tordai A, Varadi A. Identification of a DNA methylation-dependent activator sequence in the pseudoxanthoma elasticum gene, ABCC6.
J. Biol. Chem. 280: 18643-18550 (2005).
*
-
Arason GJ, Kolka R, Hreidarsson AB, Gudjonsson H, Schneider PM, Fry L, Arnason A. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
Clin. Exp. Immunol. 140: 572-579 (2005).
*
-
Arat M, Idilman R, Soydan EA, Soykan I, Erden E, Karayalcin S, Akan H. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
Clin. Transplant. 19: 798-803 (2005).
*
-
Araujo FG, Novaes FC, Santos NP, Martins VC, Souza SM, Santos SE, Ribeiro-Dos-Santos AK. Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil.
Braz. J. Med. Biol. Res. 38: 11-15 (2005).
*
-
Araujo SE, Nahas SC, Seid VE, Marchini GS, Torricelli FC. Laparoscopy-assisted ileal pouch-anal anastomosis: surgical outcomes after 10 cases.
Surg. Laparosc. Endosc. Percutan. Tech. 15: 321-324 (2005).
-
Araya E, Rodriguez A, Rubio J, Spada A, Joglar J, Llebaria A, Lagunas C, Fernandez AG, Spisani S, Perez JJ. Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T.
Bioorg. Med. Chem. Lett. 15: 1493-1496 (2005).
*
-
Arbour L, Rupps R, Field L, Ross P, Erikson A, Henderson H, Hill W, Yoshida E. Characteristics of primary biliary cirrhosis in British Columbia's First Nations population.
Can. J. Gastroenterol. 19: 305-310 (2005).
*
-
Arcaroli J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis.
Shock 24: 300-312 (2005).
*
-
Arcasoy MO, Chao NJ. T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.
Am. J. Hematol. 78: 161-163 (2005).
*
-
Arciello M, Rotilio G, Rossi L. Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage.
Biochem. Biophys. Res. Commun. 327: 454-459 (2005).
*
-
Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease.
Drugs 65: 2253-2286 (2005).
-
Ardizzone S, Porro GB. Should azathioprine be withdrawn in patients with Crohn's disease who are in long-term remission?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 348-349 (2005).
*
-
Ardoin SP, Schanberg LE. The management of pediatric systemic lupus erythematosus.
Nat. Clin. Pract. Rheumatol. 1: 82-92 (2005).
*
-
Arduino C, Salacone P, Pasini B, Brusco A, Salmin P, Bacillo E, Robecchi A, Cestino L, Cirillo S, Regge D, Cappello N, Gaia E. Association of a new cationic trypsinogen gene mutation (V39A) with chronic pancreatitis in an Italian family.
Gut 54: 1663-1664 (2005).
*
-
Arfaoui D, Elloumi H, Salah A, Ajmi S. Predictive factors of recurrence in Crohn's disease.
Tunis. Med. 83: 83-86 (2005).
-
Arguedas MR, Fallon MB. Hepatopulmonary syndrome.
Clin. Liver Dis. 9: 733-746 (2005).
-
Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
Mediators Inflamm. 2005: 273-279 (2005).
*
-
Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S, Gotlinger KH, Serhan CN. The docosatriene protectin D1 is produced by TH2-skewing and promotes human T cell apoptosis via lipid-raft clustering.
J. Biol. Chem. 280: 43079-43086 (2005).
*
-
Aries PM, Hellmich B, Gross WL. Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?
Clin. Rev. Allergy Immunol. 29: 237-246 (2005).
-
Arima K, Sato K, Tanaka G, Kanaji S, Terada T, Honjo E, Kuroki R, Matsuo Y, Izuhara K. Characterization of the interaction between interleukin-13 and interleukin-13 receptors.
J. Biol. Chem. 280: 24915-24922 (2005).
*
-
Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y, Mineta M, Takeichi M, Yamada S, Imamura A, Ohara K, Shibuya H, Ohara K, Suzuki Y, Muratake T, Kaneko N, Someya T, Inada T, Yoshikawa T, Toyota T, Yamada K, Kojima T, Takahashi S, et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.
Am. J. Hum. Genet. 77: 937-944 (2005).
*
-
Aris RM, Guise TA. Cystic fibrosis and bone disease: are we missing a genetic link?
Eur. Respir. J. 25: 9-11 (2005).
*
-
Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
J. Exp. Med. 201: 713-722 (2005).
*
-
Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids.
Biochem. Biophys. Res. Commun. 338: 149-157 (2005).
*
-
Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.
Proc. Natl. Acad. Sci. U.S.A. 102: 7671-7676 (2005).
*
-
Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance.
Nat. Med. 11: 191-198 (2005).
*
-
Armagan O, Uz T, Tascioglu F, Colak O, Oner C, Akgun Y. Serological screening for celiac disease in premenopausal women with idiopathic osteoporosis.
Clin. Rheumatol. 24: 239-243 (2005).
*
-
Armstrong JL, Redfern CP, Veal GJ. 13-cis Retinoic acid and isomerisation in paediatric oncology - is changing shape the key to success?
Biochem. Pharmacol. 69: 1299-1306 (2005).
*
-
Arnaboldi PM, Behr MJ, Metzger DW. Mucosal B cell deficiency in IgA-/- mice abrogates the development of allergic lung inflammation.
J. Immunol. 175: 1276-1285 (2005).
*
-
Arnold B, Schuler T, Hammerling GJ. Control of peripheral T-lymphocyte tolerance in neonates and adults.
Trends Immunol. 26: 406-411 (2005).
*
-
Arnott ID, Ho GT, Nimmo ER, Satsangi J, Franchimont D, Vermeire S, Deviere J, Rutgeerts PJ. Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe (Author's reply).
Gut 54: 308-309 (2005).
*
-
Aronovich R, Gurwitz D, Kloog Y, Chapman J. Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms.
Immunobiology 210: 781-788 (2005).
-
Arostegui JI, Solis P, Aldea A, Cantero T, Rius J, Bahillo P, Plaza S, Vives J, Gomez S, Yague J. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.
Eur. J. Pediatr. 164: 13-16 (2005).
*
-
Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo.
Immunology 114: 263-271 (2005).
*
-
Arroyo A, Perez-Vicente F, Serrano P, Candela F, Sanchez A, Teresa Perez-Vazquez M, Calpena R. Treatment of chronic anal fissure.
Cir. Esp. 78: 68-74 (2005).
-
Arroyo V, Torre A, Guevara M. Recent advances in hepatorenal syndrome.
Trop. Gastroenterol. 26: 13-20 (2005).
-
Arruda LK, Santos AB. Immunologic responses to common antigens in helminthic infections and allergic disease.
Curr. Opin. Allergy Clin. Immunol. 5: 399-402 (2005).
-
Arsenescu R, Blum AM, Metwali A, Elliott DE, Weinstock JV. IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation.
J. Immunol. 174: 3906-3911 (2005).
*
-
Arslan N, Buyukgebiz B, Ozturk Y. Celiac disease with Takayasu arteritis.
Pediatr. Int. 47: 708-710 (2005).
*
-
Arslan N, Buyukgebiz B, Ozturk Y, Ozer E. The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy findings.
Acta Gastroenterol. Belg. 68: 424-427 (2005).
-
Aruna BV, Sela M, Mozes E. Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells.
Proc. Natl. Acad. Sci. U.S.A. 102: 10285-10290 (2005).
*
-
Arvay JL, Zemel BS, Gallagher PR, Rovner AJ, Mulberg AE, Stallings VA, Haber BA. Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome.
J. Pediatr. Gastroenterol. Nutr. 40: 146-150 (2005).
*
-
Asakura H, Ohtsuka M, Ito H, Kimura F, Ambiru S, Shimizu H, Togawa A, Yoshidome H, Kato A, Miyazaki M. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
Hepatogastroenterology 52: 722-724 (2005).
-
Asakura H, Takayashiki T, Ku G, Flye MW. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
Surgery 138: 329-334 (2005).
*
-
Asamura H, Ito M, Takayanagi K, Kobayashi K, Ota M, Fukushima H. Hepatic portal venous gas on postmortem CT scan.
Leg. Med. (Tokyo) 7: 326-330 (2005).
-
Asano K, Tada S, Matsumoto T, Miyase S, Kamio T, Sakurai K, Iida M. A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reports.
J. Hepatol. 43: 362-365 (2005).
*
-
Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.
J. Immunol. 175: 7708-7718 (2005).
*
-
Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, Fasano M. Hemoglobin and heme scavenging.
IUBMB Life 57: 749-759 (2005).
*
-
Ashavaid TF, Kondkar AA, Dherai AJ, Raghavan R, Udani SV, Udwadia ZF, Desai D. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.
Mol. Diagn. 9: 59-66 (2005).
-
Ashcroft AJ, Carding SR. RANK ligand and osteoprotegerin: emerging roles in mucosal inflammation.
Gut 54: 1345-1346 (2005).
*
-
Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
BMJ 330: 516 (2005).
*
-
Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome in 2004 - a review.
Autoimmun. Rev. 4: 48-54 (2005).
*
-
Asherson RA. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
Immunobiology 210: 727-733 (2005).
*
-
Ashikov A, Routier F, Fuhlrott J, Helmus Y, Wild MK, Gerardy-Schahn R, Bakker H. The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine.
J. Biol. Chem. 280: 27230-27235 (2005).
*
-
Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, Ekbom A. Risk of haematopoietic cancer in patients with inflammatory bowel disease.
Gut 54: 617-622 (2005).
*
-
Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
Lancet Infect. Dis. 5: 549-557 (2005).
-
Aslan E, Tarim E, Kilicdag E, Simsek E. Sjogren's syndrome diagnosed in pregnancy: a case report.
J. Reprod. Med. 50: 67-70 (2005).
-
Asleh R, Levy AP. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Vasc. Health Risk Manag. 1: 19-28 (2005).
*
-
Asma K, Dalila G, Olfa B, Malika R, Afef K, Najet B, Jamel K, Abdeljabbar G, Sarra S, Chiraz J, Mohamed HD, Slim K, Anis BM, Abdelmajid L. Cholangitis revealing an intrahepatic Osler's disease.
Tunis. Med. 83: 495-498 (2005).
-
Assassi S, Mayes MD, McNearney T, Fischbach M, Reveille JD, Arnett FC, Tan FK. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis.
Am. J. Med. 118: 907-911 (2005).
*
-
Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays.
Curr. Opin. Rheumatol. 17: 761-767 (2005).
-
Assounga AG, Warner CM. Memory lymphocytes of young and old C57BL/6 mice express high levels of class I major histocompatibility complex (H-2 Kb) protein.
Growth Dev. Aging 69: 59-66 (2005).
-
Assy N, Schlesinger S, Hussein O. Elevated plasma protein C levels correlate with the presence of fatty liver (NASH and NAFLD).
Gut 54: 729 (2005).
*
-
Astakhov V, Cherkasov A. Prediction of HLA-A2 binding peptides using Bayesian network.
Bioinformation 1: 58-63 (2005).
*
-
Astegiano M, Bresso F, Demarchi B, Sapone N, Novero D, Palestro G, Resegotti A, Pellicano R, Rizzetto M. Association between Crohn's disease and Conn's syndrome. A report of two cases.
Panminerva Med. 47: 61-64 (2005).
-
Astorg P. Omega-3 fatty acids and depression.
Am. J. Psychiatry 162: 402 (2005).
*
-
Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas DL, Karp CL. Association of CTLA4 polymorphism with regulatory T cell frequency.
Eur. J. Immunol. 35: 2157-2162 (2005).
*
-
Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, Sieper J. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
Arthritis Rheum. 52: 892-901 (2005).
*
-
Atalay C, Atalay G, Yilmaz KB, Altinok M. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer.
Neoplasma 52: 32-35 (2005).
*
-
Atan D, Turner SJ, Kilmartin DJ, Forrester JV, Bidwell J, Dick AD, Churchill AJ. Cytokine gene polymorphism in sympathetic ophthalmia.
Invest. Ophthalmol. Vis. Sci. 46: 4245-4250 (2005).
*
-
Atar E, Bachar GN, Bartal G, Mor E, Neyman H, Graif F, Belenky A. Use of peripheral cutting balloon in the management of resistant benign ureteral and biliary strictures.
J. Vasc. Interv. Radiol. 16: 241-245 (2005).
-
Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
Clin. Rev. Allergy Immunol. 28: 187-196 (2005).
-
Atzeni F, Ardizzone S, Sarzi-Puttini P, Colombo E, Maconi G, DE Portu S, Carrabba M, Bianchi Porro G. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study.
Aliment. Pharmacol. Ther. 22: 453-461 (2005).
*
-
Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.
Autoimmun. Rev. 4: 144-152 (2005).
-
Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P. Autoimmunity and anti-TNF-alpha agents.
Ann. N. Y. Acad. Sci. 1051: 559-569 (2005).
*
-
Au WY, Ma ES, Choy C, Chung LP, Fung TK, Liang R, Kwong YL. Therapy-related lymphomas in patients with autoimmune diseases after treatment with disease-modifying anti-rheumatic drugs.
Am. J. Hematol. 81: 5-11 (2005).
*
-
Auci D, Nicoletti F, Mangano K, Pieters R, Nierkens S, Morgan L, Offner H, Frincke J, Reading C. Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases.
Ann. N. Y. Acad. Sci. 1051: 730-742 (2005).
*
-
Aue G, Carroll N, Kressel BR, Hardi R, Horne MK 3rd. Disseminated intravascular coagulation in an ambulatory young woman.
J. Lab. Clin. Med. 146: 192-196 (2005).
*
-
Auerbach SS, Stoner MA, Su S, Omiecinski CJ. Retinoid X receptor-dependent transactivation by a naturally occurring structural variant of human CAR (NR1I3).
Mol. Pharmacol. 68: 1239-1253 (2005).
*
-
Auernhammer CJ, Zitzmann K, Schnitzler F, Seiderer J, Lohse P, Vlotides G, Engelhardt D, Sackmann M, Goke B, Ochsenkuhn T. Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease.
World J. Gastroenterol. 11: 1196-1199 (2005).
*
-
Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
Eur. J. Immunol. 35: 1482-1490 (2005).
*
-
Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Arthritis Rheum. 52: 3424-3432 (2005).
*
-
Augoff K, Kula J, Gosk J, Rutowski R. Epidermal growth factor in Dupuytren's disease.
Plast. Reconstr. Surg. 115: 128-133 (2005).
-
Augustin MT, Kokkonen J, Karttunen R, Karttunen TJ. Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease.
J. Allergy Clin. Immunol. 115: 157-162 (2005).
*
-
Augustin MT, Kokkonen J, Karttunen TJ. Duodenal cytotoxic lymphocytes in cow's milk protein sensitive enteropathy and coeliac disease.
Scand. J. Gastroenterol. 40: 1398-1406 (2005).
*
-
Augustine LM, Markelewicz RJ Jr, Boekelheide K, Cherrington NJ. Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier.
Drug Metab. Dispos. 33: 182-189 (2005).
*
-
Auli M, Fernandez E. Characterization of functional and morphological changes in a rat model of colitis induced by Trichinella spiralis.
Dig. Dis. Sci. 50: 1432-1443 (2005).
*
-
Aumais G, Lefebvre M, Massicotte J, Tremblay C, Kasbo J, Brunet JS, Cardinal C, Grace M, Spenard J. Pharmacokinetics and pilot efficacy of a mesalazine rectal gel in distal ulcerative colitis.
Drugs R. D. 6: 41-46 (2005).
-
Auricchio L, Vitiello L, Adriani M, Ferri P, Chiocchetti A, Pettinato G, Racioppi L, Maiuri L, Dianzani U, Pignata C. Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood.
Dermatology 210: 336-340 (2005).
-
Ausch C, Hochwarter G, Taher M, Holzer B, Rosen HR, Urban M, Sebesta C, Hruby W, Schiessel R. Improving the safety of laparoscopic cholecystectomy: the routine use of preoperative magnetic resonance cholangiography.
Surg. Endosc. 19: 574-580 (2005).
*
-
Auslander JN, Lieberman DA, Sonnenberg A. Lack of seasonal variation in the endoscopic diagnoses of Crohn's disease and ulcerative colitis.
Am. J. Gastroenterol. 100: 2233-2238 (2005).
*
-
Aust DE, Haase M, Dobryden L, Markwarth A, Lohrs U, Wittekind C, Baretton GB, Tannapfel A. Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma.
Int. J. Cancer 115: 673-677 (2005).
*
-
Austin MT, Feurer ID, Chari RS, Gorden DL, Wright JK, Pinson CW. Survival after pediatric liver transplantation: why does living donation offer an advantage?
Arch. Surg. 140: 465-470 (2005).
*
-
Ausubel FM. Are innate immune signaling pathways in plants and animals conserved?
Nat. Immunol. 6: 973-979 (2005).
*
-
Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, Wallot M, Borchers T, Vester U, Grasemann C, Hauffa B, Hoyer PF, Gerken G, Voit T. Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children.
J. Pediatr. Gastroenterol. Nutr. 40: 54-59 (2005).
*
-
Auth MK, Woitaschek D, Beste M, Schreiter T, Kim HS, Oppermann E, Joplin RE, Baumann U, Hilgard P, Nadalin S, Markus BH, Blaheta RA. Preservation of the synthetic and metabolic capacity of isolated human hepatocytes by coculture with human biliary epithelial cells.
Liver Transpl. 11: 410-419 (2005).
*
-
Autschbach F, Eisold S, Hinz U, Zinser S, Linnebacher M, Giese T, Loffler T, Buchler MW, Schmidt J. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease.
Gut 54: 944-949 (2005).
*
-
Autschbach F, Funke B, Katzenmeier M, Gassler N. Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver - an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens.
Cell. Immunol. 236: 110-114 (2005).
*
-
Auvin S, Molinie F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A, Turck D. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in Northern France (1988-1999).
J. Pediatr. Gastroenterol. Nutr. 41: 49-55 (2005).
*
-
Avagliano L, Grillo C, Prioli MA. Congenital heart disease: a retrospective study of their frequency.
Minerva Ginecol. 57: 171-178 (2005).
-
Aversano M, Caiazzo P, Iorio G, Ponticiello L, Lagana B, Leccese F. Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response?
Allergy 60: 489-493 (2005).
*
-
Avidan B, Sakhnini E, Lahat A, Lang A, Koler M, Zmora O, Bar-Meir S, Chowers Y. Risk factors regarding the need for a second operation in patients with Crohn's disease.
Digestion 72: 248-253 (2005).
-
Avila-Funes JA, Montano-Loza A, Zepeda-Gomez S, Meza-Junco J, Melano-Carranza E, Valdovinos-Andraca F, Valdovinos-Díaz MA, Ponce de Leon-Rosales S. Endoscopic retrograde cholangiopancreatography in the elderly.
Rev. Invest. Clin. 57: 666-670 (2005).
-
Avolio AW, Nardo B, Agnes S, Montalti R, Pepe G, Cavallari A, Castagneto M. The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor.
Transplant. Proc. 37: 2584-2586 (2005).
*
-
Awara WM, El-Sisi AE, El-Refaei M, El-Naa MM, El-Desoky K. Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.
Rev. Diabet. Stud. 2: 146-156 (2005).
*
-
Awayn NH, Rosenberg MF, Kamis AB, Aleksandrov LA, Riordan JR, Ford RC. Crystallographic and single-particle analyses of native- and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Biochem. Soc. Trans. 33: 996-999 (2005).
*
-
Axelrod D, Koffron A, Kulik L, Al-Saden P, Mulcahy M, Baker T, Fryer J, Abecassis M. Living donor liver transplant for malignancy.
Transplantation 79: 363-366 (2005).
-
Axelrod DA, Koffron AJ, Baker T, Al-Saden P, Dixler I, McNatt G, Sumner S, Mike V, Abecassis M. The economic impact of MELD on liver transplant centers.
Am. J. Transplant. 5: 2297-2301 (2005).
*
-
Ayala-Garcia I, Hernandez-Segura AM, Castell-Rodriguez A, Alvarez Perez SJ, Tellez BH, Ramirez-Gonzalez MD. Participation of epidermal Langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
Proc. West. Pharmacol. Soc. 48: 13-20 (2005).
-
Aydin G, Keles I, Atalar E, Orkun S. Extensive erosive arthropathy in a patient with Behcet's disease: case report.
Clin. Rheumatol. 24: 645-647 (2005).
*
-
Aydogan K, Karadogan S, Balaban Adim S, Tunali S. Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature.
J. Eur. Acad. Dermatol. Venereol. 19: 621-627 (2005).
-
Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, Yagci RV, Tokat Y. Outcome of pediatric liver transplant recipients in Turkey: single center experience.
Pediatr. Transplant. 9: 723-728 (2005).
-
Aygun C, Uraz S, Damci T, Osar Z, Yumuk V, Akdenizli E, Ilkova H. Celiac disease in an adult Turkish population with type 1 diabetes mellitus.
Dig. Dis. Sci. 50: 1462-1466 (2005).
*
-
Azar GA, Sekaly RP, Thibodeau J. A defective viral superantigen-presenting phenotype in HLA-DR transfectants is corrected by CIITA.
J. Immunol. 174: 7548-7557 (2005).
*
-
Azer SA. A multimedia CD-ROM tool to improve student understanding of bile salts and bilirubin metabolism: evaluation of its use in a medical hybrid PBL course.
Adv. Physiol. Educ. 29: 40-50 (2005).
*
-
Aziz KA, Polson RJ. Serological diagnosis of celiac disease.
Saudi Med. J. 26: 1340-1345 (2005).
-
Azpiroz F. Intestinal gas dynamics: mechanisms and clinical relevance.
Gut 54: 893-895 (2005).
*
-
Azuz-Lieberman N, Markel G, Mizrahi S, Gazit R, Hanna J, Achdout H, Gruda R, Katz G, Arnon TI, Battat S, Zamir E, Adawi M, Mader R, Mandelboim O. The involvement of NK cells in ankylosing spondylitis.
Int. Immunol. 17: 837-845 (2005).
*
-
Azzolini F, Pagnini C, Camellini L, Scarcelli A, Merighi A, Primerano AM, Bertani A, Antonioli A, Manenti F, Rigo GP. Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.
Dig. Dis. Sci. 50: 246-251 (2005).
*
-
Baba A, Hara S, Sato Y, Yamada K, Fujimoto S, Eto T. Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjogren's syndrome.
Nippon Jinzo Gakkai Shi 47: 882-886 (2005).
-
Baba T, Ishizu A, Ikeda H, Miyatake Y, Tsuji T, Suzuki A, Tomaru U, Yoshiki T. Chronic graft-versus-host disease-like autoimmune disorders spontaneously occurred in rats with neonatal thymus atrophy.
Eur. J. Immunol. 35: 1731-1740 (2005).
*
-
Babalini C, Tarsi T, Martinez-Labarga C, Scano G, Pepe G, De Stefano GF, Rickards O. COL1A2 (type I collagen) polymorphisms in the Colorado Indians of Ecuador.
Ann. Hum. Biol. 32: 666-678 (2005).
-
Babaya N, Nakayama M, Eisenbarth GS. The stages of type 1A diabetes.
Ann. N. Y. Acad. Sci. 1051: 194-204 (2005).
*
-
Babcock TA, Dekoj T, Espat NJ. Experimental studies defining omega-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes.
Nutr. Clin. Pract. 20: 62-74 (2005).
-
Babic Z, Svoboda-Beusan I, Kucisec-Tepes N, Dekaris D, Troskot R. Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection.
World J. Gastroenterol. 11: 2720-2725 (2005).
*
-
Babyn P, Doria AS. Radiologic investigation of rheumatic diseases.
Pediatr. Clin. North Am. 52: 373-411 (2005).
-
Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity.
Immunol. Rev. 204: 9-26 (2005).
-
Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity.
Trends Immunol. 26: 5-8 (2005).
*
-
Baccarani U, Adani GL, Sainz M, Donini A, Risaliti A, Bresadola F. Human hepatocyte transplantation for acute liver failure: state of the art and analysis of cell sources.
Transplant. Proc. 37: 2702-2704 (2005).
*
-
Bacchetta R, Gregori S, Roncarolo MG. CD4(+) regulatory T cells: mechanisms of induction and effector function.
Autoimmun. Rev. 4: 491-496 (2005).
-
Bach G. Mucolipin 1: endocytosis and cation channel - a review.
Pflugers Arch. 451: 313-317 (2005).
*
-
Bach JF. Six questions about the hygiene hypothesis.
Cell. Immunol. 233: 158-161 (2005).
*
-
Bach JF. Infections and autoimmune diseases.
J. Autoimmun. 25: S74-S80 (2005).
-
Bach JF. The protective effect of infections on immune disorders.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S8 (2005).
*
-
Bach JF. A Toll-like trigger for autoimmune disease.
Nat. Med. 11: 120-121 (2005).
*
-
Bachelez H. Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity.
J. Autoimmun. 25: S69-S73 (2005).
-
Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A, Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.
Gastroenterology 128: 907-921 (2005).
*
-
Bachmaier K, Penninger JM. Chlamydia and antigenic mimicry.
Curr. Top. Microbiol. Immunol. 296: 153-163 (2005).
-
Bachmann O, Baus S, Hoffmann MW, Manns MP, Gebel M. Incarcerated Spieghel-Hernie mimicking an acute exacerbation of Crohn's disease.
Z. Gastroenterol. 43: 1309-1312 (2005).
-
Bachor E, Kremmer S, Kreuzfelder E, Jahnke K, Seidahmadi S. Antiphospholipid antibodies in patients with sensorineural hearing loss.
Eur. Arch. Otorhinolaryngol. 262: 622-626 (2005).
-
Backes JM, Gibson CA, Howard PA. Optimal lipid modification: the rationale for combination therapy.
Vasc. Health Risk Manag. 1: 317-331 (2005).
-
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine.
Science 307: 1915-1920 (2005).
*
-
Backlund MG, Mann JR, Dubois RN. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
Oncology 69: 28S-32S (2005).
-
Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL,Katkuri S, Dubois RN. 15-Hydroxyprostaglandin dehydrogenase is downregulated in colorectal cancer.
J. Biol. Chem. 280: 3217-3223 (2005).
*
-
Badami E, Maiuri L, Quaratino S. High incidence of spontaneous autoimmune thyroiditis in immunocompetent self-reactive human T cell receptor transgenic mice.
J. Autoimmun. 24: 85-91 (2005).
-
Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars.
Science 307: 1909-1914 (2005).
*
-
Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4(+)CD25(+) T cells.
Clin. Immunol. 115: 10-18 (2005).
*
-
Bagenstose LM, Agarwal RK, Silver PB, Harlan DM, Hoffmann SC, Kampen RL, Chan CC, Caspi RR. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
J. Immunol. 175: 124-130 (2005).
*
-
Baggio B, Musacchio E, Priante G. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications.
J. Nephrol. 18: 362-367 (2005).
-
Bahadursingh AM, Longo WE. Malignant transformation of chronic perianal Crohn's fistula.
Am. J. Surg. 189: 61-62 (2005).
*
-
Baharav E, Bar-Yehuda S, Madi L, Silberman D, Rath-Wolfson L, Halpren M, Ochaion A, Weinberger A, Fishman P. Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
J. Rheumatol. 32: 469-476 (2005).
-
Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, Seckin D, Sahin K. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Hepatogastroenterology 52: 1549-1553 (2005).
-
Bahloul M, Chaari A, Khlaf-Bouaziz N, Kallel H, Chaari L, Ben Hamida C, Chelly H, Rekik N, Bouaziz M. Celiac disease, cerebral venous thrombosis and protein S deficiency, a fortuitous association?
J. Mal. Vasc. 30: 228-230 (2005).
-
Bai AP, Ouyang Q, Hu RW. Diallyl trisulfide inhibits tumor necrosis factor-alpha expression in inflammed mucosa of ulcerative colitis.
Dig. Dis. Sci. 50: 1426-1431 (2005).
*
-
Bai D, Brar P, Holleran S, Ramakrishnan R, Green P. Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men.
Scand. J. Gastroenterol. 40: 183-187 (2005).
*
-
Bai JC. New frontiers in the celiac disease knowledge.
Rev. Gastroenterol. Mex. 70 Suppl. 3: 35-36 (2005).
-
Bai S, Kitaura H, Zhao H, Chen J, Muller JM, Schule R, Darnay B, Novack DV, Ross FP, Teitelbaum SL. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
J. Clin. Invest. 115: 2742-2751 (2005).
*
-
Bai Y, Onuma H, Bai X, Medvedev AV, Misukonis M, Weinberg JB, Cao W, Robidoux J, Floering LM, Daniel KW, Collins S. Persistent NF-kappa B activation in Ucp2-/-mice leads to enhanced nitric oxide and inflammatory cytokine production.
J. Biol. Chem. 280: 19062-19069 (2005).
*
-
Baichi MM, Arifuddin RM, Mantry PS, Bozorgzadeh A, Ryan C. Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis.
Transplantation 80: 1630-1632 (2005).
-
Baidoo L, Lichtenstein GR. What next after infliximab?
Am. J. Gastroenterol. 100: 80-83 (2005).
*
-
Bailey CJ. Drugs on the horizon for diabesity.
Curr. Diab. Rep. 5: 353-359 (2005).
-
Bailey M, Haverson K, Inman C, Harris C, Jones P, Corfield G, Miller B, Stokes C. The development of the mucosal immune system pre- and post-weaning: balancing regulatory and effector function.
Proc. Nutr. Soc. 64: 451-457 (2005).
*
-
Bailey M, Haverson K, Inman C, Harris C, Jones P, Corfield G, Miller B, Stokes C. The influence of environment on development of the mucosal immune system.
Vet. Immunol. Immunopathol. 108: 189-198 (2005).
*
-
Bailey-Wilson JE, Almasy L, de Andrade M, Bailey J, Bickeboller H, Cordell HJ, Daw EW, Goldin L, Goode EL, Gray-McGuire C, Hening W, Jarvik G, Maher BS, Mendell N, Paterson AD, Rice J, Satten G, Suarez B, Vieland V, Wilcox M, Zhang H, Ziegler A, et al. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans.
BMC Genet. 6 Suppl. 1: S1 (2005).
*
-
Baillie GM. Pharmacokinetics of antiviral agents for the treatment of cytomegalovirus infection.
Am. J. Health Syst. Pharm. 62 Suppl. 1: S14-S17 (2005).
*
-
Bain LJ, Feldman RA. Altered expression of sulfotransferases, glucuronosyltransferases and mrp transporters in FVB/mrp1-/- mice.
Xenobiotica 33: 1173-1183 (2005).
*
-
Bajaj JS, Saeian K, Varma RR, Franco J, Knox J F, Podoll J, Emmons J, Levy M, Binion DG. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Am. J. Gastroenterol. 100: 1121-1125 (2005).
*
-
Bajtner E, Nandakumar KS, Engstrom A, Holmdahl R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen.
Arthritis Res. Ther. 7: R1148-R1157 (2005).
*
-
Baker DE. Safety of balsalazide therapy in the treatment of inflammatory bowel disease.
Rev. Gastroenterol. Disord. 5: 135-141 (2005).
-
Baker DE. Rifaximin: a nonabsorbed oral antibiotic.
Rev. Gastroenterol. Disord. 5: 19-30 (2005).
-
Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, Sweeney S, Long MH, Iles KE, Baker LM, Branchaud BP, Chen YE, Freeman BA. Fatty acid transduction of nitric oxide signaling: identification of unsaturated fatty acid nitro derivatives and PPAR receptor-dependent signaling activity.
J. Biol. Chem. 280: 42464-42475 (2005).
*
-
Baker SS, Borowitz D, Baker RD. Pancreatic exocrine function in patients with cystic fibrosis.
Curr. Gastroenterol. Rep. 7: 227-233 (2005).
-
Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway.
Arthritis Rheum. 53: 850-855 (2005).
*
-
Balaban B, Yasar E, Ozgul A, Dincer K, Kalyon TA. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.
Rheumatol. Int. 25: 641-644 (2005).
*
-
Balakrishnan A, Sussman DJ, Polli JE. Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).
Pharm. Res. 22: 1269-1280 (2005).
*
-
Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.
Blood 105: 735-741 (2005).
*
-
Balandraud N, Gouret P, Danchin EG, Blanc M, Zinn D, Roudier J, Pontarotti P. A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example.
BMC Genomics 6: 153 (2005).
*
-
Balas A, Aviles MJ, Alonso-Nieto M, Zarapuz L, Blanco L, Garcia-Sanchez F, Vicario JL. HLA-DQA1 introns 2 and 3 sequencing: DQA1 sequencing-based typing and characterization of a highly polymorphic microsatellite at intron 3 of DQA1*0505.
Hum. Immunol. 66: 903-911 (2005).
-
Balasubramaniyan N, Shahid M, Suchy FJ, Ananthanarayanan M. Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G251-G260 (2005).
*
-
Baldari CT, Lanzavecchia A, Telford JL. Immune subversion by Helicobacter pylori.
Trends Immunol. 26: 199-207 (2005).
*
-
Baldassarre ME, Delvecchio M, Fanelli M, Stasolla S, Acquafredda A. Isolated increased serum TSH response to TRH is prevalent in celiac disease and predicts poor response to treatment.
Gastroenterol. Clin. Biol. 29: 1063-1064 (2005).
-
Balendiran GK, Rajkumar B. Fibrates inhibit aldose reductase activity in the forward and reverse reactions.
Biochem. Pharmacol. 70: 1653-1663 (2005).
*
-
Balistreri WF, Bezerra JA, Jansen P, Karpen SJ, Shneider BL, Suchy FJ. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference.
Hepatology 42: 222-235 (2005).
*
-
Balk EM, Lau J, Bonis PA. Reading and critically appraising systematic reviews and meta-analyses: a short primer with a focus on hepatology.
J. Hepatol. 43: 729-736 (2005).
*
-
Balkwill F. Immunology for the next generation.
Nat. Rev. Immunol. 5: 509-512 (2005).
*
-
Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease.
Cancer Cell 7: 211-217 (2005).
*
-
Ballatori N. Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta.
Exp. Biol. Med. (Maywood) 230: 689-698 (2005).
*
-
Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, Madejczyk MS, Li N. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.
Hepatology 42: 1270-1279 (2005).
*
-
Ballatori N, Hammond CL, Cunningham JB, Krance SM, Marchan R. Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins.
Toxicol. Appl. Pharmacol. 204: 238-255 (2005).
*
-
Ballester I, Gonzalez R, Nieto A, Zarzuelo A, Sanchez de Medina F. Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment.
Life Sci. 76: 2965-2980 (2005).
*
-
Balloy V, Si-Tahar M, Takeuchi O, Philippe B, Nahori MA, Tanguy M, Huerre M, Akira S, Latge JP, Chignard M. Involvement of Toll-like receptor 2 in experimental invasive pulmonary aspergillosis.
Infect. Immun. 73: 5420-5425 (2005).
*
-
Balog A, Gyulai Z, Boros LG, Farkas G, Takacs T, Lonovics J, Mandi Y. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis.
Pancreas 30: e46-e50 (2005).
-
Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma.
Arterioscler. Thromb. Vasc. Biol. 25: 1280-1286 (2005).
*
-
Balsara KP, Shah CR, Maru S, Sehgal R. Laparoscopic-assisted ileo-colectomy for tuberculosis.
Surg. Endosc. 19: 986-989 (2005).
*
-
Bamias G, Martin C, Mishina M, Ross WG, Rivera-Nieves J, Marini M, Cominelli F. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation.
Gastroenterology 128: 654-666 (2005).
*
-
Bamias G, Nyce MR, De La Rue SA, Cominelli F; American College of Physicians; American Physiological Society. New concepts in the pathophysiology of inflammatory bowel disease.
Ann. Intern. Med. 143: 895-904 (2005).
*
-
Ban M, Maranian M, Wai Yeo T, Gray J, Compston A, Sawcer S. Cis acting expression loci in multiple sclerosis.
J. Neuroimmunol. 162: 3-4 (2005).
-
Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity.
Pediatr. Endocrinol. Rev. 3: 20-32 (2005).
-
Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity.
Clin. Dev. Immunol. 12: 47-58 (2005).
*
-
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.
Autoimmunity 38: 151-153 (2005).
-
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese.
Thyroid 15: 1115-1118 (2005).
-
Banan A, Zhang L, Farhadi A, Fields JZ, Shaikh M, Forsyth CB, Choudhary S, Keshavarzian A. Critical role of the atypical lambda ({lambda}) isoform of PKC (PKC-{lambda}) in oxidant-induced disruption of the microtubule cytoskeleton and barrier function of intestinal epithelium.
J. Pharmacol. Exp. Ther. 312: 458-471 (2005).
*
-
Banares R, Nunez O, Escudero M, Fernandez C, Vaquero J, Beceiro I, Echenagusia A, Clemente G, Santos L. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma.
Hepatology 41: 566-571 (2005).
*
-
Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer.
Nat. Rev. Immunol. 5: 296-306 (2005).
*
-
Banerjee A, Ray A, Chang C, Swaan PW. Site-directed mutagenesis and use of bile acid-MTS conjugates to probe the role of cysteines in the human apical sodium-dependent bile acid transporter (SLC10A2).
Biochemistry 44: 8908-8917 (2005).
*
-
Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein.
Arch. Biochem. Biophys. 433: 144-156 (2005).
*
-
Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins.
J. Immunol. 174: 4345-4355 (2005).
*
-
Banno S, Ito Y, Tanaka C, Hori T, Fujimoto K, Suzuki T, Hashimoto T, Ueda R, Mizokami M. Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation.
Clin. Lab. Haematol. 27: 292-296 (2005).
*
-
Banno T, Gazel A, Blumenberg M. Pathway-specific profiling identifies the NFkB-dependent TNFa-regulated genes in epidermal keratinocytes.
J. Biol. Chem. 280: 18973-18980 (2005).
*
-
Bansal D, Chahoud G, Ison K, Gupta E, Montgomery M, Garza L, Mehta JL. Pleuropericarditis and pericardial tamponade associated with inflammatory bowel disease.
J. Ark. Med. Soc. 102: 16-19 (2005).
-
Bansal MB, Kovalovich K, Gupta R, Li W, Agarwal A, Radbill B, Alvarez CE, Safadi R, Fiel MI, Friedman SL, Taub RA. Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.
J. Hepatol. 42: 548-556 (2005).
*
-
Bansal V, Syres KM, Makarenkova V, Brannon R, Matta B, Harbrecht BG, Ochoa JB. Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets.
JPEN J. Parenter. Enteral Nutr. 29: S75-S80 (2005).
*
-
Bantel H, Strassburg CP, Manns MP. Autoimmune hepatitis.
Curr. Gastroenterol. Rep. 7: 81-83 (2005).
-
Bao J, Miao S, Kayser F, Kotliar AJ, Baker RK, Doss GA, Felix JP, Bugianesi RM, Slaughter RS, Kaczorowski GJ, Garcia ML, Ha SN, Castonguay L, Koo GC, Shah K, Springer MS, Staruch MJ, Parsons WH, Rupprecht KM. Potent Kv1.3 inhibitors from correolide-modification of the C18 position.
Bioorg. Med. Chem. Lett. 15: 447-451 (2005).
*
-
Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Eur. J. Immunol. 35: 2496-2506 (2005).
*
-
Baptista ML, Koda YK, Mitsunori R, Nisihara, Ioshii SO. Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus.
J. Pediatr. Gastroenterol. Nutr. 41: 621-624 (2005).
*
-
Barabas AZ, Lafreniere R. Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.
Autoimmun. Rev. 4: 565-570 (2005).
-
Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin.
Adv. Dermatol. 21: 357-374 (2005).
-
Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-Perez D, Nino-Moreno P, Valencia-Pacheco G, Abud-Mendoza C, Alcocer-Varela J, Gonzalez-Amaro R. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
Rheumatology (Oxford) 44: 1507-1513 (2005).
*
-
Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Vourc'h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
J. Immunol. 175: 1483-1490 (2005).
*
-
Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease.
Am. J. Gastroenterol. 100: 2560-2568 (2005).
*
-
Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, Camps M, Ruckle T, Schwarz MK, Rodriguez S, Martinez-A C, Balomenos D, Rommel C, Carrera AC. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
Nat. Med. 11: 933-935 (2005).
*
-
Barber MD, Fearon KC, Ross JA. Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responses.
Nutrition 21: 588-593 (2005).
*
-
Barbi E, Vaupel JW. Comment on "Inflammatory exposure and historical changes in human life-spans".
Science 308: 1743 (2005).
*
-
Barbosa KV, de Souza AF, Chebli JM, Proietti FA, Meirelles RS, de Souza JL. Hereditary hemochromatosis: population screening based on phenotype in Brazilian blood donors.
J. Clin. Gastroenterol. 39: 430-434 (2005).
-
Barcelo-Coblijn G, Collison LW, Jolly CA, Murphy EJ. Dietary alpha-linolenic acid increases brain but not heart and liver docosahexaenoic acid levels.
Lipids 40: 787-798 (2005).
-
Bardel C, Danjean V, Hugot JP, Darlu P, Genin E. On the use of haplotype phylogeny to detect disease susceptibility loci.
BMC Genet. 6: 24 (2005).
*
-
Bardella MT, Bianchi ML,Teti A. Chronic inflammatory intestinal diseases and bone loss.
Gut 54: 1508 (2005).
*
-
Bardella MT, Fredella C, Saladino V, Trovato C, Cesana BM, Quatrini M, Prampolini L. Gluten intolerance: gender- and age-related differences in symptoms.
Scand. J. Gastroenterol. 40: 15-19 (2005).
-
Bardon S, Benelli C, Bernard-Gallon D, Blottiere H, Demarquoy J, Duee PH, Forest C. Dietary fatty acids and cancer: potential cellular and molecular mechanisms.
Bull. Cancer 92: 697-707 (2005).
-
Barish CF. Alicaforsen therapy in inflammatory bowel disease.
Expert Opin. Biol. Ther. 5: 1387-1391 (2005).
-
Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM. A nuclear receptor atlas: macrophage activation.
Mol. Endocrinol. 19: 2466-2477 (2005).
*
-
Barkay O, Moshkowitz M, Reif S. Crohn's disease diagnosed by wireless capsule endoscopy in adolescents with abdominal pain, protein-losing enteropathy, anemia and negative endoscopic and radiologic findings.
Isr. Med. Assoc. J. 7: 216-218 (2005).
*
-
Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Diabetes Care 28: 850-855 (2005).
*
-
Barkholt L, Lofberg R. Resetting the immune system in refractory Crohn's disease: is autologous hematopoietic stem cell transplantation the way forward?
Gastroenterology 128: 786-799 (2005).
*
-
Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, Lamb J, Bailey AJ, Monaco AP; International Molecular Genetics Study of Autism Consortium. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT.
Am. J. Hum. Genet. 76: 950-966 (2005).
*
-
Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
J. Pharm. Pharmacol. 57: 929-954 (2005).
-
Barnes NM. 5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!
Gut 54: 1056-1057 (2005).
*
-
Barnes T, Moots RJ, Goodacre J. Cytokine medicines in clinical practice: current issues.
Cytokine 32: 62-66 (2005).
-
Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kappaB activation in muramyl dipeptide recognition.
J. Cell. Biol. 170: 21-26 (2005).
*
-
Barnich N, Hisamatsu T, Aguirre JE, Xavier R, Reinecker HC, Podolsky DK. GRIM-19 interacts with NOD2 and serves as down-stream effector of anti-bacterial function in intestinal epithelial cells.
J. Biol. Chem. 280: 19021-19026 (2005).
*
-
Barollo M, D'Inca R, Scarpa M, Medici V, Cardin R, Bortolami M, Ruffolo C, Angriman I, Sturniolo GC. Effects of iron manipulation on trace elements level in a model of colitis in rats.
World J. Gastroenterol. 11: 4396-4399 (2005).
*
-
Baron JA. Dietary fiber and colorectal cancer: an ongoing saga.
JAMA 294: 2904-2906 (2005).
*
-
Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study.
Gut 54: 357-363 (2005).
*
-
Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome.
Arthritis Rheum. 52: 1773-1784 (2005).
*
-
Baroni F, Ghisla MK, Leonardi R, Grassi V. Celiac disease in the elderly: a case report.
Ann. Ital. Med. Int. 20: 253-257 (2005).
-
Barral S, Haynes C, Levenstien MA, Gordon D. Precision and type I error rate in the presence of genotype errors and missing parental data: a comparison between the original transmission disequilibrium test (TDT) and TDTae statistics.
BMC Genet. 6 Suppl. 1: S150 (2005).
*
-
Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
J. Exp. Med. 202: 1131-1139 (2005).
*
-
Barratt HS, Kalantzis C, Polymeros D, Forbes A. Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status.
Aliment. Pharmacol. Ther. 21: 141-147 (2005).
*
-
Barreto VM, Ramiro AR, Nussenzweig MC. Activation-induced deaminase: controversies and open questions.
Trends Immunol. 26: 90-96 (2005).
*
-
Barrie III AM, Plevy SE. The interleukin-12 family of cytokines: therapeutic targets for inflammatory disease mediation.
Clin. Appl. Immunol. Rev. 5: 225-240 (2005). *
-
Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL. High-throughput mapping of a dynamic signaling network in mammalian cells.
Science 307: 1621-1625 (2005).
*
-
Barry E, Derhammer T, Elsea SH. Prevalence of three hereditary hemochromatosis mutant alleles in the Michigan Caucasian population.
Community Genet. 8: 173-179 (2005).
-
Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Orthotopic liver transplantation for biliary atresia: the U.S. experience.
Liver Transpl. 11: 1193-1200 (2005).
*
-
Barshes NR, Lee TC, Udell IW, O'Mahoney CA, Carter BA, Karpen SJ, Goss JA. Adult liver transplant candidate attitudes toward graft sharing are not obstacles to split liver transplantation.
Am. J. Transplant. 5: 2047-2051 (2005).
*
-
Barshes NR, Myers GD, Lee D, Karpen SJ, Lee TC, Patel AJ, Finegold M, Goss JA. Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data.
Liver Transpl. 11: 525-531 (2005).
*
-
Barta Z, Mekkel G, Csipo I, Toth L, Szakall S, Szabo GG, Bako G, Szegedi G, Zeher M. Microscopic colitis: a retrospective study of clinical presentation in 53 patients.
World J. Gastroenterol. 11: 1351-1355 (2005).
*
-
Barta Z, Szabo GG, Zeher M, Szegedi G. Microscopic colitis.
Orv. Hetil. 146: 1913-1917 (2005).
-
Barth A, Rost M, Kindt A, Peiker G. Serum bile acid profile in women during pregnancy and childbed.
Exp. Clin. Endocrinol. Diabetes 113: 372-375 (2005).
-
Barth C, Bosse A, Andus T. Severe acute cholestatic hepatitis by infiltration of monoclonal plasma cells in multiple myeloma.
Z. Gastroenterol. 43: 1129-1132 (2005).
-
Barthel HR, Gille T, Halbsguth A, Kramer M. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
J. Gastroenterol. Hepatol. 20: 1464-1465 (2005).
*
-
Barthet M, Gay G, Sautereau D, Ponchon T, Napoleo B, Boyer J, Canard JM, Dalbies P, Escourrou J, Greff M, Lapuelle J, Letard JC, Marchetti B, Palazzo L, Rey JF. Endoscopic surveillance of chronic inflammatory bowel disease.
Endoscopy 37: 597-599 (2005).
-
Bartholo RM, Zaltman C, Elia C, Cardoso AP, Flores V, Lago P, Cassabian L, Carvalho Dorileo F, Lapa-E-Silva JR. Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease.
Braz. J. Med. Biol. Res. 38: 197-203 (2005).
*
-
Bartholomew JR, Begelman SM, Almahameed A. Heparin-induced thrombocytopenia: principles for early recognition and management.
Cleve. Clin. J. Med. 72 Suppl. 1: S31-S36 (2005).
*
-
Bartoli E, Delcenserie R, Yzet T, Brazier F, Geslin G, Regimbeau JM, Dupas JL. Endoscopic treatment of chronic pancreatitis.
Gastroenterol. Clin. Biol. 29: 515-521 (2005).
-
Barton A, Bowes J, Eyre S, Symmons D, Worthington J, Silman A. Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis.
Ann. Rheum. Dis. 64: 1311-1315 (2005).
*
-
Barton A, Eyre S, Bowes J, Ho P, John S, Worthington J. Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients.
Arthritis Rheum. 52: 752-758 (2005).
*
-
Barton JC, Sublett S, Boyd GL. Management of hemochromatosis in a Jehovah's Witness.
Am. J. Hematol. 78: 83 (2005).
*
-
Barton JC, Wiener HW, Acton RT, Go RC. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Blood Cells Mol. Dis. 34: 38-47 (2005).
-
Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies.
Mutat. Res. 591: 34-44 (2005).
-
Barzon L, Stefani AL, Pacenti M, Palu G. Versatility of gene therapy vectors through viruses.
Expert Opin. Biol. Ther. 5: 639-662 (2005).
-
Basavappa S, Vulapalli SR, Zhang H, Yule D, Coon S, Sundaram U. Chloride channels in the small intestinal cell line IEC-18.
J. Cell Physiol. 202: 21-31 (2005).
*
-
Basit AW. Advances in colonic drug delivery.
Drugs 65: 1991-2007 (2005).
-
Baskin-Bey ES, Devarbhavi HC, Nagorney DM, Farnell MB, Donohue JH, Sanderson SO, Stadheim LM, Gores GJ. Idiopathic benign biliary strictures in surgically resected patients with presumed cholangiocarcinoma.
HPB (Oxford) 7: 283-288 (2005).
*
-
Baskol G, Baskol M, Yurci A, Ozbakir O, Yucesoy M. Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis.
Cell. Biochem. Funct. 24: 283-286 (2005).
-
Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, Petersen LJ, Beurskens FJ, Schuurman J, van de Winkel JG, Parren PW, Gracie JA, Jongbloed S, Liew FY, McInnes IB. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.
Arthritis Rheum. 52: 2686-2692 (2005).
*
-
Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Mol. Carcinog. 44: 151-161 (2005).
*
-
Bassi MT, Manzoni M, Bresciani R, Pizzo MT, Della Monica A, Barlati S, Monti E, Borsani G. Cellular expression and alternative splicing of SLC25A23, a member of the mitochondrial Ca(2+)-dependent solute carrier gene family.
Gene 345: 173-182 (2005).
*
-
Bastida G, Nos P, Aguas M, Beltran B, Rubin A, Dasi F, Ponce J. Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease.
Aliment. Pharmacol. Ther. 22: 775-782 (2005).
*
-
Bastonero S, Gargouri M, Ortiou S, Gueant JL, Merten MD. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.
J. Gene Med. 7: 1439-1449 (2005).
-
Basu D, Lopez I, Kulkarni A, Sellin JH. Impact of race and ethnicity on inflammatory bowel disease.
Am. J. Gastroenterol. 100: 2254-2261 (2005).
*
-
Baszko-Blaszyk D, Dworacki G, Horst-Sikorska W, Sowinski J. Primary hypoparathyroidism and hypergonadotropic hypogonadism in a male patient with common variable immunodeficiency. A case report.
Pol. Arch. Med. Wewn. 114: 1089-1092 (2005).
-
Bataller R, Brenner DA. Liver fibrosis.
J. Clin. Invest. 115: 209-218 (2005).
*
-
Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
Hepatology 41: 1046-1055 (2005).
*
-
Batliwalla FM, Baechler EC, Xiao X, Li W, Balasubramanian S, Khalili H, Damle A, Ortmann WA, Perrone A, Kantor AB, Gulko PS, Kern M, Furie R, Behrens TW, Gregersen PK. Peripheral blood gene expression profiling in rheumatoid arthritis.
Genes Immun. 6: 388-397 (2005).
*
-
Batliwalla FM, Li W, Ritchlin CT, Xiao X, Brenner M, Laragione T, Shao T, Durham R, Kemshetti S, Schwarz E, Coe R, Kern M, Baechler EC, Behrens TW, Gregersen PK, Gulko PS. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis.
Mol. Med. 11: 21-29 (2005).
*
-
Batra J, Sharma M, Chatterjee R, Sharma S, Mabalirajan U, Ghosh B. CCR5 Delta32 deletion and atopic asthma in India.
Thorax 60: 85 (2005).
*
-
Batra R, Boekhout T, Gueho E, Cabanes FJ, Dawson TL Jr, Gupta AK. Malassezia baillon, emerging clinical yeasts.
FEMS Yeast Res. 5: 1101-1113 (2005).
-
Batres LA, Russo P, Mathews M, Piccoli DA, Chuang E, Ruchelli E. Primary sclerosing cholangitis in children: a histologic follow-up study.
Pediatr. Dev. Pathol. 8: 568-576 (2005).
*
-
Battais F, Mothes T, Moneret-Vautrin DA, Pineau F, Kanny G, Popineau Y, Bodinier M, Denery-Papini S. Identification of IgE-binding epitopes on gliadins for patients with food allergy to wheat.
Allergy 60: 815-821 (2005).
*
-
Battersby IA, Peters IR, Day MJ, German AJ, Hall EJ. Effect of intestinal inflammation on fecal elastase concentration in dogs.
Vet. Clin. Pathol. 34: 49-51 (2005).
-
Battochio AP, Sartori MS, Coelho CA. Water-soluble extract of Coleus barbatus modulates weight gain, energy utilization and lipid metabolism in secondary biliary cirrhosis: an experimental study in young rats.
Acta Cir. Bras. 20: 229-236 (2005).
-
Baudon JJ, Chevalier J, Boccon-Gibod L, Le Bars MA, Johanet C, Cosnes J. Outcome of infants with celiac disease.
Gastroenterol. Clin. Biol. 29: 1097-1102 (2005).
*
-
Baudouin-Legros M, Hinzpeter A, Jaulmes A, Brouillard F, Costes B, Fanen P, Edelman A. Cell-specific posttranscriptional regulation of CFTR gene expression via the influence of MAP kinase cascades on the 3'UTR part of the transcripts.
Am. J. Physiol. Cell. Physiol. 289: C1240-C1250 (2005).
*
-
Bauduer F, Scribans C, Degioanni A, Renoux M, Dutour O. Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque Country.
Ann. Hematol. 84: 99-102 (2005).
*
-
Bauer B, Hartz AM, Fricker G, Miller DS. Modulation of P-glycoprotein transport function at the blood-brain barrier.
Exp. Biol. Med. (Maywood) 230: 118-127 (2005).
*
-
Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. Effect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis.
Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 149: 501-503 (2005).
-
Baughman RP, Bradley DA, Lower EE. Infliximab in chronic ocular inflammation.
Int. J. Clin. Pharmacol. Ther. 43: 7-11 (2005).
-
Baumgart DC, Metzke D, Schmitz J, Scheffold A, Sturm A, Wiedenmann B, Dignass AU. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
Gut 54: 228-236 (2005).
*
-
Baumgart DC, Sturm A, Wiedenmann B, Dignass AU. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis.
Gut 54: 1822-1823 (2005).
*
-
Baumgart DC, Vierziger K, Sturm A, Wiedenmann B, Dignass AU. Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism.
Scand. J. Gastroenterol. 40: 958-964 (2005).
*
-
Baumhoer D, Lorf T, Gunawan B, Armbrust T, Fuzesi L, Ramadori G. Hepatic tumorigenesis in acute hepatic failure.
Eur. J. Gastroenterol. Hepatol. 17: 1125-1130 (2005).
-
Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, Alm GV, Ronnblom L. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism.
Arthritis Rheum. 52: 1185-1195 (2005).
*
-
Baxter A, Jordan M, Silveira P, Wilson W, Van Driel I. Genetic control of susceptibility to autoimmune gastritis.
Int. Rev. Immunol. 24: 55-62 (2005).
-
Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA. Increased risk of rectal cancer after prostate radiation: a population-based study.
Gastroenterology 128: 819-824 (2005).
*
-
Bay Nielsen H, Secher NH, Clemmesen O, Ott P. Maintained cerebral and skeletal muscle oxygenation during maximal exercise in patients with liver cirrhosis.
J. Hepatol. 43: 266-271 (2005).
*
-
Bayat A, Walter J, Lambe H, Watson JS, Stanley JK, Marino M, Ferguson MW, Ollier WE. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC.
Plast. Reconstr. Surg. 115: 134-141 (2005).
-
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials.
Methods Find. Exp. Clin. Pharmacol. 27: 265-284 (2005).
-
Bayrakci B, Ersoy F, Sanal O, Kilic S, Metin A, Tezcan I. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
Turk. J. Pediatr. 47: 239-246 (2005).
-
Bayston R, Bhundia C, Ashraf W. Hydromer-coated catheters to prevent shunt infection?
J. Neurosurg. 102: S207-S212 (2005).
-
Bazan NG. Lipid signaling in neural plasticity, brain repair, and neuroprotection.
Mol. Neurobiol. 32: 89-103 (2005).
-
Beagle B, Yang TL, Hung J, Cogger EA, Moriarty DJ, Caudill MA. The glycine N-methyltransferase (GNMT) 1289 C->T variant influences plasma total homocysteine concentrations in young women after restricting folate intake.
J. Nutr. 135: 2780-2785 (2005).
*
-
Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C, Malone L, Kollias G, Arthur JS. Generation and characterization of p38beta (MAPK11) gene-targeted mice.
Mol. Cell. Biol. 25: 10454-10464 (2005).
*
-
Beattie RM. Enteral nutrition as primary therapy in childhood Crohn's disease: control of intestinal inflammation and anabolic response.
JPEN J. Parenter. Enteral Nutr. 29: S151-S159 (2005).
*
-
Beaudet MJ, Desrochers M, Lachaud AA, Anderson A. The CYP2B2 phenobarbital response unit contains binding sites for hepatocyte nuclear factor 4, PBX-PREP1, the thyroid hormone receptor beta, and the liver X receptor.
Biochem. J. 388: 407-418 (2005).
*
-
Beaudreuil S, Lasfargues G, Laueriere L, Ghoul ZE, Fourquet F, Longuet C, Halimi JM, Nivet H, Buchler M. Occupational exposure in ANCA-positive patients: a case-control study.
Kidney Int. 67: 1961-1966 (2005).
*
-
Beaugerie L. What is an inflammatory bowel disease?
Rev. Prat. 55: 943-948 (2005).
-
Beaugrand M, N'kontchou G, Seror O, Ganne N, Trinchet JC. Local/regional and systemic treatments of hepatocellular carcinoma.
Semin. Liver Dis. 25: 201-211 (2005).
-
Beaussier M, Wendum D, Fouassier L, Rey C, Barbu V, Lasnier E, Lienhart A, Scoazec JY, Rosmorduc O, Housset C. Adaptative bile duct proliferative response in experimental bile duct ischemia.
J. Hepatol. 42: 257-265 (2005).
*
-
Bebo BF Jr, Dveksler GS. Evidence that pregnancy specific glycoproteins regulate T-cell function and inflammatory autoimmune disease during pregnancy.
Curr. Drug Targets Inflamm. Allergy 4: 231-237 (2005).
-
Bebok Z, Collawn J, Wakefield J, Parker W, Varga K, Li Y, Sorscher EJ, Clancy JP. Failure of cAMP agonists to activate rescued DeltaF508 CFTR in CFBE41o- airway epithelial monolayers.
J. Physiol. 569: 601-615 (2005).
*
-
Beck K, Hayashi K, Dang K, Hayashi M, Boyd CD. Analysis of ABCC6 (MRP6) in normal human tissues.
Histochem. Cell. Biol. 123: 517-528 (2005).
*
-
Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, Lehr HA, Galle PR, Neurath MF. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.
Gut 54: 950-954 (2005).
*
-
Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, Rose-John S, Neurath MF. IL-6 signaling promotes tumor growth in colorectal cancer.
Cell Cycle 4: 217-220 (2005).
*
-
Becker C, Wirtz S, Neurath MF. Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors.
Inflamm. Bowel Dis. 11: 755-764 (2005).
*
-
Becker E, Horn S, Hussla B, Irle H, Knorr I, Korsukewitz C, Pottins I, Rohwetter M, Schuhknecht P, Timner K. Guidelines for the sociomedical assessment of performance in patients suffering from inflammatory bowel disease.
Gesundheitswesen 67: 396-415 (2005).
-
Becker MD, Smith JR, Max R, Fiehn C. Management of sight-threatening uveitis: new therapeutic options.
Drugs 65: 497-519 (2005).
-
Becker ML, Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis.
Curr. Rheumatol. Rep. 7: 427-433 (2005).
-
Becker-Merok A, Nossent H. Antiphospholipid antibody syndrome in autoimmune hepatitis.
Isr. Med. Assoc. J. 7: 268-269 (2005).
*
-
Beckmann L, Ziegler A, Duggal P, Bailey-Wilson JE. Haplotypes and haplotype-tagging single-nucleotide polymorphism: presentation Group 8 of Genetic Analysis Workshop 14.
Genet. Epidemiol. 29: S59-S71 (2005).
-
Beckwith J, Cong Y, Sundberg JP, Elson CO, Leiter EH. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens.
Gastroenterology 129: 1473-1484 (2005).
*
-
Becvar R, Stork J, Pesakova V, Stanova A, Hulejova H, Rysova L, Zatloukalova A, Zatloukal P, Jachymova M, Pourova L. Clinical correlations of potential activity markers in systemic sclerosis.
Ann. N. Y. Acad. Sci. 1051: 404-412 (2005).
*
-
Bednarz W, Olewinski R, Wojczys R, Sutkowski K, Domoslawski P, Balcerzak W. Leal-pouch-anal anastomosis after restorative proctocolectomy in patients with ulcerative colitis or familial adenomatous polyposis.
Hepatogastroenterology 52: 1101-1105 (2005).
-
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Hepatology 42: 44-52 (2005).
*
-
Bedu E, Wahli W, Desvergne B. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
Expert Opin. Ther. Targets 9: 861-873 (2005).
-
Beeton C, Chandy KG. Potassium channels, memory T cells, and multiple sclerosis.
Neuroscientist 11: 550-562 (2005).
*
-
Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, Khaytin I, Calabresi PA, Chen CY, Gutman GA, Chandy KG. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
Mol. Pharmacol. 67: 1369-1381 (2005).
*
-
Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma.
Gastroenterology 128: 1752-1764 (2005).
*
-
Begg DJ, O'Brien R, Mackintosh CG, Griffin JF. Experimental infection model for Johne's disease in sheep.
Infect. Immun. 73: 5603-5611 (2005).
*
-
Begley M, Gahan CG, Hill C. The interaction between bacteria and bile.
FEMS Microbiol. Rev. 29: 625-651 (2005).
*
-
Begni B, Amadori M, Ritelli M, Podavini D. Effects of IFN-alpha on the inflammatory response of swine leukocytes to bacterial endotoxin.
J. Interferon. Cytokine Res. 25: 202-208 (2005).
-
Begovich AB, Caillier SJ, Alexander HC, Penko JM, Hauser SL, Barcellos LF, Oksenberg JR. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis.
Am. J. Hum. Genet. 76: 184-187 (2005).
*
-
Behi ME, Dubucquoi S, Lefranc D, Zephir H, Seze JD, Vermersch P, Prin L. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Immunol. Lett. 96: 11-26 (2005).
-
Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis.
Biochem. Soc. Trans. 33: 672-675 (2005).
*
-
Behrens TW, Graham RR, Kyogoku C, Baechler EC, Ramos PS, Gillett C, Bauer J, Ortmann WA, Hippen KL, Peterson E, Langefeld CD, Moser KL, Gaffney PM, Gregersen PK. Progress towards understanding the genetic pathogenesis of systemic lupus erythematosus.
Novartis Found. Symp. 267: 145-160 (2005).
-
Beilhack GF, Landa RR, Masek MA, Shizuru JA. Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.
Diabetes 54: 1770-1779 (2005).
*
-
Beissbarth T, Tye-Din JA, Smyth GK, Speed TP, Anderson RP. A systematic approach for comprehensive T-cell epitope discovery using peptide libraries.
Bioinformatics 21: i29-i37 (2005).
*
-
Bekris LM, Shephard C, Peterson M, Hoehna J, Yserloo BV, Rutledge E, Farin F, Kavanagh TJ, Lernmark A. Glutathione-S-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset.
Autoimmunity 38: 567-575 (2005).
-
Belanger JE, Wooltorton E. Is the timing of infant cereal introduction a risk factor for celiac disease autoimmunity?
CMAJ 173: 1324 (2005).
*
-
Belardinelli R, Mucaj A, Lacalaprice F, Solenghi M, Principi F, Tiano L, Littarru GP. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure.
Biofactors 25: 137-145 (2005).
-
Belghiti J. Transplantation for liver tumors.
Semin. Oncol. 32: S29-S32 (2005).
-
Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen ZS, Grinberg A, Westphal H, Klein-Szanto A, Lerro A, Kruh GD. Analysis of the in vivo functions of Mrp3.
Mol. Pharmacol. 68: 160-168 (2005).
*
-
Belkahla N, Maamouri N, Ouerghi H, Ben Ammar A. Role of intestinal flora in inflammatory bowel disease and probiotics place in their management.
Tunis. Med. 83: 132-136 (2005).
-
Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease.
Nat. Immunol. 6: 353-360 (2005).
*
-
Bell E, Bird L. Autoimmunity.
Nature 435: 583 (2005).
*
-
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, Davies DR. The molecular structure of the Toll-like receptor 3 ligand-binding domain.
Proc. Natl. Acad. Sci. U.S.A. 102: 10976-10980 (2005).
*
-
Bellentani S. Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?
Eur. J. Gastroenterol. Hepatol. 17: 137-140 (2005).
*
-
Bellodi-Privato M, Aubert D, Pichard V, Myara A, Trivin F, Ferry N. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors.
Hepatology 42: 431-438 (2005).
*
-
Belloni Fortina A, Piaserico S, Zattra E, Alaibac M. Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease.
Melanoma Res. 15: 223-224 (2005).
-
Bellosta S, Bernini F. Modulation of macrophage function and metabolism.
Handb. Exp. Pharmacol. 170: 665-695 (2005).
-
Bellou A, Finn PW. Costimulation: critical pathways in the immunologic regulation of asthma.
Curr. Allergy Asthma Rep. 5: 149-154 (2005).
-
Bellows CF, Berger DH, Crass RA. Management of gallstones.
Am. Fam. Physician 72: 637-642 (2005).
*
-
Belmiro CL, Souza HS, Elia CC, Castelo-Branco MT, Silva FR, Machado RL, Pavao MS. Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease.
Int. J. Colorectal Dis. 20: 295-304 (2005).
*
-
Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity.
J. Virol. 79: 12507-12514 (2005).
*
-
Beltinger J, Froehlich F. Patients with inflammatory bowel disease in specialist gastroenterology practice: a prospective survey.
Schweiz. Rundsch. Med. Prax. 94: 459-465 (2005).
-
Belzer C, Stoof J, Beckwith CS, Kuipers EJ, Kusters JG, van Vliet AH. Differential regulation of urease activity in Helicobacter hepaticus and Helicobacter pylori.
Microbiology 151: 3989-3995 (2005).
*
-
Ben Lagha N, Poulesquen V, Roujeau JC, Alantar A, Maman L. Pemphigus vulgaris: a case-based update.
J. Can. Dent. Assoc. 71: 667-672 (2005).
-
Ben Temime L, Gherib BS, Daldoul S, Bel Hadj Salah R, Abdesselem Mel M, Zaouche A. Adenocarcinoma at the site of ileo-anal anastomosis in Crohn's disease: report of a case.
Tunis. Med. 83: 55-58 (2005).
-
Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, Zick A, Sharoni Y, Levy J. Carotenoids activate the antioxidant response element transcription system.
Mol. Cancer Ther. 4: 177-186 (2005).
*
-
Ben-Haim M, Carmiel M, Lubezky N, Keidar R, Katz P, Blachar A, Nimrod A, Sorkine P, Oren R, Klausner JM, Nakache R. Donor recruitment and selection for adult-to-adult living donor liver transplantation in urgent and elective circumstances.
Isr. Med. Assoc. J. 7: 169-173 (2005).
*
-
Bendas G. Inhibitors of membrane receptors involved with leukocyte extravasation.
Mini. Rev. Med. Chem. 5: 575-584 (2005).
-
Bendicho MT, Guedes JC, Silva NN, Santana GO, dos Santos RR, Lyra AC, Lyra LG, Meyer R, Lemaire DC. Polymorphism of cytokine genes (TGF-beta1, IFN-gamma, IL-6, IL-10, and TNF-alpha) in patients with chronic pancreatitis.
Pancreas 30: 333-336 (2005).
-
Bendinelli P, Piccoletti R, Maroni P. Leptin rapidly activates PPARs in C2C12 muscle cells.
Biochem. Biophys. Res. Commun. 332: 719-725 (2005).
*
-
Bene J, Komlosi K, Gasztonyi B, Juhasz M, Tulassay Z, Melegh B. Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet.
World J. Gastroenterol. 11: 6671-6675 (2005).
*
-
Benes Z. Crohn's disease and infectious agents.
Klin. Mikrobiol. Infekc. Lek. 11: 15-19 (2005).
-
Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature.
J. Gynecol. Obstet. Biol. Reprod. (Paris) 34: 581-588 (2005).
-
Benlloch M, Ortega A, Ferrer P, Segarra R, Obrador E, Asensi M, Carretero J, Estrela JM. Acceleration of glutathione efflux and inhibition of gamma-glutamyl transpeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity.
J. Biol. Chem. 280: 6950-6959 (2005).
*
-
Benninger J, Grobholz R, Oeztuerk Y, Antoni CH, Hahn EG, Singer MV, Strauss R. Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.
World J. Gastroenterol. 11: 4199-4205 (2005).
*
-
Bennink RJ, Hamann J, de Bruin K, Ten Kate FJ, van Deventer SJ, Te Velde AA. Dedicated pinhole SPECT of intestinal neutrophil recruitment in a mouse model of dextran sulfate sodium-induced colitis.
J. Nucl. Med. 46: 526-531 (2005).
*
-
Bensa C, Boscagli A, Bourg V, Bensaken S, Chanalet S, Lebrun C. Recurrent aseptic meningitis associated with primary biliary cirrhosis.
Rev. Neurol. (Paris) 161: 87-91 (2005).
-
Bensalem N, Ventura AP, Vallee B, Lipecka J, Tondelier D, Davezac N, Dos Santos A, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprevote O, Edelman A. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients.
Mol. Cell. Proteomics 4: 1591-1601 (2005).
*
-
Benseler SM, Silverman ED. Systemic lupus erythematosus.
Pediatr. Clin. North Am. 52: 443-467 (2005).
-
Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease.
Am. J. Ther. 12: 133-141 (2005).
-
Bentabak K, Graba A, Boudjema K, Griene B, Debzi N, Bekkouche N, Yahiatene S, Fellah N, Benmoussa D, Faraoun SA, Bodin JM, Lakehal M, Bendib SE, Boucekkine T. Adult-to-adult living related liver transplantation: preliminary results of the hepatic transplantation group in Algiers.
Transplant. Proc. 37: 2873-2874 (2005).
*
-
Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, Gupta S. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice.
Hepatology 42: 140-148 (2005).
*
-
Benten D, Kumaran V, Joseph B, Schattenberg J, Popov Y, Schuppan D, Gupta S. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat.
Hepatology 42: 1072-1081 (2005).
*
-
Benzinger P, Alscher DM. Untreated homocystinuria in adulthood.
Dtsch. Med. Wochenschr. 130: 2439-2443 (2005).
-
Beran J, Dedek P, Stepanova V, Spliio M, Pozler O. Safety and immunogenicity of a combined vaccine against hepatitis A and B in patients with autoimmune hepatitis.
Cent. Eur. J. Public Health 13: 20-23 (2005).
-
Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, Avila MA. Amphiregulin: an early trigger of liver regeneration in mice.
Gastroenterology 128: 424-432 (2005).
*
-
Beraza N, Marques JM, Martinez-Anso E, Iniguez M, Prieto J, Bustos M. Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration.
Hepatology 41: 460-469 (2005).
*
-
Berber E, Rogers S, Siperstein A. Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer. A prospective study.
Surg. Endosc. 19: 710-714 (2005).
*
-
Berberat PO, A-Rahim YI, Yamashita K, Warny MM, Csizmadia E, Robson SC, Bach FH. Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis.
Inflamm. Bowel Dis. 11: 350-359 (2005).
*
-
Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
Nutrition 21: 131-136 (2005).
*
-
Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease?
Gastroenterol. Clin. North Am. 34: 235-245 (2005).
-
Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children.
J. Mol. Med. 83: 535-541 (2005).
*
-
Berek C. Do B cells play an important role in the pathogenesis of rheumatoid arthritis?
Z. Rheumatol. 64: 383-388 (2005).
-
Berenguer M. Treatment of hepatitis C after liver transplantation.
Clin. Liver Dis. 9: 579-600 (2005).
-
Bergamaschi G. Two novel mutations, L490R and V561X, in transferrin receptor 2 in Japanese patients with hemochromatosis.
Haematologica 90: 289A (2005).
*
-
Bergasa NV. The pruritus of cholestasis.
J. Hepatol. 43: 1078-1088 (2005).
*
-
Berge RK, Tronstad KJ, Berge K, Rost TH, Wergedahl H, Gudbrandsen OA, Skorve J. The metabolic syndrome and the hepatic fatty acid drainage hypothesis.
Biochimie 87: 15-20 (2005).
-
Berger AL, Ikuma M, Welsh MJ. Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.
Proc. Natl. Acad. Sci. U.S.A. 102: 455-460 (2005).
*
-
Berger AL, Randak CO, Ostedgaard LS, Karp PH, Vermeer DW, Welsh MJ. Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity.
J. Biol. Chem. 280: 5221-5226 (2005).
*
-
Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease.
Trends Pharmacol. Sci. 26: 244-251 (2005).
*
-
Berger JR, Koralnik IJ. Progressive multifocal leukoencephalopathy and natalizumab - unforeseen consequences.
N. Engl. J. Med. 353: 414-416 (2005).
*
-
Bergheim I, McClain CJ, Arteel GE. Treatment of alcoholic liver disease.
Dig. Dis. 23: 275-284 (2005).
-
Berghofer B, Frommer T, Konig IR, Ziegler A, Chakraborty T, Bein G, Hackstein H. Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance.
Clin. Exp. Allergy 35: 1147-1154 (2005).
-
Bergholdt R, Nerup J, Pociot F. Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes.
J. Med. Genet. 42: 17-25 (2005).
*
-
Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
J. Leukoc. 77: 579-585 (2005).
*
-
Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D'Elios MM, Amedei A, Azzurri A, Benagiano M, Del Prete G. The story so far: Helicobacter pylori and gastric autoimmunity.
Int. Rev. Immunol. 24: 63-91 (2005).
-
Bergman R, Sloots CE. Diagnostic image (246). A man with faecal production of the umbilicus.
Ned. Tijdschr. Geneeskd. 149: 1940 (2005).
-
Bergonzelli GE, Blum S, Brussow H, Corthesy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases?
Digestion 72: 57-68 (2005).
-
Bergquist A, Lindberg G, Saarinen S, Broome U. Increased prevalence of primary sclerosing cholangitis among first-degree relatives.
J. Hepatol. 42: 252-256 (2005).
*
-
Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease associated HLA-DQ2 molecule.
J. Biol. Chem. 280: 21791-21796 (2005).
*
-
Beri R, Peterlana D, Puccetti A, Simeoni S, Garzotti P, Biasi D, Caramaschi P, Tinazzi E, Lunardi C. HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations.
Recenti Prog. Med. 96: 139-143 (2005).
-
Beringer PM, Slaughter RL. Transporters and their impact on drug disposition.
Ann. Pharmacother. 39: 1097-1108 (2005).
-
Berkelhammer C, Debre M, Gutti P. Piriformis muscle abscess complicating Crohn's ileitis.
Inflamm. Bowel Dis. 11: 1028-1029 (2005).
*
-
Berkenstam A, Gustafsson JA. Nuclear receptors and their relevance to diseases related to lipid metabolism.
Curr. Opin. Pharmacol. 5: 171-176 (2005).
-
Berkers CR, Ovaa H. Immunotherapeutic potential for ceramide-based activators of iNKT cells.
Trends Pharmacol. Sci. 26: 252-257 (2005).
*
-
Berkun Y, Gershwin ME, Shoenfeld Y. Autoimmune hepatitis: a part of the antiphospholipid syndrome?
Isr. Med. Assoc. J. 7: 264-265 (2005).
*
-
Berlie I, Leboucher B, Leblanc M, Troussier F, Pellier I, Chevailler A, Ginies JL. Antineutrophil cytoplasmic antibodies in cystic fibrosis. Frequency and significance.
Arch. Pediatr. 12: 140-143 (2005).
-
Berlit P, Stueper B, Fink I, Rebmann V, Hoyer P, Kreuzfelder E, Grosse-Wilde H. Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteins.
Vasa 34: 176-180 (2005).
-
Berlo SE, van Kooten PJ, Ten Brink CB, Hauet-Broere F, Oosterwegel MA, Glant TT, Van Eden W, Broeren CP. Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation.
J. Autoimmun. 25: 172-180 (2005).
-
Bermejo JL, Eng C, Hemminki K. Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer.
Gastroenterology 129: 1889-1899 (2005).
*
-
Bernardi M, Predieri S. Disturbances of acid-base balance in cirrhosis: a neglected issue warranting further insights.
Liver Int. 25: 463-466 (2005).
*
-
Bernasconi P, Barberis M, Baggi F, Passerini L, Cannone M, Arnoldi E, Novellino L, Cornelio F, Mantegazza R. Increased Toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.
Am. J. Pathol. 167: 129-139 (2005).
*
-
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin P, Gordon C, Barr S, Edworthy S, Bae SC, Petri M, Sibley J, Isenberg D, Rahman A, Steinsson K, Aranow C, Dooley MA, Alarcon GS, Hanly J, Sturfelt G, Nived O, Pope J, et al. Race/ethnicity and cancer occurrence in systemic lupus erythematosus.
Arthritis Rheum. 53: 781-784 (2005).
*
-
Bernatsky S, Ramsey-Goldman R, Rajan R, Boivin JF, Joseph L, Lachance S, Cournoyer D, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Steinsson K, Nived O, Sturfelt G, St Pierre Y, Clarke A. Non-Hodgkin's lymphoma in systemic lupus erythematosus.
Ann. Rheum. Dis. 64: 1507-1509 (2005).
*
-
Berndtsson I, Lindholm E, Ekman I. Thirty years of experience living with a continent ileostomy.
J. Wound Ostomy Continence Nurs. 32: 321-326 (2005).
-
Bernig T, Breunis W, Brouwer N, Hutchinson A, Welch R, Roos D, Kuijpers T, Chanock S. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannose-binding lectin.
Hum. Genet. 118: 404-415 (2005).
*
-
Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms.
Inflamm. Bowel Dis. 11: 909-918 (2005).
*
-
Bernklev T, Jahnsen J, Schulz T, Sauar J, Lygren I, Henriksen M, Stray N, Kjellevold O, Aadland E, Vatn M, Moum B. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis.
Eur. J. Gastroenterol. Hepatol. 17: 1037-1045 (2005).
-
Bernstein CN. Limiting fracture risk in Crohn's disease: is there anything better than calcium and vitamin D?
Clin. Gastroenterol. Hepatol. 3: 110-112 (2005).
*
-
Bernstein CN, Greenberg H, Boult I, Chubey S, Leblanc C, Ryner L. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease.
Am. J. Gastroenterol. 100: 2493-2502 (2005).
*
-
Bernstein CN, Leslie WD. Therapy insight: osteoporosis in inflammatory bowel disease - advances and retreats.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 232-239 (2005).
*
-
Bernstein CN, Sargent M, Leslie WD. Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study.
Inflamm. Bowel Dis. 11: 325-330 (2005).
*
-
Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in IBD: a population-based study.
Gastroenterology 129: 827-836 (2005).
*
-
Bernstein M, Irwin S, Greenberg GR. Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease.
Am. J. Gastroenterol. 100: 2031-2035 (2005).
*
-
Berrettini WH, Lerman CE. Pharmacotherapy and pharmacogenetics of nicotine dependence.
Am. J. Psychiatry 162: 1441-1451 (2005).
*
-
Berrih-Aknin S, Fuchs S, Souroujon MC. Vaccines against myasthenia gravis.
Expert Opin. Biol. Ther. 5: 983-995 (2005).
*
-
Bert F, Bellier C, Lassel L, Lefranc V, Durand F, Belghiti J, Mentre F, Fantin B. Risk factors for Staphylococcus aureus infection in liver transplant recipients.
Liver Transpl. 11: 1093-1099 (2005).
*
-
Berti S, Amato L, Chiarini C, Fabbri P. Case study: an itching and excoriated dermatosis during intrahepatic cholestasis of pregnancy.
Skinmed. 4: 248-249 (2005).
-
Bertolaccini ML, Atsumi T, Koike T, Hughes GR, Khamashta MA. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus.
Thromb. Haemost. 93: 289-297 (2005).
-
Bertolaccini ML, Khamashta MA, Hughes GR. Diagnosis of antiphospholipid syndrome.
Nat. Clin. Pract. Rheumatol. 1: 40-46 (2005).
*
-
Bertolami MC. Mechanisms of hepatotoxicity.
Arq. Bras. Cardiol. 85 Suppl. 4: 25-27 (2005).
-
Bertolino P, Schrage A, Bowen DG, Klugewitz K, Ghani S, Eulenburg K, Holz L, Hogg N, McCaughan GW, Hamann A. Early intrahepatic antigen-specific retention of naive CD8(+) T cells is predominantly ICAM-1/LFA-1 dependent in mice.
Hepatology 42: 1063-1071 (2005).
*
-
Berton G, Mocsai A, Lowell CA. Src and Syk kinases: key regulators of phagocytic cell activation.
Trends Immunol. 26: 208-214 (2005).
*
-
Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Cancer Epidemiol. Biomarkers Prev. 14: 1991-1997 (2005).
*
-
Bertoni M, Niccoli L, Porciello G, Storri L, Nannini C, Manes A, Palazzini M, Galie N, Cantini F. Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature.
Clin. Rheumatol. 24: 431-434 (2005).
*
-
Bertram JS, Vine AL. Cancer prevention by retinoids and carotenoids: independent action on a common target.
Biochim. Biophys. Acta 1740: 170-178 (2005).
*
-
Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, Elliott KJ, Velicelebi G, Moscarillo T, Hyman BT, Wagner SL, Becker KD, Blacker D, Tanzi RE. Family-based association between Alzheimer's disease and variants in UBQLN1.
N. Engl. J. Med. 352: 884-894 (2005).
*
-
Bertrandt J, Klos A, Debski B. Polyunsaturated fatty acid (PUFA) changes in serum and liver of undernourished rats given dietary vitamin B6 supplementation.
J. Nutr. Sci. Vitaminol. (Tokyo) 51: 129-134 (2005).
-
Bessems M, Doorschodt BM, van Vliet AK, van Gulik TM. Improved rat liver preservation by hypothermic continuous machine perfusion using polysol, a new, enriched preservation solution.
Liver Transpl. 11: 539-546 (2005).
*
-
Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappaB to repress cytokine gene expression and effector functions of T helper cells.
Proc. Natl. Acad. Sci. U.S.A. 102: 5138-5143 (2005).
*
-
Bettelli E, Kuchroo VK. IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together.
J. Exp. Med. 201: 169-171 (2005).
*
-
Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).
Diabet. Med. 22: 144-151 (2005).
*
-
Betz S, Kaser A, Nagaishi T, Yoshida M, Hussain M, vander Lugt B, Exley M, Blumberg RS. Lipids and IBD: microsomal triglyceride transfer protein - the new dimension?
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 23 (2005). *
-
Beuers U. Hepatic overlap syndromes.
J. Hepatol. 42 Suppl. 1: S93-S99 (2005).
*
-
Beuers U, Rust C. Overlap syndromes.
Semin. Liver Dis. 25: 311-320 (2005).
-
Beutler B. The Toll-like receptors: analysis by forward genetic methods.
Immunogenetics 57: 385-392 (2005).
*
-
Beutler B, Crozat K, Koziol JA, Georgel P. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model.
Curr. Opin. Immunol. 17: 36-43 (2005).
-
Bevins CL. Defensins and other antibacterial mediators.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 45 (2005). *
-
Bevins CL. Events at the host-microbial interface of the gastrointestinal tract V. Paneth cell alpha-defensins in intestinal host defense.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G173-G176 (2005).
*
-
Bewtra M, Lichtenstein GR. Infliximab use in Crohn's disease.
Expert Opin. Biol. Ther. 5: 589-599 (2005).
-
Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hunig T, Kerkau T, Gold R. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
J. Exp. Med. 202: 445-455 (2005).
*
-
Beyersdorf N, Hanke T, Kerkau T, Hunig T. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
Ann. Rheum. Dis. 64 Suppl. 4: iv91-iv95 (2005).
*
-
Bezbradica JS, Hill T, Stanic AK, Van Kaer L, Joyce S. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny.
Proc. Natl. Acad. Sci. U.S.A. 102: 5114-5119 (2005).
*
-
Bezerra EL, Vilar MJ, da Trindade Neto PB, Inoue Sato EL. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
Arthritis Rheum. 52: 3073-3078 (2005).
*
-
Bezerra JA. Potential etiologies of biliary atresia.
Pediatr. Transplant. 9: 646-651 (2005).
-
Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM. RANK, RANKL and osteoprotegerin in arthritic bone loss.
Braz. J. Med. Biol. Res. 38: 161-170 (2005).
*
-
Bhaduri S, Jenkinson S, Lewis F. Vulval Crohn's disease - a multi-specialty approach.
Int. J. STD AIDS 16: 512-514 (2005).
-
Bhagavathula N, Nerusu KC, Reddy M, Ellis CN, Chittiboyina A, Avery M, Pershadsingh HA, Kurtz TW, Varani J. BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel, synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin - SCID mouse transplants following topical application.
J. Pharmacol. Exp. Ther. 315: 996-1004 (2005).
*
-
Bharucha AE, Fletcher JG, Seide B, Riederer SJ, Zinsmeister AR. Phenotypic variation in functional disorders of defecation.
Gastroenterology 128: 1199-1210 (2005).
*
-
Bhasin DK, Rana SS, Chandail VS, Nanda M, Nadkarni N, Sinha SK, Nagi B. An intra-hepatic pancreatic pseudocyst successfully treated endoscopic transpapillary drainage alone.
JOP 6: 593-597 (2005).
*
-
Bhatia A, Schafer HJ, Hrycyna CA. Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers.
Biochemistry 44: 10893-10904 (2005).
*
-
Bhatia M. Molecular mimicry in autoimmune pancreatitis: an interesting idea.
J. Cell. Mol. Med. 9: 745 (2005).
*
-
Bhatia S, Edidin M, Almo SC, Nathenson SG. Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling.
Proc. Natl. Acad. Sci. U.S.A. 102: 15569-15574 (2005).
*
-
Bhatia V, Tandon RK. Stress and the gastrointestinal tract.
J. Gastroenterol. Hepatol. 20: 332-339 (2005).
*
-
Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR, Fischbach M, Fernandes G. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Faslpr mice by n-3 fatty acids.
J. Am. Coll. Nutr. 24: 200-209 (2005).
*
-
Bhuket T, Takami M, Fisher L. The use of wireless capsule endoscopy in clinical diagnostic gastroenterology.
Expert Rev. Med. Devices 2: 259-266 (2005).
-
Biagi F, Campanella J, Alvisi C, Versino M, Corazza GR. Unusual association of neurofibromatosis type 1 and coeliac disease in a single patient.
Funct. Neurol. 20: 33-34 (2005).
-
Bialecka M, Hnatyszyn G, Bielicka-Cymerman J, Drozdzik M. The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy.
Neurol. Neurochir. Pol. 39: 476-481 (2005).
-
Bian GX, Miao H, Qiu L, Cao DM, Guo BY. Profiling of differentially expressed chemotactic-related genes in MCP-1 treated macrophage cell line using human cDNA arrays.
World J. Gastroenterol. 11: 2508-2512 (2005).
*
-
Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes.
Arthritis Res. Ther. 7: R1325-R1337 (2005).
*
-
Bianchi G, Marzocchi R, Agostini F, Marchesini G. Update on branched-chain amino acid supplementation in liver diseases.
Curr. Opin. Gastroenterol. 21: 197-200 (2005).
-
Bianchi ML. How to manage osteoporosis in children.
Best Pract. Res. Clin. Rheumatol. 19: 991-1005 (2005).
-
Biancofiore G, Bindi ML, Romanelli AM, Boldrini A, Bisa M, Esposito M, Urbani L, Catalano G, Mosca F, Filipponi F. Fast track in liver transplantation: 5 years' experience.
Eur. J. Anaesthesiol. 22: 584-590 (2005).
-
Biancofiore G, Bindi ML, Romanelli AM, Urbani L, Mosca F, Filipponi F. Stress-inducing factors in ICUs: what liver transplant recipients experience and what caregivers perceive.
Liver Transpl. 11: 967-972 (2005).
*
-
Biancone L, Schillaci O, Capoccetti F, Bozzi RM, Fina D, Petruzziello C, Geremia A, Simonetti G, Pallone F. Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration.
Am. J. Gastroenterol. 100: 344-354 (2005).
*
-
Biasco G, Di Marco MC. Folate and prevention of colorectal cancer in ulcerative colitis.
Eur. J. Cancer Prev. 14: 395-398 (2005).
-
Biason-Lauber A, Boehm B, Lang-Muritano M, Gauthier BR, Brun T, Wollheim CB, Schoenle EJ. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.
Diabetologia 48: 900-905 (2005).
*
-
Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.
Am. J. Gastroenterol. 100: 1539-1546 (2005).
*
-
Bickston SJ, Foley E, Lawrence C, Rockoff T, Shaffer HA Jr, Yeaton P. Terminal ileal stricture in Crohn's disease: treatment using a metallic enteral endoprosthesis.
Dis. Colon Rectum 48: 1081-1085 (2005).
*
-
Bid HK, Chaudhary H, Mittal RD. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis.
Pediatr. Nephrol. 20: 773-776 (2005).
*
-
Bien CG, Bauer J. T-cells in human encephalitis.
Neuromolecular Med. 7: 243-254 (2005).
-
Bienenstock J, McDermott MR. Bronchus- and nasal-associated lymphoid tissues.
Immunol. Rev. 206: 22-31 (2005).
*
-
Bienvenu T, Viel M, Leroy C, Cartault F, Lesure JF, Renouil M. Spectrum of CFTR mutations on Reunion Island: impact on neonatal screening.
Hum. Biol. 77: 705-714 (2005).
-
Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products.
J. Mol. Med. 83: 876-886 (2005).
*
-
Bierhaus A, Humpert PM, Stern DM, Arnold B, Nawroth PP. Advanced glycation end product receptor-mediated cellular dysfunction.
Ann. N. Y. Acad. Sci. 1043: 676-680 (2005).
*
-
Biering H, Bohner G, Strasburger CJ. Autoimmune hypophysitis.
Dtsch. Med. Wochenschr. 130: 2826-2828 (2005).
-
Biet F, Boschiroli ML, Thorel MF, Guilloteau LA. Zoonotic aspects of Mycobacterium bovis and Mycobacterium avium-intracellulare complex (MAC).
Vet. Res. 36: 411-436 (2005).
*
-
Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation.
Hepatology 41: 32-39 (2005).
*
-
Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G646-G653 (2005).
*
-
Bijvelds MJ, Jorna H, Verkade HJ, Bot AG, Hofmann F, Agellon LB, Sinaasappel M, de Jonge HR. Activation of CFTR by ASBT-mediated bile salt absorption.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G870-G879 (2005).
*
-
Bilaj F, Hyslop WB, Rivero H, Firat Z, Vaidean G, Shrestha R, Woosley JT, Semelka RC. MR imaging findings in autoimmune hepatitis: correlation with clinical staging.
Radiology 236: 896-902 (2005).
*
-
Bilic M, Bumber Z, Blagaic AB, Batelja L, Seiwerth S, Sikiric P. The stable gastric pentadecapeptide BPC 157, given locally, improves CO(2) laser healing in mice.
Burns 31: 310-315 (2005).
-
Billings PR, Carlson RJ, Carlson J, Cain M, Wilson C, Shorett P, Everett W. Ready for genomic medicine? Perspectives of health care decision makers.
Arch. Intern. Med. 165: 1917-1919 (2005).
*
-
Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, Thivolet C. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging.
Radiology 236: 579-587 (2005).
*
-
Binder EB, Holsboer F. Pharmacogenomics.
Handb. Exp. Pharmacol. 169: 527-546 (2005).
-
Binder V. Clinical epidemiology - how important now?
Gut 54: 574-575 (2005).
*
-
Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF, Blanche H, Le Bail B, Saric J, Laurent-Puig P, Balabaud C, Zucman-Rossi J. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.
Gastroenterology 128: 1211-1218 (2005).
*
-
Biragyn A. Defensins - non-antibiotic use for vaccine development.
Curr. Protein Pept. Sci. 6: 53-60 (2005).
-
Birbe R, Palazzo JP, Walters R, Weinberg D, Schulz S, Waldman SA. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Hum. Pathol. 36: 170-179 (2005).
*
-
Birch KE, Vukmanovic-Stejic M, Reed JR, Akbar AN, Rustin MH. The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin.
Br. J. Dermatol. 152: 409-417 (2005).
*
-
Birchard KR, Brown MA, Hyslop WB, Firat Z, Semelka RC. MRI of acute abdominal and pelvic pain in pregnant patients.
AJR Am. J. Roentgenol. 184: 452-458 (2005).
*
-
Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA, Orntoft TF. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid.
Gut 54: 374-384 (2005).
*
-
Birnie AJ, Perkins W. A case of linear IgA disease occurring in a patient with colonic Crohn's disease.
Br. J. Dermatol. 153: 1050-1052 (2005).
*
-
Biro T, Ko MC, Bromm B, Wei ET, Bigliardi P, Siebenhaar F, Hashizume H, Misery L, Bergasa NV, Kamei C, Schouenborg J, Roostermann D, Szabo T, Maurer M, Bigliardi-Qi M, Meingassner JG, Hossen MA, Schmelz M, Steinhoff M. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches.
Exp. Dermatol. 14: 225-240 (2005).
*
-
Biros E, Jordan MA, Baxter AG. Genes mediating environment interactions in type 1 diabetes.
Rev. Diabet. Stud. 2: 192-207 (2005).
*
-
Birring SS, Patel RB, Parker D, McKenna S, Hargadon B, Monteiro WR, Falconer Smith JF, Pavord ID. Airway function and markers of airway inflammation in patients with treated hypothyroidism.
Thorax 60: 249-253 (2005).
*
-
Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives.
Gastroenterology 128: 1089-1113 (2005).
*
-
Bishop MD, Freedman SD, Zielenski J, Ahmed N, Dupuis A, Martin S, Ellis L, Shea J, Hopper I, Corey M, Kortan P, Haber G, Ross C, Tzountzouris J, Steele L, Ray PN, Tsui LC, Durie PR. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
Hum. Genet. 118: 372-381 (2005).
*
-
Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective.
Curr. Opin. Pulm. Med. 11: 35-42 (2005).
-
Bister V, Kolho KL, Karikoski R, Westerholm-Ormio M, Savilahti E, Saarialho-Kere U. Metalloelastase (MMP-12) is upregulated in the gut of pediatric patients with potential celiac disease and in type 1 diabetes.
Scand. J. Gastroenterol. 40: 1413-1422 (2005).
*
-
Bistritz L, Tamboli C, Bigam D, Bain VG. Polycystic liver disease: experience at a teaching hospital.
Am. J. Gastroenterol. 100: 2212-2217 (2005).
*
-
Bitton A. Preventing postoperative recurrence in Crohn's disease with 6-mercaptopurine and azathioprine: approaching the cutting edge.
Inflamm. Bowel Dis. 11: 513-514 (2005).
*
-
Bjornsson E. Interpretation of liver tests is decisive for the choice of examination in hepatocellular jaundice.
.
Lakartidningen 102: 2154-2157 (2005).
-
Bjornsson E, Cederborg A, Akvist A, Simren M, Stotzer PO, Bjarnason I. Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis.
Scand. J. Gastroenterol. 40: 1090-1094 (2005).
*
-
Bjornsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden.
Scand. J. Gastroenterol. 40: 1095-1101 (2005).
*
-
Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease.
Hepatology 42: 481-489 (2005).
*
-
Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue is not a specific symptom in patients with primary biliary cirrhosis.
Eur. J. Gastroenterol. Hepatol. 17: 351-357 (2005).
-
Bjursten M, Bland PW, Willen R, Hornquist EH. Long-term treatment with anti-alpha4 integrin antibodies aggravates colitis in Galphai2-deficient mice.
Eur. J. Immunol. 35: 2274-2283 (2005).
*
-
Bjursten M, Willen R, Hultgren Hornquist E. Transfer of colitis by Galphai2-deficient T lymphocytes: impact of subpopulations and tissue origin.
Inflamm. Bowel Dis. 11: 997-1005 (2005).
*
-
Blach-Olszewska Z. Innate immunity: cells, receptors, and signaling pathways.
Arch. Immunol. Ther. Exp. (Warsz.) 53: 245-253 (2005).
-
Black DD. Chronic cholestasis and dyslipidemia: what is the cardiovascular risk?
J. Pediatr. 146: 306-307 (2005).
-
Black M, Mignogna M, Scully C. Pemphigus vulgaris.
Oral Dis. 11: 119-130 (2005).
*
-
Blackwell K, Malone PS, Denny A, Connett G, Maddison J. The prevalence of stress urinary incontinence in patients with cystic fibrosis: an under-recognized problem.
J. Pediatr. Urol. 1: 5-9 (2005).
-
Blanc JF, Bioulac-Sage P, Balabaud C, Desmouliere A. Investigation of liver fibrosis in clinical practice.
Hepatol. Res. 32: 1-8 (2005).
-
Blanchard C, Durual S, Estienne M, Emami S, Vasseur S, Cuber JC. Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6.
Int. J. Biochem. Cell. Biol. 37: 2559-2573 (2005).
*
-
Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?
Drug Discov. Today. 10: 197-204 (2005).
-
Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Arthritis Rheum. 52: 201-211 (2005).
*
-
Blanco P, Viallard JF, Pellegrin JL, Moreau JF. Cytotoxic T lymphocytes and autoimmunity.
Curr. Opin. Rheumatol. 17: 731-734 (2005).
-
Blanco PG, Salem RO, Ollero M, Zaman MM, Cluette-Brown JE, Freedman SD, Laposata M. Ethanol administration to cystic fibrosis knockout mice results in increased fatty acid ethyl ester production.
Alcohol Clin. Exp. Res. 29: 2039-2045 (2005).
*
-
Blanco Y, Saiz A, Carreras E, Graus F. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis.
Lancet Neurol. 4: 54-63 (2005).
-
Blank C, Gajewski TF, Mackensen A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
Cancer Immunol. Immunother. 54: 307-314 (2005).
*
-
Blank M, Aron-Maor A, Shoenfeld Y. From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?
Lupus 14: 697-701 (2005).
-
Blank M, Nur I, Toub O, Maor A, Shoenfeld Y. Toward molecular targeting with specific intravenous immunoglobulin preparation.
Clin. Rev. Allergy Immunol. 29: 213-218 (2005).
-
Blank MC, Stefanescu RN, Masuda E, Marti F, King PD, Redecha PB, Wurzburger RJ, Peterson MG, Tanaka S, Pricop L. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.
Hum. Genet. 117: 220-227 (2005).
*
-
Blankenhorn EP, Rodemich L, Martin-Fernandez C, Leif J, Greiner DL, Mordes JP. The rat diabetes susceptibility locus iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.
Diabetes 54: 1233-1237 (2005).
*
-
Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.
J. Immunother. 28: 593-598 (2005).
-
Blaszyk H, Wild PJ, Oliveira A, Kelly DG, Burgart LJ. Hepatic copper in patients receiving long-term total parenteral nutrition.
J. Clin. Gastroenterol. 39: 318-320 (2005).
-
Bleau C, Lamontagne L, Savard R. New Lactobacillus acidophilus isolates reduce the release of leptin by murine adipocytes leading to lower interferon-gamma production.
Clin. Exp. Immunol. 140: 427-435 (2005).
*
-
Bleich A, Mahler M. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and Helicobacter-induced gastritis.
Pathobiology 72: 293-307 (2005).
-
Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA, Vasen HF, Aaronson NK. Screening behavior of individuals at high risk for colorectal cancer.
Gastroenterology 128: 280-287 (2005).
*
-
Blendis L. Trial for treatment of refractory ascites TIPS the scales.
Gastroenterology 128: 797-798 (2005).
*
-
Blendis L. What are Helicobacter doing in the hepatobiliary system?
Gastroenterology 129: 761-763 (2005).
*
-
Blendis L. Steroids in the management of PBC: why do we need them?
Gastroenterology 129: 1350-1352 (2005).
*
-
Blendis L. Mortality from acute portal hypertensive, upper GI bleeding: are we winning?
Gastroenterology 128: 507-508 (2005).
*
-
Blendis L. Chaos in hepatology: do we know what our patients are taking?
Gastroenterology 128: 239-240 (2005).
*
-
Bloch AS. Low carbohydrate diets, pro: time to rethink our current strategies.
Nutr. Clin. Pract. 20: 3-12 (2005).
-
Bloch DB, Yu JH, Yang WH, Graeme-Cook F, Lindor KD, Viswanathan A, Bloch KD, Nakajima A. The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis.
J. Rheumatol. 32: 477-483 (2005).
-
Blomhoff A, Helen Kemp E, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
Pigment Cell Res. 18: 55-58 (2005).
*
-
Blonski WC, Katzka DA, Lichtenstein GR, Metz DC. Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
Eur. J. Gastroenterol. Hepatol. 17: 441-444 (2005).
-
Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria.
J. Clin. Gastroenterol. 39: S167-S175 (2005).
-
Bluestone JA. Opinion: regulatory T-cell therapy: is it ready for the clinic?
Nat. Rev. Immunol. 5: 343-349 (2005).
*
-
Bluestone JA. CTLA-4Ig is finally making it: a personal perspective.
Am. J. Transplant. 5: 423-424 (2005).
*
-
Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity?
Curr. Opin. Immunol. 17: 638-642 (2005).
-
Blum HE. Treatment of hepatocellular carcinoma.
Best Pract. Res. Clin. Gastroenterol. 19: 129-145 (2005).
-
Blum HE. Hepatocellular carcinoma: therapy and prevention.
World J. Gastroenterol. 11: 7391-7400 (2005).
*
-
Blyth K, Cameron ER, Neil JC. The RUNX genes: gain or loss of function in cancer.
Nat. Rev. Cancer 5: 376-387 (2005).
*
-
Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Blood 105: 1574-1581 (2005).
*
-
Boban Blagaic A, Blagaic V, Mirt M, Jelovac N, Dodig G, Rucman R, Petek M, Turkovic B, Anic T, Dubovecak M, Staresinic M, Seiwerth S, Sikiric P. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
Eur. J. Pharmacol. 512: 173-179 (2005).
*
-
Bochner BS, Alvarez RA, Mehta P, Bovin NV, Blixt O, White JR, Schnaar RL. Glycan array screening reveals a candidate ligand for Siglec-8.
J. Biol. Chem. 280: 4307-4312 (2005).
*
-
Bock KW, Kohle C. UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects.
Methods Enzymol. 400: 57-75 (2005).
-
Bockelmann R, Horn T, Gollnick H, Bonnekoh B. Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects.
Skin Pharmacol. Physiol. 18: 42-54 (2005).
-
Bockermann R, Schubert D, Kamradt T, Holmdahl R. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase.
Arthritis Res. Ther. 7: R1316-R1324 (2005).
*
-
Bockhorn M, Frilling A, Nadalin S, Weber F, Beckebaum S, Malago M, Broelsch CE. New techniques in liver transplantation.
Schweiz. Rundsch. Med. Prax. 94: 735-741 (2005).
-
Boddi W, Machetti S, Sodi N, Sammicheli L, Cati G, Marotta G, Sabatini L, Cappelli R. Acquired factor VIII hemophilia in a geriatric patient.
Ann. Ital. Med. Int. 20: 192-196 (2005).
-
Bode C, Bode JC. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?
Alcohol Clin. Exp. Res. 29: 166S-171S (2005).
-
Bodger K. Economic implications of biological therapies for Crohn's disease: review of infliximab.
Pharmacoeconomics 23: 875-888 (2005).
-
Bodin K, Lindbom U, Diczfalusy U. Novel pathways of bile acid metabolism involving CYP3A4.
Biochim. Biophys. Acta 1687: 84-93 (2005).
*
-
Bodini A, D'Orazio C, Peroni D, Corradi M, Folesani G, Baraldi E, Assael BM, Boner A, Piacentini GL. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Pediatr. Pulmonol. 40: 494-499 (2005).
-
Boehncke WH, Schon MP, Giromolomi G, Bos JD, Thestrup-Pedersen K, Cavani A, Nestle F, Bonish BK, Campbell JJ, Nickoloff B. Leukocyte extravasation as a target for anti-inflammatory therapy - which molecule to choose?
Exp. Dermatol. 14: 70 (2005).
-
Bogazzi F, Russo D, Locci MT, Chifenti B, Ultimieri F, Raggi F, Viacava P, Cecchetti D, Cosci C, Sardella C, Acerbi G, Gasperi M, Martino E. Peroxisome proliferator-activated receptor (PPAR)gamma is highly expressed in normal human pituitary gland.
J. Endocrinol. Invest. 28: 899-904 (2005).
-
Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, Vlachogiannakos J, Ma Y, Burroughs AK, Vergani D. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
Hepatology 42: 458-465 (2005).
*
-
Bogdanos DP, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.
Clin. Dev. Immunol. 12: 217-224 (2005).
*
-
Boguniewicz M. Chronic urticaria in children.
Allergy Asthma Proc. 26: 13-17 (2005).
-
Bohgaki T, Amasaki Y, Nishimura N, Bohgaki M, Yamashita Y, Nishio M, Sawada KI, Jodo S, Atsumi T, Koike T. Up regulated expression of tumour necrosis factor alpha converting enzyme in peripheral monocytes of patients with early systemic sclerosis.
Ann. Rheum. Dis. 64: 1165-1173 (2005).
*
-
Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, Trunecka P, Krawczyk M, Clavien PA, Ducerf C, Margarit C, Margreiter R, Pallardo JM, Hoeckerstedt K, Pageaux GP. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
Liver Transpl. 11: 61-67 (2005).
*
-
Boin F, Wigley FM, Schneck JP, Oelke M, Rosen A. Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis.
Ann. N. Y. Acad. Sci. 1062: 137-145 (2005).
*
-
Boirivant M, Strober W, Fuss IJ. Regulatory cells induced by feeding TNP-haptenated colonic protein cross-protect mice from colitis induced by an unrelated hapten.
Inflamm. Bowel Dis. 11: 48-55 (2005).
*
-
Bokarewa M, Dahlberg L, Tarkowski A. Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis.
Arthritis Res. Ther. 7: R1014-R1022 (2005).
*
-
Bokarewa M, Hultgren O. Is interleukin-18 useful for monitoring rheumatoid arthritis?
Scand. J. Rheumatol. 34: 433-436 (2005).
*
-
Boland CR, Luciani MG, Gasche C, Goel A. Infection, inflammation, and gastrointestinal cancer.
Gut 54: 1321-1331 (2005).
*
-
Bollheimer LC, Buettner R, Kullmann A, Kullmann F. Folate and its preventive potential in colorectal carcinogenesis. How strong is the biological and epidemiological evidence?
Crit. Rev. Oncol. Hematol. 55: 13-36 (2005).
-
Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
Hepatology 42: 27-34 (2005).
*
-
Bolstad AI, Jonsson R. Gene therapeutics in Sjogren's syndrome.
Expert Opin. Biol. Ther. 5: 763-772 (2005).
-
Bolton WK, Chen L, Hellmark T, Fox J, Wieslander J. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
Trans. Am. Clin. Climatol. Assoc. 116: 229-236 (2005).
*
-
Bolton WK, Chen L, Hellmark T, Wieslander J, Fox JW. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
J. Am. Soc. Nephrol. 16: 2657-2666 (2005).
*
-
Bolu SE, Orkunoglu Suer FE, Deniz F, Uckaya G, Imirzalioglu N, Kutlu M. The vitamin D receptor fokI start codon polymorphism and bone mineral density in male hypogonadotrophic hypogonadism.
J. Endocrinol. Invest. 28: 810-814 (2005).
-
Bolukbas C, Bolukbas FF, Horoz M, Baba ZF, Eser M, Uzunkoy A, Ucar E, Kaya Z, Guran S. Magnetic resonance cholangiopancreatography in cholestatic diseases.
Hepatogastroenterology 52: 705-708 (2005).
-
Bolukbas FF, Bolukbas C, Horoz M, Baba F, Uzunkoy A. A case of previously undiagnosed Crohn's disease presenting with acute pancreatitis as an extraintestinal manifestation.
Ann. Saudi Med. 25: 71-73 (2005).
-
Bombieri C, Bonizzato A, Castellani C, Assael BM, Pignatti PF. Frequency of large CFTR gene rearrangements in Italian CF patients.
Eur. J. Hum. Genet. 13: 687-689 (2005).
*
-
Bompadre SG, Ai T, Cho JH, Wang X, Sohma Y, Li M, Hwang TC. CFTR gating I: Characterization of the ATP-dependent gating of a phosphorylation-independent CFTR channel (DeltaR-CFTR).
J. Gen. Physiol. 125: 361-375 (2005).
*
-
Bompadre SG, Cho JH, Wang X, Zou X, Sohma Y, Li M, Hwang TC. CFTR gating II: effects of nucleotide binding on the stability of open states.
J. Gen. Physiol. 125: 377-394 (2005).
*
-
Bona D, Incarbone R, Chella B, Vecchi M, Bonavina L. Heartburn and multiple-site foregut perforations as primary manifestation of Crohn's disease.
Dis. Esophagus 18: 199-201 (2005).
*
-
Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Arthritis Res. Ther. 7: R1072-R1081 (2005).
*
-
Bonamico M, Sabbatella L, Di Tola M, Vetrano S, Ferri M, Nenna R, Mariani P, Picarelli A. Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children.
J. Pediatr. Gastroenterol. Nutr. 40: 165-169 (2005).
*
-
Bonar A, Chmiela M, Rudnicka W, Rozalska B. Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro.
Arch. Immunol. Ther. Exp. (Warsz.) 53: 437-441 (2005).
-
Bond JH. Progress in refining virtual colonoscopy for colorectal cancer screening.
Gastroenterology 129: 2103-2106 (2005).
*
-
Bonder CS, Norman MU, Swain MG, Zbytnuik LD, Yamanouchi J, Santamaria P, Ajuebor M, Salmi M, Jalkanen S, Kubes P. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1.
Immunity 23: 153-163 (2005).
*
-
Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schonauer V, Exner M, Klepetko W, Kneussl MP, Maurer G, Lang I. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension.
Thromb. Haemost. 93: 512-516 (2005).
-
Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis.
Semin. Ophthalmol. 20: 147-154 (2005).
-
Bonfioli AA, de Miranda SS, Campos WR, Orefice F. Tuberculosis.
Semin. Ophthalmol. 20: 169-175 (2005).
-
Bongardt F, Schopfer-Wendels A, Huth C, Heid I, Rathmann W, Martin S, Vollmert C, Holle R, Thorand B, Wichmann HE, Koenig W, Kolb H, Herder C. Genetics of type 2 diabetes: impact of interleukin-6 gene variants.
Gesundheitswesen 67 Suppl. 1: 122-126 (2005).
-
Bongartz T, Coras B, Vogt T, Scholmerich J, Muller-Ladner U. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
Rheumatology (Oxford) 44: 126-129 (2005).
*
-
Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes.
J. Immunol. 174: 3695-3702 (2005).
*
-
Boniface K, Lecron JC, Bernard FX, Dagregorio G, Guillet G, Nau F, Morel F. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis.
Eur. Cytokine Netw. 16: 309-319 (2005).
-
Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP Jr, Orange JS, Routes JM, Shearer WT, Sorensen RU. Practice parameter for the diagnosis and management of primary immunodeficiency.
Ann. Allergy Asthma Immunol. 94: S1-S63 (2005).
*
-
Bonini S. The hygiene hypothesis: epidemiologic evidence.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S37-S38 (2005).
*
-
Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases.
J. Mol. Med. 83: 308-315 (2005).
*
-
Bonnevier JL, Zhang R, Mueller DL. E3 ubiquitin ligases and their control of T cell autoreactivity.
Arthritis Res. Ther. 7: 233-242 (2005).
*
-
Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F, Ando S. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Clin. Cancer Res. 11: 6139-6147 (2005).
*
-
Bonovas S, Filioussi K, Sitaras NM. Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis.
Br. J. Clin. Pharmacol. 60: 194-203 (2005).
*
-
Bontrop RE, Watkins DI. MHC polymorphism: AIDS susceptibility in non-human primates.
Trends Immunol. 26: 227-233 (2005).
*
-
Booker CD, White KL Jr. Benzo(a)pyrene-induced anemia and splenomegaly in NZB/WF1 mice.
Food Chem. Toxicol. 43: 1423-1431 (2005).
*
-
Boomkens SY, Rave S, Pot RG, Egberink HF, Penning LC, Rothuizen J, Zondervan PE, Kusters JG. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.
FEMS Immunol. Med. Microbiol. 44: 221-225 (2005).
*
-
Boot EP, Koning GA, Storm G, Wagenaar-Hilbers JP, van Eden W, Everse LA, Wauben MH. CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis.
Arthritis Res. Ther. 7: R604-R615 (2005).
*
-
Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, Armati PJ, Pollard JD, Heard RN, Stewart GJ; The Southern MS Genetics Consortium. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
J. Mol. Med. 83: 822-830 (2005).
*
-
Boraschi P, Donati F, Cossu MC, Gigoni R, Vignali C, Filipponi F, Bartolozzi C, Falaschi F. Multi-detector computed tomography angiography of the hepatic artery in liver transplant recipients.
Acta Radiol. 46: 455-461 (2005).
-
Borchers AT, Aoki CA, Naguwa SM, Keen CL, Shoenfeld Y, Gershwin ME. Neuropsychiatric features of systemic lupus erythematosus.
Autoimmun. Rev. 4: 329-344 (2005).
-
Bordeianou L, Hodin RA. Expanding the role of strictureplasty: can resections be made obsolete?
Inflamm. Bowel Dis. 11: 861-862 (2005).
*
-
Borel P, Drai J, Faure H, Fayol V, Galabert C, Laromiguiere M, Le Moel G. Recent knowledge about intestinal absorption and cleavage of carotenoids.
Ann. Biol. Clin. (Paris) 63: 165-177 (2005).
-
Borgognone M, Perez LM, Basiglio CL, Ochoa JE, Roma MG. Signaling modulation of bile salt-induced necrosis in isolated rat hepatocytes.
Toxicol. Sci. 83: 114-125 (2005).
*
-
Borm ME, Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
Int. J. Immunogenet. 32: 401-405 (2005).
*
-
Borm ME, He J, Kelsall B, Pena AS, Strober W, Bouma G. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models.
Gastroenterology 128: 74-85 (2005).
*
-
Boros LG, Nichelatti M, Shoenfeld Y. Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases.
Ann. N. Y. Acad. Sci. 1051: 529-542 (2005).
-
Borowski E, Bontemps-Gracz MM, Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Acta Biochim. Pol. 52: 609-627 (2005).
*
-
Borza DB, Bondar O, Colon S, Todd P, Sado Y, Neilson EG, Hudson BG. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis.
J. Biol. Chem. 280: 27147-27154 (2005).
*
-
Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen.
Am. J. Kidney Dis. 45: 397-406 (2005).
-
Bos JD, de Rie MA, Teunissen MB, Piskin G. Psoriasis: dysregulation of innate immunity.
Br. J. Dermatol. 152: 1098-1107 (2005).
*
-
Bosch J, Reverter JC. The coagulopathy of cirrhosis: myth or reality?
Hepatology 41: 434-435 (2005).
*
-
Bosch T. Therapeutic apheresis - state of the art in the year 2005.
Ther. Apher. Dial. 9: 459-468 (2005).
*
-
Boschetti N, Stucki M, Spath PJ, Kempf C. Virus safety of intravenous immunoglobulin: future challenges.
Clin. Rev. Allergy Immunol. 29: 333-344 (2005).
-
Bossa F, Caserta L, Selvaggi F, Riegler G. Infliximab in refractory, severe ulcerative colitis: a case report.
Minerva Gastroenterol. Dietol. 51: 261-262 (2005).
-
Bossowski A, Stasiak-Barmuta A, Czarnocka B, Urban M, Dadan J. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometrydagger.
Autoimmunity 38: 605-611 (2005).
-
Bossowski A, Stasiak-Barmuta A, Urban M. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Horm. Res. 64: 189-197 (2005).
-
Botsios C. Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases.
Autoimmun. Rev. 4: 162-170 (2005).
-
Bottcher S, Ritgen M, Bruggemann M, Raff T, Luschen S, Humpe A, Kneba M, Pott C. Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism.
J. Immunol. Methods 306: 128-136 (2005).
*
-
Bottini N, Gloria-Bottini F, Amante A, Saccucci P, Bottini E. Genetic polymorphism and Th1/Th2 orientation.
Int. Arch. Allergy Immunol. 138: 328-333 (2005).
-
Bottini N, Stefanini L, Lucarelli P, Bottini E. Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms.
Am. J. Phys. Anthropol. 128: 194-198 (2005).
*
-
Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors.
Trends Immunol. 26: 221-226 (2005).
*
-
Bouali F, Berrah A, Si Ahmed-Bouali D, Harrieche F, Benhalima M, Hamladji RM, Arrada M. Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients).
Rev. Med. Interne. 26: 777-783 (2005).
-
Boucherie S, Koukoui O, Nicolas V, Combettes L. Cholestatic bile acids inhibit gap junction permeability in rat hepatocyte couplets and normal rat cholangiocytes.
J. Hepatol. 42: 244-251 (2005)
(2005).
*
-
Boudewijns M, Jeurissen A, Wuyts M, Moens L, Boon L, Van Neerven JJ, Kasran A, Overbergh L, Lenaerts C, Waer M, Mathieu C, Ceuppens JL, Bossuyt X. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides.
J. Leukoc. Biol. 78: 1060-1069 (2005).
*
-
Boudjelal M, Mason SJ, Katso RM, Fleming JM, Parham JH, Condreay JP, Merrihew RV, J Cairns W. The application of BacMam technology in nuclear receptor drug discovery.
Biotechnol. Annu. Rev. 11: 101-125 (2005).
-
Boudko DY, Kohn AB, Meleshkevitch EA, Dasher MK, Seron TJ, Stevens BR, Harvey WR. Ancestry and progeny of nutrient amino acid transporters.
Proc. Natl. Acad. Sci. U.S.A. 102:1360-1365 (2005).
*
-
Bougnoux P, Menanteau J. Dietary fatty acids and experimental carcinogenesis.
Bull. Cancer 92: 685-696 (2005).
-
Bouhet S, Oswald IP. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response.
Vet. Immunol. Immunopathol. 108: 199-209 (2005).
*
-
Bouhnik Y. Diagnostic tools in inflammatory bowel diseases.
Rev. Prat. 55: 977-983 (2005).
-
Boukouvala S, Fakis G. Arylamine N-acetyltransferases: what we learn from genes and genomes.
Drug Metab. Rev. 37: 511-564 (2005).
-
Boulenger-Vazel A, Kupfer-Bessaguet I, Gouedard C, Leberre R, Leroy JP, Sonnet E, Desvignes O, Misery L, Sassolas B. Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies).
Ann. Dermatol. Venereol. 132: 27-31 (2005).
-
Boulias K, Katrakili N, Bamberg K, Underhill P, Greenfield A, Talianidis I. Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.
EMBO J. 24: 2624-2633 (2005).
*
-
Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases.
Semin. Arthritis Rheum. 34: 805-812 (2005).
*
-
Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans.
Hum. Reprod. Update 11: 411-423 (2005).
-
Boumendjel A, Baubichon-Cortay H, Trompier D, Perrotton T, Di Pietro A. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
Med. Res. Rev. 25 453-472 (2005).
*
-
Boumpas DT, Sidiropoulos P, Bertsias G. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
Nat. Clin. Pract. Rheumatol. 1: 22-30 (2005).
*
-
Bour G, Gaillard E, Bruck N, Lalevee S, Plassat JL, Busso D, Samama JP, Rochette-Egly C. Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7.
Proc. Natl. Acad. Sci. U.S.A. 102: 16608-16613 (2005).
*
-
Bour-Jordan H, Thompson HL, Bluestone JA. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.
J. Immunol. 175: 5649-5655 (2005).
*
-
Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson MP, Dechelotte P, Bommelaer G, Eschalier A, Ardid D. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.
Gastroenterology 128: 1996-2008 (2005).
*
-
Bourgey M, Leutenegger AL, Cousin E, Bourgain C, Babron MC, Clerget-Darpoux F. Modeling the effect of a genetic factor for a complex trait in a simulated population.
BMC Genet. 6 Suppl. 1: S87 (2005).
*
-
Bourinbaiar AS, Abulafia-Lapid R. Autoimmunity, alloimmunization and immunotherapy of AIDS.
Autoimmun. Rev. 4: 403-409 (2005).
-
Bourre JM. Omega-3 fatty acids in psychiatry.
Med. Sci. (Paris) 21: 216-221 (2005).
-
Bourre JM. Dietary omega-3 fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging.
J. Nutr. Health Aging 9: 31-38 (2005).
-
Bourriaud C, Robins RJ, Martin L, Kozlowski F, Tenailleau E, Cherbut C, Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident.
J. Appl. Microbiol. 99: 201-212 (2005).
*
-
Boursier L, Gordon JN, Thiagamoorthy S, Edgeworth JD, Spencer J. Human intestinal IgA response is generated in the organized gut-associated lymphoid tissue but not in the lamina propria.
Gastroenterology 128: 1879-1889 (2005).
*
-
Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
Inflamm. Bowel Dis. 11: 833-839 (2005).
*
-
Boutin SR, Shen Z, Rogers AB, Feng Y, Ge Z, Xu S, Sterzenbach T, Josenhans C, Schauer DB, Suerbaum S, Fox JG. Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis.
Infect. Immun. 73: 8449-8452 (2005).
*
-
Bouton D, Escriva H, de Mendonca RL, Glineur C, Bertin B, Noel C, Robinson-Rechavi M, de Groot A, Cornette J, Laudet V, Pierce RJ. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
J. Mol. Endocrinol. 34: 567-582 (2005).
*
-
Boutron-Ruault MC, Marteau P, Lavergne-Slove A, Myara A, Gerhardt MF, Franchisseur C, Bornet F. Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas.
Nutr. Cancer 53: 160-168 (2005).
*
-
Bouvet JP, Zouali M. Silent antibodies.
Arch. Inst. Pasteur Tunis. 82: 3-8 (2005).
-
Bouwman LH, Eerligh P, Terpstra OT, Daha MR, de Knijff P, Ballieux BE, Bruining GJ, van der Slik AR, Roos A, Roep BO. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles.
Diabetes 54: 3002-3006 (2005).
*
-
Bouwman LH, Ling Z, Duinkerken G, Pipeleers DG, Roep BO. HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors.
Hum. Immunol. 66: 494-500 (2005).
-
Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, van der Slik AR, Doxiadis II, Roep BO, Schaapherder AF. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation.
Gastroenterology 129: 408-414 (2005).
*
-
Bouysset M, Noel E, Tebib JG. Rheumatoid arthritis: a general disease and local diseases.
Rev. Prat. 55: 2121-2133 (2005).
-
Bouza E, Munoz P, Alonso R. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Clin. Microbiol. Infect. 11 Suppl. 4: 57-64 (2005).
-
Bovenberg SA, van Uum SH, Hermus A. Dehydroepiandrosterone administration in humans: evidence based?
Neth. J. Med. 63: 300-304 (2005).
*
-
Bowcock AM. The genetics of psoriasis and autoimmunity.
Annu. Rev. Genomics Hum. Genet. 6: 93-122 (2005).
*
-
Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology.
Immunol. Res. 32: 45-56 (2005).
*
-
Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis.
Nat. Rev. Immunol. 5: 699-711 (2005).
*
-
Bowdish DM, Hancock RE. Anti-endotoxin properties of cationic host defence peptides and proteins.
J. Endotoxin Res. 11: 230-236 (2005).
*
-
Bowen DG, McCaughan GW, Bertolino P. Intrahepatic immunity: a tale of two sites?
Trends Immunol. 26: 512-517 (2005).
*
-
Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O'keefe RJ, Xing L. TNFa and pathologic bone resorption.
Keio. J. Med. 54: 127-131 (2005).
*
-
Boyce HW. Dilation of difficult benign esophageal strictures.
Am. J. Gastroenterol. 100: 744-745 (2005).
*
-
Boyce JM, Havill NL. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus.
Am. J. Gastroenterol. 100: 1828-1834 (2005).
*
-
Boyer JL. Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?
Gastroenterology 129: 735-740 (2005).
*
-
Boyer TD. Primary prophylaxis for variceal bleeding: are we there yet?
Gastroenterology 128: 1120-1122 (2005).
*
-
Boyman O, Conrad C, Dudli C, Kielhorn E, Nickoloff BJ, Nestle FO. Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis.
Br. J. Dermatol. 152: 1211-1218 (2005).
*
-
Bozymski EM. Acid-related diseases: biology and treatment.
Gastroenterology 128: 1526 (2005).
-
Bozzola M, Giovenale D, Bozzola E, Meazza C, Martinetti M, Tinelli C, Corazza GR. Growth hormone deficiency and coeliac disease: an unusual association?
Clin. Endocrinol. (Oxf.) 62: 372-375 (2005).
*
-
Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, Spek A, van Kampen A, van Deventer S, Peppelenbosch M, Hommes D. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.
J. Mol. Med. 83: 601-609 (2005).
*
-
Brabender J, Metzger R, Salonga D, Danenberg KD, Danenberg PV, Holscher AH, Schneider PM. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
Carcinogenesis 26: 525-530 (2005).
*
-
Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD. A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
J. Rheumatol. 32: 417-423 (2005).
-
Bradley LM, Haynes L, Swain SL. IL-7: maintaining T-cell memory and achieving homeostasis.
Trends Immunol. 26: 172-176 (2005).
*
-
Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Am. J. Hematol. 78: 275-280 (2005).
*
-
Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides.
J. Invest. Dermatol. 125: 9-13 (2005).
*
-
Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G. Integrated treatment approach improves cognitive function in demented and clinically depressed patients.
Am. J. Alzheimers Dis. Other Demen. 20: 21-26 (2005).
-
Brancatelli G, Federle MP, Blachar A. Primary biliary cirrhosis.
N. Engl. J. Med. 353: 2719-2720 (2005).
*
-
Brand O, Gough S, Heward J. HLA , CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?
Expert Rev. Mol. Med. 7: 1-15 (2005).
-
Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Goke B, Lohse P, Ochsenkuhn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
Inflamm. Bowel Dis. 11: 645-652 (2005).
*
-
Brandao M, Oliveira JC, Bravo F, Reis J, Garrido I, Porto G. The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis.
Haematologica 90: 31-37 (2005).
*
-
Brandenburg B, Stockl L, Gutzeit C, Roos M, Lupberger J, Schwartlander R, Gelderblom H, Sauer IM, Hofschneider PH, Hildt E. A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle.
Hepatology 42: 1300-1309 (2005).
*
-
Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T cells.
Science 309: 264-268 (2005).
*
-
Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
Liver Transpl. 11: 1361-1369 (2005).
*
-
Brandt J, Listing J, Haibel H, Sorensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
Rheumatology (Oxford) 44: 342-348 (2005).
*
-
Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties.
Immunol. Rev. 206: 32-63 (2005).
*
-
Brannagan TH 3rd, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, Green PH, Latov N. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings.
Arch. Neurol. 62: 1574-1578 (2005).
*
-
Brant SR, McGovern DP. NOD2, not yet: con.
Inflamm. Bowel Dis. 11: 507-509 (2005).
*
-
Braumann C, Menenakos C, Jacobi CA. Pneumatosis intestinalis - a pitfall for surgeons?
Scand. J. Surg. 94: 47-50 (2005).
-
Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation.
Blood 106: 2375-2381 (2005).
*
-
Brazowski E, Rozen P, Misonzhnick-Bedny F, Gitstein G. Characteristics of familial juvenile polyps expressing cyclooxygenase-2.
Am. J. Gastroenterol. 100: 130-138 (2005).
*
-
Breedveld FC. Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept.
Ned. Tijdschr. Geneeskd. 149: 2273-2277 (2005).
-
Breen DP, Marinaki AM, Arenas M, Hayes PC. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
Liver Transpl. 11: 826-833 (2005).
*
-
Bregenzer N, Lange A, Furst A, Gross V, Scholmerich J, Andus T. Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being.
Z. Gastroenterol. 43: 367-371 (2005).
-
Breitkopf K, Sawitza I, Westhoff JH, Wickert L, Dooley S, Gressner AM. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.
Gut 54: 673-681 (2005).
*
-
Brem RB, Kruglyak L. The landscape of genetic complexity across 5,700 gene expression traits in yeast.
Proc. Natl. Acad. Sci. U.S.A. 102: 1572-1577 (2005).
*
-
Bremner A, Roked S, Robinson R, Phillips I, Beattie M. Faecal calprotectin in children with chronic gastrointestinal symptoms.
Acta Paediatr. 94: 1855-1858 (2005).
*
-
Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases.
Photodermatol. Photoimmunol. Photomed. 21: 157-165 (2005).
-
Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, Gulko PS. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage.
Arthritis Rheum. 52: 322-332 (2005).
*
-
Brentano F, Kyburz D, Schorr O, Gay R, Gay S. The role of Toll-like receptor signalling in the pathogenesis of arthritis.
Cell. Immunol. 233: 90-96 (2005).
*
-
Bresolin T, de Freitas Rebelo M, Celso Dias Bainy A. Expression of PXR, CYP3A and MDR1 genes in liver of zebrafish.
Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 140: 403-407 (2005).
*
-
Bressler B, Pinto R, El-Ashry D, Heathcote EJ. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
Gut 54: 407-410 (2005).
*
-
Bresson D, Rebuffat SA, Nguyen B, Banga JP, Gardas A, Peraldi-Roux S. New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies.
Endocrinology 146: 2834-2844 (2005).
*
-
Bresson D, Rebuffat SA, Peraldi-Roux S. Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: an update.
J. Autoimmune Dis. 2: 2 (2005).
*
-
Brewer GJ. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Drug Discov. Today. 10: 1103-1109 (2005).
-
Brewer GJ. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
CNS Drugs 19: 185-192 (2005).
-
Brewer GJ, Askari FK. Wilson's disease: clinical management and therapy.
J. Hepatol. 42 Suppl.: S13-S21 (2005).
*
-
Briani C, Zara G, Toffanin E, Ruggero S, Ferrarini A, DE Lazzari F, Luca M, Faggian D, Grassivaro F, Ermani M, Pezzani R, Giometto B, D'Odorico A. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients.
Ann. N. Y. Acad. Sci. 1051: 148-155 (2005).
*
-
Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Cochrane Database Syst. Rev. 1: CD004610 (2005).
*
-
Briend E, Young LL, McKenzie GJ, Tugal T, Ragno S, Champion BR. Modulation of the notch pathway for immunotherapy.
Curr. Opin. Mol. Ther. 7: 56-61 (2005).
-
Brigelius-Flohe R. Induction of drug metabolizing enzymes by vitamin E.
J. Plant Physiol. 162: 797-802 (2005).
-
Brihier H, Nion-Larmurier I, Afchain P, Tiret E, Beaugerie L, Gendre JP, Cosnes J. Intestinal perforation in Crohn's disease.
Gastroenterol. Clin. Biol. 29: 1105-1111 (2005).
*
-
Brill TJ, Elshorst-Schmidt T, Valesky EM, Kaufmann R, Thaci D. Successful treatment of acrodermatitis continua of hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
Dermatology 211: 351-355 (2005).
-
Brilot F, Geenen V. Role of viral infections in the pathogenesis of type 1 diabetes.
Rev. Med. Liege. 60: 297-302 (2005).
-
Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Mayer L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease.
J. Immunol. 174: 5814-5822 (2005).
*
-
Bringer MA, Barnich N, Glasser AL, Bardot O, Darfeuille-Michaud A. HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease.
Infect. Immun. 73: 712-721 (2005).
*
-
Brittan M, Chance V, Elia G, Poulsom R, Alison MR, Macdonald TT, Wright NA. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts.
Gastroenterology 128: 1984-1995 (2005).
*
-
Brittenden J, Hosker HS, Healey C, Porter G. Oesophago-bronchial fistula causing cough and recurrent lower respiratory tract infections in a patient with Crohn's disease.
Hosp. Med. 66: 310-311 (2005).
-
Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Orstavik KH, Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity.
J. Clin. Endocrinol. Metab. 90: 5949-5953 (2005).
*
-
Brocchi E, Tomassetti P, Volta U, Piscitelli L, Bonora M, Campana D, Corinaldesi R. Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb.
Eur. J. Gastroenterol. Hepatol. 17: 1413-1415 (2005).
-
Brockmann JG, August C, Wolters HH, Homme R, Palmes D, Baba H, Spiegel HU, Dietl KH. Sequence of reperfusion influences ischemia/reperfusion injury and primary graft function following porcine liver transplantation.
Liver Transpl. 11: 1214-1222 (2005).
*
-
Brodsky RA, Jones RJ. Aplastic anaemia.
Lancet 365: 1647-1656 (2005).
*
-
Broelsch CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma - yes, of course!
J. Hepatol. 43: 569-573 (2005).
*
-
Broering DC, Walter J, Bassas AF. Overcoming the portal steal phenomenon in auxiliary partial orthotopic liver transplantation by modulation of the venous outflow of the native liver.
Liver Transpl. 11: 1140-1143 (2005).
*
-
Brogan AP, Dickerson TJ, Boldt GE, Janda KD. Altered retinoid homeostasis catalyzed by a nicotine metabolite: implications in macular degeneration and normal development.
Proc. Natl. Acad. Sci. U.S.A. 102: 10433-10438 (2005).
*
-
Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism.
Nat. Rev. Immunol. 5: 641-654 (2005).
*
-
Brooks WH. Autoimmune disorders result from loss of epigenetic control following chromosome damage.
Med. Hypotheses 64: 590-598 (2005).
-
Brooling JT, Campbell JS, Mitchell C, Yeoh GC, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma.
Hepatology 41: 906-915 (2005).
*
-
Broome U. Clinical concepts in PSC.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 76 (2005). *
-
Brosens LA, Keller JJ, Offerhaus GJ, Goggins M, Giardiello FM. Prevention and management of duodenal polyps in familial adenomatous polyposis.
Gut 54: 1034-103 (2005).
*
-
Brouillard F, Bensalem N, Hinzpeter A, Tondelier D, Trudel S, Gruber AD, Ollero M, Edelman A. Blue native-SDS PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice.
Mol. Cell. Proteomics 4: 1762-1775 (2005).
*
-
Brousse N, Meijer JW. Malignant complications of coeliac disease.
Best Pract. Res. Clin. Gastroenterol. 19: 401-412 (2005).
-
Brower V. Feeding the flame: new research adds to role of inflammation in cancer development.
J. Natl. Cancer Inst. 97: 251-253 (2005).
*
-
Brown AC, Shovic A, Ibrahim SA, Holck P, Huang A. A non-dairy probiotic's (poi) influence on changing the gastrointestinal tract's microflora environment.
Altern. Ther. Health Med. 11: 58-64 (2005).
*
-
Brown CJ, Maclean AR, Cohen Z, Macrae HM, O'Connor BI, McLeod RS. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.
Dis. Colon Rectum 48: 1542-1549 (2005).
*
-
Brown JH, Cohen C. Regulation of muscle contraction by tropomyosin and troponin: how structure illuminates function.
Adv. Protein Chem. 71: 121-159 (2005).
-
Brown JH, Zhou Z, Reshetnikova L, Robinson H, Yammani RD, Tobacman LS, Cohen C. Structure of the mid-region of tropomyosin: bending and binding sites for actin.
Proc. Natl. Acad. Sci. U.S.A. 102: 18878-18883 (2005).
*
-
Brown JM, Pfau JC, Pershouse MA, Holian A. Silica, apoptosis, and autoimmunity.
J. Immunotoxicol. 1: 177-187 (2005).
-
Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A. Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice.
Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L990-L998 (2005).
*
-
Brown KA. Liver transplantation.
Curr. Opin. Gastroenterol. 21: 331-336 (2005).
-
Brown RS Jr, Lake JR. The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution.
Am. J. Transplant. 5: 203-204 (2005).
*
-
Brown RS, Armen S, Padmanabhan A, Hartranft TH, Price PD. A 49-year-old male with acute superior mesenteric artery occlusion during active ulcerative colitis: report of a case.
Dis. Colon Rectum 48: 572-574 (2005).
-
Brown SJ, Abreu MT. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
Curr. Opin. Drug Discov. Devel. 8: 160-168 (2005).
-
Brown SJ, Ullman T, Sachar DB. Filtering out the phagocytes in inflammatory bowel disease.
J. Clin. Gastroenterol. 39: 845-846 (2005).
-
Browning SR, Briley JD, Briley LP, Chandra G, Charnecki JH, Ehm MG, Johansson KA, Jones BJ, Karter AJ, Yarnall DP, Wagner MJ. Case-control single-marker and haplotypic association analysis of pedigree data.
Genet. Epidemiol. 28: 110-122 (2005).
*
-
Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, Calandra G, Bridger G, Dale DC, Srour EF. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
J. Exp. Med. 201: 1307-1318 (2005).
*
-
Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio AL, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients.
Lupus 14: 670-674 (2005).
-
Bruce IN. Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?
Best Pract. Res. Clin. Rheumatol. 19: 823-838 (2005).
-
Bruce IN. Atherogenesis and autoimmune disease: the model of lupus.
Lupus 14: 687-690 (2005).
-
Bruce WR, Cirocco M, Giacca A, Kim YI, Marcon N, Minkin S. A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation.
Br. J. Cancer 93: 639-646 (2005).
-
Bruck N, Bastien J, Bour G, Tarrade A, Plassat JL, Bauer A, Adam-Stitah S, Rochette-Egly C. Phosphorylation of the retinoid X receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity.
Cell. Signal. 17: 1229-1239 (2005).
*
-
Bruder D, Westendorf AM, Hansen W, Prettin S, Gruber AD, Qian Y, von Boehmer H, Mahnke K, Buer J. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes.
Diabetes 54: 3395-3401 (2005).
*
-
Bruemmer D, Law RE. Liver X receptors: potential novel targets in cardiovascular diseases.
Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 533-540 (2005).
-
Brugge WR. Endoscopic techniques to diagnose and manage biliary tumors.
J. Clin. Oncol. 23: 4561-4565 (2005).
-
Bruggemann H. Insights in the pathogenic potential of Propionibacterium acnes from its complete genome.
Semin. Cutan. Med. Surg. 24: 67-72 (2005).
-
Bruguera M, Barrera J, Corradi F, Mas A. Hypertransaminasemia greater than 400 U/l in adults attended.
Gastroenterol. Hepatol. 28: 15-19 (2005).
-
Bruix J, Sherman M. Diagnosis of small HCC.
Gastroenterology 129: 1364 (2005).
*
-
Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G571-G578 (2005).
*
-
Brun P, Mastrotto C, Beggiao E, Stefani A, Barzon L, Sturniolo GC, Palu G, Castagliuolo I. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G621-G629 (2005).
*
-
Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene.
PLoS Genet. 1: e83 (2005).
*
-
Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Nat. Rev. Immunol. 5: 149-161 (2005).
*
-
Brunn GJ, Bungum MK, Johnson GB, Platt JL. Conditional signaling by Toll-like receptor 4.
FASEB J. 19: 872-874 (2005).
*
-
Brunner B, Hirschi C, Weimann R, Seibold F. Treatment-resistant lingual Crohn's disease disappears after infliximab.
Scand. J. Gastroenterol. 40: 1255-1259 (2005).
*
-
Brunner J, Kern PM, Gaipl US, Munoz LE, Voll RE, Kalden JR, Wiesenhutter CW, Herrmann M. The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis.
Mod. Rheumatol. 15: 9-18 (2005).
-
Bruno ME, Kaetzel CS. Long-term exposure of the HT-29 human intestinal epithelial cell line to TNF causes sustained up-regulation of the polymeric Ig receptor and proinflammatory genes through transcriptional and posttranscriptional mechanisms.
J. Immunol. 174: 7278-7284 (2005).
*
-
Bruno R, Ferretti E, Tosi E, Arturi F, Giannasio P, Mattei T, Scipioni A, Presta I, Morisi R, Gulino A, Filetti S, Russo D. Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin.
J. Clin. Endocrinol. Metab. 90: 5692-5697 (2005).
*
-
Bruno S, Cattaneo D, Perico N, Remuzzi G. Emerging drugs for diabetic nephropathy.
Expert Opin. Emerg. Drugs 10: 747-771 (2005).
-
Brunt EM. Pathology of hepatic iron overload.
Semin. Liver Dis. 25: 392-401 (2005).
-
Brunt EM, Tiniakos DG. Pathological features of NASH.
Front. Biosci. 10: 1475-1484 (2005).
-
Brunt EM, Wolverson MK, Di Bisceglie AM. Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report.
Semin. Liver Dis. 25: 230-236 (2005).
-
Brydak-Godowska J, Moneta-Wielgos J, Pauk-Domanska M, Drobecka-Brydak E, Samsel A, Kecik M, Kowalewski C, Mackiewicz W, Kecik D. Diagnostics and farmacological treatment of ocular cicatrical pemphigoid.
Klin. Oczna. 107: 725-727 (2005).
-
Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
Arthritis Rheum. 52: 2996-3003 (2005).
*
-
Bucala R, Lolis E. Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases.
Drug News Perspect. 18: 417-426 (2005).
-
Buchel O, Roskams T, Van Damme B, Nevens F, Pirenne J, Fevery J. Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia.
Gut 54: 1021-1023 (2005).
*
-
Bucher C, Degen L, Dirnhofer S, Pless M, Herrmann R, Schraml P, Went P. Biologics in inflammatory disease: infliximab associated risk of lymphoma development.
Gut 54: 732-733 (2005).
*
-
Buchman AL, Paine MF, Wallin A, Ludington SS. A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein content.
Dig. Dis. Sci. 50: 2312-2315 (2005).
*
-
Buchwald PC, Westin G, Akerstrom G. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Int. J. Mol. Med. 15: 701-706 (2005).
-
Buckingham RE. Thiazolidinediones: pleiotropic drugs with potent anti-inflammatory properties for tissue protection.
Hepatol. Res. 33: 167-170 (2005).
-
Buckland MS, Mylonaki M, Rampton D, Longhurst HJ. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
Clin. Diagn. Lab. Immunol. 12: 1328-1330 (2005).
*
-
Buckowitz A, Knaebel HP, Benner A, Blaker H, Gebert J, Kienle P, von Knebel Doeberitz M, Kloor M. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.
Br. J. Cancer 92: 1746-1753 (2005).
-
Bufton S. Development of an educational booklet for children of adult liver transplant recipients.
Prog. Transplant. 15: 33-35 (2005).
-
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Burgner D, Stewart GJ. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients.
Eur. J. Hum. Genet. 13: 815-822 (2005).
*
-
Bugianesi E. Late complications of NASH: a challenge for hepatologists.
J. Hepatol. 42: 784-785 (2005).
-
Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Am. J. Gastroenterol. 100: 1082-1090 (2005).
*
-
Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease.
Hepatology 42: 987-1000 (2005).
*
-
Buhl A, Weickert U, Teichmann J, Riemann JF. Rare cause of cholestatic hepatitis.
Internist (Berl.) 46: 1035-1037 (2005).
-
Buijsman RC, Hermkens PH, van Rijn RD, Stock HT, Teerhuis NM. Non-steroidal steroid receptor modulators.
Curr. Med. Chem. 12: 1017-1075 (2005).
-
Bukulmez H, Fife M, Tsoras M, Thompson SD, Twine NA, Woo P, Olson JM, Elston RC, Glass DN, Colbert RA. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study.
Arthritis Res. Ther. 7: R285-R290 (2005).
*
-
Bulte M, Schonenbrucher H, Abdulmawjood A. From farm to fork - Mycobacterium avium ssp. paratuberculosis (MAP) as zoonotic agent?
Berl. Munch. Tierarztl. Wochenschr. 118: 377-385 (2005).
-
Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, Singh M, Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals.
J. Biol. Chem. 280: 20961-20967 (2005).
*
-
Bungard CI, McGivan JD. Identification of the promoter elements involved in the stimulation of ASCT2 expression by glutamine availability in HepG2 cells and the probable involvement of FXR/RXR dimers.
Arch. Biochem. Biophys. 443: 53-59 (2005).
*
-
Buning C, Genschel J, Jurga J, Fiedler T, Voderholzer W, Fiedler EM, Worm M, Weltrich R, Lochs H, Schmidt H, Ockenga J. Introducing genetic testing for adult-type hypolactasia.
Digestion 71: 245-250 (2005).
-
Buning C, Molnar T, Nagy F, Lonovics J, Weltrich R, Bochow B, Genschel J, Schmidt H, Lochs H. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different?
World J. Gastroenterol. 11: 407-411 (2005).
*
-
Bunnett NW. The stressed gut: contributions of intestinal stress peptides to inflammation and motility.
Proc. Natl. Acad. Sci. U.S.A. 102: 7409-7410 (2005).
*
-
Buratti E, Brindisi A, Giombi M, Tisminetzky SG, Ayala YM, Baralle FE. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of CFTR exon 9 splicing.
J. Biol. Chem. 280: 37572-37584 (2005).
*
-
Burdelski MM, Rogiers X. What lessons have we learned in pediatric liver transplantation?
J. Hepatol. 42: 28-33 (2005).
*
-
Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.
Reprod. Nutr. Dev. 45: 581-597 (2005).
*
-
Burgess JW, Neville TA, Rouillard P, Harder Z, Beanlands DS, Sparks DL. Phosphatidylinositol raises HDL-C levels in humans.
J. Lipid Res. 46: 350-355 (2005).
*
-
Buri C, Burri P, Bahler P, Straumann A, Muller-Schenker B, Birrer S, Mueller C. Cytotoxic T cells are preferentially activated in the duodenal epithelium from patients with florid coeliac disease.
J. Pathol. 206: 178-185 (2005).
*
-
Burk O, Arnold KA, Geick A, Tegude H, Eichelbaum M. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression.
Biol. Chem. 386: 503-513 (2005).
-
Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M. Anti-malarial artemisinin drugs induce CYP and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor.
Mol. Pharmacol. 67: 1954-1965 (2005).
*
-
Burkard I, von Eckardstein A, Rentsch KM. Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 826: 147-159 (2005).
*
-
Burke AP, Mont E, Kolodgie F, Virmani R. Thrombotic thrombocytopenic purpura causing rapid unexpected death. Value of CD61 immunohistochemical staining in diagnosis.
Cardiovasc. Pathol. 14: 150-155 (2005).
-
Burkhardt H, Huffmeier U, Spriewald B, Bohm B, Rau R, Kallert S, Engstrom A, Holmdahl R, Reis A. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis.
Arthritis Rheum. 54: 82-89 (2005).
*
-
Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Eur. J. Immunol. 35: 1643-1652 (2005).
*
-
Burlet-Schiltz O, Claverol S, Gairin JE, Monsarrat B. The use of mass spectrometry to identify antigens from proteasome processing.
Methods Enzymol. 405: 264-300 (2005).
-
Burman A, Haworth O, Hardie DL, Amft EN, Siewert C, Jackson DG, Salmon M, Buckley CD. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis.
J. Immunol. 174: 1693-1700 (2005).
*
-
Burne P, Mitchell S, Rees Smith B. Point-of-care assays for autoantibodies to thyroid peroxidase and to thyroglobulin.
Thyroid 15: 1005-1010 (2005).
-
Burnett BG, Pittman RN. The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.
Proc. Natl. Acad. Sci. U.S.A. 102: 4330-4335 (2005).
*
-
Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, Leonard MB. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease.
Am. J. Clin. Nutr. 82: 413-420 (2005).
*
-
Burns CE, Traver D, Mayhall E, Shepard JL, Zon LI. Hematopoietic stem cell fate is established by the Notch-Runx pathway.
Genes Dev. 19: 2331-2342 (2005).
*
-
Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.
J. Infect. Dis. 192: 344-349 (2005).
*
-
Burns JC, Shimizu C, Shike H, Newburger JW, Sundel RP, Baker AL, Matsubara T, Ishikawa Y, Brophy VA, Cheng S, Grow MA, Steiner LL, Kono N, Cantor RM. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.
Genes Immun. 6: 438-444 (2005).
*
-
Burr ML, Dunstan FD, George CH. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results.
J. Membr. Biol. 206: 155-163 (2005).
*
-
Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett KS, Stayrook KR. The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand.
Mol. Pharmacol. 67: 948-954 (2005).
*
-
Burrows GG. Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands.
Curr. Drug Targets Inflamm. Allergy 4: 185-193 (2005).
-
Burstein S. PPAR-gamma: a nuclear receptor with affinity for cannabinoids.
Life Sci. 77: 1674-1684 (2005).
*
-
Burt R, Neklason DW. Genetic testing for inherited colon cancer.
Gastroenterology 128: 1696-1716 (2005).
*
-
Burton EC, Burns DK, Opatowsky MJ, El-Feky WH, Fischbach B, Melton L, Sanchez E, Randall H, Watkins DL, Chang J, Klintmalm G. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients.
Arch. Neurol. 62: 873-882 (2005).
*
-
Burton J. Case study: diagnosis and treatment of pyoderma gangrenosum.
Br. J. Nurs. 14: S10-S13 (2005).
-
Burton JR Jr, Rosen HR. Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States.
Clin. Gastroenterol. Hepatol. 3: 700-704 (2005).
-
Busch R, Rinderknecht CH, Roh S, Lee AW, Harding JJ, Burster T, Hornell TM, Mellins ED. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Immunol. Rev. 207: 242-260 (2005).
*
-
Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.
Clin. Ther. 27: 1181-1195 (2005).
*
-
Bushara KO. Neurologic presentation of celiac disease.
Gastroenterology 128: S92-S97 (2005).
*
-
Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Todd Hubisz M, Glanowski S, Tanenbaum DM, White TJ, Sninsky JJ, Hernandez RD, Civello D, Adams MD, Cargill M, Clark AG. Natural selection on protein-coding genes in the human genome.
Nature 437: 1153-1157 (2005).
*
-
Butovich IA. On the structure, synthesis and mechanism of formation of neuroprotectin D1-a novel anti-inflammatory compound of docosahexaenoic acid family.
J. Lipid Res. 46: 2311-2314 (2005).
*
-
Butt C, Rahman P, Siannis F, Farewell VT, Gladman DD. Corneodesmosin polymorphisms in psoriatic arthritis.
Rheumatology (Oxford) 44: 684-685 (2005).
*
-
Butt C, Sun S, Greenwood C, Gladman D, Rahman P. Lack of association of SLC22A4, SLC22A5, SLC9A3R1 and RUNX1 variants in psoriatic arthritis.
Rheumatology (Oxford) 44: 820-821 (2005).
*
-
Butt C, Sun S, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of nuclear factor-kappaB in psoriatic arthritis.
J. Rheumatol. 32: 1742-1744 (2005).
-
Butt MT, Bener A, Al-Kaabi S, Yakoub R. Clinical characteristics of Crohn s disease in Qatar.
Saudi Med. J. 26: 1796-1799 (2005).
-
Buttgereit F, Burmester GR, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear.
Lancet 365: 801-803 (2005).
*
-
Buttgereit F, Saag KG, Cutolo M, da Silva JA, Bijlsma JW. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.
Scand. J. Rheumatol. 34: 14-21 (2005).
-
Buttgereit F, Song IH, Straub RH, Burmester GR. Current insights into the development of new glucocorticoid receptor ligands.
Z. Rheumatol. 64: 170-176 (2005).
-
Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Eur. J. Immunol. 35: 282-289 (2005).
*
-
Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Ulmer AJ. Lipopeptide structure determines TLR2 dependent cell activation level.
FEBS J. 272: 6354-6364 (2005).
*
-
Buyon JP. Dispelling the preconceived notion that lupus pregnancies result in poor outcomes.
J. Rheumatol. 32: 1641-1642 (2005).
-
Buyse M, Radeva G, Bado A, Farinotti R. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity.
Biochem. Pharmacol. 69: 1745-1754 (2005).
*
-
Buysschaert M, Tomasi JP, Hermans MP. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with type 1 diabetes.
Diabet. Med. 22: 889-892 (2005).
*
-
Buzas EI, Vegvari A, Murad YM, Finnegan A, Mikecz K, Glant TT. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis.
Cell. Immunol. 235: 98-108 (2005).
*
-
Buzzetti R, Petrone A, Caiazzo AM, Alemanno I, Zavarella S, Capizzi M, Mein CA, Osborn JA, Vania A, DI Mario U. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
Pediatr. Res. 57: 138-40 (2005).
*
-
Byeon JS, Yang SK, Myung SJ, Pyo SI, Park HJ, Kim YM, Lee YJ, Hong SS, Kim KJ, Lee GH, Jung HY, Hong WS, Kim JH, Min YI. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status.
Inflamm. Bowel Dis. 11: 366-371 (2005).
*
-
Byrne FR, Morony S, Warmington K, Geng Z, Brown HL, Flores SA, Fiorino M, Yin SL, Hill D, Porkess V, Duryea D, Pretorius JK, Adamu S, Manuokian R, Danilenko DM, Sarosi I, Lacey DL, Kostenuik PJ, Senaldi G. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin.
Gut 54: 78-86 (2005).
*
-
Byron RJ Jr, Osborne PD. Dental management of liver transplant patients.
Gen. Dent. 53: 66-9 (2005).
-
Bystryn JC, Rudolph JL. Pemphigus.
Lancet 366: 61-73 (2005).
*
-
Byun JR, Cho SH, Yang DH, Kim YK, Ju JK, Choi SK, Chung IJ. Ileovesical fistula caused by hepatocellular carcinoma.
Korean J. Intern. Med. 20: 76-79 (2005).
-
Cabello GM, Cabello PH, Lopez-Camelo JS, Llerena JC Jr, Fernandes O. Haplotype distribution of and linkage disequilibrium between four polymorphic markers near the CFTR locus in Brazilian cystic fibrosis patients.
Hum. Biol. 77: 853-865 (2005).
-
Cabello GM, Cabello PH, Otsuki K, Gombarovits ME, Llerena JC Jr, Fernandes O. Molecular analysis of 23 exons of the CFTR gene in Brazilian patients leads to the finding of rare cystic fibrosis mutations.
Hum. Biol. 77: 125-135 (2005).
-
Cabranes A, Venderova K, de Lago E, Fezza F, Sanchez A, Mestre L, Valenti M, Garcia-Merino A, Ramos JA, Di Marzo V, Fernandez-Ruiz J. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Neurobiol. Dis. 20: 207-217 (2005).
-
Cabre E, Gassull MA. Nutrition in liver disease.
Curr. Opin. Clin. Nutr. Metab. Care 8: 545-551 (2005).
-
Cabrera CM, Lopez-Nevot MA. APC and chromosome instability in colorectal cancer.
Rev. Esp. Enferm. Dig. 97: 738-743 (2005).
-
Cabrera-Rode E, Sarmiento L, Molina G, Perez C, Arranz C, Galvan JA, Prieto M, Barrios J, Palomera R, Fonseca M, Mas P, Diaz-Diaz O, Diaz-Horta O. Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report.
J. Med. Virol. 76: 373-377 (2005).
*
-
Cabrero A, Cubero M, Llaverias G, Alegret M, Sanchez R, Laguna JC, Vazquez-Carrera M. Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages.
Mol. Cell. Biochem. 275: 173-179 (2005).
*
-
Caccavo D, Rigon A, Picardi A, Galluzzo S, Vadacca M, Ferri GM, Amoroso A, Afeltra A. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
Clin. Rheumatol. 24: 381-387 (2005).
*
-
Caccio SM. Molecular epidemiology of human cryptosporidiosis.
Parassitologia 47: 185-192 (2005).
-
Cacev T, Radosevic S, Spaventi R, Pavelic K, Kapitanovic S. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.
Gut 54: 1129-1135 (2005).
*
-
Cadahia V, Rodrigo L, Fuentes D, Riestra S, De Francisco R, Fernandez M. Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: a family study.
Rev. Esp. Enferm. Dig. 97: 907-913 (2005).
*
-
Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.
Eur. Cytokine Netw. 16: 289-292 (2005).
-
Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
Nat. Med. 11: 183-190 (2005).
*
-
Cai G, Zhang J, Liu L, Shen Q. Successful treatment of experimental autoimmune myocarditis by adenovirus-mediated gene transfer of antisense CIITA.
J. Mol. Cell. Cardiol. 38: 593-605 (2005).
*
-
Cai W, Khaoustov VI, Xie Q, Pan T, Le W, Yoffe B. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
J. Hepatol. 42: 880-887 (2005).
*
-
Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice.
Gastroenterology 128: 1937-1952 (2005).
*
-
Cai X, Zhou H, Wong YF, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis.
Biochem. Biophys. Res. Commun. 337: 586-594 (2005).
*
-
Calabrese C, Fabbri A, di Febo G. Colitis evolving into ulcerative colitis.
Gut 54: 1347-1348 (2005).
*
-
Calabrese E, La Seta F, Buccellato A, Virdone R, Pallotta N, Corazziari E, Cottone M. Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema.
Inflamm. Bowel Dis. 11: 139-145 (2005).
*
-
Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
J. Neurol. Sci. 233: 145-162 (2005).
*
-
Calabro P, Samudio I, Safe SH, Willerson JT, Yeh ET. Inhibition of tumor-necrosis-factor-alpha-induced endothelial cell activation by a new class of PPAR-gamma agonists.
J. Vasc. Res. 42: 509-516 (2005).
*
-
Calamita G, Ferri D, Bazzini C, Mazzone A, Botta G, Liquori GE, Paulmichl M, Portincasa P, Meyer G, Svelto M. Expression and subcellular localization of the AQP8 and AQP1 water channels in the mouse gallbladder epithelium.
Biol. Cell 97: 415-423 (2005).
*
-
Calamita G, Ferri D, Gena P, Liquori GE, Marinelli RA, Meyer G, Portincasa P, Svelto M. Water transport into bile and role in bile formation.
Curr. Drug Targets Immune Endocr. Metabol. Disord. 5: 137-142 (2005).
-
Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, Corneli RB, Ferretti E, Gulino A, Grasso F, De Simone C, Di Mario U, Falorni A, Boirivant M, Dotta F. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.
Diabetologia 48: 1565-1575 (2005).
*
-
Calder PC. Polyunsaturated fatty acids and inflammation.
Biochem. Soc. Trans. 33: 423-427 (2005).
*
-
Caldwell CC, Okaya T, Martignoni A, Husted T, Schuster R, Lentsch AB. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G969-G976 (2005).
*
-
Calenda KA, Schornagel IL, Sadeghi-Nejad A, Grand RJ. Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study.
Inflamm. Bowel Dis. 11: 435-441 (2005).
*
-
Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis.
Hepatology 42: 1373-1381 (2005).
*
-
Call ME, Wucherpfennig KW. The T cell receptor: critical role of the membrane environment in receptor assembly and function.
Annu. Rev. Immunol. 23: 101-125 (2005).
*
-
Callejas Rubio JL, Ortego Centeno N, Cardena Perez C, Navas-Parejo A. Infliximab and amyloidosis secondary to inflammatory bowel diseases.
Med. Clin. (Barc.) 124: 757-758 (2005).
-
Callen JP. Management of 'refractory' skin disease in patients with lupus erythematosus.
Best Pract. Res. Clin. Rheumatol. 19: 767-784 (2005).
-
Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.
Eur. J. Neurosci. 22: 617-626 (2005).
*
-
Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F. Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18.
Autoimmun. Rev. 4: 542-548 (2005).
-
Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, Large Scale Collab Res Program IA. A network-based analysis of systemic inflammation in humans.
Nature 437: 1032-1037 (2005).
*
-
Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status.
J. Nutr. 135: 310-316 (2005).
*
-
Cambien F, Tiret L. Atherosclerosis: from genetic polymorphisms to system genetics.
Cardiovasc. Toxicol. 5: 143-152 (2005).
-
Cameron D. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease.
J. Pediatr. Gastroenterol. Nutr. 40: 383 (2005).
*
-
Camilleri M. GIH clinical research update: 2004-2005.
Clin. Gastroenterol. Hepatol. 3: 1161-1166 (2005).
-
Caminiti L, Passalacqua G, Magazzu G, Comisi F, Vita D, Barberio G, Sferlazzas C, Pajno GB. Chronic urticaria and associated coeliac disease in children: a case-control study.
Pediatr. Allergy Immunol. 16: 428-432 (2005).
*
-
Cammarota G, Gasbarrini A, Gasbarrini G. No more biopsy in the diagnostic work-up of celiac disease.
Gastrointest. Endosc. 62: 119-121 (2005).
*
-
Camp NJ, Cox A, di Giovine FS, McCabe D, Rich W, Duff GW. Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis.
Genes Immun. 6: 467-471 (2005).
*
-
Campana G, Pasini P, Roda A, Spampinato S. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
Biochem. Pharmacol. 69: 1755-1763 (2005).
*
-
Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Trancassini M, Tovagliari D, et al. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
J. Clin. Microbiol. 43: 5136-5142 (2005).
*
-
Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance.
Sci. Prog. 88: 157-202 (2005).
-
Campbell IW. The clinical significance of PPAR gamma agonism.
Curr. Mol. Med. 5: 349-363 (2005).
-
Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
Proc. Natl. Acad. Sci. U.S.A. 102: 3389-3394 (2005).
*
-
Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.
Liver Transpl. 11: 1048-1055 (2005).
*
-
Campbell MS, Lichtenstein GR, Rhim AD, Pazianas M, Faust T. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.
Liver Int. 25: 311-316 (2005).
*
-
Campbell R, Marik PE. Severe autoimmune hemolytic anemia treated by paralysis, induced hypothermia, and splenic embolization.
Chest 127: 678-681 (2005).
*
-
Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience.
Eur. J. Gastroenterol. Hepatol. 17: 79-84 (2005).
-
Campino S, Bagot S, Bergman ML, Almeida P, Sepulveda N, Pied S, Penha-Goncalves C, Holmberg D, Cazenave PA. Genetic control of parasite clearance leads to resistance to Plasmodium berghei ANKA infection and confers immunity.
Genes Immun. 6: 416-421 (2005).
*
-
Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J. Diet and colorectal cancer: current evidence for etiology and prevention.
Nutr. Hosp. 20: 18-25 (2005).
-
Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers.
Alcohol. Clin. Exp. Res. 29: 1206-1213 (2005).
*
-
Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
Nat. Med. 11: 936-943 (2005).
*
-
Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis.
J. Nutr. 135: 687-694 (2005).
*
-
Camuesco D, Peran L, Comalada M, Nieto A, Di Stasi LC, Rodriguez-Cabezas ME, Concha A, Zarzuelo A, Galvez J. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.
Inflamm. Bowel Dis. 11: 265-271 (2005).
*
-
Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes.
Diabetes 54: 3326-3330 (2005).
*
-
Candia L, Marquez J, Espinoza LR. Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma.
Semin. Arthritis Rheum. 35: 49-56 (2005).
*
-
Cannons JL, Chamberlain G, Howson J, Smink LJ, Todd JA, Peterson LB, Wicker LS, Watts TH. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
J. Autoimmun. 25: 13-20 (2005).
-
Canny G, Colgan SP. Events at the host-microbial interface of the gastrointestinal tract. I. Adaptation to a microbial world: role of epithelial bactericidal/permeability-increasing protein.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G593-G597 (2005).
*
-
Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, Baeten D. Functional haplotypes of PADI4: relevance for rheumatoid arthritis-specific synovial intracellular citrullinated proteins and anti-citrullinated protein antibodies.
Ann. Rheum. Dis. 64: 1316-1320 (2005).
*
-
Canter RJ, Kesmodel SB, Heitjan DF, Veeramachaneni NK, Mokadam NA, Drebin JA, Fraker DL. Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer.
Ann. Surg. Oncol. 12: 733-742 (2005).
*
-
Canto E, Rodriguez-Sanchez JL, Vidal S. Naive CD4+ cells from cord blood can generate competent Th effector cells.
Transplantation 80: 850-858 (2005).
-
Canton I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF, Weetman AP, Kemp EH. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo.
Genes Immun. 6: 584-587 (2005).
*
-
Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Am. J. Gastroenterol. 100: 1134-1142 (2005).
*
-
Cantorna MT, Mahon BD. D-hormone and the immune system.
J. Rheumatol. Suppl. 76: 11-20 (2005).
*
-
Cantu P, Hookey LC, Morales A, Le Moine O, Deviere J. The treatment of patients with symptomatic common bile duct stenosis secondary to chronic pancreatitis using partially covered metal stents: a pilot study.
Endoscopy 37: 735-739 (2005).
-
Cao D, Li M, Xue R, Zheng W, Liu Z, Wang X. Chronic administration of ethyl docosahexaenoate decreases mortality and cerebral edema in ischemic gerbils.
Life Sci. 78: 74-81 (2005).
*
-
Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra A. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
Int. J. Gastrointest. Cancer 36: 39-46 (2005).
-
Cao HB, Wang A, Martin B, Koehler DR, Zeitlin PL, Tanawell AK, Hu J. Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference.
Cell Res. 15: 111-119 (2005).
*
-
Cao HX, Zhao L, Zhou LX. HLA-DRB1 allele polymorphosm associated with susceptibility to leukemia in Han nationality of Gansu.
Zhongguo Shi Yan Xue Ye Xue Za Zhi 13: 788-792 (2005).
-
Cao P, Xia Z, Song W, Zhang S. Neutralizing human anti-B-cell-activating factor of the TNF family (BAFF) scFv selected from phage antibody library.
Immunol. Lett. 101: 87-94 (2005).
-
Cao Q, Si JM, Gao M, Zhou G, Hu WL, Li JH. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China.
Chin. Med. J. (Engl.) 118: 747-752 (2005).
-
Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, Reuter V, Scher H, Cordon-Cardo C, Figlin RA, Belldegrun A, Zhang ZF. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma.
Cancer 104: 2400-2408 (2005).
*
-
Cao W, Fiocchi C, Pricolo VE. Production of interleukin-1beta, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis.
Am. J. Physiol. Cell. Physiol. 289: C1408-C1416 (2005).
*
-
Cao YB, Zhang JD, Diao YY, Yan L, Wang DJ, Jia XM, Gao PH, Cheng MH, Xu Z, Wang Y, Jiang YY. Effects of Changtai granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats.
World J. Gastroenterol. 11: 3539-3543 (2005).
*
-
Cao Z, Li C, Jin L, Corbet EF. Association of matrix metalloproteinase-1 promoter polymorphism with generalized aggressive periodontitis in a Chinese population.
J. Periodontal Res. 40: 427-431 (2005).
*
-
Capasso R, Matias I, Lutz B, Borrelli F, Capasso F, Marsicano G, Mascolo N, Petrosino S, Monory K, Valenti M, Di Marzo V, Izzo AA. Fatty acid amide hydrolase controls mouse intestinal motility in vivo.
Gastroenterology 129: 941-951 (2005).
*
-
Capeau J, Magre J, Lascols O, Caron M, Bereziat V, Vigouroux C, Bastard JP. Diseases of adipose tissue: genetic and acquired lipodystrophies.
Biochem. Soc. Trans. 33: 1073-1077 (2005).
*
-
Capell WH, Eckel RH. Severe hypertriglyceridemia with a history of treatment failure.
Nat. Clin. Pract. Endocrinol. Metab. 1: 53-58 (2005).
*
-
Capelli A, Di Stefano A, Gnemmi I, Donner CF. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis.
Eur. Respir. J. 25: 701-707 (2005).
*
-
Capellino S, Montagna P, Villaggio B, Cutolo M. Effects of estrogen peripheral metabolism in rheumatoid arthritis.
Reumatismo 57: 78-82 (2005).
-
Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL, et al. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Neurol. Sci. 26 Suppl. 4: s200-s203 (2005).
*
-
Capitani G, De Biase D, Gut H, Ahmed S, Grutter MG. Structural model of human GAD65: prediction and interpretation of biochemical and immunogenic features.
Proteins 59: 7-14 (2005).
*
-
Capitanich P, Herrera J, Iovaldi ML, Balbuena R, Casas G, Malizia P, Bun M, Mezzadri N. Bile duct replacement using an autologous femoral vein graft: an experimental study. Preliminary results.
J. Gastrointest. Surg. 9: 369-373 (2005).
-
Caplan L, Russell AS, Wolfe F. Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
J. Rheumatol. 32: 1863-1865 (2005).
-
Caponi L, Petit-Teixeira E, Sebbag M, Bongiorni F, Moscato S, Pratesi F, Pierlot C, Osorio J, Chapuy-Regaud S, Guerrin M, Cornelis F, Serre G, Migliorini P; ECRAF. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population.
Ann. Rheum. Dis. 64: 587-593 (2005).
*
-
Cappione A, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.
J. Clin. Invest. 115: 3205-3216 (2005).
*
-
Caprilli R, Angelucci E, Cocco A. Early or late guided missile in the treatment of Crohn's disease?
Dig. Liver Dis. 37: 973-979 (2005).
-
Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Dig. Liver Dis. 37: 407-417 (2005).
-
Capristo E, Farnetti S, Mingrone G, Certo M, Greco AV, Addolorato G, Gasbarrini G. Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment.
Scand. J. Gastroenterol. 40: 430-436 (2005).
*
-
Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
Arthritis Res. Ther. 7: R250-R255 (2005).
*
-
Capuano P, Bacic D, Stange G, Hernando N, Kaissling B, Pal R, Kocher O, Biber J, Wagner CA, Murer H. Expression and regulation of the renal Na/phosphate cotransporter NaPi-IIa in a mouse model deficient for the PDZ protein PDZK1.
Pflugers Arch. 449: 392-402 (2005).
*
-
Capurro MI, Xiang YY, Lobe C, Filmus J. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
Cancer Res. 65: 6245-6254 (2005).
*
-
Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, Cedola FN, Targovnik HM, Frechtel GD. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA).
Autoimmunity 38: 277-281 (2005).
-
Carabana J, Ortigoza E, Krangel MS. Regulation of the murine Ddelta2 promoter by upstream stimulatory factor 1, Runx1, and c-Myb.
J. Immunol. 174: 4144-4152 (2005).
*
-
Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V, Spies T, Pollio G, Cosman D, Catalano L, Tassone P, Rotoli B, Venuta S. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Blood 105: 251-258 (2005).
*
-
Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
Ann. N. Y. Acad. Sci. 1051: 666-671 (2005).
*
-
Cardell LO, Hagge M, Uddman R, Adner M. Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis.
Respir. Res. 6: 132 (2005).
*
-
Cardenas A. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
Am. J. Gastroenterol. 100: 460-467 (2005).
*
-
Cardenas A, Gines P. Management of complications of cirrhosis in patients awaiting liver transplantation.
J. Hepatol. 42 Suppl.: S124-S133 (2005).
*
-
Cardoso CB, Uthida-Tanaka AM, Magalhaes RF, Magna LA, Kraemer MH. Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis.
Eur. J. Dermatol. 15: 159-163 (2005).
-
Cariello NF, Romach EH, Colton HM, Ni H, Yoon L, Falls JG, Casey W, Creech D, Anderson SP, Benavides GR, Hoivik DJ, Brown R, Miller RT. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
Toxicol. Sci. 88: 250-264 (2005).
*
-
Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.
Gut 54: 1182-1193 (2005).
*
-
Cario E, Podolsky DK. Intestinal epithelial Tollerance versus inTollerance of commensals.
Mol. Immunol. 42: 887-893 (2005).
*
-
Carl PL, Temple BR, Cohen PL. Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity.
Arthritis Res. Ther. 7: R1360-R1374 (2005).
*
-
Carlen LM, Sanchez F, Bergman AC, Becker S, Hirschberg D, Franzen B, Coffey J, Jornvall H, Auer G, Alaiya AA, Stahle M. Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis.
J. Invest. Dermatol. 124: 63-69 (2005).
*
-
Carlisle AC, John AM, Fife-Schaw C, Lloyd M. The self-regulatory model in women with rheumatoid arthritis: relationships between illness representations, coping strategies, and illness outcome.
Br. J. Health Psychol. 10: 571-587 (2005).
-
Carlson H, Zhang AS, Fleming WH, Enns CA. The hereditary hemochromatosis protein, HFE, lowers intracellular iron levels independently of transferrin receptor 1 in TRVb cells.
Blood 105: 2564-2570 (2005).
*
-
Carlsson M, Sjoholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, Truedsson L. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship.
Clin. Exp. Immunol. 139: 306-313 (2005).
*
-
Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, Begovich AB. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis.
Am. J. Hum. Genet. 77: 567-581 (2005).
*
-
Carmena R. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.
Am. Heart J. 150: 859-870 (2005).
*
-
Carnahan VE, Redinbo MR. Structure and function of the human nuclear xenobiotic receptor PXR.
Curr. Drug Metab. 6: 357-367 (2005).
-
Carneiro AA, Fernandes JP, de Araujo DB, Elias J Jr, Martinelli AL, Covas DT, Zago MA, Angulo IL, St Pierre TG, Baffa O. Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry.
Magn. Reson. Med. 54: 122-128 (2005).
-
Caro AA, Cederbaum AI. Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine.
Biochem. Pharmacol. 69: 1081-1093 (2005).
*
-
Caron G, Duluc D, Fremaux I, Jeannin P, David C, Gascan H, Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.
J. Immunol. 175: 1551-1557 (2005).
*
-
Caron J, Loredo-Osti JC, Morgan K, Malo D. Mapping of interactions and mouse congenic strains identified novel epistatic QTLs controlling the persistence of Salmonella Enteritidis in mice.
Genes Immun. 6: 500-508 (2005).
*
-
Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G, Haglund C. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.
Gut 54: 385-387 (2005).
*
-
Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
J. Immunol. 175: 5222-5229 (2005).
*
-
Carrada-Bravo T. Miliary tuberculosis involving the central nervous system.
Neurologia 20: 426-429 (2005).
*
-
Carrasco MA, Cohen EJ, Rapuano CJ, Laibson PR. Therapeutic decision in anterior scleritis: our experience at a tertiary care eye center.
J. Fr. Ophtalmol. 28: 1065-1069 (2005).
-
Carrasco-Chaumel E, Rosello-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A, Gelpi E, Rodes J, Peralta C. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation.
J. Hepatol. 43: 997-1006 (2005).
*
-
Carrat Ugrave P, Dragonieri S, Nocerino MC, Trabucco SM, Lacedonia D, Parisi G, Resta O. A case of cryptogenic organizing pneumonia occurring in Crohn's disease.
Can. Respir. J. 12: 437-439 (2005).
*
-
Carreira PE, Gonzalez-Crespo MR, Ciruelo E, Pablos JL, Santiago B, Gomez-Camara A, Gomez-Reino JJ. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population.
Arthritis Rheum. 52: 3015-3019 (2005).
*
-
Carreno BM, Carter LL, Collins M. Therapeutic opportunities in the B7/CD28 family of ligands and receptors.
Curr. Opin. Pharmacol. 5: 424-430 (2005).
-
Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
Arch. Dermatol. 141: 43-46 (2005).
*
-
Carroll MC, Holers VM. Innate autoimmunity.
Adv. Immunol. 86: 137-157 (2005).
-
Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, Plebani A, Aiuti F, Quinti I. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.
J. Allergy Clin. Immunol. 115: 412-417 (2005).
*
-
Carstanjen D, Yamauchi A, Koornneef A, Zang H, Filippi MD, Harris C, Towe J, Atkinson S, Zheng Y, Dinauer MC, Williams DA. Rac2 regulates neutrophil chemotaxis, superoxide production, and myeloid colony formation through multiple distinct effector pathways.
J. Immunol. 174: 4613-4620 (2005).
*
-
Carta G, Iovenitti P, Falciglia K. Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates.
Clin. Exp. Obstet. Gynecol. 32: 49-51 (2005).
-
Carter JD. Treatment of relapsing polychondritis with a TNF antagonist.
J. Rheumatol. 32: 1413 (2005).
-
Carter RE, Lipsitz SR, Tilley BC. Quasi-likelihood estimation for relative risk regression models.
Biostatistics 6: 39-44 (2005).
-
Caruso C, Candore G, Colonna-Romano G, Lio D, Franceschi C. Inflammation and life-span.
Science 307: 208-209 (2005).
*
-
Casanova JL, Fieschi C, Bustamante J, Reichenbach J, Remus N, von Bernuth H, Picard C. From idiopathic infectious diseases to novel primary immunodeficiencies.
J. Allergy Clin. Immunol. 116: 426-430 (2005).
*
-
Case S. The gluten-free diet: how to provide effective education and resources.
Gastroenterology 128: S128-S134 (2005).
*
-
Casellas F, Arenas JI, Baudet JS, Fabregas S, Garcia N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L, Malagelada JR. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study.
Inflamm. Bowel Dis. 11: 488-496 (2005).
*
-
Casellas F, Lopez Vivancos J, Malagelada JR. Perceived health status in celiac disease.
Rev. Esp. Enferm. Dig. 97: 794-804 (2005).
-
Casellas F, Vivancos JL, Sampedro M, Malagelada JR. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life.
Am. J. Gastroenterol. 100: 2737-2742 (2005).
*
-
Casellini C, Citera G, Rosemffet M, Ruggeri S, Saviotti A, Cocco JA. Audiovestibular disorders in patients with ankylosing spondylitis.
J. Clin. Rheumatol. 11: 81-85 (2005).
-
Cashman KD. Homocysteine and osteoporotic fracture risk: a potential role for B vitamins.
Nutr. Rev. 63: 29-36 (2005).
-
Casillas S, Delaney CP. Laparoscopic surgery for inflammatory bowel disease.
Dig. Surg. 22: 135-142 (2005).
-
Casimiro L, Barnsley L, Brosseau L, Milne S, Robinson V, Tugwell P, Wells G, Casimiro L. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis.
Cochrane Database Syst. Rev. 4: CD003788 (2005).
*
-
Cassell S, Kavanaugh A. Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatment.
J. Immune Based Ther. Vaccines 3: 6 (2005).
*
-
Cassis L, Aiello S, Noris M. Natural versus adaptive regulatory T cells.
Contrib. Nephrol. 146: 121-131 (2005).
-
Cassis TB, Callen JP. Bupropion-induced subacute cutaneous lupus erythematosus.
Australas. J. Dermatol. 46: 266-269 (2005).
-
Cassuto H, Kochan K, Chakravarty K, Cohen H, Blum B, Olswang Y, Hakimi P, Xu C, Massillon D, Hanson RW, Reshef L. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver via an extended glucocorticoid regulatory unit.
J. Biol. Chem. 280: 33873-33884 (2005).
*
-
Castagna A, Biswas P, Beretta A, Lazzarin A. The appealing story of HIV entry inhibitors: from discovery of biological mechanisms to drug development.
Drugs 65: 879-904 (2005).
-
Castaldo G, Polizzi A, Tomaiuolo R, Cazeneuve C, Girodon E, Santostasi T, Salvatore D, Raia V, Rigillo N, Goossens M, Salvatore F. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population.
Ann. Hum. Genet. 69: 15-24 (2005).
*
-
Castaneda FE, Walia B, Vijay-Kumar M, Patel NR, Roser S, Kolachala VL, Rojas M, Wang L, Oprea G, Garg P, Gewirtz AT, Roman J, Merlin D, Sitaraman SV. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.
Gastroenterology 129: 1991-2008 (2005).
*
-
Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency.
Nat. Genet. 37: 829-834 (2005).
*
-
Castillo E, Thomassie LM, Whitlow CB, Margolin DA, Malcolm J, Beck DE. Continent ileostomy: current experience.
Dis. Colon Rectum 48: 1263-1268 (2005).
*
-
Castro RE, Sola S, Ma X, Ramalho RM, Kren BT, Steer CJ, Rodrigues CM. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid.
J. Hepatol. 42: 897-906 (2005).
*
-
Casu A, Trucco M, Pietropaolo M. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
Pediatr. Clin. North Am. 52: 1779-1804 (2005).
-
Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, Lu Y, Rong LL, Hofmann MA, Kislinger T, Pachydaki SI, Jenkins DG, Weinberg A, Lefkowitch J, Rogiers X, Yan SF, Schmidt AM, Emond JC. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB.
J. Exp. Med. 201: 473-484 (2005).
*
-
Catassi C. The world map of celiac disease.
Acta Gastroenterol. Latinoam. 35: 37-55 (2005).
-
Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers.
Gastroenterology 128: S79-S86 (2005).
*
-
Catenacci MH, King KK. Images in emergency medicine. Crohn's disease.
Ann. Emerg. Med. 46: 559, 564 (2005).
-
Cather JC, Menter A. Combining traditional agents and biologics for the treatment of psoriasis.
Semin. Cutan. Med. Surg. 24: 37-45 (2005).
-
Cattan D. MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage.
Curr. Drug Targets Inflamm. Allergy 4: 105-112 (2005).
-
Cauffiez C, Pottier N, Tournel G, Lo-Guidice JM, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly F. CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations.
Xenobiotica 35: 661-669 (2005).
*
-
Caunedo Alvarez A, Herrerias Gutierrez JM. Role of endoscopic capsule in the diagnosis of digestive diseases.
Med. Clin. (Barc.) 124: 427-433 (2005).
-
Cauwels A, Bultinck J, Brouckaert P. Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress.
Cell. Mol. Life Sci. 62: 1632-1640 (2005).
*
-
Cauza E, Hanusch-Enserer U, Etemad M, Koller M, Kostner K, Georg P, Dunky A, Ferenci P. HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis.
Clin. Exp. Rheumatol. 23: 7-12 (2005).
-
Cavadini P, Vermi W, Facchetti F, Fontana S, Nagafuchi S, Mazzolari E, Sediva A, Marrella V, Villa A, Fischer A, Notarangelo LD, Badolato R. AIRE deficiency in thymus of 2 patients with Omenn syndrome.
J. Clin. Invest. 115: 728-732 (2005).
*
-
Cavazzana I, Franceschini F, Danieli E, Frassi M, Vianelli M, Gorla R, Airo P, Cattaneo R. Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies.
Reumatismo 57: 267-272 (2005).
-
Cavazzana I, Franceschini F, Vassalini C, Danieli E, Quinzanini M, Airo P, Cattaneo R. Clinical and serological features of 35 patients with anti-Ki autoantibodies.
Lupus 14: 837-841 (2005).
-
Cave D. Capsule endoscopy and Crohn's disease.
Gastrointest. Endosc. 61: 262-263 (2005).
*
-
Cavestro GM, Comparato G, Nouvenne A, Sereni G, Bertolini S, Frulloni L, Dalla Valle R, Soliani P, Zanelli PF, Sianesi M, Franze A, Di Mario F. Genetics of chronic pancreatitis.
JOP 6: S53-S59 (2005).
*
-
Cawood AL, Carroll MP, Wootton SA, Calder PC. Is there a case for n-3 fatty acid supplementation in cystic fibrosis?
Curr. Opin. Clin. Nutr. Metab. Care 8: 153-159 (2005).
-
Cawood TJ, McKenna MJ, Gallagher CG, Smith D, Wen YC, Gibney J, Dodd JD, O'Shea D. Oral bisphosphonates improve bone mineral density in adults with cystic fibrosis.
Ir. Med. J. 98: 270-273 (2005).
-
Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia.
Best Pract. Res. Clin. Haematol. 18: 251-263 (2005).
-
Cebecauerova D, Jirasek T, Budisova L, Mandys V, Volf V, Novotna Z, Subhanova I, Hrebicek M, Elleder M, Jirsa M. Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome.
Gastroenterology 129: 315-320 (2005).
*
-
Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products.
J. Immunol. 175: 8296-8302 (2005).
*
-
Cederholm A, Frostegard J. Annexin A5 in cardiovascular disease and systemic lupus erythematosus.
Immunobiology 210: 761-768 (2005).
*
-
Ceelen L, Decostere A, Verschraegen G, Ducatelle R, Haesebrouck F. Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons.
J. Clin. Microbiol. 43: 2984-2986 (2005).
*
-
Celi D, Desogus AI, Cucinotta A, Lucibello L, Giordano T, Metro D, Bonardelli P, Cocuzza G, Brunetto D. Complex anal fistula with a recess above the levator ani muscles: report of a case complicated by haemorrhagic colitis.
Chir. Ital. 57: 531-534 (2005).
-
Celik T, Goren MZ, Cinar K, Gurdal H, Onder FO, Tan A, Terzioglu B, Bozdayi AM, Bozkaya H, Uzunalimoglu O, Yurdaydin C. Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
Hepatology 41: 731-737 (2005).
*
-
Cellier C, Green PH, Collin P, Murray J. ICCE consensus for celiac disease.
Endoscopy 37: 1055-1059 (2005).
-
Cellot S, Sauvageau G. Gfi-1: another piece in the HSC puzzle.
Trends Immunol. 26: 68-71 (2005).
*
-
Cem Ar M, Soysal T, Hatemi G, Salihoglu A, Yazici H, Ulku B. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma.
Ann. Hematol. 84: 609-613 (2005).
*
-
Cenac N, Cellars L, Steinhoff M, Andrade-Gordon P, Hollenberg MD, Wallace JL, Fiorucci S, Vergnolle N. Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response.
Inflamm. Bowel Dis. 11: 792-798 (2005).
*
-
Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk - four states, 2005.
MMWR Morb. Mortal. Wkly. Rep. 54: 1201-1205 (2005).
*
-
Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Bussow K, Sommer N, Hemmer B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.
J. Clin. Invest. 115: 1352-1360 (2005).
*
-
Certad G, Arenas-Pinto A, Pocaterra L, Ferrara G, Castro J, Bello A, Nunez L. Cryptosporidiosis in HIV-infected Venezuelan adults is strongly associated with acute or chronic diarrhea.
Am. J. Trop. Med. Hyg. 73: 54-57 (2005).
-
Cervera R, Asherson RA. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics.
Immunobiology 210: 735-741 (2005).
-
Cervera R, Font J, Gomez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, Ramos-Casals M, Ingelmo M, Piette JC, Shenfeld Y, Asherson RA, Caps Registry Project Group MO. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
Ann. Rheum. Dis. 64: 1205-1209 (2005).
*
-
Cescon M, Spada M, Colledan M, Andorno E, Valente U, Rossi G, Reggiani P, Grazi GL, Tisone G, Majno P, Rogiers X, Santamaria ML, Baccarani U, Ettorre GM, Cillo U, Rossi M, Scalamogna M, Gridelli B. Split-liver transplantation with pediatric donors: a multicenter experience.
Transplantation 79: 1148-1153 (2005).
-
Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats.
Tohoku J. Exp. Med. 206: 131-139 (2005).
*
-
Ch'ng CL, Biswas M, Benton A, Jones MK, Kingham JG. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
Clin. Endocrinol. (Oxf.) 62: 303-306 (2005).
*
-
Chabas D. Osteopontin, a multi-faceted molecule.
Med. Sci. (Paris) 21: 832-838 (2005).
-
Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure.
Ann. Dermatol. Venereol. 132: 891-893 (2005).
-
Chadha S, Miller K, Farwell L, Lightstone LB, Daly MJ, Rioux JD, Vyse TJ. Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus.
Eur. J. Hum. Genet. 13: 669-676 (2005).
*
-
Chadwick CC, Chippari S, Matelan E, Borges-Marcucci L, Eckert AM, Keith JC Jr, Albert LM, Leathurby Y, Harris HA, Bhat RA, Ashwell M, Trybulski E, Winneker RC, Adelman SJ, Steffan RJ, Harnish DC. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
Proc. Natl. Acad. Sci. U.S.A. 102: 2543-2548 (2005).
*
-
Chae SC, Park YR, Shim SC, Lee IK, Chung HT. Eotaxin-3 gene polymorphisms are associated with rheumatoid arthritis in a Korean population.
Hum. Immunol. 66: 314-320 (2005).
-
Chae SC, Park YR, Song JH, Shim SC, Yoon KS, Chung HT. The polymorphisms of Tim-1 promoter region are associated with rheumatoid arthritis in a Korean population.
Immunogenetics 56: 696-701 (2005).
*
-
Chai JG, Xue SA, Coe D, Addey C, Bartok I, Scott D, Simpson E, Stauss HJ, Hori S, Sakaguchi S, Dyson J. Regulatory T cells, derived from naive CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.
Transplantation 79: 1310-1316 (2005).
-
Chai SK, Altman GM, Yazdanbakhsh M, Tsuji J, Godat L, Takaro TK. Production of interleukin 10 and transforming growth factor beta in concomitant allergy and autoimmunity.
Ann. Allergy Asthma Immunol. 94: 279-285 (2005).
-
Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
Cell. Metab. 1: 309-322 (2005).
*
-
Chakravarti S, Sabatos CA, Xiao S, Illes Z, Cha EK, Sobel RA, Zheng XX, Strom TB, Kuchroo VK. Tim-2 regulates T helper type 2 responses and autoimmunity.
J. Exp. Med. 202: 437-444 (2005).
*
-
Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver.
Hepatology 41: 690-695 (2005).
*
-
Chalasani N, Boyer TD. Primary prophylaxis against variceal bleeding: beta-blockers, endoscopic ligation, or both?
Am. J. Gastroenterol. 100: 805-807 (2005).
*
-
Chalasani N, Teal E, Hall SD. Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.
Am. J. Gastroenterol. 100: 1317-1321 (2005).
*
-
Chamberland D, Weight C, Rasmussen M, Abraham D. Thyroxine malabsorption in a patient with type 1 diabetes and celiac disease.
Endocr. Pract. 11: 203-204 (2005).
-
Chambers SA, Isenberg D. Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases.
Lupus 14: 210-214 (2005).
*
-
Chambers WM, Warren BF, Jewell DP, McC Mortensen NJ. Cancer surveillance in ulcerative colitis.
Br. J. Surg. 92: 928-936 (2005).
*
-
Chamian F, Lowes MA, Lin SL, Lee E, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris.
Proc. Natl. Acad. Sci. U.S.A. 102: 2075-2080 (2005).
*
-
Chamouard P, Desprez D, Hugel B, Kunzelmann C, Gidon-Jeangirard C, Lessard M, Baumann R, Freyssinet JM, Grunebaum L. Circulating cell-derived microparticles in Crohn's disease.
Dig. Dis. Sci. 50: 574-580 (2005).
*
-
Chamouard P, Walter P, Baumann R, Poupon R. Prolonged cholestasis associated with short-term use of celecoxib.
Gastroenterol. Clin. Biol. 29: 1286-1288 (2005).
-
Chan AC. Defining molecular targets for drug design: synergism between academia and industry.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S47 (2005).
*
-
Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, Fuchs CS. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
J. Natl. Cancer Inst. 97: 917-926 (2005).
*
-
Chan CW, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK. Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model.
Scand. J. Gastroenterol. 40: 1081-1089 (2005).
*
-
Chan CW, Gunsar F, Feudjo M, Rigamonti C, Vlachogiannakos J, Carpenter JR, Burroughs AK. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Aliment. Pharmacol. Ther. 21: 217-226 (2005).
*
-
Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.
Kidney Int. 67: 602-612 (2005).
*
-
Chan RY, Tan CE, Czech-Schmidt G, Petersen C. Computerized three-dimensional study of a rotavirus model of biliary atresia: comparison with human biliary atresia.
Pediatr. Surg. Int. 21: 615-620 (2005).
*
-
Chan SM, Utz PJ. The challenge of analyzing the proteome in humans with autoimmune diseases.
Ann. N. Y. Acad. Sci. 1062: 61-68 (2005).
*
-
Chan TM. Lupus nephritis: induction therapy.
Lupus 14 Suppl. 1: s27-s32 (2005).
-
Chan TM. Histological reclassification of lupus nephritis.
Curr. Opin. Nephrol. Hypertens. 14: 561-566 (2005).
-
Chan V, Crocetti G, Grehan M, Zhang L, Danon S, Lee A, Mitchell H. Visualization of Helicobacter species within the murine cecal mucosa using specific fluorescence in situ hybridization.
Helicobacter 10: 114-124 (2005).
*
-
Chande N, Driman DK, Reynolds RP. Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation.
Scand. J. Gastroenterol. 40: 343-347 (2005).
*
-
Chande N, McDonald J, Macdonald J, Chande N. Interventions for treating collagenous colitis.
Cochrane Database Syst. Rev. 4: CD003575 (2005).
*
-
Chande N, Ponich T, Gregor J. A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease.
Can. J. Gastroenterol. 19: 553-558 (2005).
*
-
Chandra P, Johnson BM, Zhang P, Pollack GM, Brouwer KL. Modulation of hepatic canalicular or basolateral transport alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver.
Drug Metab. Dispos. 33: 1238-1243 (2005).
*
-
Chang DK, Kim YH, Byeon JS, Yang SK, Chung YW, Han DS, Kim SG, Kim TI, Kim WH, Jeen YT, Eun CS, Choi H, Choi KY, Song IS. The current status of ulcerative colitis-associated colorectal cancer in Korea: a KASID study.
Korean J. Gastroenterol. 46: 276-282 (2005).
-
Chang F, Deere H, Vu C. Atypical forms of microscopic colitis: morphological features and review of the literature.
Adv. Anat. Pathol. 12: 203-211 (2005).
-
Chang HK. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
J. Korean Med. Sci. 20: 883-885 (2005).
*
-
Chang HS, Kim JS, Lee JH, Cho JI, Rhim TY, Uh ST, Park BL, Chung IY, Park CS, Shin HD. A single nucleotide polymorphism on the promoter of eotaxin1 associates with its mRNA expression and asthma phenotypes.
J. Immunol. 174: 1525-1531 (2005).
*
-
Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27.
Surv. Ophthalmol. 50: 364-388 (2005).
*
-
Chang JM, Lee JM, Suh KS, Yi NJ, Kim YT, Kim SH, Han JK, Choi BI. Biliary complications in living donor liver transplantation: imaging findings and the roles of interventional procedures.
Cardiovasc. Intervent. Radiol. 28: 756-767 (2005).
-
Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, Wen LQ, Wu W, Jiang ZP, Huang ZT. Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock.
World J. Gastroenterol. 11: 5485-5491 (2005).
*
-
Chang KM. Regulatory T cells and the liver: a new piece of the puzzle.
Hepatology 41: 700-702 (2005).
*
-
Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Am. J. Gastroenterol. 100: 115-123 (2005).
*
-
Chang ML, Yeh CT, Chang PY, Chen JC. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.
World J. Gastroenterol. 11: 4167-4172 (2005).
*
-
Chang PK, Holt EG, De Villiers WJ, Boulanger BR. A new complication from a new technology: what a general surgeon should know about wireless capsule endoscopy.
Am. Surg. 71: 455-458 (2005).
-
Chang TK, Waxman DJ. Pregnane X receptor-mediated transcription.
Methods Enzymol. 400: 588-598 (2005).
-
Chang WW, Su IJ, Lai MD, Chang WT, Huang W, Lei HY. Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression.
World J. Gastroenterol. 11: 6631-6637 (2005).
*
-
Chang X, Gao JX, Jiang Q, Wen J, Seifers N, Su L, Godfrey VL, Zuo T, Zheng P, Liu Y. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis.
J. Exp. Med. 202: 1141-1151 (2005).
*
-
Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Rheumatology (Oxford) 44: 293-298 (2005).
*
-
Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Rheumatology (Oxford) 44: 1374-1382 (2005).
*
-
Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Rheumatology (Oxford) 44: 40-50 (2005).
*
-
Chang Y, Yap S, Ge X, Piganelli J, Bertera S, Giannokakis N, Mathews C, Prud'homme G, Trucco M. DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.
Gene Ther. 12: 1679-1685 (2005).
*
-
Chang YH, Huang CN, Wu CY, Shiau MY. Association of Interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus.
Hum. Immunol. 66: 1258-1263 (2005).
-
Chang YT, Liu HN, Shiao YM, Lin MW, Lee DD, Liu MT, Wang WJ, Wu S, Lai CY, Tsai SF. A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis.
Br. J. Dermatol. 153: 90-96 (2005).
*
-
Chao CC, Ng Jao YT, Mo LR. Capsule endoscopy for gastrointestinal bleeding with an obscure etiology.
J. Formos. Med. Assoc. 104: 659-665 (2005).
-
Chao PM, Yang MF, Tseng YN, Chang KM, Lu KS, Huang CJ. Peroxisome proliferation in liver of rats fed oxidized frying oil.
J. Nutr. Sci. Vitaminol. (Tokyo) 51: 361-368 (2005).
-
Chao SC, Yang CC, Lee JY. Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease.
Ann. Pharmacother. 39: 1552-1556 (2005).
-
Chao YC, Chu HC, Chang WK, Huang HH, Hsieh TY. CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis.
World J. Gastroenterol. 11: 6043-6048 (2005).
*
-
Chaoui Z, Bernoussi A, Belmekki M, Berraho A. Uveitis and chronic intestinal inflammatory diseases: three case studies.
J. Fr. Ophtalmol. 28: 854-856 (2005).
-
Chapman JR, Larson DW, Wolff BG, Dozois EJ, Cima RR, Pemberton JH, Crownhart BS, Larson DR. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome?
Arch. Surg. 140: 534-540 (2005).
*
-
Chapuy-Regaud S, Sebbag M, Baeten D, Clavel C, Foulquier C, De Keyser F, Serre G. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides.
J. Immunol. 174: 5057-5064 (2005).
*
-
Charach G, Grosskopf I, Rotmensch HH, Kitzis I, Weintraub M. Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal disease.
Nephron. Clin. Pract. 100: c120-c125 (2005).
-
Charatcharoenwitthaya P, Lindor KD. Current concepts in the pathogenesis of primary biliary cirrhosis.
Ann. Hepatol. 4: 161-175 (2005).
*
-
Charbonnel B. What a psychiatrist needs to know about diabetes.
Eur. Psychiatry 20 Suppl. 4: S330-S334 (2005).
-
Chari ST, Vege SS. Is magnetic resonance cholangiography of clinical value in the diagnosis and treatment of gallstone pancreatitis?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 170-171 (2005).
*
-
Charnaux N, Brule S, Chaigneau T, Saffar L, Sutton A, Hamon M, Prost C, Lievre N, Vita C, Gattegno L. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
Glycobiology 15: 119-130 (2005).
*
-
Charonis A, Sideraki V, Kaltezioti V, Alberti A, Vlahakos D, Wu K, Tsilibary E. Basement membrane peptides: functional considerations and biomedical applications in autoimmunity.
Curr. Med. Chem. 12: 1495-1502 (2005).
-
Charron D. Immunogenomics of hematopoietic stem cell transplantation.
Pathol. Biol. (Paris) 53: 171-173 (2005).
-
Charytan D, MacDonald B, Sugimoto H, Pastan S, Staton G, Hennigar R, Kalluri R. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
Am. J. Kidney Dis. 45: 743-748 (2005).
-
Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.
J. Med. Genet. 42: 881-892 (2005).
*
-
Chatenoud L. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications.
Curr. Opin. Immunol. 17: 632-637 (2005).
-
Chatenoud L, Bach JF. Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance.
Expert Opin. Biol. Ther. 5 Suppl. 1: S73-S81 (2005).
-
Chatila TA. Role of regulatory T cells in human diseases.
J. Allergy Clin. Immunol. 116: 949-959 (2005).
*
-
Chatterjee B, Echchgadda I, Song CS. Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1.
Methods Enzymol. 400: 165-191 (2005).
-
Chatterjee R, Batra J, Kumar A, Mabalirajan U, Nahid S, Niphadkar PV, Ghosh B. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians.
Clin. Exp. Allergy 35: 914-919 (2005).
-
Chaudhary R, Ghosh S. Prediction of response to infliximab in Crohn's disease.
Dig. Liver Dis. 37: 559-563 (2005).
-
Chaudhary R, Ghosh S. Infliximab in refractory coeliac disease.
Eur. J. Gastroenterol. Hepatol. 17: 603-604 (2005).
-
Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis.
Med. Hypotheses 64: 608-618 (2005).
-
Chaudhuri A, Behan PO. Multiple sclerosis: looking beyond autoimmunity.
J. R. Soc. Med. 98: 303-306 (2005).
*
-
Chaudhuri N, Dower SK, Whyte MK, Sabroe I. Toll-like receptors and chronic lung disease.
Clin. Sci. (Lond.) 109: 125-133 (2005).
*
-
Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, Anegon I. Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression.
Blood 106: 1694-1702 (2005).
*
-
Chauveau E, Terrier F, Casassus-Buihle D, Moncoucy X, Oddes B. Macrophage activation syndrome after treatment with infliximab for fistulated Crohn's disease.
Presse. Med. 34: 583-584 (2005).
-
Chavez ML. Herbal-drug interactions.
InetCE 9: 2-30 (www.InetCE.com; 221-999-05-056-H01) (2005). *
-
Chavez-Lopez M, Delgado-Villafana J, Gallaga A, Huerta-Yanez G. Severe anaphylactic reaction during the second infusion of infliximab in a patient with psoriatic arthritis.
Allergol. Immunopathol. (Madr.) 33: 291-292 (2005).
-
Chazenbalk GD, Pichurin PN, Guo J, Rapoport B, McLachlan SM. Interactions between the mannose receptor and thyroid autoantigens.
Clin. Exp. Immunol. 139: 216-224 (2005).
*
-
Cheema SK, Agarwal-Mawal A, Murray CM, Tucker S. Lack of stimulation of cholesterol ester transfer protein by cholesterol in the presence of a diet high in monounsaturated fatty acids.
J. Lipid Res. 46: 2356-2366 (2005).
*
-
Chemin J, Patel A, Duprat F, Zanzouri M, Lazdunski M, Honore E. Lysophosphatidic acid-operated K+ channels.
J. Biol. Chem. 280: 4415-4421 (2005).
*
-
Chen AH, Innis SM, Davidson AG, James SJ. Phosphatidylcholine and lysophosphatidylcholine excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine.
Am. J. Clin. Nutr. 81: 686-691 (2005).
*
-
Chen C, Bazan NG. Lipid signaling: sleep, synaptic plasticity, and neuroprotection.
Prostaglandins Other Lipid Mediat. 77: 65-76 (2005).
-
Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice.
Proc. Natl. Acad. Sci. U.S.A. 102: 11408-11413 (2005).
*
-
Chen CC, Huang CY, Huang FY, Dang CW, Lin CL, Lo FS, Lin CH, Tsang CC, Li HJ, Liu HF, Chu CC, Lin M, Lee YJ. The CBLB gene and Graves' disease in children.
J. Pediatr. Endocrinol. Metab. 18: 1119-1126 (2005).
-
Chen CC, Su MY, Tung SY, Chang FY, Wong JM, Geraint M. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults.
Curr. Med. Res. Opin. 21: 1595-1602 (2005).
-
Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
J. Surg. Res. 124: 169-174 (2005).
*
-
Chen CH, Nagayama K, Enomoto N, Miyasaka Y, Kurosaki M, Sakamoto N, Maekawa S, Kakinuma S, Ikeda T, Izumi N, Sato C, Watanabe M. Enhancement of mitochondrial gene expression in the liver of primary biliary cirrhosis.
Hepatol. Res. 31: 24-30 (2005).
-
Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, Lu SN, Liu HW. High prevalence of immunoglobulin a antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
J. Rheumatol. 32: 44-47 (2005).
-
Chen CY, Lin XZ, Wu HC, Shiesh SC. The value of biliary amylase and Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-associated Protein I (HIP/PAP-I) in diagnosing biliary malignancies.
Clin. Biochem. 38: 520-525 (2005).
*
-
Chen HJ, Lin SP, Lee HC, Chen CP, Chiu NC, Hung HY, Chern SR, Chuang CK. Cystic fibrosis with homozygous R553X mutation in a Taiwanese child.
J. Hum. Genet. 50: 674-678 (2005).
*
-
Chen HL, Chen HL, Liu YJ, Feng CH, Wu CY, Shyu MK, Yuan RH, Chang MH. Developmental expression of canalicular transporter genes in human liver.
J. Hepatol. 43: 472-477 (2005).
*
-
Chen IH, Kuo MC, Hwang SJ, Chang JM, Chen HC. Allopurinol-induced severe hypersensitivity with acute renal failure.
Kaohsiung J. Med. Sci. 21: 228-232 (2005).
-
Chen J, Liu C. Sulfasalazine for ankylosing spondylitis.
Cochrane Database Syst. Rev. 2: CD004800 (2005).
*
-
Chen J, Wang Y, Kunkel G, Zhao H, Xue H, Xie X, Li L, Xu C, Shen L, Gu L. Use of CD34(+) autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus.
Clin. Rheumatol. 24: 464-468 (2005).
*
-
Chen JY, Wang CM, Ma CC, Chow YH, Luo SF. The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.
Genes Immun. 6: 123-128 (2005).
*
-
Chen K, Wei Y, Alter A, Sharp GC, Braley-Mullen H. Chemokine expression during development of fibrosis versus resolution in a murine model of granulomatous experimental autoimmune thyroiditis.
J. Leukoc. Biol. 78: 716-724 (2005).
*
-
Chen L, Cencioni MT, Angelini DF, Borsellino G, Battistini L, Brosnan CF. Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands.
J. Immunol. 174: 6144-6152 (2005).
*
-
Chen LS, Wei JB, Zhou YC, Zhang S, Liang JL, Cao YF, Tang ZJ, Zhang XL, Gao F. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.
World J. Gastroenterol. 11: 6120-6124 (2005).
*
-
Chen M, Beaven SW, Tontonoz P. Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha.
J. Lipid Res. 46: 2570-2579 (2005).
*
-
Chen M, Dittmann A, Kuhn A, Ruzicka T, Mikecz AV. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma.
Arthritis Rheum. 52: 877-884 (2005).
*
-
Chen M, von Mikecz A. Proteasomal processing of nuclear autoantigens in systemic autoimmunity.
Autoimmun. Rev. 4: 117-122 (2005).
-
Chen M, von Mikecz A. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma.
Ann. N. Y. Acad. Sci. 1051: 382-389 (2005).
*
-
Chen M, Wang YY, Zhao MH, Zhang YK, Wang HY. Autoantibodies against glomerular mesangial cells and their target antigens in lupus nephritis.
Ren. Fail. 27: 507-513 (2005).
-
Chen M, Xia B, Rodriguez-Gueant RM, Bigard M, Gueant JL. Genotypes 677TT and 677CT+1298AC of methylenetetrahydrofolate reductase are associated with the severity of ulcerative colitis in central China.
Gut 54: 733-734 (2005).
*
-
Chen M, Yu F, Zhang Y, Zhao MH. An analysis of multi-system involvement and renal pathology of anti-neutrophil cytoplasmic autoantibodies-related vasculitis.
Zhonghua Nei Ke Za Zhi 44: 828-831 (2005).
-
Chen M, Yu F, Zhang Y, Zhao MH. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre.
Postgrad. Med. J. 81: 723-727 (2005).
*
-
Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.
Kidney Int. 68: 2225-2229 (2005).
*
-
Chen M, Zhao MH, Zhang YK, Wang HY. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
Nephrology (Carlton) 10: 491-495 (2005).
*
-
Chen Q, Ross AC. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells.
Proc. Natl. Acad. Sci. U.S.A. 102: 14142-14149 (2005).
*
-
Chen QK, Yuan SZ, Wen ZF, Zhong YQ, Li CJ, Wu HS, Mai CR, Xie PY, Lu YM, Yu ZL. Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.
World J. Gastroenterol. 11: 2462-2466 (2005).
*
-
Chen R, Bronner MP, Crispin DA, Rabinovitch PS, Brentnall TA. Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions.
Cancer Genet. Cytogenet. 162: 99-106 (2005).
-
Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA. The initiation of colon cancer in a chronic inflammatory setting.
Carcinogenesis 26: 1513-1519 (2005).
*
-
Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R, Brentnall TA. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape.
Gastroenterology 129: 1187-1197 (2005).
*
-
Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease.
J. Clin. Lab. Anal. 19: 133-138 (2005).
-
Chen RH, Chen WC, Wang TY, Tsai CH, Tsai FJ. Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves' disease.
Int. J. Immunogenet. 32: 343-347 (2005).
*
-
Chen S, Beaton D, Nguyen N, Senekeo-Effenberger K, Brace-Sinnokrak E, Argikar U, Remmel R, Trottier J, Barbier O, Ritter JK, Tukey RH. Tissue specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus.
J. Biol. Chem. 280: 37547-37557 (2005).
*
-
Chen W, Cai MY, Wei DP, Wang X. Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma.
World J. Gastroenterol. 11: 3297-3299 (2005).
*
-
Chen W, Esselman WJ, Jump DB, Busik JV. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells.
Invest. Ophthalmol. Vis. Sci. 46: 4342-4347 (2005).
*
-
Chen W, Gluud C. Bile acids for liver-transplanted patients.
Cochrane Database Syst. Rev. 3: CD005442 (2005).
*
-
Chen W, Herold KC, Bluestone JA. Achieving antigen-specific tolerance in diabetes: regulating specifically.
Int. Rev. Immunol. 24: 287-305 (2005).
-
Chen WY, Cheng YT, Lei HY, Chang CP, Wang CW, Chang MS. IL-24 inhibits the growth of hepatoma cells in vivo.
Genes Immun. 6: 493-499 (2005).
*
-
Chen X, Oppenheim JJ, Howard OM. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
J. Leukoc. Biol. 78: 114-121 (2005).
*
-
Chen X, Wang L, Zhi L, Zhou G, Wang H, Zhang X, Hao B, Zhu Y, Cheng Z, He F. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Clin. Pharmacol. Ther. 78: 249-259 (2005).
*
-
Chen Y, Bellamy WP, Seabra MC, Field MC, Ali BR. ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome.
Hum. Mol. Genet. 14: 2559-2569 (2005).
*
-
Chen Y, Donnelly E, Kobayashi H, Debusk LM, Lin PC. Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction.
Arthritis Rheum. 52: 1585-1594 (2005).
*
-
Chen Y, Kissling G, Negishi M, Goldstein JA. The nuclear receptors CAR and PXR cross talk with HNF4alpha to synergistically activate the human CYP2C9 promoter.
J. Pharmacol. Exp. Ther. 314: 1125-1133 (2005).
*
-
Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP, Morel L. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.
J. Immunol. 175: 1080-1089 (2005).
*
-
Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Cancer Res. 65: 11771-11778 (2005).
*
-
Chen YC, Kuo MC, Chen HC, Lai YH, Hwang SJ. HCV infection complicated with nephrotic syndrome, immune complex crescentic glomerulonephritis and acute renal failure: a case report.
Kaohsiung J. Med. Sci. 21: 470-474 (2005).
-
Chen YF, Morel L. Genetics of T cell defects in lupus.
Cell. Mol. Immunol. 2: 403-409 (2005).
*
-
Chen YH, Wang JP, Wang H, Sun MF, Wei LZ, Wei W, Xu DX. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta.
Toxicology 211: 242-252 (2005).
*
-
Chen Z, Ding Y, Li G. Configuration of a new bioartificial liver support system and in vitro evaluation of its functions.
Ann. Clin. Lab. Sci. 35: 7-14 (2005).
-
Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide and leukotriene C4 by human multidrug resistance protein 8 (ABCC11).
Mol. Pharmacol. 67: 545-557 (2005).
*
-
Cheng CL, Fogel EL, Sherman S, McHenry L, Watkins JL, Croffie JM, Gupta SK, Fitzgerald JF, Lazzell-Pannell L, Schmidt S, Lehman GA. Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report.
J. Pediatr. Gastroenterol. Nutr. 41: 445-453 (2005).
*
-
Cheng J, Imanishi H, Morisaki H, Liu W, Nakamura H, Morisaki T, Hada T. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1.
J. Hepatol. 43: 465-471 (2005).
*
-
Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G, Sementchenko V, Piccolboni A, Bekiranov S, Bailey DK, Ganesh M, Ghosh S, Bell I, Gerhard DS, Gingeras TR. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution.
Science 308: 1149-1154 (2005).
*
-
Cheng J, Wang H, Guggino WB. Regulation of cystic fibrosis transmembrane regulator trafficking and protein expression by a Rho family small GTPase TC10.
J. Biol. Chem. 280: 3731-3739 (2005).
*
-
Cheng L, Harnett KM, Cao W, Liu F, Behar J, Fiocchi C, Biancani P. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis.
Gastroenterology 129: 1675-1685 (2005).
*
-
Cheng PT, Mukherjee R. PPARs as targets for metabolic and cardiovascular diseases.
Mini. Rev. Med. Chem. 5: 741-753 (2005).
-
Cheng VC, Ho PL, Yuen KY. Two probable cases of serious drug interaction between clarithromycin and colchicine.
South Med. J. 98: 811-813 (2005).
-
Cheng X, Maher JM, Dieter MZ, Klaassen CD. Regulation of mouse organic anion transporting polypeptides (Oatps) in liver by prototypical microsome enzyme inducers that activate distinct transcription factor pathways.
Drug Metab. Dispos. 33: 1276-1282 (2005).
*
-
Cheng Y, Desreumaux P. 5-Aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.
World J. Gastroenterol. 11: 309-314 (2005).
*
-
Cheon Y, Nara TY, Band MR, Beever JE, Wallig MA, Nakamura MT. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPAR alpha in non-proliferating species.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R1525-R1535 (2005).
*
-
Cheong HS, Kim LH, Park BL, Choi YH, Park HS, Hong SJ, Choi BW, Park CS, Shin HD. Association analysis of interleukin 5 receptor alpha subunit (IL5RA) polymorphisms and asthma.
J. Hum. Genet. 50: 628-634 (2005).
*
-
Cheong JY, Cho SW, Lim SK, Shin do H, Yoon SK, Lee JE, Hahm KB, Kim JH. Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population.
J. Korean Med. Sci. 20: 65-69 (2005).
*
-
Cheong JY, Lee KM, Cho SW, Won JH, Kim JK, Wang HJ, Hahm KB, Kim JH. Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Hepatol. Res. 32: 127-133 (2005).
-
Cheow HK, Voutnis DD, Evans JW, Szczepura KR, Swift EA, Bird NJ, Ruparelia P, Solanki CK, Ballinger JR, Chilvers ER, Middleton SJ, Peters AM. Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease.
Eur. J. Nucl. Med. Mol. Imaging 32: 329-337 (2005).
*
-
Chernajovsky Y. Gene therapy for arthritis - where do we stand?
Arthritis Res. Ther. 7: 227-229 (2005).
*
-
Chernova MN, Jiang L, Friedman DJ, Darman RB, Lohi H, Kere J, Vandorpe DH, Alper SL. Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity.
J. Biol. Chem. 280: 8564-8580 (2005).
*
-
Cheroutre H. IELs: enforcing law and order in the court of the intestinal epithelium.
Immunol. Rev. 206: 114-131 (2005).
*
-
Cherry K. Improved bone mineral density with alendronate in primary biliary cirrhosis patients.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 554 (2005).
*
-
Cherry K. Ursodeoxycholic acid for treatment of intrahepatic cholestasis of pregnancy.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 555 (2005).
*
-
Cheung C, Yu AM, Ward JM, Akiyama TE, Feigenbaum L, Gonzalez FJ. The CYP2E1 humanized transgenic mouse: role of CYP2E1 acetaminophen hepatotoxicity.
Drug Metab. Dispos. 33: 449-457 (2005).
*
-
Cheung CM, Murray PI, Savage CO. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.
Br. J. Ophthalmol. 89: 1542 (2005).
*
-
Cheung DY, Kim JK, Jo DH, Oh HJ, Kim TH, Lee SY, Park SH, Han JY, Chung KW, Sun HS. A case of portal vein thrombosis associated with acute pancreatitis and cholangitis.
Korean J. Gastroenterol. 46: 60-65 (2005).
-
Cheung R, Erclik MS, Mitchell J. Increased expression of G(11)alpha in osteoblastic cells enhances parathyroid hormone activation of phospholipase C and AP-1 regulation of matrix metalloproteinase-13 mRNA.
J. Cell. Physiol. 204: 336-343 (2005).
*
-
Cheung VG. Genomics: polymorphic landscape of the human genome.
Eur. J. Hum. Genet. 13: 133-135 (2005).
*
-
Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association.
Nature 437: 1365-1369 (2005).
*
-
Cheung YH, Chang NH, Cai YC, Bonventi G, Macleod R, Wither JE. Functional interplay between intrinsic B and T cell defects leads to amplification of autoimmune disease in New Zealand Black chromosome 1 congenic mice.
J. Immunol. 175: 8154-8164 (2005).
*
-
Cheunsuk S, Lian ZX, Yang GX, Gershwin ME, Gruen JR, Bowlus CL. Prss16 is not required for T-cell development.
Mol. Cell. Biol. 25: 789-796 (2005).
*
-
Chevalier-Porst F, Souche G, Bozon D. Identification and characterization of three large deletions and a deletion/polymorphism in the CFTR gene.
Hum. Mutat. 25: 504 (2005).
*
-
Chey WY, Shah A. Infliximab for ulcerative colitis.
J. Clin. Gastroenterol. 39: 920 (2005).
-
Chi CH, Liu IL, Lo WY, Liaw BS, Wang YS, Chi KH. Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.
World J. Gastroenterol. 11: 1496-1502 (2005).
*
-
Chiang JY. Nuclear receptor regulation of lipid metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases.
Curr. Opin. Investig. Drugs 6: 994-1001 (2005).
-
Chiang N, Arita M, Serhan CN. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Prostaglandins Leukot. Essent. Fatty Acids 73: 163-177 (2005).
*
-
Chiang PC, Chien CL, Pan SL, Chen WP, Teng CM, Shen YC, Guh JH. Induction of endoplasmic reticulum stress and apoptosis by a marine prostanoid in human hepatocellular carcinoma.
J. Hepatol. 43: 679-686 (2005).
*
-
Chiappetta N, Steier J, Gruber B. Rituximab in the treatment of refractory dermatomyositis.
J. Clin. Rheumatol. 11: 264-266 (2005).
-
Chiarenza L, Pignataro A, Lanza V. Refeeding syndrome in early pregnancy. Case report.
Minerva Anestesiol. 71: 803-808 (2005).
-
Chiba K. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Pharmacol. Ther. 108: 308-319 (2005).
*
-
Chiba M, Akashi T, Ando H, Matsuhashi T, Kato J. Three Japanese cases of inflammatory bowel disease associated with left-sided colonic diverticulosis: its implication.
Inflamm. Bowel Dis. 11: 952-954 (2005).
*
-
Chiche L. A complicated case of Crohn's disease.
J. Chir. (Paris) 142: 49-53 (2005).
-
Chichili GR, Nohr D, Schaffer M, von Lintig J, Biesalski HK. beta-Carotene conversion into vitamin A in human retinal pigment epithelial cells.
Invest. Ophthalmol. Vis. Sci. 46: 3562-3569 (2005).
*
-
Chida Y, Sudo N, Kubo C. Social isolation stress exacerbates autoimmune disease in MRL/lpr mice.
J. Neuroimmunol. 158: 138-144 (2005).
-
Chida Y, Sudo N, Takaki A, Kubo C. The hepatic sympathetic nerve plays a critical role in preventing Fas induced liver injury in mice.
Gut 54: 994-1002 (2005).
*
-
Chignard N, Mergey M, Barbu V, Finzi L, Tiret E, Paul A, Housset C. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
Hepatology 42: 549-557 (2005).
*
-
Chikuma S, Abbas AK, Bluestone JA. B7-independent inhibition of T cells by CTLA-4.
J. Immunol. 175: 177-181 (2005).
*
-
Chilcott-Lauber C, Burkhard PR, Giostra E. Wilson's disease: clinical presentations.
Rev. Med. Suisse. 1: 2018, 2020-2022 (2005).
-
Chilton PM, Rezzoug F, Ratajczak MZ, Fugier-Vivier I, Ratajczak J, Kucia M, Huang Y, Tanner MK, Ildstad ST. Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients.
Blood 105: 2189-2197 (2005).
*
-
Chimenos-Kustner E, Pascual M, Blanco I, Finestres F. Hereditary familial polyposis and Gardner's syndrome: contribution of the odonto-stomatology examination in its diagnosis and a case description.
Med. Oral Patol. Oral Cir. Bucal. 10: 402-409 (2005).
-
Chin G, Luxton G, Harvey JM. Infliximab and nephrotic syndrome.
Nephrol. Dial. Transplant. 20: 2824-2826 (2005).
*
-
Chin RL, Latov N. Peripheral neuropathy and celiac disease.
Curr. Treat. Options Neurol. 7: 43-48 (2005).
-
Chinetti-Gbaguidi G, Fruchart JC, Staels B. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
Curr. Opin. Pharmacol. 5: 177-183 (2005).
-
Chinetti-Gbaguidi G, Fruchart JC, Staels B. Therapeutical effects of PPAR agonists assessed by biomarker modulation.
Biomarkers 10 Suppl. 1: 30-36 (2005).
-
Chinetti-Gbaguidi G, Rigamonti E, Helin L, Mutka AL, Lepore M, Fruchart JC, Clavey V, Ikonen E, Lestavel S, Staels B. Peroxisome proliferator-activated receptor-alpha controls cellular cholesterol trafficking in macrophages.
J. Lipid Res. 46: 2717-2725 (2005).
*
-
Chinnery PF, Dimauro S. Mitochondrial hepatopathies.
J. Hepatol. 43: 207-209 (2005).
*
-
Chino A, Sakurai H, Choo MK, Koizumi K, Shimada Y, Terasawa K, Saiki I. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages.
Int. Immunopharmacol. 5: 871-882 (2005).
-
Chinratanapisit S, Tunsuriyawong P, Vichyanond P, Visitsunthorn N, Luangwedchakarn V, Jirapongsananuruk O. Chronic rhinosinusitis and recurrent nasal polyps in two children with IgG subclass deficiency and review of the literature.
J. Med. Assoc. Thai. 88 Suppl. 8: S251-S258 (2005).
-
Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski AS. Survivin: a novel target for indomethacin-induced gastric injury.
Gastroenterology 128: 63-73 (2005).
*
-
Chirdo FG, Garrote JA, Arranz E. Celiac disease. New therapeutic alternatives based on a better knowledge of molecular pathogenesis.
Acta Gastroenterol. Latinoam. 35: 183-189 (2005).
-
Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R, Gervasi PG. CAR and PXR expression and inducibility of CYP2B and CYP3A activities in rat and rabbit lungs.
Life Sci. 76: 2535-2546 (2005).
*
-
Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis.
J. Autoimmune Dis. 2: 1 (2005).
*
-
Chistiakov DA, Chernisheva A, Savost'anov KV, Turakulov RI, Kuraeva TL, Dedov II, Nosikov VV. The TAF5L gene on chromosome 1q42 is associated with type 1 diabetes in Russian affected patients.
Autoimmunity 38: 283-293 (2005).
-
Chistiakov DA, Seryogin YA, Turakulov RI, Savost'anov KV, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set.
J. Autoimmun. 24: 243-250 (2005).
-
Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review.
Am. J. Gastroenterol. 100: 1868-1875 (2005).
*
-
Chiu A, Tam S, Au WY, Chan SC, Liu CL, Fan ST. MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation.
Liver Transpl. 11: 353-355 (2005).
*
-
Chiu YF, Liu SY, Tsai YY. A comparison in association and linkage genome-wide scans for alcoholism susceptibility genes using single-nucleotide polymorphisms.
BMC Genet. 6 Suppl. 1: S89 (2005).
*
-
Cho DH, Choi MS, Kim DH, Kim do Y, Shim SG, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC. A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcholic fatty liver disease.
Korean J. Hepatol. 11: 261-267 (2005).
-
Cho HH, Park HT, Kim YJ, Bae YC, Suh KT, Jung JS. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
J. Cell. Biochem. 96: 533-542 (2005).
*
-
Cho HY, Reddy SP, Debiase A, Yamamoto M, Kleeberger SR. Gene expression profiling of NRF2-mediated protection against oxidative injury.
Free Radic. Biol. Med. 38: 325-343 (2005).
-
Cho SB, Chun EY, Bang D, Lee KH, Lee ES, Lee S. Coexistence of Behcet's disease and autoimmune disease: clinical features of 11 cases.
J. Dermatol. 32: 614-616 (2005).
-
Choe J, Kelker MS, Wilson IA. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain.
Science 309: 581-585 (2005).
*
-
Chofflon M. Mechanisms of action for treatments in multiple sclerosis: does a heterogeneous disease demand a multi-targeted therapeutic approach?
BioDrugs 19: 299-308 (2005).
-
Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression.
Biochem. Biophys. Res. Commun. 327: 1066-1071 (2005).
*
-
Choi EW, Shin IS, Youn HY, Kim DY, Lee H, Chae YJ, Lee CW. Gene therapy using non-viral peptide vector in a canine systemic lupus erythematosus model.
Vet. Immunol. Immunopathol. 103: 223-233 (2005).
*
-
Choi GY, Kim A, Kim CN, Yoon SJ, Jung SH, Ko BS, Yang HY, John BM, Kim SH, Nam HJ, Go H. A case of subphrenic abscess with ileal fistula caused by metastatic adenocarcinoma of unknown origin.
Korean J. Gastroenterol. 46: 471-474 (2005).
-
Choi HK. Dietary risk factors for rheumatic diseases.
Curr. Opin. Rheumatol. 17: 141-146 (2005).
-
Choi J, Park JK, Lee KT, Park KK, Kim WB, Lee JH, Jung HJ, Park HJ. In vivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4-dicaffeoylquinic acid.
J. Med. Food 8: 348-352 (2005).
-
Choi JY, Bae SH, Yoon SK, Cho SH, Yang JM, Han JY, Ahn BM, Chung KW, Sun HS, Kim DG. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study.
Liver Int. 25: 740-745 (2005).
*
-
Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Biochem. Biophys. Res. Commun. 336: 747-753 (2005).
*
-
Choi KD, Song HJ, Kim JS, Jung HC, Song IS. Efficacy and safety of treatment with infliximab in Crohn's disease - the experience of single center in Korea.
Korean J. Gastroenterol. 46: 48-55 (2005).
-
Choi KH, Lee EB, Yoo CD, Baek HJ, Kang SW, Shin KC, Lee YJ, Kim HA, Jeon JH, Kim CW, Shin DM, Kim IG, Son YW. Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis.
Exp. Mol. Med. 37: 546-552 (2005).
*
-
Choi MY, Partridge AW, Daniels C, Du K, Lukacs GL, Deber CM. Destabilization of the transmembrane domain induces misfolding in a phenotypic mutant of the cystic fibrosis transmembrane conductance regulator.
J. Biol. Chem. 280: 4968-4974 (2005).
*
-
Choi P, Xanthaki D, Rose SJ, Haywood M, Reiser H, Morley BJ. Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene.
Genes Immun. 6: 290-297 (2005).
*
-
Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis.
Curr. Opin. Gastroenterol. 21: 702-707 (2005).
-
Choi SH, Yang SH, Song YB, Kim HJ, Seo YT, Choi DS, Moon KH, Byun JH, Yu ES. A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol.
Korean J. Hepatol. 11: 80-85 (2005).
-
Choi SJ, Gwak MS, Kim MH, Yang M, Ko JS, Hahm TS, Kim GS. Differences of perioperative liver function, transfusion, and complications according to the type of hepatectomy in living donors.
Transpl. Int. 18: 548-555 (2005).
*
-
Choi SW, Lim MK, Shin DH, Park JJ, Shim SC. Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in korean patients with rheumatoid arthritis.
J. Korean Med. Sci. 20: 473-478 (2005).
*
-
Choi SY, Sohn MH, Kwon BC, Kim KE. CTLA-4 expression in T cells of patients with atopic dermatitis.
Pediatr. Allergy Immunol. 16: 422-427 (2005).
*
-
Choi Y, Park JK, Park NH, Shin JW, Yoo CI, Lee CR, Lee H, Kim HK, Kim SR, Jung TH, Park J, Yoon CS, Kim Y. Whole blood and red blood cell manganese reflected signal intensities of T1-weighted magnetic resonance images better than plasma manganese in liver cirrhotics.
J. Occup. Health 47: 68-73 (2005).
-
Choi YA, Kang OH, Park HJ, Tae J, Kim DK, Kang CS, Choi SC, Yun KJ, Choi SJ, Nah YH, Kim YH, Bae KH, Lee YM. Effect of processed Scutellaria baicalensis on dextran sulfate sodium-induced colitis in mice.
Int. J. Mol. Med. 16: 667-672 (2005).
-
Chong AK, Taylor A, Miller A, Hennessy O, Connell W, Desmond P. Capsule endoscopy vs. push enteroscopy and enteroclysis in suspected small-bowel Crohn's disease.
Gastrointest. Endosc. 61: 255-261 (2005).
*
-
Choo-Kang BS, Hutchison S, Nickdel MB, Bundick RV, Leishman AJ, Brewer JM, McInnes IB, Garside P. TNF-blocking therapies: an alternative mode of action?
Trends Immunol. 26: 518-522 (2005).
*
-
Choopong P, Khan N, Sangwan VS, Zafirakis P, Rallatos CL, Rojas B, Baltatzis S, Foster CS. Eosinophil activation in Wegener's granulomatosis: a harbinger of disease progression?
Ocul. Immunol. Inflamm. 13: 439-445 (2005).
-
Chorny A, Gonzalez-Rey E, Fernandez-Martin A, Pozo D, Ganea D, Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
Proc. Natl. Acad. Sci. U.S.A. 102: 13562-13567 (2005).
*
-
Chou LS, Gedge F, Lyon E. Complete gene scanning by temperature gradient capillary electrophoresis using the cystic fibrosis transmembrane conductance regulator gene as a model.
J. Mol. Diagn. 7: 111-120 (2005).
*
-
Chou LS, Lyon E, Wittwer CT. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.
Am. J. Clin. Pathol. 124: 330-338 (2005).
-
Chou YH, Tiu CM, Li WY, Liu CY, Cheng YC, Chiou HJ, Chiou SY, Wang HK, Hung GS. Chronic sclerosing sialadenitis of the parotid gland: diagnosis using color Doppler sonography and sonographically guided needle biopsy.
J. Ultrasound Med. 24: 551-555 (2005).
-
Choudhry S, Avila PC, Nazario S, Ung N, Kho J, Rodriguez-Santana JR, Casal J, Tsai HJ, Torres A, Ziv E, Toscano M, Sylvia JS, Alioto M, Salazar M, Gomez I, Fagan JK, Salas J, Lilly C, Matallana H, Castro RA, Selman M, Weiss ST, Ford JG, Drazen JM, et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma.
Am. J. Respir. Crit. Care Med. 172: 173-182 (2005).
*
-
Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease.
BMC Gastroenterol. 5: 27 (2005).
*
-
Choudhuri S, Valerio LG Jr. Usefulness of studies on the molecular mechanism of action of herbals/botanicals: the case of St. John's wort.
J. Biochem. Mol. Toxicol. 19: 1-11 (2005).
*
-
Choudhury J, Sanyal AJ. Insulin resistance in NASH.
Front. Biosci. 10: 1520-1533 (2005).
-
Chounta A, Zouridakis S, Ellinas C, Tsiodras S, Zoumpouli C, Kopanakis S, Giamarellou H. Cholestatic liver injury after glimepiride therapy.
J. Hepatol. 42: 944-946 (2005).
*
-
Chow AY, Mellman I. Old lysosomes, new tricks: MHC II dynamics in DCs.
Trends Immunol. 26: 72-78 (2005).
*
-
Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease.
Autoimmunity 38: 303-317 (2005).
-
Chowdhry IA, Kowal C, Hardin J, Zhou Z, Diamond B. Autoantibodies that bind glomeruli: cross-reactivity with bacterial antigen.
Arthritis Rheum. 52: 2403-2410 (2005).
*
-
Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR. Structural disorder in the complex of human PXR and the macrolide antibiotic rifampicin.
Mol. Endocrinol. 19: 1125-1134 (2005).
*
-
Chretien-Leprince P, Ballot E, Andre C, Olsson NO, Fabien N, Escande A, Oksman F, Dubuquoi S, Jego S, Goetz J, Chevailler A, Sanmarco M, Humbel RL, Johanet C. Diagnostic value of anti-F-actin antibodies in a French multicenter study.
Ann. N. Y. Acad. Sci. 1050: 266-273 (2005).
*
-
Christen U, von Herrath MG. Infections and autoimmunity - good or bad?
J. Immunol. 174: 7481-7486 (2005).
*
-
Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.
J. Exp. Med. 202: 321-331 (2005).
*
-
Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Rev. Med. Virol. 15: 179-211 (2005).
*
-
Christians U, Schmitz V, Haschke M. Functional interactions between P-glycoprotein and CYP3A in drug metabolism.
Expert Opin. Drug Metab. Toxicol. 1: 641-654 (2005).
-
Chu NF. Plasma hyperhomocysteinemia, MTHFR polymorphism and thromboembolic disease: an example of gene-nutrition interactions in chronic disease.
J. Chin. Med. Assoc. 68: 557-559 (2005).
-
Chua R, Keogh A, Miyashita M. Novel use of sildenafil in the treatment of portopulmonary hypertension.
J. Heart Lung Transplant. 24: 498-500 (2005).
-
Chuah MK. Cutting through the obstacles and resurrecting the promise of gene therapy.
IDrugs 8: 818-821 (2005).
-
Chuang KH, Lee YF, Lin WJ, Chu CY, Altuwaijri S, Wan YJ, Chang C. 9-Cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor.
Mol. Endocrinol. 19: 1200-1212 (2005).
*
-
Chuang YH, Lian ZX, Cheng CM, Lan RY, Yang GX, Moritoki Y, Chiang BL, Ansari AA, Tsuneyama K, Coppel RL, Gershwin ME. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives.
J. Autoimmun. 25: 126-132 (2005).
-
Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors.
Arthritis Rheum. 52: 3045-3053 (2005).
*
-
Chung EK, Wu YL, Yang Y, Zhou B, Yu CY. Human complement components C4A and C4B genetic diversities: complex genotypes and phenotypes.
Curr. Protoc. Immunol. Chapter 13: Unit 13.8 (2005).
-
Chung L, Berry GJ, Chakravarty EF. Giant cell myocarditis: a rare cardiovascular manifestation in a patient with systemic lupus erythematosus.
Lupus 14: 166-169 (2005).
-
Chung Moh M, Hoon Lee L, Shen S. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.
J. Hepatol. 42: 833-841 (2005).
*
-
Chung S, Brown JM, Provo JN, Hopkins R, McIntosh MK. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production.
J. Biol. Chem. 280: 38445-38456 (2005).
*
-
Ciacci C, Iovino P, Amoruso D, Siniscalchi M, Tortora R, Di Gilio A, Fusco M, Mazzacca G. Grown-up coeliac children: the effects of only a few years on a gluten-free diet in childhood.
Aliment. Pharmacol. Ther. 21: 421-429 (2005).
*
-
Cianci R, Cammarota G, Raducci F, Pandolfi F. The impact of biological agents interfering with receptor/ligand binding in the immune system.
Eur. Rev. Med. Pharmacol. Sci. 9: 305-314 (2005).
-
Ciarimboli G, Koepsell H, Iordanova M, Gorboulev V, Durner B, Lang D, Edemir B, Schroter R, Van Le T, Schlatter E. Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation.
J. Am. Soc. Nephrol. 16: 1562-1570 (2005).
*
-
Ciarimboli G, Schlatter E. Regulation of organic cation transport.
Pflugers Arch. 449: 423-441 (2005).
*
-
Cicala M, Gabbrielli A, Emerenziani S, Guarino MP, Ribolsi M, Caviglia R, Costamagna G. Effect of endoscopic augmentation of the lower oesophageal sphincter (gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux.
Gut 54: 183-186 (2005).
*
-
Ciccocioppo R, Corazza GR. Is a life-long gluten-free diet for patients with celiac disease successful?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 290-291 (2005).
*
-
Ciccocioppo R, Di Sabatino A, Corazza GR. The immune recognition of gluten in coeliac disease.
Clin. Exp. Immunol. 140: 408-416 (2005).
*
-
Ciccocioppo R, Sabatino AD, Bauer M, Riccia DN, Bizzini F, Biagi F, Cifone MG, Corazza GR, Schuppan D. Matrix metalloproteinase pattern in celiac duodenal mucosa.
Lab. Invest. 85: 397-407 (2005).
*
-
Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Moller H, Ponz de Leon M, Launoy G, Raverdy N, Williams EM, Gatta G. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery.
Gut 54: 268-273 (2005).
*
-
Cicero AF, Derosa G, Miconi A, Laghi L, Nascetti S, Gaddi A. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
Biomed. Pharmacother. 59: 312-317 (2005).
-
Cichy M, Adamek-Guzik T, Uracz D, Uracz W, Czerniawska-Mysik G, Korbut R, Guzik TJ. The functional relevance of Arg16Gly and Gln27Glu-beta2-adrenoreceptor polymorphism in patients with asthma and allergic rhinitis.
Folia. Med. Cracov. 46: 33-51 (2005).
-
Ciclitira PJ, Ellis HJ, Lundin KE. Gluten-free diet - what is toxic?
Best Pract. Res. Clin. Gastroenterol. 19: 359-371 (2005).
-
Ciclitira PJ, Johnson MW, Dewar DH, Ellis HJ. The pathogenesis of coeliac disease.
Mol. Aspects Med. 26: 421-458 (2005).
-
Ciecierski R, Wisniewski M, Paczek L. Liver regeneration.
Pol. Merkuriusz. Lek. 18: 473-477 (2005).
-
Cignarella A, Engel T, Eckardstein A, Kratz M, Lorkowski S, Lueken A, Assmann G, Cullen P. Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors.
Atherosclerosis 179: 229-236 (2005).
-
Cijevschi C, Mihai C, Zbranca E, Gogalniceanu P. Osteoporosis in liver cirrhosis.
Rom. J. Gastroenterol. 14: 337-341 (2005).
*
-
Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis.
Arch. Surg. 140: 300-310 (2005).
*
-
Cintorino D, Spada M, Clarizia S, Vasta F, Mandala L, Arico M, Traverso G, Luca A, Panarello G, Minervini M, Gruttadauria S, Verzaro R, Volpes R, Foglieni CS, Gridelli B. Pediatric liver transplantation: preliminary results at Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione.
Transplant. Proc. 37: 2597-2598 (2005).
*
-
Cioffi U, De Simone M, Ferrero S, Ciulla MM, Lemos A, Contessini Avesani E. Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn's disease patient.
BMC Cancer 5: 157 (2005).
*
-
Cipriano C, Caruso C, Lio D, Giacconi R, Malavolta M, Muti E, Gasparini N, Franceschi C, Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases.
Int. J. Immunogenet. 32: 13-18 (2005).
*
-
Civatte M, Bartoli C, Schleinitz N, Chetaille B, Pellissier JF, Figarella-Branger D. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies.
Neuropathol. Appl. Neurobiol. 31: 70-79 (2005).
-
Claas FH, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen DL, Duquesnoy RJ, Doxiadis II. Differential immunogenicity of HLA mismatches in clinical transplantation.
Transpl. Immunol. 14: 187-191 (2005).
-
Clain J, Lehmann-Che J, Dugueperoux I, Arous N, Girodon E, Legendre M, Goossens M, Edelman A, de Braekeleer M, Teulon J, Fanen P. Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype.
Hum. Mutat. 25: 360-371 (2005).
*
-
Clain J, Lehmann-Che J, Girodon E, Lipecka J, Edelman A, Goossens M, Fanen P. A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.
Hum. Genet. 116: 454-460 (2005).
*
-
Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Arthritis Rheum. 52: 3079-3086 (2005).
*
-
Claria J, Kent JD, Lopez-Parra M, Escolar G, Ruiz-Del-Arbol L, Gines P, Jimenez W, Vucelic B, Arroyo V. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Hepatology 41: 579-587 (2005).
*
-
Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period.
J. Rheumatol. 32: 1709-1712 (2005).
-
Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process.
Gastroenterology 128: 1258-1267 (2005).
*
-
Clark EA, Ledbetter JA. How does B cell depletion therapy work, and how can it be improved?
Ann. Rheum. Dis. 64 Suppl. 4: iv77-iv80 (2005).
*
-
Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, Marder K. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.
Mov. Disord. 20: 100-103 (2005).
*
-
Clark R, Kupper T. Old meets new: the interaction between innate and adaptive immunity.
J. Invest. Dermatol. 125: 629-637 (2005).
*
-
Clarke AE, Ramsey-Goldman R, Bernatsky S. Revisiting the issue of malignancy risk in systemic lupus erythematosus.
Curr. Rheumatol. Rep. 7: 476-481 (2005).
-
Clarke G, Robb A, Sugarman I, McCallion WA. Investigating painless rectal bleeding-is there scope for improvement?
J. Pediatr. Surg. 40: 1920-1922 (2005).
-
Claudel T, Staels B, Kuipers F. The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
Arterioscler. Thromb. Vasc. Biol. 25: 2020-2030 (2005).
*
-
Claustres M. Molecular pathology of the CFTR locus in male infertility.
Reprod. Biomed. Online 10: 14-41 (2005).
-
Clavien PA. Third forum on liver transplantation living donor liver transplantation. Who needs it? How to do it? Who should do it?
J. Hepatol. 43: 11-12 (2005).
*
-
Clavien PA. Fourth Forum on Liver Transplantation Hepatocellular Carcinoma: where are the controversies?
J. Hepatol. 43: 556-557 (2005).
*
-
Clavien PA. First forum on liver transplantation. Liver transplantation in the year 2005: where do we stand?
J. Hepatol. 42: 15 (2005).
-
Clayton RF, Rinaldi A, Kandyba EE, Edward M, Willberg C, Klenerman P, Patel AH. Liver cell lines for the study of hepatocyte functions and immunological response.
Liver Int. 25: 389-402 (2005).
*
-
Cleland LG, James MJ, Keen H, Danda D, Caughey G, Proudman SM. Fish oil - an example of an anti-inflammatory food.
Asia Pac. J. Clin. Nutr. 14: S66-S71 (2005).
-
Cleland LG, James MJ, Proudman SM. Fish oil: what the prescriber needs to know.
Arthritis Res. Ther. 8: 202 (2005).
*
-
Clifford KS, Demierre MF. Progression of classic Kaposi's sarcoma with rituximab.
J. Am. Acad. Dermatol. 53: 155-157 (2005).
-
Clump DA, Qazi IH, Sudol M, Flynn DC. c-Yes response to growth factor activation.
Growth Factors 23: 263-272 (2005).
-
Cluster 17 Collaboration. Fine mapping of the psoriasis susceptibility gene PSORS1: a reassessment of risk associated with a putative risk haplotype lacking HLA-Cw6.
J. Invest. Dermatol. 124: 921-930 (2005).
*
-
Coban S, Ceydilek B, Ekiz F, Erden R, Soykan I. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
Ann. Pharmacother. 39: 1737-1740 (2005).
-
Coban S, Ensari A, Kuzu MA, Yalcin S, Palabiyikoglu M, Ormeci N. Cytomegalovirus infection in a patient with Crohn's ileocolitis.
Can. J. Gastroenterol. 19: 109-111 (2005).
*
-
Coban S, Palabiyikoglu M, Ensari A, Idilman R, Koklu S, Yolcu OF, Ormeci N. Intestinal B cell lymphoma associated with chronic hepatitis C and celiac disease.
Dig. Dis. Sci. 50: 2359-2361 (2005).
*
-
Cobb BA, Kasper DL. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens.
Cell. Microbiol. 7: 1398-1403 (2005).
*
-
Cobb BA, Kasper DL. Coming of age: carbohydrates and immunity.
Eur. J. Immunol. 35: 352-356 (2005).
*
-
Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, Xiao W, Laudanski K, Brownstein BH, Elson CM, Hayden DL, Herndon DN, Lowry SF, Maier RV, Schoenfeld DA, Moldawer LL, Davis RW, Tompkins RG, Baker HV, Bankey P, Billiar T, Brownstein BH, et al. Application of genome-wide expression analysis to human health and disease.
Proc. Natl. Acad. Sci. U.S.A. 102: 4801-4806 (2005).
*
-
Cobbold SP. T cell tolerance induced by therapeutic antibodies.
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360: 1695-1705 (2005).
*
-
Cobbold SP. New trends in immunosuppression.
Int. Immunopharmacol. 5: 1-5 (2005).
-
Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease.
Immunol. Rev. 206: 277-295 (2005).
*
-
Coccia EM, Remoli ME, Di Giacinto C, Del Zotto B, Giacomini E, Monteleone G, Boirivant M. Cholera toxin subunit B inhibits IL-12 and IFN-gamma production and signalling in experimental colitis and Crohn's disease.
Gut 54: 1558-1564 (2005).
*
-
Coelho JC, Parolin MB, Baretta GA, Pimentel SK, de Freitas AC, Colman D. Donor quality of life after living donor liver transplantation.
Arq. Gastroenterol. 42: 83-88 (2005).
-
Coelho SM, Vaisman M, Carvalho DP. Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer.
Curr. Pharm. Des. 11: 2525-2531 (2005).
-
Coggins RP, Cawkwell L, Bell SM, Crockford GP, Quirke P, Finan PJ, Bishop DT. Association between family history and mismatch repair in colorectal cancer.
Gut 54: 636-642 (2005).
*
-
Cogulu O, Onay H, Ozgenc F, Karaca E, Gunduz C, Tzetis M, Cankaya T, Kanavakis E, Ozkinay F. Trigonocephaly and Wilson's disease in two siblings.
Clin. Dysmorphol. 14: 161-164 (2005).
-
Cohavy O, Zhou J, Ware CF, Targan SR. LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling.
J. Immunol. 174: 646-653 (2005).
*
-
Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Thromb. Haemost. 94: 750-759 (2005).
-
Cohen G, Courvoisier N, Cohen JD, Zaltni S, Sany J, Combe B. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol. 23: 795-800 (2005).
-
Cohen J. Retrovirus meeting. Gut assumes sinister new role in HIV pathogenesis.
Science 307: 1395 (2005).
*
-
Cohen JL, Strong SA, Hyman NH, Buie WD, Dunn GD, Ko CY, Fleshner PR, Stahl TJ, Kim DG, Bastawrous AL, Perry WB, Cataldo PA, Rafferty JF, Ellis CN, Rakinic J, Gregorcyk S, Shellito PC, Kilkenny JW 3rd, Ternent CA, Koltun W, Tjandra JJ, Orsay CP, et al. Practice parameters for the surgical treatment of ulcerative colitis.
Dis. Colon Rectum 48: 1997-2009 (2005).
*
-
Cohen JT, Bellinger DC, Connor WE, Shaywitz BA. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development.
Am. J. Prev. Med. 29: 366-374 (2005).
*
-
Cohen RD. Mycobacterium in Crohn's: something to ruminate about?
Gastroenterology 128: 2167-2168 (2005).
*
-
Cohen RD. Worms, germs and IBD: is it your mother's fault?
Gastroenterology 129: 1127-1128 (2005).
*
-
Cohen RD. Treating ulcerative colitis without medications-"look mom, no drugs!".
Gastroenterology 128: 235-236 (2005).
*
-
Cohen SL, Moore AM, Ward WE. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice.
J. Nutr. Biochem. 16: 368-374 (2005).
*
-
Cohen SM, Gundlapalli S, Shah AR, Johnson TJ, Rechner JA, Jensen DM. The downstream financial effect of hepatology.
Hepatology 41: 968-975 (2005).
*
-
Cohen Z, Senagore AJ, Dayton MT, Koruda MJ, Beck DE, Wolff BG, Fleshner PR, Thirlby RC, Ludwig KA, Larach SW, Weiss EG, Bauer JJ, Holmdahl L. Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study.
Dis. Colon Rectum 48: 1130-1139 (2005).
*
-
Cohen-Kaminsky S, Jambou F. Prospects for a T-cell receptor vaccination against myasthenia gravis.
Expert Rev. Vaccines 4: 473-492 (2005).
-
Cohly HH, Panja A. Immunological findings in autism.
Int. Rev. Neurobiol. 71: 317-341 (2005).
-
Cohn JA. Reduced CFTR function and the pathobiology of idiopathic pancreatitis.
J. Clin. Gastroenterol. 39: S70-S77 (2005).
-
Cohn JA, Mitchell RM, Jowell PS. The impact of cystic fibrosis and PSTI/SPINK1 gene mutations on susceptibility to chronic pancreatitis.
Clin. Lab. Med. 25: 79-100 (2005).
-
Cohn JA, Neoptolemos JP, Feng J, Yan J, Jiang Z, Greenhalf W, McFaul C, Mountford R, Sommer SS. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers.
Hum. Mutat. 26: 303-307 (2005).
-
Cole BJ, Schumacher HR Jr. Injectable corticosteroids in modern practice.
J. Am. Acad. Orthop. Surg. 13: 37-46 (2005).
-
Cole DE, Olivier KN. The challenge of nontuberculous mycobacteria in patients with cystic fibrosis.
South Med. J. 98: 964 (2005).
-
Cole DK, Rizkallah PJ, Sami M, Lissin NM, Gao F, Bell JI, Boulter JM, Glick M, Vuidepot AL, Jakobsen BK, Gao GF. Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHC.
Acta Crystallograph. Sect. F. Struct. Biol. Cryst. Commun. 61: 285-287 (2005).
*
-
Coleman WB, Best DH. Cellular responses in experimental liver injury: possible cellular origins of regenerative stem-like progenitor cells.
Hepatology 41: 1173-1176 (2005).
*
-
Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease.
Methods Enzymol. 401: 9-42 (2005).
-
Collie A. Cognition in liver disease.
Liver Int. 25: 1-8 (2005).
*
-
Collie MH, Potter MA, Bartolo DC. Myocutaneous flaps promote perineal healing in inflammatory bowel disease.
Br. J. Surg. 92: 740-741 (2005).
*
-
Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening?
Gastroenterology 128: S104-S108 (2005).
*
-
Collin P, Kaukinen K, Vogelsang H, Korponay-Szabo I, Sommer R, Schreier E, Volta U, Granito A, Veronesi L, Mascart F, Ocmant A, Ivarsson A, Lagerqvist C, Burgin-Wolff A, Hadziselimovic F, Furlano RI, Sidler MA, Mulder CJ, Goerres MS, Mearin ML, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study.
Eur. J. Gastroenterol. Hepatol. 17: 85-91 (2005).
-
Collin P, Wahab PJ, Murray JA. Intraepithelial lymphocytes and coeliac disease.
Best Pract. Res. Clin. Gastroenterol. 19: 341-350 (2005).
-
Collins J. The future of academic publishing: what is open access?
J. Am. Coll. Radiol. 2: 321-326 (2005).
-
Collins SM. Dysregulation of peripheral cytokine production in irritable bowel syndrome.
Am. J. Gastroenterol. 100: 2517-2518 (2005).
*
-
Collison LW, Collison RE, Murphy EJ, Jolly CA. Dietary n-3 polyunsaturated fatty acids increase T-lymphocyte phospholipid mass and acyl-CoA binding protein expression.
Lipids 40: 81-87 (2005).
-
Colmegna I, Maldonado-Cocco JA. Polyarteritis nodosa revisited.
Curr. Rheumatol. Rep. 7: 288-296 (2005).
-
Colombara M, Antonini V, Riviera AP, Mainiero F, Strippoli R, Merola M, Fracasso G, Poffe O, Brutti N, Tridente G, Colombatti M, Ramarli D. Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells.
J. Immunol. 175: 7021-7028 (2005).
*
-
Colombel JF. IBD: genotypes - phenotypes.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 19 (2005). *
-
Colombel JF. Inflammatory bowel diseases: a disease of the century.
Rev. Prat. 55: 941-942 (2005).
-
Colombo C, Costantini D, Rocchi A, Romano G, Rossi G, Bianchi ML, Bertoli S, Battezzati A. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis.
Transpl. Int. 18: 246-255 (2005).
-
Colombo M, Donato MF. Prevention of hepatocellular carcinoma.
Semin. Liver Dis. 25: 155-161 (2005).
-
Colovai AI, Vasilescu ER. Intravenous immunoglobulin treatment in transplantation and autoimmune diseases.
Hum. Immunol. 66: 333 (2005).
-
Colquhoun D, Ferreira-Jardim A, Eden B. Fish, fish oils and long chain omega 3 fatty acids - cardiac benefit and risk: review by the Nutrition and Metabolism Committee of the National Heart Foundation of Australia.
Asia Pac. J. Clin. Nutr. 14: S83 (2005).
-
Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection.
Nat. Rev. Immunol. 5: 807-817 (2005).
*
-
Comar KM, Kirby DF. Herbal remedies in gastroenterology.
J. Clin. Gastroenterol. 39: 457-468 (2005).
-
Comaru-Schally AM, Schally AV. A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review).
Int. J. Oncol. 26: 301-309 (2005).
-
Combarros O, Infante J, Rodriguez E, Llorca J, Pena N, Fernandez-Viadero C, Berciano J. CD14 receptor polymorphism and Alzheimer's disease risk.
Neurosci. Lett. 380: 193-196 (2005).
*
-
Combarros O, Riancho JA, Infante J, Sanudo C, Llorca J, Zarrabeitia MT, Berciano J. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
Dement. Geriatr. Cogn. Disord. 20: 153-157 (2005).
-
Combes B. Reflections on therapeutic trials in primary biliary cirrhosis.
Hepatology 42: 1009 (2005).
*
-
Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers Jr RL, Rosoff Jr L, Garcia-Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, et al. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Hepatology 42: 1184-1193 (2005).
*
-
Comite de nutrition de la Societe francaise de pediatrie. Nutritional treatment in childhood Crohn's disease.
Arch. Pediatr. 12: 1255-1266 (2005).
-
Compe E, Drane P, Laurent C, Diderich K, Braun C, Hoeijmakers JH, Egly JM. Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations.
Mol. Cell. Biol. 25: 6065-6076 (2005).
*
-
Comporti M, Arezzini B, Signorini C, Sgherri C, Monaco B, Gardi C. F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?
Lab. Invest. 85: 1381-1391 (2005).
*
-
Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families.
Diabetes 54: 2995-3001 (2005).
*
-
Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C, Jansen PL, Scharschmidt B, Prieto J. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
J. Hepatol. 43: 630-636 (2005).
*
-
Condino AA, Fidanza S, Hoffenberg EJ. A home infliximab infusion program.
J. Pediatr. Gastroenterol. Nutr. 40: 67-69 (2005).
*
-
Condino AA, Hoffenberg EJ, Accurso F, Penvari C, Anthony M, Gralla J, O'Connor JA. Frequency of ASCA seropositivity in children with cystic fibrosis.
J. Pediatr. Gastroenterol. Nutr. 41: 23-26 (2005).
*
-
Condino AA, Ivy DD, O'Connor JA, Narkewicz MR, Mengshol S, Whitworth JR, Claussen L, Doran A, Sokol RJ. Portopulmonary hypertension in pediatric patients.
J. Pediatr. 147: 20-26 (2005).
*
-
Cong Y, Konrad A, Iqbal N, Hatton RD, Weaver CT, Elson CO. Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function.
J. Immunol. 174: 2787-2795 (2005).
*
-
Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, Shurtleff SA. Genetic analysis of patients with defects in early B-cell development.
Immunol. Rev. 203: 216-234 (2005).
*
-
Conrad C, Trueb RM. Pyoderma gangrenosum.
J. Dtsch. Dermatol. Ges. 3: 334-342 (2005).
-
Conrad K, Bachmann MP, Matsuura E, Shoenfeld Y. From animal models to human genetics: research on the induction and pathogenicity of autoantibodies.
Autoimmun. Rev. 4: 178-187 (2005).
-
Conseil G, Deeley RG, Cole SP. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters.
Pharmacogenet. Genomics 15: 523-533 (2005).
-
Consoli A, Devangelio E. Thiazolidinediones and inflammation.
Lupus 14: 794-797 (2005).
-
Constantinescu CS, Tani M, Ransohoff RM, Wysocka M, Hilliard B, Fujioka T, Murphy S, Tighe PJ, Sarma JD, Trinchieri G, Rostami A. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23.
J. Neurochem. 95: 331-340 (2005).
*
-
Contardi E, Palmisano GL, Tazzari PL, Martelli AM, Fala F, Fabbi M, Kato T, Lucarelli E, Donati D, Polito L, Bolognesi A, Ricci F, Salvi S, Gargaglione V, Mantero S, Alberghini M, Ferrara GB, Pistillo MP. CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction.
Int. J. Cancer 117: 538-550 (2005).
*
-
Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S. Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
Dig. Liver Dis. 37: 761-767 (2005).
-
Contreras G, Tozman E, Nahar N, Metz D. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Lupus 14 Suppl. 1: s33-s38 (2005).
-
Conwell DL, Zuccaro G, Purich E, Fein S, Vanlente F, Vargo J, Dumot J, O'laughlin C, Trolli P. The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated endoscopic pancreatic function test (ePFT).
Am. J. Gastroenterol. 100: 1161-1166 (2005).
*
-
Cook SD. Updates in multiple sclerosis and related disorders.
Rev. Neurol. Dis. 2: 138-143 (2005).
-
Cook SD. Symptomatic and disease-modifying therapies for multiple sclerosis: recent developments.
Rev. Neurol. Dis. 2: 23-26 (2005).
-
Cooley P, Taylor KH, Czika W, Seifer C, Taylor JF. Analysis of a biomarker for Wegener's granulomatosis.
Int. J. Immunogenet. 32: 237-243 (2005).
*
-
Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis.
Immunol. Rev. 204: 184-194 (2005).
*
-
Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation.
Clin. Med. Res. 3: 87-92 (2005).
*
-
Copaci I, Micu L, Iliescu L, Voiculescu M. New therapeutical indications of ursodeoxycholic acid.
Rom. J. Gastroenterol. 14: 259-266 (2005).
*
-
Cope N, Harold D, Hill G, Moskvina V, Stevenson J, Holmans P, Owen MJ, O'Donovan MC, Williams J. Strong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia.
Am. J. Hum. Genet. 76: 581-591 (2005).
*
-
Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D; Inflammation and the Host Response to Injury Investigators. Acute inflammatory response to endotoxin in mice and humans.
Clin. Diagn. Lab. Immunol. 12: 60-67 (2005).
*
-
Coradini D, Speranza A. Histone deacetylase inhibitors for treatment of hepatocellular carcinoma.
Acta Pharmacol. Sin. 26: 1025-1033 (2005).
-
Corazza GR, Stefano MD, Maurino E, Bai JC. Bones in coeliac disease: diagnosis and treatment.
Best Pract. Res. Clin. Gastroenterol. 19: 453-465 (2005).
-
Corazza GR, Villanacci V. Coeliac disease.
J. Clin. Pathol. 58: 573-574 (2005).
*
-
Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404.
Tissue Antigens 65: 448-458 (2005).
*
-
Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors.
Annu. Rev. Nutr. 25: 341-390 (2005).
*
-
Cormier K, Mager D, Bannister L, Fortin M, Richards H, Jackson C, Pencharz P. Resting energy expenditure in the parenterally fed pediatric population with Crohn's disease.
JPEN J. Parenter. Enteral Nutr. 29: 102-107 (2005).
*
-
Cornell HJ, Macrae FA, Melny J, Pizzey CJ, Cook F, Mason S, Bhathal PS, Stelmasiak T. Enzyme therapy for management of coeliac disease.
Scand. J. Gastroenterol. 40: 1304-1312 (2005).
*
-
Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.
Gastroenterology 128: 297-303 (2005).
*
-
Correa F, Mestre L, Docagne F, Guaza C. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.
Br. J. Pharmacol. 145: 441-448 (2005).
*
-
Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism.
J. Rheumatol. 32: 219-224 (2005).
-
Corsini E, Racchi M, Sinforiani E, Lucchi L, Viviani B, Rovati GE, Govoni S, Galli CL, Marinovich M. Age-related decline in RACK-1 expression in human leukocytes is correlated to plasma levels of dehydroepiandrosterone.
J. Leukoc. Biol. 77: 247-256 (2005).
*
-
Corthesy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Muller M, van Belzen N, van Ommen B. Nutrigenomics: the impact of biomics technology on nutrition research.
Ann. Nutr. Metab. 49: 355-365 (2005).
-
Corton JC, Brown-Borg HM. Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity.
J. Gerontol. A. Biol. Sci. Med. Sci. 60: 1494-1509 (2005).
-
Corvalan A, Ding S, Koriyama C, Carrascal E, Carrasquilla G, Backhouse C, Urzua L, Argandona J, Palma M, Eizuru Y, Akiba S. Association of a distinctive strain of Epstein-Barr virus with gastric cancer.
Int. J. Cancer 118: 1736-1742 (2005).
*
-
Corvera CU, Blumgart LH, Darvishian F, Klimstra DS, Dematteo R, Fong Y, D'Angelica M, Jarnagin WR. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma.
J. Am. Coll. Surg. 201: 862-869 (2005).
*
-
Coskun M, Bacanli A, Sallakci N, Alpsoy E, Yavuzer U, Yegin O. Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease.
Exp. Dermatol. 14: 124-129 (2005).
*
-
Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
Gut 54: 237-241 (2005).
*
-
Costa Carvalho BT, Nagao AT, Arslanian C, Carneiro Sampaio MM, Naspitz CK, Sorensen RU, Leiva L, Sole D. Immunological evaluation of allergic respiratory children with recurrent sinusitis.
Pediatr. Allergy Immunol. 16: 534-538 (2005).
-
Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
Gut 54: 364-368 (2005).
*
-
Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, Levesque R, Chiasson J, Rabasa-Lhoret R. Diabetes: a major co-morbidity of cystic fibrosis.
Diabetes Metab. 31: 221-232 (2005).
*
-
Costabel U, Guzman J. Pulmonary alveolar proteinosis: a new autoimmune disease.
Sarcoidosis Vasc. Diffuse Lung Dis. 22 Suppl. 1:S67-S73 (2005).
-
Costantini S, Rossi M, Colonna G, Facchiano AM. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
J. Mol. Graph. Model. 23: 419-431 (2005).
*
-
Costanzo A, Mazzotta A, Papoutsaki M, Nistico S, Chimenti S. Safety and efficacy study on etanercept in patients with plaque psoriasis.
Br. J. Dermatol. 152: 187-189 (2005).
-
Costas J, Salas A, Phillips C, Carracedo A. Human genome-wide screen of haplotype-like blocks of reduced diversity.
Gene 349: 219-225 (2005).
*
-
Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A, Lu T, Gurbuz Y, Nikolaus S, Albrecht M, Hampe J, Lucius R, Kloppel G, Eickhoff H, Lehrach H, Lengauer T, Schreiber S. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.
PLoS Med. 2: e199 (2005).
*
-
Costenbader KH, Karlson EW. Cigarette smoking and systemic lupus erythematosus: a smoking gun?
Autoimmunity 38: 541-547 (2005).
-
Costenbader KH, Karlson EW, Gall V, Pablo PD, Finckh A, Lynch M, Bermas B, Schur PH, Liang MH. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.
Arthritis Rheum. 53: 718-723 (2005).
*
-
Cotrim C, Simoes O, Loureiro MJ, Cordeiro P, Lopes L, Almeida S, Iala M, Miranda R, Carrageta M. Stress echocardiography in the evaluation of exercise physiology in patients with severe arterial pulmonary hypertension. New methodology.
Rev. Port. Cardiol. 24: 1451-1460 (2005).
-
Cottin V, Thibout Y, Bey-Omar F, Durieu I, Laoust L, Morel Y, Cordier JF. Late CF caused by homozygous IVS8-5T CFTR polymorphism.
Thorax 60: 974-975 (2005).
*
-
Couchie D, Lafdil F, Martin-Garcia N, Laperche Y, Zafrani ES, Mavier P. Expression and role of Gas6 protein and of its receptor Axl in hepatic regeneration from oval cells in the rat.
Gastroenterology 129: 1633-1642 (2005).
*
-
Coulouarn C, Derambure C, Lefebvre G, Daveau R, Hiron M, Scotte M, Francois A, Daveau M, Salier JP. Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
J. Hepatol. 42: 860-869 (2005).
*
-
Courter DL, Lomas L, Scatena M, Giachelli CM. Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB.
J. Biol. Chem. 280: 12145-12151 (2005).
*
-
Coutinho A, Caramalho I, Seixas E, Demengeot J. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Curr. Top. Microbiol. Immunol. 293: 43-71 (2005).
-
Coutinho JM, Singaraja RR, Kang M, Arenillas DJ, Bertram LN, Bissada N, Staels B, Fruchart JC, Fievet C, Joseph-George AM, Wasserman WW, Hayden MR. Complete functional rescue of the ABCA1-/-mouse by human BAC transgenesis.
J. Lipid Res. 46: 1113-1123 (2005).
*
-
Couzin J. Clinical research. Advocating, the clinical way.
Science 308: 940-942 (2005).
*
-
Couzin J. Human RNA slows down a primate retrovirus.
Science 308: 480a-481a (2005).
*
-
Couzin J. New haplotype map may overhaul gene hunting.
Science 310: 601 (2005).
*
-
Couzin J. Drug development. Lupus drug company asks FDA for second chance.
Science 307: 835 (2005).
*
-
Cowling T, Jennings LW, Goldstein RM, Sanchez EQ, Chinnakotla S, Dawson S 3rd, Randall HB, Klintmalm GB, Levy MF. MELD scores do not predict patient morbidity while on the liver transplant waiting list.
Transplant. Proc. 37: 2174-2178 (2005).
*
-
Cox AL, Thompson SA, Jones JL, Robertson VH, Hale G, Waldmann H, Compston DA, Coles AJ. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
Eur. J. Immunol. 35: 3332-3342 (2005).
*
-
Cox CE, Davis-Allen A, Judson MA. Sarcoidosis.
Med. Clin. North Am. 89: 817-828 (2005).
-
Cox D. Understanding your blood glucose - a new internet-based program.
Diabetes Forecast 58: 66 (2005).
-
Cox DG, Crusius JB, Peeters PH, Bueno-de-Mesquita HB, Pena AS, Canzian F. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.
World J. Gastroenterol. 11: 6003-6008 (2005).
*
-
Coyle AT, O'keeffe MB, Kinsella BT. 15-Deoxy delta-prostaglandin J suppresses transcription by promoter 3 of the human thromboxane A receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
FEBS J. 272: 4754-4773 (2005).
*
-
Coyne K, Joshua-Gotlib S, Kimel M, Thompson C, Lewis A, Danilewitz M. Validation of the treatment satisfaction questionnaire for Crohn's disease (TSQ-C).
Dig. Dis. Sci. 50: 252-258 (2005).
*
-
Cracowski JL, Berdeaux O, Durand T. Isoprostanes, biomarkers of lipid peroxidation in humans. Part 3: Biomarkers and mediators in vascular physiology and disease.
Pathol. Biol. (Paris) 53: 364-368 (2005).
-
Cragg RA, Phillips SR, Piper JM, Varma JS, Campbell FC, Mathers JC, Ford D. Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation.
Gut 54: 469-478 (2005).
*
-
Crane IJ, Forrester JV. Th1 and Th2 lymphocytes in autoimmune disease.
Crit. Rev. Immunol. 25: 75-102 (2005).
-
Cranney A, Rostom A, Sy R, Dube C, Saloogee N, Garritty C, Moher D, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, Macneil J. Consequences of testing for celiac disease.
Gastroenterology 128: S109-S120 (2005).
*
-
Crawford NP, Colliver DW, Funke AA, Young MN, Kelley S, Cobbs GA, Petras RE, Galandiuk S. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
Hum. Mutat. 25: 156-166 (2005).
*
-
Crawford NP, Eichenberger MR, Colliver DW, Lewis RK, Cobbs GA, Petras RE, Galandiuk S. Evaluation of Slc11a1 as an inflammatory bowel disease candidate gene.
BMC Med. Genet. 6: 10 (2005).
*
-
Crema E, Ribeiro LB, Silva FG, Pastore R, Meneses AC, Silva AA. Secondary sclerosing cholangitis in a patient with acquired immunodeficiency syndrome treated by common hepatic duct plasty by the laparoscopic route.
Rev. Soc. Bras. Med. Trop. 38: 438-441 (2005).
-
Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors.
Gastroenterol. Clin. North Am. 34: 189-204 (2005).
-
Cresci S. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.
Expert Opin. Pharmacother. 6: 2577-2591 (2005).
-
Crestani B. The respiratory system in connective tissue disorders.
Allergy 60: 715-734 (2005).
*
-
Cretney E, McQualter JL, Kayagaki N, Yagita H, Bernard CC, Grewal IS, Ashkenazi A, Smyth MJ. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
Immunol. Cell Biol. 83: 511-519 (2005).
*
-
Crew RJ, Ratner LE. Overcoming immunologic incompatibility: transplanting the difficult to transplant patient.
Semin. Dial. 18: 474-481 (2005).
-
Crimeen-Irwin B, Scalzo K, Gloster S, Mottram PL, Plebanski M. Failure of immune homeostasis - the consequences of under and over reactivity.
Curr. Drug Targets Immune Endocr. Metabol. Disord. 5: 413-422 (2005).
-
Crisler-Roberts R, Ge Z, Kearney MT, Singletary KB, Fox JG, Roberts CS, Baker DG. Evaluation of Helicobacter hepaticus bacterial shedding in fostered and sex-segregated C57BL/6 mice.
Comp. Med. 55: 515-522 (2005).
-
Crispin JC, Martinez-Banos D, Alcocer-Varela J. Adult-onset Still disease as the cause of fever of unknown origin.
Medicine (Baltimore) 84: 331-337 (2005).
-
Cristiano L, Cimini A, Moreno S, Ragnelli AM, Paola Ceru M. Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures.
Neuroscience 131: 577-587 (2005).
*
-
Criswell LA, Gregersen PK. Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developments.
Rheumatology (Oxford) 44 Suppl. 4: iv9-iv13 (2005).
*
-
Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.
Am. J. Hum. Genet. 76: 561-571 (2005).
*
-
Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, Costello E, Neoptolemos J, Lemoine NR. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
Gastroenterology 129: 1454-1463 (2005).
*
-
Crocenzi FA, Basiglio CL, Perez LM, Portesio MS, Pozzi EJ, Roma MG. Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP.
Biochem. Pharmacol. 69: 1113-1120 (2005).
*
-
Crocenzi FA, D'Andrea V, Catania VA, Luquita MG, Pellegrino JM, Ochoa JE, Mottino AD, Sanchez Pozzi E. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Drug Metab. Dispos. 33: 888-891 (2005).
*
-
Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study.
Arch. Pediatr. Adolesc. Med. 159: 151-157 (2005).
*
-
Croft M. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA.
Trends Immunol. 26: 292-294 (2005).
*
-
Crofts C, Krimsky S. Emergence of a scientific and commercial research and development infrastructure for human gene therapy.
Hum. Gene Ther. 16: 169-177 (2005).
-
Croker JA, Kimberly RP. Genetics of susceptibility and severity in systemic lupus erythematosus.
Curr. Opin. Rheumatol. 17: 529-537 (2005).
-
Croker JA, Kimberly RP. SLE: challenges and candidates in human disease.
Trends Immunol. 26: 580-586 (2005).
*
-
Crombez L, Marques B, Lenormand JL, Mouz N, Polack B, Trocme C, Toussaint B. High level production of secreted proteins: example of the human tissue inhibitor of metalloproteinases 1.
Biochem. Biophys. Res. Commun. 337: 908-915 (2005).
*
-
Crombie DE, Turer M, Zuasti BB, Wood B, McNaughton D, Nandakumar KS, Holmdahl R, Van Damme MP, Rowley MJ. Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro.
Arthritis Res. Ther. 7: R927-R937 (2005).
*
-
Cronin E. Best practice in discharging patients with a stoma.
Nurs. Times 101: 67-68 (2005).
-
Croquelois A, Blindenbacher A, Terracciano L, Wang X, Langer I, Radtke F, Heim MH. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice.
Hepatology 41: 487-496 (2005).
*
-
Crosby MB, Svenson J, Gilkeson GS, Nowling TK. A novel PPAR response element in the murine iNOS promoter.
Mol. Immunol. 42: 1303-1310 (2005).
*
-
Cross RK, Wilson KT, Binion DG. Polypharmacy and Crohn's disease.
Aliment. Pharmacol. Ther. 21: 1211-1216 (2005).
*
-
Cross RK, Wilson KT, Binion DG. Narcotic use in patients with Crohn's disease.
Am. J. Gastroenterol. 100: 2225-2259 (2005).
*
-
Crow MK. Interferon pathway activation in systemic lupus erythematosus.
Curr. Rheumatol. Rep. 7: 463-468 (2005).
-
Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy.
Curr. Opin. Gastroenterol. 21: 32-38 (2005).
-
Crowson CS, Nicola PJ, Kremers HM, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
Arthritis Rheum. 52: 3039-3044 (2005).
*
-
Crowther MA. Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.
Cleve. Clin. J. Med. 72: 245-249 (2005).
*
-
Croxford JL, Anger HA, Miller SD. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.
J. Immunol. 174: 907-917 (2005).
*
-
Croxford JL, Olson JK, Anger HA, Miller SD. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis.
J. Virol. 79: 8581-8590 (2005).
*
-
Cruickshank SM, English NR, Felsburg PJ, Carding SR. Characterization of colonic dendritic cells in normal and colitic mice.
World J. Gastroenterol. 11: 6338-6347 (2005).
*
-
Crum NF, Lederman ER, Wallace MR. Infections associated with tumor necrosis factor-alpha antagonists.
Medicine (Baltimore) 84: 291-302 (2005).
-
Cruyssen BV, Peeters H, Hoffman IE, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, De Vos M, De Keyser F. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in Caucasian Crohn's disease patients.
Clin. Exp. Immunol. 140: 354-359 (2005).
*
-
Csanady L, Chan KW, Nairn AC, Gadsby DC. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
J. Gen. Physiol. 125: 43-55 (2005).
*
-
Csanady L, Seto-Young D, Chan KW, Cenciarelli C, Angel BB, Qin J, McLachlin DT, Krutchinsky AN, Chait BT, Nairn AC, Gadsby DC. Preferential phosphorylation of R-domain serine 768 dampens activation of CFTR channels by PKA.
J. Gen. Physiol. 125: 171-186 (2005).
*
-
Csepregi A, Treiber G, Rocken C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix.
World J. Gastroenterol. 11: 4114-4116 (2005).
*
-
Cserni T, Szekeres JP, Furka I, Nemeth N, Jozsa T, Miko I. Hydrostatic characteristics of the ileocolic valve and intussuscepted nipple valves: an animal model.
J. Invest. Surg. 18: 185-191 (2005).
*
-
Csillag C, Nielsen OH, Borup R, Nielsen FC. Microarrays and Crohn's disease: collecting reliable information.
Scand. J. Gastroenterol. 40: 369-377 (2005).
*
-
Csipo I, Kiss E, Bako E, Szegedi G, Kavai M. Soluble complement receptor 1 (CD35) bound to immune complexes in sera of patients with systemic lupus erythematosus.
Arthritis Rheum. 52: 2950-2951 (2005).
*
-
Cua IH, George J. Non-alcoholic fatty liver disease.
Hosp. Med. 66: 106-111 (2005).
-
Cucchetti A, Vivarelli M, Piscaglia F, Nardo B, Montalti R, Grazi GL, Ravaioli M, La Barba G, Cavallari A, Bolondi L, Pinna AD. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
J. Hepatol. 43: 310-316 (2005).
*
-
Cuchacovich M, Merino G, Yamamoto JH, Villarroel F, Saavedra T, Jofre S, Gatica H, Velasquez V, Pizzo SV, Gonzalez-Gronow M. Behcet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
Clin. Exp. Rheumatol. 23: S27-S34 (2005).
-
Cucnik S, Bozic B, Kveder T, Tomsic M, Rozman B. Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome.
Ann. N. Y. Acad. Sci. 1051: 141-147 (2005).
*
-
Cuff M, Dyer J, Jones M, Shirazi-Beechey S. The human colonic monocarboxylate transporter isoform 1: its potential importance to colonic tissue homeostasis.
Gastroenterology 128: 676-686 (2005).
*
-
Cuffari C, Dubinsky M, Darbari A, Sena L, Baldassano R. Crohn's jejunoileitis: the pediatrician's perspective on diagnosis and management.
Inflamm. Bowel Dis. 11: 696-704 (2005).
*
-
Cuffari C, Present DH, Bayless TM, Lichtenstein GR. Optimizing therapy in patients with pancolitis.
Inflamm. Bowel Dis. 11: 937-946 (2005).
*
-
Cui NQ, Zhang SK, Cui YF, Li DH, Chen C, Wu XZ. Overexpression of sterol carrier protein-2 mRNA in patients with cholesterol gallstones.
Hepatobiliary Pancreat Dis. Int. 4: 117-120 (2005).
*
-
Cui X, Thomas A, Montgomery D, Gu C, Morrison RA, White RE, Cheng KC. Rat PXR reporter-gene activity correlates with the induction of CYP3A in rat precision-cut liver slices.
Comb. Chem. High Throughput Screen. 8: 341-346 (2005).
-
Cullen SN, Chapman RW. Review article: current management of primary sclerosing cholangitis.
Aliment. Pharmacol. Ther. 21: 933-948 (2005).
*
-
Culley CM, Krenzelok EP. A clinical and pharmacoeconomic justification for intravenous acetylcysteine: a US perspective.
Toxicol. Rev. 24: 131-143 (2005).
-
Culliford A, Daly J, Diamond B, Rubin M, Green PH. The value of wireless capsule endoscopy in patients with complicated celiac disease.
Gastrointest. Endosc. 62: 55-61 (2005).
*
-
Culligan B. Orbital myositis following streptococcal pharyngitis in a pediatric patient.
Optometry 76: 250-258 (2005).
-
Culver B, Itkin A, Pischel K. Case report and review of minocycline-induced cutaneous polyarteritis nodosa.
Arthritis Rheum. 53: 468-470 (2005).
*
-
Cummings JR, Herrlinger KR, Travis SP, Gorard DA, McIntyre AS, Jewell DP. Oral methotrexate in ulcerative colitis.
Aliment. Pharmacol. Ther. 21: 385-389 (2005).
*
-
Cummings JR, Jewell DP. Clinical implications of inflammatory bowel disease genetics on phenotype.
Inflamm. Bowel Dis. 11: 56-61 (2005).
*
-
Cunard R. The potential use of PPARalpha agonists as immunosuppressive agents.
Curr. Opin. Investig. Drugs 6: 467-472 (2005).
-
Cunningham S, Patterson CC, McDonnell G, Hawkins S, Vandenbroeck K. Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis.
Genes Immun. 6: 265-270 (2005).
*
-
Cunningham-Rundles C, Ponda PP. Molecular defects in T- and B-cell primary immunodeficiency diseases.
Nat. Rev. Immunol. 5: 880-892 (2005).
*
-
Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.
Am. J. Pathol. 167: 887-899 (2005).
*
-
Curgunlu A, Vural P, Canbaz M, Erten N, Karan MA, Tascioglu C. Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis.
J. Clin. Lab. Anal. 19: 177-181 (2005).
-
Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, Cynober L. Almost all about citrulline in mammals.
Amino Acids 29: 177-205 (2005).
*
-
Curran C. Adult-to-adult living donor liver transplantation: history, current practice, and implications for the future.
Prog. Transplant. 15: 36-42 (2005).
-
Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Azim DM, Cai G, Mahaney MC, Comuzzie AG, Dyer TD, Walder KR, Zimmet P, Maccluer JW, Collier GR, Kissebah AH, Blangero J. Genetic variation in selenoprotein S influences inflammatory response.
Nat. Genet. 37: 1234-1241 (2005).
*
-
Curran S, Roberts S, Thomas S, Veltman M, Browne J, Medda E, Pickles A, Sham P, Bolton PF. An association analysis of microsatellite markers across the Prader-Willi/Angelman critical region on chromosome 15 (q11-13) and autism spectrum disorder.
Am. J. Med. Genet. B. Neuropsychiatr. Genet. 137B: 25-28 (2005).
-
Curry MP, Hegarty JE. The gallbladder and biliary tract in cystic fibrosis.
Curr. Gastroenterol. Rep. 7: 147-153 (2005).
-
Cush JJ. Biological drug use: US perspectives on indications and monitoring.
Ann. Rheum. Dis. 64 Suppl. 4: iv18-iv23 (2005).
*
-
Cush JJ, Yazici Y. Laboratory monitoring of biologic therapies.
Clin. Exp. Rheumatol. 23: S90-S92 (2005).
-
Cutler A, Brombacher F. Cytokine therapy.
Ann. N. Y. Acad. Sci. 1056: 16-29 (2005).
*
-
Cutolo M, Lahita RG. Estrogens and arthritis.
Rheum. Dis. Clin. North Am. 31: 19-27 (2005).
-
Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms.
Autoimmun. Rev. 4: 497-502 (2005).
-
Cutting G. Genetics and pediatric diseases.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S44 (2005).
*
-
Cutting GR. Modifier genetics: cystic fibrosis.
Annu. Rev. Genomics Hum. Genet. 6: 237-260 (2005).
*
-
Cuttner J, Spiera H, Troy K, Wallenstein S. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
J. Rheumatol. 32: 1884-1887 (2005).
-
Cuzzocrea S, Rossi A, Mazzon E, Di Paola R, Genovese T, Muia C, Caputi AP, Sautebin L. 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration.
Lab. Invest. 85: 808-822 (2005).
*
-
Cuzzocrea S, Saadat F, Di Paola R, Mirshafiey A. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis.
Immunopharmacol. Immunotoxicol. 27: 615-630 (2005).
-
Cvetkovic I, Al-Abed Y, Miljkovic D, Maksimovic-Ivanic D, Roth J, Bacher M, Lan HY, Nicoletti F, Stosic-Grujicic S. Critical role of macrophage migration inhibitory factor (MIF) activity in experimental autoimmune diabetes.
Endocrinology 146: 2942-2951 (2005).
*
-
Cvetkovic JT, Wiklund PG, Ahmed E, Weinehall L, Hallmans G, Lefvert AK. Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case-control study of their association with risk for stroke.
J. Stroke Cerebrovasc. Dis. 14: 29-35 (2005).
-
Cvetkovic RS, Wellington K. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.
Drugs 65: 859-878 (2005).
-
Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
Annu. Rev. Immunol. 23: 127-159 (2005).
*
-
Czaja AJ. Autoimmune liver disease.
Curr. Opin. Gastroenterol. 21: 293-299 (2005).
-
Czaja AJ. Current concepts in autoimmune hepatitis.
Ann. Hepatol. 4: 6-24 (2005).
*
-
Czaja AJ. Autoantibodies in autoimmune liver disease.
Adv. Clin. Chem. 40: 127-164 (2005).
-
Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis.
Minerva Gastroenterol. Dietol. 51: 313-333 (2005).
-
Czaja AJ, Bianchi FB, Carpenter HA, Krawitt EL, Lohse AW, Manns MP, McFarlane IG, Mieli-Vergani G, Toda G, Vergani D, Vierling J, Zeniya M. Treatment challenges and investigational opportunities in autoimmune hepatitis.
Hepatology 41: 207-215 (2005).
*
-
Czaja AJ, Carpenter HA. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
J. Clin. Gastroenterol. 39: 819-825 (2005).
-
Czaja MJ. Another way for NADPH oxidase to send a signal for liver injury.
Gastroenterology 129: 2110-2113 (2005).
*
-
Czajkowsky DM, Iwamoto H, Szabo G, Cover TL, Shao Z. Mimicry of a host anion channel by a Helicobacter pylori pore-forming toxin.
Biophys. J. 89: 3093-3101 (2005).
*
-
Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases.
Curr. Pharm. Des. 11: 1017-1030 (2005).
-
Czlonkowska A, Tarnacka B, Litwin T, Gajda J, Rodo M. Wilson's disease - cause of mortality in 164 patients during 1992-2003 observation period.
J. Neurol. 252: 698-703 (2005).
*
-
D'Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L, Indelicato M, Giacopelli F, Marchini M, Scorza R, Danieli MG, Cappelli M, Migliaresi S, Bigliardo B, Sabbadini MG, Baldissera E, Galeazzi M, Sebastiani GD, Minisola G, Ravazzolo R. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.
Arthritis Rheum. 52: 539-547 (2005).
*
-
D'Amico C, Vitale A, Angriman I, Ruffolo C, D'Amico F, Valente D, Berto M, Vella V, Scarpa M, D'Amico DF. Early surgery for the treatment of toxic megacolon.
Digestion 72: 146-149 (2005).
-
D'Amico G. Developing concepts on MELD: delta and cutoffs.
J. Hepatol. 42: 790-792 (2005).
*
-
D'Amico G, Luca A, Morabito A, Miraglia R, D'amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.
Gastroenterology 129: 1282-1293 (2005).
*
-
D'Amico MA, Holmes J, Stavropoulos SN, Frederick M, Levy J, Defelice AR, Kazlow PG, Green PH. Presentation of pediatric celiac disease in the United States: prominent effect of breastfeeding.
Clin. Pediatr. (Phila.) 44: 249-258 (2005).
-
D'Andrea MR. Add Alzheimer's disease to the list of autoimmune diseases.
Med. Hypotheses 64: 458-463 (2005).
-
D'Argenio G, Calvani M, Della Valle N, Cosenza V, Di Matteo G, Giorgio P, Margarucci S, Petillo O, Jori FP, Galderisi U, Peluso G. Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.
Gut 54: 496-502 (2005).
*
-
D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, T cells and cytokines: the "dangerous liaisons".
FEMS Immunol. Med. Microbiol. 44: 113-119 (2005).
*
-
D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways.
J. Biol. Chem. 280: 36334-36341 (2005).
*
-
D’Haens G. Pratical use of steroids in IBD.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 30 (2005). *
-
D'haens G. Infliximab for ulcerative colitis: finally some answers.
Gastroenterology 128: 2161-2164 (2005).
*
-
D'halluin PN, Tribut O, Branger B, Lebreton C, Bretagne JF, Bentue-Ferrer D, Heresbach D. RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine.
Gastroenterol. Clin. Biol. 29: 1264-1269 (2005).
-
D'Souza CA, Wood DD, She YM, Moscarello MA. Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry.
Biochemistry 44: 12905-12913 (2005).
*
-
D'Souza R, Sinnott P, Glynn MJ, Sabin CA, Foster GR. An unusual form of autoimmune hepatitis in young Somalian men.
Liver Int. 25: 325-330 (2005).
*
-
DaCosta RS, Wilson BC, Marcon NE. Optical techniques for the endoscopic detection of dysplastic colonic lesions.
Curr. Opin. Gastroenterol. 21: 70-79 (2005).
-
Daddaoua A, Puerta V, Zarzuelo A, Suarez MD, Sanchez de Medina F, Martinez-Augustin O. Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis.
J. Nutr. 135: 1164-1170 (2005).
*
-
Daghfous R, El Aidli S, Zaiem A, Loueslati MH, Belkahia C. Sildenafil-associated hepatotoxicity.
Am. J. Gastroenterol. 100: 1895-1896 (2005).
*
-
Dahl M, Ravn P. Development of tuberculosis after treatment with the TNF-alpha inhibitor infliximab.
Ugeskr. Laeger. 167: 527-528 (2005).
-
Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
Respir. Res. 6: 113 (2005).
*
-
Dahlbom I, Olsson M, Forooz NK, Sjoholm AG, Truedsson L, Hansson T. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients.
Clin. Diagn. Lab. Immunol. 12: 254-258 (2005).
*
-
Dai G, Chou N, He L, Gyamfi MA, Mendy AJ, Slitt AL, Klaassen CD, Wan YJ. RXRalpha regulates the expression of glutathione S-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver.
Mol. Pharmacol. 68: 1590-1596 (2005).
*
-
Dai G, Wan YJ. Animal models of xenobiotic receptors.
Curr. Drug Metab. 6: 341-355 (2005).
-
Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data.
Nucleic Acids Res. 33: e175 (2005).
*
-
Dai Y, Liang YH, Xie PY, Chen BW, Liu XG. Clinical analysis of primary biliary cirrhosis: a report of 42 cases.
Beijing Da Xue Xue Bao 37: 410-414 (2005).
-
Dai YD, Carayanniotis G, Sercarz E. Antigen processing by autoreactive B cells promotes determinant spreading.
Cell. Mol. Immunol. 2: 169-175 (2005).
*
-
Dale RC. Post-streptococcal autoimmune disorders of the central nervous system.
Dev. Med. Child. Neurol. 47: 785-791 (2005).
-
Dalgic A, Ozcay F, Arslan G, Emiroglu R, Sozen H, Moray G, Karakayali H, Bilgin N, Haberal M. Living-related liver transplantation in pediatric patients.
Transplant. Proc. 37: 3133-3136 (2005).
-
Dalgic B, Dursun I, Akyol G. A case of visceral leishmaniasis misdiagnosed as autoimmune hepatitis.
Turk. J. Gastroenterol. 16: 52-53 (2005).
*
-
Dalhoff K, Buus Jensen K, Enghusen Poulsen H. Cancer and molecular biomarkers of phase 2.
Methods Enzymol. 400: 618-627 (2005).
-
Dall'era MC, Cardarelli PM, Preston BT, Witte A, Davis JC. Type I interferon correlates with clinical and serologic manifestations of systemic lupus erythematosus.
Ann. Rheum. Dis. 64: 1692-1697 (2005).
*
-
Dalle IJ, Maes BD, Geboes KP, Lemahieu W, Geboes K. Crohn's-like changes in the colon due to mycophenolate?
Colorectal Dis. 7: 27-34 (2005).
*
-
Dallos T, Kovacs L. CTLA-4 and the genetic predisposition to autoimmunity.
Bratisl. Lek. Listy. 106: 55-62 (2005).
-
Daly M. Patterns of genetic variation in humans and mice.
Novartis Found. Symp. 267: 2-8 (2005).
-
Daly MJ, Pearce AV, Farwell L, Fisher SA, Latiano A, Prescott NJ, Forbes A, Mansfield J, Sanderson J, Langelier D, Cohen A, Bitton A, Wild G, Lewis CM, Annese V, Mathew CG, Rioux JD. Association of DLG5 R30Q variant with inflammatory bowel disease.
Eur. J. Hum. Genet. 13: 835-839 (2005).
*
-
Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Invest. Ophthalmol. Vis. Sci. 46: 2465-2471 (2005).
*
-
Damoiseaux JG, Slot MC, Vaessen M, Stegeman CA, Van Paassen P, Cohen Tervaert JW. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
J. Clin. Immunol. 25: 202-208 (2005).
*
-
Damore M, Minenna G, D'Amore S. Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia.
Recenti Prog. Med. 96: 552-555 (2005).
-
Dan Z, Popov Y, Patsenker E, Preimel D, Liu C, Wang XD, Seitz HK, Schuppan D, Stickel F. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential.
FASEB J. 19: 845-847 (2005).
*
-
Dancey CP, Attree EA, Bardos G, Kovacs A. Is there a link between irritable bowel syndrome and left-handedness?: an exploratory study.
Integr. Physiol. Behav. Sci. 40: 55-59 (2005).
-
Danda D, Kurian G, Chacko A, Chandy G, Patra S, Mathew A, Thomas K. Crohn's disease in rheumatology clinic - an Indian experience.
J. Postgrad. Med. 51: 269-272 (2005).
*
-
Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. Kidney involvement in a nongenetic rat model of type 2 diabetes.
Kidney Int. 68: 2562-2571 (2005).
*
-
Dandachi N, Balic M, Stanzer S, Halm M, Resel M, Hinterleitner TA, Samonigg H, Bauernhofer T. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
J. Mol. Diagn. 7: 631-637 (2005).
*
-
Dane S, Timur H. Sex-related differences in tuberculin reaction, free and total testosterone concentrations in patients with autoimmune disorders and controls.
Int. J. Neurosci. 115: 911-916 (2005).
-
Danese S, De la Rue SA, Gasbarrini A. Antibody to alpha4beta7 integrin for ulcerative colitis.
N. Engl. J. Med. 353: 1180-1181 (2005).
*
-
Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease.
Crit. Rev. Immunol. 25: 103-122 (2005).
-
Danese S, Gasbarrini A. Chemokines in inflammatory bowel disease.
J. Clin. Pathol. 58: 1025-1027 (2005).
*
-
Danese S, Sans M, Gasbarrini A. CD40 antisense based strategy for inflammatory bowel disease: shutting down multiple cellular communication systems.
Gut 54: 891-892 (2005).
*
-
Danese S, Semeraro S, Marini M, Roberto I, Armuzzi A, Papa A, Gasbarrini A. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
Dig. Liver Dis. 37: 811-818 (2005).
-
Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease.
World J. Gastroenterol. 11: 7227-7236 (2005).
*
-
Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
Am. J. Gastroenterol. 100: 886-895 (2005).
*
-
Dang I, Nelson JK, DeVries GH. c-Kit receptor expression in normal human Schwann cells and Schwann cell lines derived from neurofibromatosis type 1 tumors.
J. Neurosci. Res. 82: 465-471 (2005).
*
-
Dang ZC, Lowik C. Dose-dependent effects of phytoestrogens on bone.
Trends Endocrinol. Metab. 16: 207-213 (2005).
*
-
Daniel C, Schlauch T, Zugel U, Steinmeyer A, Radeke HH, Steinhilber D, Stein J. 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities.
Eur. J. Clin. Invest. 35: 343-349 (2005).
-
Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, Ziol M, Coutarel P, Loison P, Jian R, Marteau P. Azathioprine induced nodular regenerative hyperplasia in IBD patients.
Gastroenterol. Clin. Biol. 29: 600-603 (2005).
-
Daniels G. The molecular genetics of blood group polymorphism.
Transpl. Immunol. 14: 143-153 (2005).
-
Daniels I, Cavill D, Murray IA, Long RG. Elevated expression of iNOS mRNA and protein in coeliac disease.
Clin. Chim. Acta 356: 134-142 (2005).
*
-
Danko IM, Chaschin NA. Association of CYP2E1 gene polymorphism with predisposition to cancer development.
Exp. Oncol. 27: 248-256 (2005).
-
Dann SM, Wang HC, Gambarin KJ, Actor JK, Robinson P, Lewis DE, Caillat-Zucman S, White AC Jr. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan Cryptosporidium.
J. Infect. Dis. 192: 1294-1302 (2005).
*
-
Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation.
N. Engl. J. Med. 352: 1371-1373 (2005).
*
-
Daoud G, Simoneau L, Masse A, Rassart E, Lafond J. Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation.
Biochim. Biophys. Acta 1687: 181-194 (2005).
*
-
Daraio F, Ryan E, Gleeson F, Roetto A, Crowe J, Camaschella C. Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient.
Blood Cells Mol. Dis. 35: 174-176 (2005).
-
Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, Ahuja R, Nguyen K, Freeman GJ, Greenfield EA, Sobel RA, Kuchroo VK. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions.
J. Immunol. 175: 1558-1565 (2005).
*
-
Darling AL. A therapeutic guide to common problems in gastroenterology.
Gastroenterology 128: 516 (2005).
*
-
Darlington PJ, Kirchhof MG, Criado G, Sondhi J, Madrenas J. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
J. Immunol. 175: 996-1004 (2005).
*
-
Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, Sorrentini I, Di Marzo V. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies.
Neuropharmacology 48: 1154-1163 (2005).
-
Daroszewska A, Ralston SH. Genetics of Paget's disease of bone.
Clin. Sci. (Lond.) 109: 257-263 (2005).
*
-
Dart J. Cicatricial pemphigoid and dry eye.
Semin. Ophthalmol. 20: 95-100 (2005).
-
Das K, Kar P. Non-alcoholic steatohepatitis.
J. Assoc. Physicians India 53: 195-199 (2005).
-
Das UN. A defect in the activity of Delta(6) and Delta(5) desaturases may be a factor predisposing to the development of insulin resistance syndrome.
Prostaglandins Leukot. Essent. Fatty Acids 72: 343-350 (2005).
*
-
Das UN. Is angiotensin-II an endogenous pro-inflammatory molecule?
Med. Sci. Monit. 11: RA155-RA162 (2005).
*
-
Das UN. Essential fatty acids and acquired immunodeficiency syndrome.
Med. Sci. Monit. 11: RA206-RA211 (2005).
*
-
Das UN. Pathophysiology of metabolic syndrome X and its links to the perinatal period.
Nutrition 21: 762-773 (2005).
*
-
Das UN. COX-2 inhibitors and metabolism of essential fatty acids.
Med. Sci. Monit. 11: RA233-RA237 (2005).
*
-
Das UN. Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids?
J. Assoc. Physicians India 53: 623-627 (2005).
-
Dasari P, Nicholson IC, Hodge G, Dandie GW, Zola H. Expression of Toll-like receptors on B lymphocytes.
Cell. Immunol. 236: 140-145 (2005).
*
-
Dassanayake RP, Griep MA, Duhamel GE. The cytolethal distending toxin B sub-unit of Helicobacter hepaticus is a Ca2+- and Mg2+-dependent neutral nuclease.
FEMS Microbiol. Lett. 251: 219-225 (2005).
-
Dassopoulos T. When the love is lost: adalimumab for patients with an attenuated response to infliximab.
Inflamm. Bowel Dis. 11: 948-949 (2005).
*
-
Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study.
Eur. J. Clin. Nutr. 59: 723-726 (2005).
-
Daum S, Cellier C, Mulder CJ. Refractory coeliac disease.
Best Pract. Res. Clin. Gastroenterol. 19: 413-424 (2005).
-
Dave S, Honney S, Raymond J, Flume PA. An unusual presentation of cystic fibrosis in an adult.
Am. J. Kidney Dis. 45: e41-e44 (2005).
-
Davi G, Falco A. Oxidant stress, inflammation and atherogenesis.
Lupus 14: 760-764 (2005).
-
David A, Fridlich R, Aviram I. The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558.
Exp. Cell Res. 308: 156-165 (2005).
*
-
David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, Walton RT, Grasby PM. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.
J. Neurosci. 25: 2586-2590 (2005).
*
-
David-Henriau L, Bui S, Molinari I, Montaudon D, Lamireau T. Fecal elastase-1: a useful test in pediatric practice.
Arch. Pediatr. 12: 1221-1225 (2005).
-
Davidson A, Diamond B, Wofsy D, Daikh D. Block and tackle: CTLA4Ig takes on lupus.
Lupus 14: 197-203 (2005).
-
Davidson AL, Chen J. Structural biology. Flipping lipids: is the third time the charm?
Science 308: 963-965 (2005).
*
-
Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat.
Am. J. Pathol. 166: 729-736 (2005).
*
-
Davies J, Alton E, Griesenbach U. Cystic fibrosis modifier genes.
J. R. Soc. Med. 98 Suppl. 45: 47-54 (2005).
*
-
Davies JC, Griesenbach U, Alton E. Modifier genes in cystic fibrosis.
Pediatr. Pulmonol. 39: 383-391 (2005).
*
-
Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, Judah DJ, Dinsdale D, Edwards RE, Greaves P, Gant TW, Smith AG. Hepatic gene expression in protoporphyic fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.
Am. J. Pathol. 166: 1041-1053 (2005).
*
-
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.
Gut 54: 533-539 (2005).
*
-
Davis BR, Harris H, Vitale GC. The evolution of endoscopy: wireless capsule cameras for the diagnosis of occult gastrointestinal bleeding and inflammatory bowel disease.
Surg. Innov. 12: 129-133 (2005).
-
Davis J, Chinen J, Garafalo M, Woltz P, Malech H, Puck J. Clinical picture of boys with XSCID and the road to gene therapy.
Nurs. Health Sci. 7: 144 (2005).
-
Davis JM, Maradit-Kremers H, Gabriel SE. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
J. Rheumatol. 32: 1856-1862 (2005).
-
Davis SR, Quinlivan EP, Shelnutt KP, Ghandour H, Capdevila A, Coats BS, Wagner C, Shane B, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW, Gregory JF 3rd. Homocysteine synthesis is elevated but total remethylation is unchanged by the methylenetetrahydrofolate reductase 677C->T polymorphism and by dietary folate restriction in young women.
J. Nutr. 135: 1045-1050 (2005).
*
-
Davis SR, Quinlivan EP, Shelnutt KP, Maneval DR, Ghandour H, Capdevila A, Coats BS, Wagner C, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW, Gregory JF 3rd. The methylenetetrahydrofolate reductase 677C->T polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women.
J. Nutr. 135: 1040-1044 (2005).
*
-
Daw EW, Heath SC, Lu Y. Single-nucleotide polymorphism versus microsatellite markers in a combined linkage and segregation analysis of a quantitative trait.
BMC Genet. 6 Suppl. 1: S32 (2005).
*
-
Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?
Arthritis Rheum. 52: 2984-2995 (2005).
*
-
Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, Ballatori N. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.
J. Biol. Chem. 280: 6960-6968 (2005).
*
-
Dawson PA, Markovich D. Pathogenetics of the human SLC26 transporters.
Curr. Med. Chem. 12: 385-396 (2005).
-
Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation?
Trends Immunol. 26: 637-643 (2005).
*
-
Day AS, Whitten KE, Bohane TD. Childhood inflammatory bowel disease: parental concerns and expectations.
World J. Gastroenterol. 11: 1028-1031 (2005).
*
-
Day CP. Alcoholic liver disease.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 77 (2005). *
-
Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis.
Gastroenterology 129: 375-378 (2005).
*
-
Day CP. Genetic studies to identify hepatic fibrosis genes and SNPs in human populations.
Methods Mol. Med. 117: 315-332 (2005).
-
Dayer JM, Molnarfi N, Burger D. From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?
Expert Opin. Biol. Ther. 5 Suppl. 1: S83-S96 (2005).
-
Daysal S, Akcil G, Goker B, Haznedaroglu S, Ercan N, Ozturk MA. Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis.
Arthritis Rheum. 53: 146-147 (2005).
*
-
Dazzi A, Lauro A, Di Benedetto F, Masetti M, Cautero N, De Ruvo N, Quintini C, Ramacciato G, Miller CM, Pinna AD. Living donor liver transplantation in adult patients: our experience.
Transplant. Proc. 37: 2595-2596 (2005).
*
-
de Almeida Vasconcelos Fonseca EM, Chagas CE, Mazzantini RP, Heidor R, Ong TP, Moreno FS. All-trans and 9-cis retinoic acids, retinol and beta-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage.
Carcinogenesis 26: 1940-1946 (2005).
*
-
de Almeidaa CJ, Linden R. Phagocytosis of apoptotic cells: a matter of balance.
Cell. Mol. Life Sci. 62: 1532-1546 (2005).
*
-
De Bellis A, Bizzarro A, Perrino S, Coronella C, Conte M, Pasquali D, Sinisi AA, Betterle C, Bellastella A. Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine diseases.
Clin. Endocrinol. (Oxf.) 63: 45-49 (2005).
*
-
De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity.
Pituitary 8: 25-30 (2005).
*
-
de Benedetti F, Martini A. Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?
Arthritis Rheum. 52: 687-693 (2005).
*
-
De Boeck K, Weren M, Proesmans M, Kerem E. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
Pediatrics 115: e463-e469 (2005).
*
-
De Boer M, Grootenhuis M, Derkx B, Last B. Health-related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease.
Inflamm. Bowel Dis. 11: 400-406 (2005).
*
-
de Boer MT, Molenaar IQ, Hendriks HG, Slooff MJ, Porte RJ. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques.
Dig. Surg. 22: 265-275 (2005).
-
de Boer NK, Derijks LJ, Gilissen LP, Hommes DW, Engels LG, de-Boer SY, den Hartog G, Hooymans PM, Makelburg AB, Westerveld BD, Naber AH, Mulder CJ, de Jong DJ. On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.
World J. Gastroenterol. 11: 5540-5544 (2005).
*
-
De Boer NK, Graaf P, Wilhelm AJ, Mulder CJ, Bodegraven AA. On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.
Aliment. Pharmacol. Ther. 22: 447-451 (2005).
*
-
de Boer NK, Mulder CJ, van Bodegraven AA. Myelotoxicity and hepatotoxicity during azathioprine therapy.
Neth. J. Med. 63: 444-446 (2005).
*
-
de Boer NK, Van Elburg RM, Wilhelm AJ, Remmink AJ, Van Vugt JM, Mulder CJ, Van Bodegraven AA. 6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child.
Scand. J. Gastroenterol. 40: 1374-1377 (2005).
*
-
de Boer NK, van Nieuwkerk CM, Aparicio Pages MN, de Boer SY, Derijks LJ, Mulder CJ. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.
Eur. J. Gastroenterol. Hepatol. 17: 457-461 (2005).
-
De Bosscher K, Vanden Berghe W, Beck IM, Van Molle W, Hennuyer N, Hapgood J, Libert C, Staels B, Louw A, Haegeman G. A fully dissociated compound of plant origin for inflammatory gene repression.
Proc. Natl. Acad. Sci. U.S.A. 102: 15827-15832 (2005).
*
-
de Buys P, Khanna D, Furst DE. Hemopoietic stem cell transplantation in rheumatic diseases-an update.
Autoimmun. Rev. 4: 442-449 (2005).
-
De Carvalho Bittencourt M, Herren S, Graber P, Vilbois F, Pasquali C, Berney C, Plitz T, Nicoletti F, Kosco-Vilbois MH. Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes.
Eur. J. Immunol. 35: 1501-1509 (2005).
*
-
De Caterina M, Grimaldi E, Di Pascale G, Salerno G, Rosiello A, Passaretti M, Scopacasa F. The soluble transferrin receptor (sTfR)-ferritin index is a potential predictor of celiac disease in children with refractory iron deficiency anemia.
Clin. Chem. Lab. Med. 43: 38-42 (2005).
*
-
De Caterina R, Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes.
J. Membr. Biol. 206: 103-116 (2005).
*
-
de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study.
Genes Immun. 6: 167-170 (2005).
*
-
De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J. The molecular basis of ferroportin-linked hemochromatosis.
Proc. Natl. Acad. Sci. U.S.A. 102: 8955-8960 (2005).
*
-
de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension.
J. Hepatol. 43: 167-176 (2005).
*
-
de Gottardi A, de Saussure P. Celiac disease in disguise.
Rev. Med. Suisse. 1: 2008-2011 (2005).
-
de Gouvea EF, Branco RC, Monteiro RC, Halpern M, Ferreira AL, Alves EM, Moreira BM, Ribeiro-Filho J, Santoro-Lopes G. Surveillance for vancomycin-resistant enterococci colonization among patients of a liver transplant program.
Transpl. Int. 18: 1218-1220 (2005).
*
-
de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
Thorax 60: 558-563 (2005).
*
-
de Groot A, de Rosny E, Juillan-Binard C, Ferrer JL, Laudet V, Pierce RJ, Pebay-Peyroula E, Fontecilla-Camps JC, Borel F. Crystal structure of a novel tetrameric complex of agonist-bound ligand-binding domain of Biomphalaria glabrata retinoid X receptor.
J. Mol. Biol. 354: 841-853 (2005).
*
-
de Groot K, Schnabel A. Pulmonary-renal syndrome.
Internist (Berl.) 46: 769-782 (2005).
-
De Groote D, Van Doorn LJ, Van den Bulck K, Vandamme P, Vieth M, Stolte M, Debongnie JC, Burette A, Haesebrouck F, Ducatelle R. Detection of non-pylori Helicobacter species in "Helicobacter heilmannii"-infected humans.
Helicobacter 10: 398-406 (2005).
*
-
de Haan EC, Moret EE, Wagenaar-Hilbers JP, Liskamp RM, Wauben MH. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
Mol. Immunol. 42: 365-373 (2005).
*
-
de Hingh YC, van der Vossen PW, Gemen EF, Mulder AB, Hop WC, Brus F, de Vries E. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome.
J. Pediatr. 147: 744-747 (2005).
*
-
de J Ribeiro P, Narciso JL, de Toledo CF, Borges DR. gamma-Glutamyltransferase decreases in patients with the chronic form of Schistosomiasis mansoni treated with ursodeoxycholic acid.
J. Clin. Pathol. 58: 783-784 (2005).
*
-
de Jong AE, Morreau H, Nagengast FM, Mathus-Vliegen EM, Kleibeuker JH, Griffioen G, Cats A, Vasen HF. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
Am. J. Gastroenterol. 100: 139-143 (2005).
*
-
de Jong DJ, Tielen J, Habraken CM, Wetzels JF, Naber AH. 5-Aminosalicylates and effects on renal function in patients with Crohn's disease.
Inflamm. Bowel Dis. 11: 972-976 (2005).
*
-
de Jong MM, Niens M, Nolte IM, Te Meerman GJ, van der Graaf WT, Mulder MJ, van der Steege G, Bruinenberg M, Schaapveld M, Sijmons RH, Hofstra RM, de Vries EG, Kleibeuker JH. The human leukocyte antigen region and colorectal cancer risk.
Dis. Colon Rectum 48: 303-306 (2005).
*
-
De Keyser F. Gut inflammation in patients with spondyloarthropathy is prevalent and is linked to Crohn's disease.
J. Postgrad. Med. 51: 272 (2005). *
-
de Kok TM, Engels LG, Moonen EJ, Kleinjans JC. Inflammatory bowel disease stimulates formation of carcinogenic N-nitroso compounds.
Gut 54: 731 (2005).
*
-
de Korte J, Van Onselen J, Kownacki S, Sprangers M, Bos J. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme.
J. Eur. Acad. Dermatol. Venereol. 19: 35-41 (2005).
*
-
de la Mora-Levy JG, Baron TH. Endoscopic management of the liver transplant patient.
Liver Transpl. 11: 1007-1021 (2005).
*
-
de la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suarez C. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
Hepatology 41: 572-578 (2005).
*
-
de la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles LF, Malm D, Berg T, Paoletti S, Maitre B, Mourey L, Salamero J, Cazenave JP, Hanau D, Mori L, Puzo G, De Libero G. Assistance of microbial glycolipid antigen processing by CD1e.
Science 310: 1321-1324 (2005).
*
-
De La Vega FM, Isaac H, Collins A, Scafe CR, Halldorsson BV, Su X, Lippert RA, Wang Y, Laig-Webster M, Koehler RT, Ziegle JS, Wogan LT, Stevens JF, Leinen KM, Olson SJ, Guegler KJ, You X, Xu LH, Hemken HG, Kalush F, Itakura M, Zheng Y, de The G, et al. The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern.
Genome Res. 15: 454-462 (2005).
*
-
De Lange T, Larsen S, Aabakken L. Image documentation of endoscopic findings in ulcerative colitis: photographs or video clips?
Gastrointest. Endosc. 61: 715-720 (2005).
*
-
de Lau LM, Koudstaal PJ, van Meurs JB, Uitterlinden AG, Hofman A, Breteler MM. Methylenetetrahydrofolate reductase C677T genotype and PD.
Ann. Neurol. 57: 927-930 (2005).
-
de Leeuw K, Kallenberg C, Bijl M. Accelerated atherosclerosis in patients with systemic autoimmune diseases.
Ann. N. Y. Acad. Sci. 1051: 362-371 (2005).
*
-
De Leeuw K, Sanders JS, Stegeman CA, Smit AJ, Kallenberg C, Bijl M. Accelerated atherosclerosis in patients with Wegener's granulomatosis.
Ann. Rheum. Dis. 64: 753-759 (2005).
*
-
De Libero G, Moran AP, Gober HJ, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, Sansano S, Tonevitsky A, Landmann R, Mori L. Bacterial infections promote T cell recognition of self-glycolipids.
Immunity 22: 763-772 (2005).
*
-
De Libero G, Mori L. Recognition of lipid antigens by T cells.
Nat. Rev. Immunol. 5: 485-496 (2005).
*
-
de Madaria E, Martinez J, Lozano B, Sempere L, Benlloch S, Such J, Uceda F, Frances R, Perez-Mateo M. Detection and identification of bacterial DNA in serum from patients with acute pancreatitis.
Gut 54: 1293-1297 (2005).
*
-
de Nigris F, Williams-Ignarro S, Lerman LO, Crimi E, Botti C, Mansueto G, D'Armiento FP, De Rosa G, Sica V, Ignarro LJ, Napoli C. Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress.
Proc. Natl. Acad. Sci. U.S.A. 102: 4896-4901 (2005).
*
-
de Oliveira SS, de Oliveira IM, De Souza W, Morgado-Diaz JA. Claudins upregulation in human colorectal cancer.
FEBS Lett. 579: 6179-6185 (2005).
*
-
De Paz R, Hernandez-Navarro F. Management, prevention and control of pernicious anemia.
Nutr. Hosp. 20: 433-435 (2005).
-
de Rave S, Hansen BE, Groenland TH, Kazemier G, de Man RA, Metselaar HJ, Terpstra OT, Tilanus HW, Ijzermans JH, Schalm SW. Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes.
Liver Transpl. 11: 396-401 (2005).
*
-
De Rose V, Arduino C, Cappello N, Piana R, Salmin P, Bardessono M, Goia M, Padoan R, Bignamini E, Costantini D, Pizzamiglio G, Bennato V, Colombo C, Giunta A, Piazza A. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
Eur. J. Hum. Genet. 13: 96-101 (2005).
*
-
De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, Veys EM, De Keyser F, Baeten D. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.
Arthritis Rheum. 52: 2323-2330 (2005).
*
-
de Saussure P, Soravia C. Images in clinical medicine. Crohn's disease.
N. Engl. J. Med. 352: 2222 (2005).
*
-
de Saussure P, Soravia C, Morel P, Hadengue A. Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis.
Aliment. Pharmacol. Ther. 22: 203-208 (2005).
*
-
de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
Arthritis Rheum. 52: 3801-3812 (2005).
*
-
de Seze J, Canva-Delcambre V, Fajardy I, Delalande S, Stojkovic T, Godet E, Vermersch P. Autoimmune hepatitis and multiple sclerosis: a coincidental association?
Mult. Scler. 11: 691-693 (2005).
*
-
de Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.
Aliment. Pharmacol. Ther. 22: 1097-1105 (2005).
*
-
de Simone C. Impact of prebiotics and probiotics on enteric flora.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S40 (2005).
*
-
De Simone P, Carrai P, Baldoni L, Petruccelli S, Coletti L, Morelli L, Filipponi F. Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation.
Liver Transpl. 11: 1080-1085 (2005).
*
-
De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins.
Biotechnol. Lett. 27: 1337-1347 (2005).
*
-
De Smet PA. Herbal medicine in Europe - relaxing regulatory standards.
N. Engl. J. Med. 352: 1176-1178 (2005).
*
-
de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB Jr, Barros SP, Line SR. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
J. Clin. Periodontol. 32: 207-211 (2005).
*
-
De Tomaso AW, Nyholm SV, Palmeri KJ, Ishizuka KJ, Ludington WB, Mitchel K, Weissman IL. Isolation and characterization of a protochordate histocompatibility locus.
Nature 438: 454-459 (2005).
*
-
de Vries RR, Huizinga TW, Toes RE. Redefining the HLA and RA association: to be or not to be anti-CCP positive.
J. Autoimmun. 25: S21-S25 (2005).
-
De Vry CG, Valdez M, Lazarov M, Muhr E, Buelow R, Fong T, Iyer S. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model.
J. Invest. Dermatol. 125: 473-481 (2005).
*
-
de Winter-de Groot KM, van der Ent CK. Nitric oxide in cystic fibrosis.
J. Cyst. Fibros. 4 Suppl. 2: S25-S29 (2005).
-
Deak G, Ruzicska E, Somogyi A. Association of IgA nephropathy, hypothyroidism and hypercholesterolemia.
J. Nephrol. 18: 773-776 (2005).
-
Dean EG, Wilson GR, Li M, Edgtton KL, O'Sullivan KM, Hudson BG, Holdsworth SR, Kitching AR. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury.
Kidney Int. 67: 566-575 (2005).
*
-
Dean M. The genetics of ATP-binding cassette transporters.
Methods Enzymol. 400: 409-429 (2005).
-
Dean M, Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.
Annu. Rev. Genomics Hum. Genet. 6: 123-142 (2005).
*
-
Deangelis RA, Markiewski MM, Taub R, Lambris JD. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha.
Hepatology 42: 1148-1157 (2005).
*
-
Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer.
Curr. Opin. Clin. Nutr. Metab. Care 8: 265-269 (2005).
-
Dearman RJ, Kimber I. Characterisation of immune responses to food allergens in mice.
Proc. Nutr. Soc. 64: 426-433 (2005).
*
-
Debard N, Py P, Kraehenbuhl JP, Fuchs J. The influence of the Internet on immunology education.
Nat. Rev. Immunol. 5: 736-740 (2005).
*
-
Debier C, Larondelle Y. Vitamins A and E: metabolism, roles and transfer to offspring.
Br. J. Nutr. 93: 153-174 (2005).
*
-
Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B, Rozmiarek A, Dziuba I, Zlowocka E, Suchy J, Gorski B, Cybulski C, Mierzejewski M, Masojc B, Medrek K, Oszurek O, Lubinski J. NOD2 variants and the risk of malignant melanoma.
Eur. J. Cancer Prev. 14: 143-146 (2005).
-
Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Liver Transpl. 11: 767-775 (2005).
*
-
Decaudin B, Beraud G, Lannoy D, Semjen E, Wierre L, Horrent S, Resibois JP, Azar R, Odou P. Fibrate-induced increase in serum creatinine levels: two cases.
Therapie 60: 601-602 (2005).
-
Decker T, Muller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection.
Nat. Rev. Immunol. 5: 675-687 (2005).
*
-
Decsi T, Campoy C, Koletzko B. Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial.
Adv. Exp. Med. Biol. 569: 109-113 (2005).
-
Dedmon M. Liver transplantation: Managing complications in primary care.
JAAPA 18: 41-49 (2005).
*
-
Dedoussis GV, Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Choumerianou D, Stefanadis C; The ATTICA Study Group. An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease.
Int. J. Cardiol. 100: 409-414 (2005).
-
Dedoussis GV, Panagiotakos DB, Vidra NV, Louizou E, Chrysohoou C, Germanos A, Mantas Y, Tokmakidis S, Pitsavos C, Stefanadis C; for the CARDIOGENE Study group. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE study.
Genet. Med. 7: 411-416 (2005).
-
Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J, Beglinger C. Effect of peptide YY(3-36) on food intake in humans.
Gastroenterology 129: 1430-1436 (2005).
*
-
Degerli N, Yilmaz E, Bardakci F. The Delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population.
Clin. Biochem. 38: 248-252 (2005).
*
-
Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage.
Nat. Rev. Immunol. 5: 112-124 (2005).
*
-
Deguchi M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.
J. Soc. Gynecol. Investig. 12: 208-213 (2005).
-
Deguchi Y, Andoh A, Inatomi O, Araki Y, Hata K, Tsujikawa T, Kitoh K, Fujiyama Y. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.
Int. J. Mol. Med. 16: 605-608 (2005).
-
Dehni N, Remacle G, Dozois RR, Banchini F, Tiret E, Parc R. Salvage reoperation for complications after ileal pouch-anal anastomosis.
Br. J. Surg. 92: 748-753 (2005).
*
-
Deichmann M, Thome M, Egner U, Hartschuh W, Kurzen H. The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin.
J. Cutan. Pathol. 32: 467-473 (2005).
*
-
Dekaney CM, Rodriguez JM, Graul MC, Henning SJ. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum.
Gastroenterology 129: 1567-1580 (2005).
*
-
Dekker E, Fockens P. Advances in colonic imaging: new endoscopic imaging methods.
Eur. J. Gastroenterol. Hepatol. 17: 803-808 (2005).
-
Dekker E, Fockens P. New imaging techniques at colonoscopy: tissue spectroscopy and narrow band imaging.
Gastrointest. Endosc. Clin. N. Am. 15: 703-714 (2005).
-
Dela Pena A, Leclercq I, Field J, George J, Jones B, Farrell G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
Gastroenterology 129: 1663-1674 (2005).
*
-
Delaini GG, Scaglia M, Colucci G, Hulten L. The ileoanal pouch procedure in the long-term perspective: a critical review.
Tech. Coloproctol. 9: 187-192 (2005).
*
-
Delaini GG, Scaglia M, Lindholm E, Colucci G, Hulten L. Is an ileal pouch an alternative for patients requiring surgery for Crohn's proctocolitis?
Tech. Coloproctol. 9: 222-224 (2005).
*
-
Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome.
Eur. J. Oral Sci. 113: 101-113 (2005).
*
-
Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.
Science 307: 1630-1634 (2005).
*
-
Delay D, Lardi C, Jaussi A, von Segesser LK. Hepato-atrial anastomosis, the "other Senning operation" for treatment of Budd-Chiari syndrome.
Swiss Med. Wkly 135: 235-237 (2005).
*
-
Delco F, Tchambaz L, Schlienger R, Drewe J, Krahenbuhl S. Dose adjustment in patients with liver disease.
Drug Saf. 28: 529-545 (2005).
-
Delgado J, Sperber AD, Novack V, Delgado B, Edelman L, Gaspar N, Krugliak P, Odes S, Jotkowitz AB, Faszczyk M, Fich A. The epidemiology of primary biliary cirrhosis in southern Israel.
Isr. Med. Assoc. J. 7: 717-721 (2005).
*
-
Delgado M, Chorny A, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
J. Leukoc. Biol. 78: 1327-1338 (2005).
*
-
Delgado M, Gonzalez-Rey E, Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
J. Immunol. 175: 7311-7324 (2005).
*
-
Dell'aquila P, Pietrini L, Barone M, Cela EM, Valle ND, Amoruso A, Minenna MF, Penna A, De Francesco V, Panella C, Ierardi E. Small intestinal contrast ultrasonography-based scoring system: a promising approach for the diagnosis and follow-up of celiac disease.
J. Clin. Gastroenterol. 39: 591-595 (2005).
-
Dellavalle R, Drake A, Graber M, Heilig L, Hester E, Johnson K, McNealy K, Schilling L, Dellavalle R. Statins and fibrates for preventing melanoma.
Cochrane Database Syst. Rev. 4: CD003697 (2005).
*
-
Dellavance A, Viana VS, Leon EP, Bonfa ES, Andrade LE, Leser PG. The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern.
J. Rheumatol. 32: 2144-2149 (2005).
-
Dellon ES, Shaheen NJ. Diabetes and hepatocellular carcinoma: associations, biologic plausibility, and clinical implications.
Gastroenterology 129: 1132-1134 (2005).
*
-
Delorme D, Miller SC. Dietary consumption of Echinacea by mice afflicted with autoimmune (type I) diabetes: effect of consuming the herb on hemopoietic and immune cell dynamics.
Autoimmunity 38: 453-461 (2005).
-
Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A, Guery JC. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses.
J. Immunol. 175: 5050-5057 (2005).
*
-
Delvaux M, Ben Soussan E, Laurent V, Lerebours E, Gay G. Clinical evaluation of the use of the M2A patency capsule system before a capsule endoscopy procedure, in patients with known or suspected intestinal stenosis.
Endoscopy 37: 801-807 (2005).
-
Demar JC Jr, Ma K, Chang L, Bell JM, Rapoport SI. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid.
J. Neurochem. 94: 1063-1076 (2005).
*
-
DeMarco RA, Fink MP, Lotze MT. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
Mol. Immunol. 42: 433-444 (2005).
*
-
Demerjian-Somogyi N, Palazzo E, Cohen-Solal M. Osteoporosis in patients with inflammatory bowel disease.
Joint Bone Spine 72: 354-356 (2005).
*
-
Demetriou AA. Hepatic assist devices.
Panminerva Med. 47: 31-37 (2005).
-
Demetter P, De Vos M, Van Huysse JA, Baeten D, Ferdinande L, Peeters H, Mielants H, Veys EM, De Keyser F, Cuvelier CA. Colon mucosa of both spondyloarthritis and Crohn's disease patients is enriched with macrophages expressing the scavenger receptor CD163.
Ann. Rheum. Dis. 64: 321-324 (2005).
*
-
Demicheli V, Jefferson T, Rivetti A, Price D, Demicheli V. Vaccines for measles, mumps and rubella in children.
Cochrane Database Syst. Rev. 4: CD004407 (2005).
*
-
Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention.
Nat. Rev. Cancer 5: 930-942 (2005).
*
-
Demir H, Yuce A, Caglar M, Kale G, Kocak N, Ozen H, Gurakan F, Saltik-Temizel IN. Cirrhosis in children with celiac disease.
J. Clin. Gastroenterol. 39: 630-633 (2005).
-
Demizieux L. Control and regulation of mitochondrial oxidation of long-chained fatty acids.
J. Soc. Biol. 199: 143-155 (2005).
-
Deml L, Aigner M, Decker J, Eckhardt A, Schutz C, Mittl PR, Barabas S, Denk S, Knoll G, Lehn N, Schneider-Brachert W. Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.
Infect. Immun. 73: 4732-4742 (2005).
*
-
Demyttenaere K, De Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder.
Int. J. Neuropsychopharmacol. 8: 93-105 (2005).
-
den Boon S, van Lill SW, Borgdorff MW, Verver S, Bateman ED, Lombard CJ, Enarson DA, Beyers N. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area.
Thorax 60: 555-557 (2005).
*
-
Deng GM, Zheng L, Ka-Ming Chan F, Lenardo M. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors.
Nat. Med. 11: 1066-1072 (2005).
*
-
Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H. Steatohepatitis induced by intragastric overfeeding in mice.
Hepatology 42: 905-914 (2005).
*
-
Deng R, Balthasar JP. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
Int. J. Pharm. 304: 51-62 (2005).
*
-
Deng T, Shan S, Li ZB, Wu ZW, Liao CZ, Ko B, Lu XP, Cheng J, Ning ZQ. A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice.
Biol. Pharm. Bull. 28: 1192-1196 (2005).
*
-
Denke MA. Diet, lifestyle, and nonstatin trials: review of time to benefit.
Am. J. Cardiol. 96: 3-10 (2005).
*
-
Denning TL, Kim G, Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis.
J. Immunol. 174: 7487-7491 (2005).
*
-
Dennison E, Syddall H, Fall C, Brandi ML, Cooper C. Evidence of sexual dimorphism in relationships between estrogen receptor polymorphisms and bone mass: the Hertfordshire study.
J. Rheumatol. 32: 2400-2404 (2005).
-
Dent P, Fang Y, Gupta S, Studer E, Mitchell C, Spiegel S, Hylemon PB. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
Hepatology 42: 1291-1299 (2005).
*
-
Dentin R, Benhamed F, Pegorier JP, Foufelle F, Viollet B, Vaulont S, Girard J, Postic C. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.
J. Clin. Invest. 115: 2843-2854 (2005).
*
-
Denton CP, Black CM. Targeted therapy comes of age in scleroderma.
Trends Immunol. 26: 596-602 (2005).
*
-
Denys A, Hichami A, Khan NA. n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and NF-kappa B signaling pathway.
J. Lipid Res. 46: 752-758 (2005).
*
-
Denzin LK, Fallas JL, Prendes M, Yi W. Right place, right time, right peptide: DO keeps DM focused.
Immunol. Rev. 207: 279-292 (2005).
-
Deocaris CC, Taira K, Kaul SC, Wadhwa R. Mimotope-hormesis and mortalin/grp75/mthsp70: a new hypothesis on how infectious disease-associated epitope mimicry may explain low cancer burden in developing nations.
FEBS Lett. 579: 586-590 (2005).
*
-
Der G, Love T, Schreck J, Horn M. Primary sclerosing cholangitis: a case presentation.
Gastroenterol. Nurs. 28: 13-16 (2005).
*
-
Derbinski J, Kyewski B. Linking signalling pathways, thymic stroma integrity and autoimmunity.
Trends Immunol. 26: 503-506 (2005).
*
-
Deretic V. Autophagy in innate and adaptive immunity.
Trends Immunol. 26: 523-528 (2005).
*
-
Derichs N, Schuster A, Grund I, Ernsting A, Stolpe C, Kortge-Jung S, Gallati S, Stuhrmann M, Kozlowski P, Ballmann M. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this Cystic Fibrosis Transmembrane Conductance Regulator mutation does not cause cystic fibrosis.
Clin. Genet. 67: 529-531 (2005).
*
-
Derijk R, de Kloet ER. Corticosteroid receptor genetic polymorphisms and stress responsivity.
Endocrine 28: 263-270 (2005).
-
Dervaux T, Caillard S, Meyer C, Ellero B, Woehl-Jaegle ML, Hannedouche T, Wolf P, Moulin B. Is sirolimus responsible for proteinuria?
Transplant. Proc. 37: 2828-2829 (2005).
*
-
Dervieux T, Meyer G, Barham R, Matsutani M, Barry M, Boulieu R, Neri B, Seidman E. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
Clin. Chem. 51: 2074-2084 (2005).
*
-
Desai HG, Gupte PA. Increasing incidence of Crohn's disease in India: is it related to improved sanitation?
Indian J. Gastroenterol. 24: 23-24 (2005).
*
-
Desai HG, Naik AS. Acute viral E hepatitis with chronic liver disease (autoimmune hepatitis).
Indian J. Med. Sci. 59: 113-115 (2005).
*
-
Descotes J. Immunotoxicology: role in the safety assessment of drugs.
Drug Saf. 28: 127-136 (2005).
-
Deshaies F, Brunet A, Diallo DA, Denzin LK, Samaan A, Thibodeau J. A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.
Proc. Natl. Acad. Sci. U.S.A. 102: 6443-6448 (2005).
*
-
Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology.
Arch. Pathol. Lab. Med. 129: 1148-1154 (2005).
*
-
Dessimoz J, Bonnard C, Huelsken J, Grapin-Botton A. Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development.
Curr. Biol. 15: 1677-1683 (2005).
*
-
Detry O, Deroover A, Delwaide J, Delbouille MH, Kaba A, Joris J, Damas P, Lamy M, Honore P, Meurisse M. Avoiding blood products during liver transplantation.
Transplant. Proc. 37: 2869-2870 (2005).
*
-
Deutschmann A, Mache CJ, Bodo K, Zebedin D, Ring E. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage.
Pediatrics 116: 1231-1233 (2005).
*
-
Devani M, Vecchi M, Ferrero S, Avesani EC, Arizzi C, Chao L, Colman RW, Cugno M. Kallikrein-kinin system in inflammatory bowel diseases: intestinal involvement and correlation with the degree of tissue inflammation.
Dig. Liver Dis. 37: 665-673 (2005).
-
DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.
Am. J. Gastroenterol. 100: 190-200 (2005).
*
-
Devbhandari MP, Raco L, Hendrickse MT, Duncan AJ. Congenital bronchoesophageal fistula in a patient with Crohn's disease: a cautionary tale.
Ann. Thorac. Surg. 79: 1776-1777 (2005).
-
Deveaux PG, Kimberling J, Galandiuk S. Crohn's disease: presentation and severity compared between black patients and white patients.
Dis. Colon Rectum 48: 1404-1409 (2005).
*
-
Devesa I, Ferrandiz ML, Terencio MC, Joosten LA, van den Berg WB, Alcaraz MJ. Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis.
Arthritis Rheum. 52: 3230-3238 (2005).
*
-
Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine - the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years.
Indian J. Dermatol. Venereol. Leprol. 71: 325-328 (2005).
*
-
Devroe H, Coene L, Mortelmans LJ, Jutten G. Colloid carcinoma arising in an anorectal fistula in Crohn's disease: a case report.
Acta Chir. Belg. 105: 110-111 (2005).
-
Devroey D, Velkeniers B, Duquet W, Betz W. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
Int. J. Cardiol. 101: 231-235 (2005).
-
Dewar DH, Ciclitira PJ. Clinical features and diagnosis of celiac disease.
Gastroenterology 128: S19-S24 (2005).
*
-
Deykin A. Targeting biologic markers in asthma - is exhaled nitric oxide the bull's-eye?
N. Engl. J. Med. 352: 2233-2235 (2005).
*
-
Dhabhai R, Kalla G, Singhi MK, Ghiya BC, Kachhawa D. Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus.
Indian J. Dermatol. Venereol. Leprol. 71: 9-13 (2005).
*
-
Dhanjal NS, Sharif AW, Rosenfelder NA, Lim AK, Taylor-Robinson SD. Cystic duct dilatation after cholecystectomy in fibropolycystic liver disease.
J. Hepatol. 43: 192 (2005).
*
-
Dharancy S, Malapel M, Perlemuter G, Roskams T, Cheng Y, Dubuquoy L, Podevin P, Conti F, Canva V, Philippe D, Gambiez L, Mathurin P, Paris JC, Schoonjans K, Calmus Y, Pol S, Auwerx J, Desreumaux P. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
Gastroenterology 128: 334-342 (2005).
*
-
Dhawan A, Ferenci P, Geubel A, Houwen R, Lerut J, Sokal E. Genes and metals: a deadly combination.
Acta Gastroenterol. Belg. 68: 26-32 (2005).
-
Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation.
Liver Transpl. 11: 441-448 (2005).
*
-
Dhawan P, Peng X, Sutton AL, MacDonald PN, Croniger CM, Trautwein C, Centrella M, McCarthy TL, Christakos S. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
Mol. Cell. Biol. 25: 472-487 (2005).
*
-
Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia.
Glia 50: 21-31 (2005).
*
-
Dhein S, Michaelis B, Mohr FW. Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids.
Naunyn. Schmiedebergs Arch. Pharmacol. 371: 202-211 (2005).
*
-
Dhillon S, Loftus EV. Medical therapy of Crohn's disease.
Curr. Treat. Options Gastroenterol. 8: 19-30 (2005).
-
Dhiman RK, Chawla YK. Herbal medicines for liver diseases.
Dig. Dis. Sci. 50: 1807-1812 (2005).
*
-
Di Bisceglie AM. Does bare-stent TIPS increase the risk of hepatocellular carcinoma in patients with cirrhosis?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 256-257 (2005).
*
-
Di Caro S, May A, Heine DG, Fini L, Landi B, Petruzziello L, Cellier C, Mulder CJ, Costamagna G, Ell C, Gasbarrini A; for the DBE-European Study Group. The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact.
Gastrointest. Endosc. 62: 545-550 (2005).
-
Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells.
J. Immunol. 174: 3237-3246 (2005).
*
-
Di Lorenzo C, Colletti RB, Lehmann HP, Boyle JT, Gerson WT, Hyams JS, Squires RH Jr, Walker LS, Kanda PT; AAP Subcommittee and NASPGHAN Committee on Chronic Abdominal Pain. Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
J. Pediatr. Gastroenterol. Nutr. 40: 249-261 (2005).
*
-
Di Lorenzo C, Colletti RB, Lehmann HP, Boyle JT, Gerson WT, Hyams JS, Squires RH Jr, Walker LS, Kanda PT; American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain and NASPGHAN Committee on Abdominal Pain. Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
J. Pediatr. Gastroenterol. Nutr. 40: 245-248 (2005).
*
-
Di Mari JF, Mifflin RC, Powell DW. The role of protein kinase C in gastrointestinal function and disease.
Gastroenterology 128: 2131-2146 (2005).
*
-
di Meglio P, Ianaro A, Ghosh S. Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation.
Arthritis Rheum. 52: 951-958 (2005).
*
-
Di Nicuolo G, Kerkhove MP, Hoekstra R, Beld MG, Amoroso P, Battisti S, Starace M, Florio E, Scuderi V, Scala S, Bracco A, Mancini A, Chamuleau RA, Calise F. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver.
Xenotransplantation 12: 286-292 (2005).
*
-
Di Paola R, Mazzon E, Patel NS, Genovese T, Muia C, Thiemermann C, De Sarro A, Cuzzocrea S. Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid.
Eur. J. Pharmacol. 507: 281-289 (2005).
*
-
Di Pierro E, Cappellini MD, Mazzucchelli R, Moriondo V, Mologni D, Poma BZ, Riva A. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
Exp. Hematol. 33: 584-591 (2005).
*
-
Di Prima L, Sferrazza C, Avila D, Pirrone G, Cappello G, Di Lorenzo G, Carroccio A, Rini GB, Di Fede G. Osteoporotic risk in Crohn's disease.
Recenti Prog. Med. 96: 254-260 (2005).
-
Di Rosa F, Pabst R. The bone marrow: a nest for migratory memory T cells.
Trends Immunol. 26: 360-366 (2005).
*
-
Di Sabatino A, Morera R, Ciccocioppo R, Cazzola P, Gotti S, Tinozzi FP, Tinozzi S, Corazza GR. Oral butyrate for mildly to moderately active Crohn's disease.
Aliment. Pharmacol. Ther. 22: 789-794 (2005).
*
-
Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, Carsetti R. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease.
Am. J. Gastroenterol. 100: 1788-1795 (2005).
*
-
Di Sario A, Bendia E, Taffetani S, Omenetti A, Candelaresi C, Marzioni M, De Minicis S, Benedetti A. Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-vitamin E complex in rats.
Dig. Liver Dis. 37: 869-876 (2005).
-
Di ZH, Shin JH, Kim JH, Song HY. Colorectal anastomotic strictures: treatment by fluoroscopic double balloon dilation.
J. Vasc. Interv. Radiol. 16: 75-80 (2005).
-
Di-Poi N, Desvergne B, Michalik L, Wahli W. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.
J. Biol. Chem. 280: 38700-38710 (2005).
*
-
Diallo M, Kane A, Sy N, Ndiaye B. Pyoderma gangrenosum in Dakar: about 14 cases.
Dakar Med. 50: 52-55 (2005).
-
Diamond B. Autoimmunity.
Immunol. Rev. 204: 5-8 (2005).
*
-
Dias Teixeira MC, de Fatima Gomes de Sa Ribeiro M, Strauss E. A new insight into the differences among non-cirrhotic and cirrhotic patients using the liver disease quality of life instrument (LDQOL).
Ann. Hepatol. 4: 264-271 (2005).
*
-
Diatchenko L, Romanov S, Malinina I, Clarke J, Tchivilev I, Li X, Makarov SS. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.
J. Leukoc. Biol. 78: 1366-1377 (2005).
*
-
Diaz M, Lawrence C. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.
Trends Immunol. 26: 215-220 (2005).
*
-
Diaz-Ortiz ML, Mico-Llorens JM, Gargallo-Albiol J, Baliellas-Comellas C, Berini-Aytes L, Gay-Escoda C. Dental health In liver transplant patients.
Med. Oral Patol. Oral Cir. Bucal. 10: 66-76 (2005).
-
Dickinson AM, Middleton PG. Beyond the HLA typing age: genetic polymorphisms predicting transplant outcome.
Blood Rev. 19: 333-340 (2005).
-
Dieckgraefe BK. What does football have in common with Crohn's disease? The best "defense-in" is a good offense.
Inflamm. Bowel Dis. 11: 322-323 (2005).
*
-
Diedrichs-Mohring M, Nelson PJ, Proudfoot AE, Thurau SR, Wildner G. The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance.
J. Neuroimmunol. 164: 22-30 (2005).
-
Diedrichs-Mohring M, Wildner G. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats.
Immunobiology 209: 711-717 (2005).
-
Diehl AM. Role of the immune system in the pathogenesis of nonalcoholic steatohepatitis.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 78 (2005). *
-
Diehl AM, Li ZP, Lin HZ, Yang SQ. Cytokines and the pathogenesis of non-alcoholic steatohepatitis.
Gut 54: 303-306 (2005).
*
-
Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA Jr, Goodman SN, David KA, Juhl H, Kinzler KW, Vogelstein B. Detection and quantification of mutations in the plasma of patients with colorectal tumors.
Proc. Natl. Acad. Sci. U.S.A. 102: 16368-16373 (2005).
*
-
Dienes HP. Autoimmune hepatitis and autoimmune cholangitis.
Verh. Dtsch. Ges. Pathol. 89: 155-162 (2005).
-
Diep JT, Gorevic PD. Geriatric autoimmune diseases: systemic lupus erythematosus, Sjogren's syndrome, and myositis.
Geriatrics 60: 32-38 (2005).
-
Dietrich CG, Geier A. It takes more than one: is a single UGT polymorphism enough to bother detoxification?
Hepatology 42: 1462 (2005).
*
-
Dieude P. Genetic aspects of rheumatoid arthritis.
Rev. Prat. 55: 2143-2145 (2005).
-
Dieude P, Cornelis F. Genetic basis of rheumatoid arthritis.
Joint Bone Spine 72: 520-526 (2005).
*
-
Dieude P, Garnier S, Michou L, Petit-Teixeira E, Glikmans E, Pierlot C, Lasbleiz S, Bardin T, Prum B, Cornelis F; European Consortium on Rheumatoid Arthritis Families. Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele.
Arthritis Res. Ther. 7: R1200-R1207 (2005).
*
-
Difedele LM, He J, Bonkowski EL, Han X, Held MA, Bohan A, Menon RK, Denson LA. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis.
Gastroenterology 128: 1278-1291 (2005).
*
-
Dignass A, Marteau P. Mesalamine in the treatment of active Crohn's disease.
Gastroenterology 128: 245-246 (2005).
*
-
Dignass AU. Management of perianal fistulizing Crohn's disease: a conservative approach.
Dtsch. Med. Wochenschr. 130: 1968 (2005).
-
Dijkstra G, Rings EH, van Dullemen HM, Bijleveld CM, Meessen NE, Karrenbeld A, Hofker HS, Porte RJ, Naber AH, Ploeg RJ. Small bowel transplantation as a treatment option for intestinal failure in children and adults.
Ned. Tijdschr. Geneeskd. 149: 391-398 (2005).
-
Dijkstra T, Dijkstra G, Bijleveld CM, Rings EH. Intestinal rehabilitation for children with short bowel syndrome.
Ned. Tijdschr. Geneeskd. 149: 413-417 (2005).
-
Diklic A, Zivaljevic V, Paunovic I, Kalezic N, Tatic S. Surgical procedures in patients with thyroid autoimmune disease.
Srp. Arh. Celok. Lek. 133 Suppl. 1: 77-83 (2005).
-
Dilger K, Denk A, Heeg MH, Beuers U. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis.
Hepatology 41: 595-602 (2005).
*
-
Dillon TJ, Carey KD, Wetzel SA, Parker DC, Stork PJ. Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4.
Mol. Cell. Biol. 25: 4117-4128 (2005).
*
-
Dilorenzo TP, Serreze DV. The good turned ugly: immunopathogenic basis for diabetogenic CD8 T cells in NOD mice.
Immunol. Rev. 204: 250-263 (2005).
*
-
Dima-Cozma C, Pandele GI, Rezus E, Constantinescu A, Mihailovici MS. Systemic lupus erythematosus with neurologic onset and secondary antiphospholIpid syndrome. A case study.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 109: 254-258 (2005).
-
Dimagno MJ, Dimagno EP. Chronic pancreatitis.
Curr. Opin. Gastroenterol. 21: 544-554 (2005).
-
DiMagno MJ, Lee SH, Hao Y, Zhou Sy, McKenna BJ, Owyang C. A proinflammatory, anti-apoptotic phenotype underlies the susceptibility to acute pancreatitis in UNC cftr (-/-) mice.
Gastroenterology 129: 665-681 (2005).
*
-
Dimasi N, Biassoni R. Structural and functional aspects of the Ly49 natural killer cell receptors.
Immunol. Cell Biol. 83: 1-8 (2005).
*
-
Dimitrova D, Kalaydjiev S, Mendizova A, Piryova E, Nakov L. Circulating antibodies to human spermatozoa in patients with ulcerative colitis.
Fertil. Steril. 84: 1533-1535 (2005).
*
-
Dimoulios P, Kolios G, Notas G, Matrella E, Xidakis C, Koulentaki M, Tsagarakis N, Kouroumalis A, Kouroumalis E. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
Aliment. Pharmacol. Ther. 21: 227-234 (2005).
*
-
Dinakarpandian D, Raheja V, Mehta S, Schuetz EG, Rogan PK. Tandem machine learning for the identification of genes regulated by transcription factors.
BMC Bioinformatics 6: 204 (2005).
*
-
Dinarello CA. Anti-cytokine therapy from the bench to the bedside.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 84-86 (2005). *
-
Dinc A, Erdem H, Rowczenio D, Simsek I, Pay S, Bahce M, Lachmann H. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
J. Nephrol. 18: 626-629 (2005).
-
Ding SZ, Torok AM, Smith MF Jr, Goldberg JB. Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection.
Helicobacter 10: 193-204 (2005).
*
-
Ding X, Hiraku Y, Ma N, Kato T, Saito K, Nagahama M, Semba R, Kuribayashi K, Kawanishi S. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease.
Cancer Sci. 96: 157-163 (2005).
*
-
Ding X, Staudinger J. Induction of drug metabolism by forskolin, the role of the pregnane X receptor and the protein kinase A signal transduction pathway.
J. Pharmacol. Exp. Ther. 312: 849-856 (2005).
*
-
Ding X, Staudinger JL. The ratio of constitutive androstane receptor to pregnane X receptor determines the activity of guggulsterone against the Cyp2b10 promoter.
J. Pharmacol. Exp. Ther. 314: 120-127 (2005).
*
-
Ding X, Staudinger JL. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C.
Biochem. Pharmacol. 69: 867-873 (2005).
*
-
Ding Y, Xia B, Lu M, Zhang Y, Li J, Ye M, Luo H, Yu J, Zhang X, Tan J. MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population.
Clin. Exp. Immunol. 142: 193-198 (2005).
*
-
Dinwiddie R. Anti-inflammatory therapy in cystic fibrosis.
J. Cyst. Fibros. 4 Suppl. 2: S45-S48 (2005).
-
Dion MF, Altschuler SJ, Wu LF, Rando OJ. Genomic characterization reveals a simple histone H4 acetylation code.
Proc. Natl. Acad. Sci. U.S.A. 102: 5501-5506 (2005).
*
-
Diosdado B, Stepniak DT, Monsuur AJ, Franke L, Wapenaar MC, Mearin ML, Koning F, Wijmenga C. No genetic association of the human prolyl endopeptidase gene found in the Dutch celiac disease population.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G495-G500 (2005).
*
-
Diosdado B, van Oort E, Wijmenga C. "Coelionomics": towards understanding the molecular pathology of coeliac disease.
Clin. Chem. Lab. Med. 43: 685-695 (2005).
*
-
Diosdado B, Wijmenga C. Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients.
Expert Rev. Mol. Diagn. 5: 681-700 (2005).
-
Dipaolo RJ, Glass DD, Bijwaard KE, Shevach EM. CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells.
J. Immunol. 175: 7135-7142 (2005).
*
-
Diradourian C, Girard J, Pegorier JP. Phosphorylation of PPARs: from molecular characterization to physiological relevance.
Biochimie 87: 33-38 (2005).
-
Dirkx R, Vanhorebeek I, Martens K, Schad A, Grabenbauer M, Fahimi D, Declercq P, Van Veldhoven PP, Baes M. Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities.
Hepatology 41: 868-878 (2005).
*
-
DiSario J. Can the risk of pancreatitis following endoscopic papillary balloon dilation for common bile duct stones be reduced?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 178-179 (2005).
*
-
Disset A, Michot C, Harris A, Buratti E, Claustres M, Tuffery-Giraud S. A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
Hum. Mutat. 25: 72-81 (2005).
*
-
Distler JH, Jungel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Muller-Ladner U, Lorenz HM, Gay S, Distler O. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Arthritis Rheum. 52: 856-864 (2005).
*
-
Dittmar M, Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity.
Thyroid 15: 239-250 (2005).
-
Divac A, Nikolic A, Mitic-Milikic M, Nagorni-Obradovic L, Petrovic-Stanojevic N, Dopudja-Pantic V, Nadaskic R, Savic A, Radojkovic D. CFTR mutations and polymorphisms in adults with disseminated bronchiectasis: a controversial issue.
Thorax 60: 85 (2005).
*
-
Dixit SG, Tirona RG, Kim RB. Beyond CAR and PXR.
Curr. Drug Metab. 6: 385-397 (2005).
-
Dixit SG, Zingarelli B, Buckley DJ, Buckley AR, Pauletti GM. Nitric oxide mediates increased P-glycoprotein activity in interferon-gamma-stimulated human intestinal cells.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G533-G540 (2005).
*
-
Dizier MH, Bouzigon E, Guilloud-Bataille M, Betard C, Bousquet J, Charpin D, Gormand F, Hochez J, Just J, Lemainque A, Le Moual N, Matran R, Neukirch F, Oryszczyn MP, Paty E, Pin I, Vervloet D, Kauffmann F, Lathrop M, Demenais F, Annesi-Maesano I. Genome screen in the French EGEA study: detection of linked regions shared or not shared by allergic rhinitis and asthma.
Genes Immun. 6: 95-102 (2005).
*
-
Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.
Arthritis Rheum. 52: 1595-1603 (2005).
*
-
Djouadi F, Aubey F, Schlemmer D, Bastin J. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 (CPT2) deficiency in human muscle cells.
J. Clin. Endocrinol. Metab. 90: 1791-1797 (2005).
*
-
Djoumerska IK, Tchorbanov AI, Donkova-Petrini VD, Pashov AD, Vassilev TL. Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.
Eur. J. Haematol. 74: 101-110 (2005).
*
-
Djurica S, Trbojevic B, Milosevic DP, Markovic N. Autoimmune thyroid disease and associated autoimmunity.
Srp. Arh. Celok. Lek. 133 Suppl. 1: 16-24 (2005).
-
Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients.
Transplantation 80: 1773-1782 (2005).
-
Doan T, Massarotti E. Rituximab.
Drugs Today (Barc.) 41: 785-797 (2005).
-
Dobbels F, Vanhaecke J, Desmyttere A, Dupont L, Nevens F, De Geest S. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates.
Transplantation 79: 1588-1595 (2005).
-
Dobrovolskaia MA, Kozlov SV. Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership.
Curr. Cancer Drug Targets 5: 325-344 (2005).
-
Dobrowolska-Zachwieja A, Kaczmarek M, Hoppe-Golebiewska J, Kalak R, Slomski R, Linke K. Does smoking influence the course of Crohn's disease in patients with the presence of gene NOD2/CARD15 mutation?
Pol. Merkuriusz. Lek. 18: 560-565 (2005).
-
Dodge JC, Clarke J, Song A, Bu J, Yang W, Taksir TV, Griffiths D, Zhao MA, Schuchman EH, Cheng SH, O'Riordan CR, Shihabuddin LS, Passini MA, Stewart GR. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease
Proc. Natl. Acad. Sci. U.S.A. 102: 17822-17827 (2005).
*
-
Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, Erpenbeck VJ, Haddad el-B, Lehr HA, Schmitt E, Bopp T, Kallen KJ, Herz U, Schmitt S, Luft C, Hecht O, Hohlfeld JM, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Renz H, et al. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.
J. Clin. Invest. 115: 313-325 (2005).
*
-
Doganci A, Neurath MF, Finotto S. Mucosal immunoregulation: transcription factors as possible therapeutic targets.
Curr. Drug Targets Inflamm. Allergy 4: 565-575 (2005).
-
Doggrell SA. Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease.
Expert Opin. Investig. Drugs 14: 535-538 (2005).
-
Doggrell SA. Inflammation, the key to much pathology.
Drug News Perspect. 18: 531-539 (2005).
-
Doherty R. IBD more common in patients with celiac disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 386 (2005). *
-
Dohi T, Ejima C, Kato R, Kawamura YI, Kawashima R, Mizutani N, Tabuchi Y, Kojima I. Therapeutic potential of follistatin for colonic inflammation in mice.
Gastroenterology 128: 411-423 (2005).
*
-
Dohmen K, Wen CY, Nagaoka S, Yano K, Abiru S, Ueki T, Komori A, Daikoku M, Yatsuhashi H, Ishibashi H. Fenofibrate-induced liver injury.
World J. Gastroenterol. 11: 7702-7703 (2005).
*
-
Dolai M. Evaluation of large intestinal mucosa regeneration in ulcerative colitis using linear measurements.
Med. Pregl. 58: 11-18 (2005).
-
Dolan C, O'halloran A, Bradley DG, Croke DT, Evans A, O'Brien JK, Dicker P, Shields DC. Genetic stratification of pathogen-response-related and other variants within a homogeneous Caucasian Irish population.
Eur. J. Hum. Genet. 13: 798-806 (2005).
*
-
Domajnko B, Ahrendt SA. Indications for non-transplant surgery in primary sclerosing cholangitis.
HPB (Oxford) 7: 292-297 (2005).
*
-
Dombrowski NC, Bergfeld WF. Alopecia areata: what to expect from current treatments.
Cleve. Clin. J. Med. 72: 758, 760-761, 765-766 (2005).
*
-
Domenech E, Esteve M, Gomollon F, Hinojosa J, Panes J, Obrador A, Gassull MA. GETECCU-2005 recommendations for the use of infliximab (Remicade(R)) in inflammatory bowel disease.
Gastroenterol. Hepatol. 28: 126-134 (2005).
-
Domenech E, Hinojosa J, Nos P, Garcia-Planella E, Cabre E, Bernal I, Gassull MA. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
Aliment. Pharmacol. Ther. 22: 1107-1113 (2005).
*
-
Domenech E, Manosa M, Masnou H, Navarro M, Garcia-Planella E, Bernal I, Gassull MA. Infliximab for the treatment of chronic anemia in Crohn's disease.
Am. J. Gastroenterol. 100: 496 (2005).
*
-
Domenech E, Nos P, Papo M, Lopez-San Roman A, Garcia-Planella E, Gassull MA. 6-Mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.
Scand. J. Gastroenterol. 40: 52-55 (2005).
*
-
Domenech Morral E, Gassull Duro MA. Erythrocyte activity of TPMT and treatment with thiopurines in inflammatory bowel disease.
Med. Clin. (Barc.) 125: 293-294 (2005).
-
Domenicali M, Ros J, Fernandez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodes J, Jimenez W. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Gut 54: 522-527 (2005).
*
-
Dominguez-Soto A, Relloso M, Vega MA, Corbi AL, Puig-Kroger A. RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters.
Immunobiology 210: 133-139 (2005).
-
Domotor A, Peidl Z, Vincze A, Hunyady B, Szolcsanyi J, Kereskay L, Szekeres G, Mozsik G. Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders.
Inflammopharmacology 13: 161-177 (2005).
-
Donaghue KC, Margan SH, Chan AK, Holloway B, Silink M, Rangel T, Bennetts B. The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents.
Diabet. Med. 22: 1315-1320 (2005).
*
-
Donaldson PT. Basic concepts in PSC.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 73-75 (2005). *
-
Donataccio M, Ruzzenente A, Pachera S, Genco B, Donataccio D. Caval anastomosis in liver transplantation: prospective experience of Verona liver transplantation program.
Transplant. Proc. 37: 2605-2606 (2005).
*
-
Donati M, Berglundh T, Hytonen AM, Hahn-Zoric M, Hanson LA, Padyukov L. Association of the -159 CD14 gene polymorphism and lack of association of the -308 TNFA and Q551R IL-4RA polymorphisms with severe chronic periodontitis in Swedish Caucasians.
J. Clin. Periodontol. 32: 474-479 (2005).
*
-
Donfack J, Schneider DH, Tan Z, Kurz T, Dubchak I, Frazer KA, Ober C. Variation in conserved non-coding sequences on chromosome 5q and susceptibility to asthma and atopy.
Respir. Res. 6: 145 (2005).
*
-
Dong C, Li WD, Li D, Price RA. Interaction between obesity-susceptibility loci in chromosome regions 2p25-p24 and 13q13-q21.
Eur. J. Hum. Genet. 13: 102-108 (2005).
*
-
Dong J, Yang G, McHaourab HS. Structural basis of energy transduction in the transport cycle of MsbA.
Science 308: 1023-1028 (2005).
*
-
Dong L, Ito S, Ishii KJ, Klinman DM. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
Arthritis Rheum. 52: 651-658 (2005).
*
-
Dongowski G, Fritzsch B, Giessler J, Hartl A, Kuhlmann O, Neubert RH. The influence of bile salts and mixed micelles on the pharmacokinetics of quinine in rabbits.
Eur. J. Pharm. Biopharm. 60: 147-151 (2005).
*
-
Donlin LT, Danzl NM, Wanjalla C, Alexandropoulos K. Deficiency in expression of the signaling protein sin/efs leads to T-lymphocyte activation and mucosal inflammation.
Mol. Cell. Biol. 25: 11035-11046 (2005).
*
-
Donowitz M, Cha B, Zachos NC, Brett CL, Sharma A, Tse CM, Li X. NHERF family and NHE3 regulation.
J. Physiol. 567: 3-11 (2005).
*
-
Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes.
Diabetes Care 28: 806-809 (2005).
*
-
Dorak MT, Yee LJ, Tang J, Shao W, Lobashevsky ES, Jacobson LP, Kaslow RA. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.
J. Med. Virol. 76: 302-310 (2005).
*
-
Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus.
Lupus 14: 683-686 (2005).
-
Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis: basic mechanisms.
Rheum. Dis. Clin. North Am. 31: 355-362 (2005).
-
Doria C, Marino IR. Bacteremia using the molecular adsorbent recirculating system in patients bridged to liver transplantation.
Exp. Clin. Transplant. 3: 289-292 (2005).
-
Dormer RL, Harris CM, Clark Z, Pereira MM, Doull IJ, Norez C, Becq F, McPherson MA. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
Thorax 60: 55-59 (2005).
*
-
Dorner T, Lipsky PE. Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity.
Clin. Exp. Med. 4: 159-169 (2005).
*
-
dos Santos JS, Junior WS, Modena JL, Brunaldi JE, Ceneviva R. Effect of preoperative endoscopic decompression on malignant biliary obstruction and postoperative infection.
Hepatogastroenterology 52: 45-47 (2005).
-
Dotan I, Rachmilewitz D. Probiotics in inflammatory bowel disease: possible mechanisms of action.
Curr. Opin. Gastroenterol. 21: 426-430 (2005).
-
Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab.
Chest 127: 1064-1071 (2005).
*
-
Downing I, MacDonald SL, Turner ML, Kilpatrick DC. Detection of an autologous ligand for mannan-binding lectin on human B lymphocytes.
Scand. J. Immunol. 62: 507-514 (2005).
*
-
Doyen V, Fournier C, Bautin N, Cortet B, Flipo RM, Wallaert B. Rheumatoid arthritis and cystic fibrosis.
Rev. Mal. Respir. 22: 667-671 (2005).
-
Doyle HA, Mamula MJ. Posttranslational modifications of self-antigens.
Ann. N. Y. Acad. Sci. 1050: 1-9 (2005).
*
-
Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs.
J. Immunol. 174: 7085-7095 (2005).
*
-
Draber P, Draberova L. Lifting the fog in store-operated Ca2+ entry.
Trends Immunol. 26: 621-624 (2005).
*
-
Draganov K, Dimitrova V, Ionkov A, Rusenov D, Tosheva E, Dimitrov K, Tonev S. Acquired entero-cutaneous fistulas - diagnostic and terapeutic approach.
Khirurgiia (Sofiia) 2: 42-46 (2005).
-
Draganov P, Forsmark CE. "Idiopathic" pancreatitis.
Gastroenterology 128: 756-763 (2005).
*
-
Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome.
J. Am. Soc. Nephrol. 16: 555-563 (2005).
*
-
Drakes ML, Blanchard TG, Czinn SJ. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis.
J. Leukoc. Biol. 78: 1291-1300 (2005).
*
-
Dranoff G. CTLA-4 blockade: unveiling immune regulation.
J. Clin. Oncol. 23: 662-664 (2005).
*
-
Dransfeld O, Gehrmann T, Kohrer K, Kircheis G, Holneicher C, Haussinger D, Wettstein M. Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver.
Liver Int. 25: 1243-1258 (2005).
*
-
Dray X, Kanaan R, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D. Malnutrition in adults with cystic fibrosis.
Eur. J. Clin. Nutr. 59: 152-154 (2005).
*
-
Dray X, Marteau P. The use of enteral nutrition in the management of Crohn's disease in adults.
JPEN J. Parenter. Enteral Nutr. 29: S166-S172 (2005).
*
-
Drazen JM. Patients at risk.
N. Engl. J. Med. 353: 417 (2005).
*
-
Dreuw A, Hermanns HM, Heise R, Joussen S, Rodriguez F, Marquardt Y, Jugert F, Merk HF, Heinrich PC, Baron JM. Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts.
J. Invest. Dermatol. 124: 28-37 (2005).
*
-
Drew JE, Arthur JR, Farquharson AJ, Russell WR, Morrice PC, Duthie GG. Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon.
Biochem. Pharmacol. 70: 888-893 (2005).
*
-
Drew JE, Farquharson AJ, Arthur JR, Morrice PC, Duthie GG. Novel sites of cytosolic glutathione peroxidase expression in colon.
FEBS Lett. 579: 6135-6139 (2005).
*
-
Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis.
Brain Res. Brain Res. Rev. 48: 322-327 (2005).
-
Drossman DA. Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists.
Gut 54: 569-573 (2005).
*
-
Drover VA, Abumrad NA. CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors.
Biochem. Soc. Trans. 33: 311-315 (2005).
*
-
Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR; Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis.
N. Engl. J. Med. 353: 1443-1453 (2005).
*
-
Drummond MF, Barbieri M, Wong JB. Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference?
Med. Decis. Making 25: 520-533 (2005).
-
Dryden GW, Deaciuc I, Arteel G, McClain CJ. Clinical implications of oxidative stress and antioxidant therapy.
Curr. Gastroenterol. Rep. 7: 308-316 (2005).
-
Du K, Sharma M, Lukacs GL. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
Nat. Struct. Mol. Biol. 12: 17-25 (2005).
*
-
du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S, Pierlot C, Quillet P, Bardin T, Prum B, Cornelis F, Clerget-Darpoux F. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility.
Arthritis Rheum. 52: 1063-1068 (2005).
*
-
Du X, Tabeta K, Mann N, Crozat K, Mudd S, Beutler B. An essential role for Rxr alpha in the development of Th2 responses.
Eur. J. Immunol. 35: 3414-3423 (2005).
*
-
Duan RS, Link H, Xiao BG. Long-term effects of IFN-gamma, IL-10, and TGF-beta-modulated dendritic cells on immune response in Lewis rats.
J. Clin. Immunol. 25: 50-56 (2005).
*
-
Duan-Porter WD, Casciola-Rosen L, Rosen A. Autoantigens: the critical partner in initiating and propagating systemic autoimmunity.
Ann. N. Y. Acad. Sci. 1062: 127-136 (2005).
*
-
Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, Fakiola M, Nancy Miller E, Blackwell JM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.
Eur. J. Hum. Genet. 13: 829-834 (2005).
*
-
Dubcenco E, Jeejeebhoy KN, Petroniene R, Tang SJ, Zalev AH, Gardiner GW, Baker JP. Capsule endoscopy findings in patients with established and suspected small-bowel Crohn's disease: correlation with radiologic, endoscopic, and histologic findings.
Gastrointest. Endosc. 62: 538-544 (2005).
-
Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, Macneil J, Mack D, Patel D, Moher D. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review.
Gastroenterology 128: S57-S67 (2005).
*
-
Dubinsky MC, Reyes E, Ofman J, Chiou CF, Wade S, Sandborn WJ. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Am. J. Gastroenterol. 100: 2239-2247 (2005).
*
-
Dubois B, Goubier A, Joubert G, Kaiserlian D. Oral tolerance and regulation of mucosal immunity.
Cell. Mol. Life Sci. 62: 1322-1332 (2005).
*
-
Dubois S, Kearney DJ. Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence.
Am. J. Gastroenterol. 100: 453-459 (2005).
*
-
Dubrac S, Lear SR, Ananthanarayanan M, Balasubramaniyan N, Bollineni J, Shefer S, Hyogo H, Cohen DE, Blanche PJ, Krauss RM, Batta AK, Salen G, Suchy FJ, Maeda N, Erickson SK. Role of CYP27A in cholesterol and bile acid metabolism.
J. Lipid Res. 46: 76-85 (2005).
*
-
Dubrous P, Gardet V, Hugard L. Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis.
Pathol. Biol. (Paris) 53: 63-67 (2005).
-
Dubucquoi S. Physiological and pathological autoimmunity in neurological disease.
Rev. Neurol. (Paris) 161: 1163-1176 (2005).
-
Ducale AE, Ward SI, Dechert T, Yager DR. Regulation of hyaluronan synthase-2 expression in human intestinal mesenchymal cells: mechanisms of interleukin-1beta mediated induction.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G462-G470 (2005).
*
-
Duclos-Vallee JC. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.
Acta Gastroenterol. Belg. 68: 331-336 (2005).
-
Duclos-Vallee JC, Di Martino V, Cazier A, Ballot E, Johanet C, Yamamoto AM, Emile JF, Guettier C, Coutarel P, Cadranel JF. Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Gastroenterol. Clin. Biol. 29: 1173-1176 (2005).
-
Duclos-Vallee JC, Yilmaz F, Johanet C, Roque-Afonso AM, Gigou M, Trichet C, Feray C, Ballot E, Dussaix E, Castaing D, Bismuth H, Samuel D, Guettier C. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
Clin. Transplant. 19: 591-599 (2005).
*
-
Duda-Krol WB, Kusz-Rynkun A, Pietrzak J, Soszka A. Family incidence of Addison-Biermer anemia.
Wiad. Lek. 58: 685-687 (2005).
-
Dudda JC, Lembo A, Bachtanian E, Huehn J, Siewert C, Hamann A, Kremmer E, Forster R, Martin SF. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments.
Eur. J. Immunol. 35: 1056-1065 (2005).
*
-
Duerksen DR, Wilhelm-Boyles C, Parry DM. Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet.
Dig. Dis. Sci. 50: 785-790 (2005).
*
-
Duez H, Lefebvre B, Poulain P, Pineda Torra I, Percevault F, Luc G, Peters JM, Gonzalez FJ, Gineste R, Helleboid S, Fruchart JC, Fievet C, Lefebvre P, Staels B. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Arterioscler. Thromb. Vasc. Biol. 25: 585-591 (2005).
*
-
Duffy D, Rader DJ. Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transport.
Curr. Opin. Cardiol. 20: 301-306 (2005).
-
Duggal P, Gillanders EM, Mathias RA, Ibay GP, Klein AP, Baffoe-Bonnie AB, Ou L, Dusenberry IP, Tsai YY, Chines PS, Doan BQ, Bailey-Wilson JE. Identification of tag single-nucleotide polymorphisms in regions with varying linkage disequilibrium.
BMC Genet. 6 Suppl. 1: S73 (2005).
*
-
Duggan JM, Duggan AE. Systematic review: the liver in coeliac disease.
Aliment. Pharmacol. Ther. 21: 515-518 (2005).
*
-
Dugueperoux I, De Braekeleer M. The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype.
Eur. Respir. J. 25: 468-473 (2005).
*
-
Duley JA, Florin TH. Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides.
Ther. Drug Monit. 27: 647-654 (2005).
-
Dulos J, Kaptein A, Kavelaars A, Heijnen C, Boots A. Tumour necrosis factor-alpha stimulates dehydroepiandrosterone metabolism in human fibroblast-like synoviocytes: a role for nuclear factor-kappaB and activator protein-1 in the regulation of expression of cytochrome p450 enzyme 7b.
Arthritis Res. Ther. 7: R1271-R1280 (2005).
*
-
Dulos J, van der Vleuten MA, Kavelaars A, Heijnen CJ, Boots AM. CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines.
Arthritis Rheum. 52: 770-778 (2005).
*
-
Duman DG, Tuney D, Bilsel S, Benli F, Karan S, Avsar E, Ozdogan O, Tozun N. Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys.
Liver Int. 25: 527-535 (2005).
*
-
Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L, Mukherjee D. Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.
Curr. Drug Targets Cardiovasc. Haemato. Disord. 5: 377-386 (2005).
-
Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.
Eur. J. Immunol. 35: 2184-2190 (2005).
*
-
Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within.
Trends Immunol. 26: 381-387 (2005).
*
-
Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, Arnold B, Bianchi ME, Manfredi AA, Rovere-Querini P. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.
J. Immunol. 174: 7506-7515 (2005).
*
-
Dumont FJ. Fontolizumab Protein Design Labs.
Curr. Opin. Investig. Drugs 6: 537-544 (2005).
-
Dumont FJ. Fingolimod (Mitsubishi Pharma/Novartis).
IDrugs 8: 236-253 (2005).
-
Dumortier J, Pianta E, Le Derf Y, Bernard P, Bouffard Y, Boucaud C, Sagnard P, Delafosse B, Boillot O. Peritoneovenous shunt as a bridge to liver transplantation.
Am. J. Transplant. 5: 1886-1892 (2005).
*
-
Dunbar SA, Jacobson JW. Rapid screening for 31 mutations and polymorphisms in the cystic fibrosis transmembrane conductance regulator gene by Lminex xMAP suspension array.
Methods Mol. Med. 114: 147-171 (2005).
-
Duncan CJ, Scott S. What caused the Black Death?
Postgrad. Med. J. 81: 315-320 (2005).
*
-
Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system.
Aliment. Pharmacol. Ther. 22: 667-683 (2005).
*
-
Duncan RE, El-Sohemy A, Archer MC. Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin.
Cancer Lett. 224: 221-228 (2005).
*
-
Duncan SR, Scott S, Duncan CJ. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation.
J. Med. Genet. 42: 205-208 (2005).
*
-
Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D(3) and its nuclear receptor.
J. Mol. Biol. 349: 248-260 (2005).
*
-
Dunn SP, Tsai A, Griffin G, Toth S, Casas-Melley AT, Falkenstein KP, Marando CA, Krueger LJ. Liver transplantation as definitive treatment for a factor V Leiden mutation.
J. Pediatr. 146: 418-422 (2005).
*
-
Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis.
Hepatology 41: 353-358 (2005).
*
-
Dunne A, O'Neill L. New insights into the post-translational modification of Toll-like receptor signaling molecules.
J. Endotoxin Res. 11: 325-332 (2005).
*
-
Dunne DW, Cooke A. Opinion: a worm's eye view of the immune system: consequences for evolution of human autoimmune disease.
Nat. Rev. Immunol. 5: 420-426 (2005).
*
-
Dunstan JA, Prescott SL. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants?
Curr. Opin. Allergy Clin. Immunol. 5: 215-221 (2005).
-
Dunster K, Lai FP, Sentry JW. Limkain b1, a novel human autoantigen localized to a subset of ABCD3 and PXF marked peroxisomes.
Clin. Exp. Immunol. 140: 556-563 (2005).
*
-
DuPont HL. Travelers' diarrhea: antimicrobial therapy and chemoprevention.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 191-198 (2005).
*
-
Durai D, Hawthorne AB. Review article: how and when to use ciclosporin in ulcerative colitis.
Aliment. Pharmacol. Ther. 22: 907-916 (2005).
*
-
Duran-Ramos O, Palomares-Chacon UR, Pulido-Garcia LR, Farias-Llamas OA, Lopez-Ramirez MK, Gonzalez-Ojeda A. Restorative proctocolectomy with J-pouch reservoir. Experience in a national medical center.
Cir. Cir. 73: 185-192 (2005).
-
Duran-Sandoval D, Cariou B, Fruchart JC, Staels B. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
Biochimie 87: 93-98 (2005).
-
Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, Staels B. The farnesoid X receptor modulates hepatic carbohydrate metabolism during fasting/refeeding transition.
J. Biol. Chem. 280: 29971-29979 (2005).
*
-
Durand F, Belghiti J. Liver transplantation in adults.
Med. Sci. (Paris) 21: 89-94 (2005).
-
Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.
J. Hepatol. 42 Suppl. 1: S100-S107 (2005).
*
-
Durandy A, Revy P, Imai K, Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
Immunol. Rev. 203: 67-79 (2005).
*
-
During A, Dawson HD, Harrison EH. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe.
J. Nutr. 135: 2305-2312 (2005).
*
-
Durinovic-Bello I, Jelinek E, Schlosser M, Eiermann T, Boehm BO, Karges W, Marchand L, Polychronakos C. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals.
Diabetes 54: S18-S24 (2005).
*
-
Durno C, Aronson M, Bapat B, Cohen Z, Gallinger S. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma.
Gut 54: 1146-1150 (2005).
*
-
Durrani K, Foster CS. Psoriatic uveitis: a distinct clinical entity?
Am. J. Ophthalmol. 139: 106-111 (2005).
*
-
Durrant C, Morris AP. Linkage disequilibrium mapping via cladistic analysis of phase-unknown genotypes and inferred haplotypes in the Genetic Analysis Workshop 14 simulated data.
BMC Genet. 6 Suppl. 1: S100 (2005).
*
-
Durusu M, Gurlek A, Simsek H, Balaban Y, Tatar G. Coincidence or causality: celiac and Crohn diseases in a case of Turner syndrome.
Am. J. Med. Sci. 329: 214-216 (2005).
-
Dusso AS, Brown AJ, Slatopolsky E. Vitamin D.
Am. J. Physiol. Renal Physiol. 289: F8-F28 (2005).
*
-
Dusunceli E, Erden A, Erden I, Karayalcin S. Primary sclerosing cholangitis: MR cholangiopancreatography and T2-weighted MR imaging findings.
Diagn. Interv. Radiol. 11: 213-218 (2005).
*
-
Duthie MS, Kahn M, White M, Kapur RP, Kahn SJ. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.
Infect. Immun. 73: 181-192 (2005).
*
-
Duyar H, Dengjel J, de Graaf KL, Wiesmuller KH, Stevanovic S, Weissert R. Peptide motif for the rat MHC class II molecule RT1.D(a): similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Immunogenetics 57: 69-76 (2005).
*
-
Duymaz-Tozkir J, Yilmaz V, Uyar FA, Hajeer AH, Saruhan-Direskeneli G, Gul A. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behcet's disease.
J. Rheumatol. 32: 93-97 (2005).
-
Dvorak M. Gluten enteropathy - occurrence, diagnosis, therapy.
Cas. Lek. Cesk. 144 Suppl. 1: 48-51 (2005).
-
Dyjas R, Bulanowski M, Ficek R, Witkowicz J, Chudek J, Wiecek A. Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hormones in females with rheumatoid arthritis.
Pol. Arch. Med. Wewn. 114: 731-737 (2005).
-
Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
Hum. Mol. Genet. 14: 2019-2026 (2005).
*
-
Dyroy E, Yndestad A, Ueland T, Halvorsen B, Damas JK, Aukrust P, Berge RK. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways.
Arterioscler. Thromb. Vasc. Biol. 25: 1364-1369 (2005).
*
-
Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.
Rheumatology (Oxford) 44: 1518-1524 (2005).
*
-
Dziarski R, Gupta D. Peptidoglycan recognition in innate immunity.
J. Endotoxin Res. 11: 304-310 (2005).
*
-
Eaker S, Johnson M, Jenkins J, Bauer M, Little S. Detection of CFTR mutations using ARMS and low-density microarrays.
Biosens. Bioelectron. 21: 933-939 (2005).
*
-
Earle KE, Tang Q, Zhou X, Liu W, Zhu S, Bonyhadi ML, Bluestone JA. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.
Clin. Immunol. 115: 3-9 (2005).
*
-
Early P. Detecting celiac disease in adult patients.
JAAPA 18: 45-50 (2005).
-
Ebach DR, Newberry R, Stenson WF. Differential role of tumor necrosis factor receptors in TNBS colitis.
Inflamm. Bowel Dis. 11: 533-540 (2005).
*
-
Ebara M. Complications of fine needle biopsy for focal liver lesions.
Hepatol. Res. 31: 3-4 (2005).
-
Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, Kondo F, Saisho H. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.
J. Hepatol. 43: 458-464 (2005).
*
-
Ebbesson SO, Ebbesson LO, Swenson M, Kennish JM, Robbins DC. A successful diabetes prevention study in Eskimos: the Alaska Siberia project.
Int. J. Circumpolar Health 64: 409-424 (2005).
-
Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project.
Int. J. Circumpolar Health 64: 396-408 (2005).
-
Eberl G. Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway?
Nat. Rev. Immunol. 5: 413-420 (2005).
*
-
Eberman LE, Cleary MA. Celiac disease in an elite female collegiate volleyball athlete: a case report.
J. Athl. Train. 40: 360-364 (2005).
-
Ebert EC. IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity.
Immunology 115: 118-126 (2005).
*
-
Ebert EC, Mehta V, Das KM. Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.
Clin. Exp. Immunol. 140: 157-165 (2005).
*
-
Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
Mol. Immunol. 42: 799-809 (2005).
*
-
Ebrahimi F, Tavakoli S, Hajrasouliha AR, Shafaroodi H, Sadeghipour H, Riazi K, Borhani AA, Houshmand G, Ahmadi SH, Dehpour AR. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Eur. J. Pharmacol. 523: 93-100 (2005).
*
-
Ebrahimkhani MR, Mani AR, Moore K. Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis.
Gut 54: 1668-1671 (2005).
*
-
Ebrahimkhani MR, Sadeghipour H, Dehghani M, Kiani S, Payabvash S, Riazi K, Honar H, Pasalar P, Mirazi N, Amanlou M, Farsam H, Dehpour AR. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis.
Life Sci. 76: 2497-2512 (2005).
*
-
Ebringer A, Rashid T, Wilson C. Bovine spongiform encephalopathy, multiple sclerosis, and Creutzfeldt-Jakob disease are probably autoimmune diseases evoked by acinetobacter bacteria.
Ann. N. Y. Acad. Sci. 1050: 417-428 (2005).
*
-
Echelmeyer S, Chari ST. Alcohol and cigarettes: partners in crime in chronic pancreatitis.
Gastroenterology 129: 1796-1798 (2005).
*
-
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora.
Science 308: 1635-1638 (2005).
*
-
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome.
Lancet 365: 1415-1428 (2005).
*
-
Ecker KW, Stallmach A, Loffler J, Greinwald R, Achenbach U. Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn's disease and ileostomy.
Dis. Colon Rectum 48: 237-242 (2005).
*
-
Eckmann L. Defence molecules in intestinal innate immunity against bacterial infections.
Curr. Opin. Gastroenterol. 21: 147-151 (2005).
-
Eckmann L, Karin M. NOD2 and Crohn's disease: loss or gain of function?
Immunity 22: 661-667 (2005).
*
-
Edelbauer M, Jungraithmayr T, Zimmerhackl LB. Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression. Case report.
Pediatr. Nephrol. 20: 811-813 (2005).
*
-
Edenberg HJ, Bierut LJ, Boyce P, Cao M, Cawley S, Chiles R, Doheny KF, Hansen M, Hinrichs T, Jones K, Kelleher M, Kennedy GC, Liu G, Marcus G, McBride C, Murray SS, Oliphant A, Pettengill J, Porjesz B, Pugh EW, Rice JP, Rubano T, Shannon S, et al. Description of the data from the Collaborative Study on the Genetics of Alcoholism (COGA) and single-nucleotide polymorphism genotyping for Genetic Analysis Workshop 14.
BMC Genet. 6 Suppl. 1: S2 (2005).
*
-
Edling AE, Tuohy VK. Stem cell reconstitution of autoimmune T cell repertoires.
J. Neuroimmunol. 169: 126-136 (2005).
-
Edouard A, Paillaud M, Merle S, Orhan C, Chenayer-Panelatti Dagger M, Cogeag EL. Incidence of inflammatory bowel disease in the French West Indies (1997-1999).
Gastroenterol. Clin. Biol. 29: 779-783 (2005).
*
-
Edwards CJ. Immunological therapies for rheumatoid arthritis.
Br. Med. Bull. 73-74: 71-82 (2005).
*
-
Edwards JC, Cambridge G. Prospects for B-cell-targeted therapy in autoimmune disease.
Rheumatology (Oxford) 44: 151-156 (2005).
*
-
Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes.
Hepatology 41: 451-459 (2005).
*
-
Efimov VM, Kovaleva VY, Markel AL. A new approach to the study of genetic variability of complex characters.
Heredity 94: 101-107 (2005).
*
-
Efthimiou P, Markenson JA. Role of biological agents in immune-mediated inflammatory diseases.
South. Med. J. 98: 192-204 (2005).
-
Egan LJ, Sandborn WJ. Positioning novel biologic, probiotic, and apheresis therapies for Crohn's disease and ulcerative colitis.
Curr. Gastroenterol. Rep. 7: 485-491 (2005).
-
Eghtesad B, Kadry Z, Fung J. Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice).
Liver Transpl. 11: 861-871 (2005).
*
-
Ehlers S. Why does tumor necrosis factor targeted therapy reactivate tuberculosis?
J. Rheumatol. Suppl. 74: 35-39 (2005).
-
Ehlers S, Lehmann J, Mossmann H, Alber G, Holscher C. Interleukin-12p40 mediates transient protection against Mycobacterium avium infection in the absence of interleukin-12.
Immunobiology 210: 217-227 (2005).
-
Eichhorst ST. Modulation of apoptosis as a target for liver disease.
Expert Opin. Ther. Targets 9: 83-99 (2005).
-
Eickhoff A, Schilling D, Jakobs R, Weickert U, Hartmann D, Eickhoff JC, Riemann JF. Long-term outcome of percutaneous transhepatic drainage for benign bile duct stenoses.
Rocz. Akad. Med. Bialymst. 50: 155-160 (2005).
-
Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis.
Inflamm. Bowel Dis. 11: 213-218 (2005).
*
-
Eikelenboom MJ, Killestein J, Uitdehaag BM, Polman CH. Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis.
Mult. Scler. 11: 520-523 (2005).
*
-
Eipel C, Schuett H, Glawe C, Bordel R, Menger MD, Vollmar B. Pifithrin-alpha induced p53 inhibition does not affect liver regeneration after partial hepatectomy in mice.
J. Hepatol. 43: 829-835 (2005).
*
-
Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Oral lichen planus: clinical features and management.
Oral Dis. 11: 338-349 (2005).
*
-
Eisenbach C, Goeggelmann C, Flechtenmacher C, Stremmel W, Encke J. Severe cholestatic hepatitis caused by azathioprine.
Immunopharmacol. Immunotoxicol. 27: 77-83 (2005).
-
Eisenberg R, Looney RJ. The therapeutic potential of anti-CD20. "What do B-cells do?"
Clin. Immunol. 117: 207-213 (2005).
*
-
Eitsuka T, Nakagawa K, Suzuki T, Miyazawa T. Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach.
Biochim. Biophys. Acta 1737: 1-10 (2005).
*
-
Eivindson M, Gronbaek H, Nielsen JN, Frystyk J, Flyvbjerg A, Jorgensen L, Vind I, Munkholm P, Jensen S, Brandslund I, Hey H. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.
Scand. J. Gastroenterol. 40: 1214-1221 (2005).
*
-
Eivindson M, Nielsen JN, Gronbaek H, Flyvbjerg A, Hey H. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
Horm. Res. 64: 9-15 (2005).
-
Ejendal KF, Hrycyna CA. Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.
Mol. Pharmacol. 67: 902-911 (2005).
*
-
Ejiri N, Katayama KI, Kiyosawa N, Baba Y, Doi K. Microarray analysis on phase II drug metabolizing enzymes expression in pregnant rats after treatment with pregnenolone-16alpha-carbonitrile or phenobarbital.
Exp. Mol. Pathol. 79: 272-277 (2005).
*
-
Ejrnaes M, Videbaek N, Christen U, Cooke A, Michelsen BK, von Herrath M. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
J. Immunol. 174: 2746-2755 (2005).
*
-
Ekins S, Kirillov E, Rakhmatulin EA, Nikolskaya T. A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism.
Drug Metab. Dispos. 33: 474-481 (2005).
*
-
Eksteen B, Walker LSK, Adams DH. Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease
Gut 54: 4-6 (2005).
*
-
El Bakkouri K, Wullaert A, Haegman M, Heyninck K, Beyaert R. Adenoviral gene transfer of the NF-kappa B inhibitory protein ABIN-1 decreases allergic airway inflammation in a murine asthma model.
J. Biol. Chem. 280: 17938-17944 (2005).
*
-
El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren's syndrome: concomitant H. pylori infection and possible correlation with clinical parameters.
Joint Bone Spine 72: 135-141 (2005).
-
El Neanaey WA, Barakat SS, Ahmed MA, El Nabie WM, Ahmed ME. The relation between HLA-DRB1 alleles and the outcome of therapy in children with idiopathic thrombocytopenic purpura.
Egypt. J. Immunol. 12: 29-38 (2005).
-
El Yafi F, Winkler R, Delvenne P, Boussif N, Belaiche J, Louis E. Altered expression of type I insulin-like growth factor receptor in Crohn's disease.
Clin. Exp. Immunol. 139: 526-533 (2005).
*
-
El-Asmar L, Springael JY, Ballet S, Urizar Andrieu E, Vassart G, Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.
Mol. Pharmacol. 67: 460-469 (2005).
*
-
El-Bayoumy K, Sinha R. Molecular chemoprevention by selenium: a genomic approach.
Mutat. Res. 591: 224-236 (2005).
-
El-Gabalawy H. Common denominators of inflammatory joint diseases.
J. Rheumatol. Suppl. 72: 3-6 (2005).
*
-
El-Gouhary I, Mohamed A, Suleiman S, Benghuzzi H. Comparison of the amelioration effects of two enzyme inducers on the inflammatory process of experimental allergic encephalitis (EAE) using immunohistochemical technique.
Biomed. Sci. Instrum. 41: 376-381 (2005).
-
El-Matary W, Dalzell AM, Ashworth M. Helicobacter pylori and autoimmune hepatitis.
Eur. J. Pediatr. 164: 54-55 (2005).
*
-
El-Medany A, Mahgoub A, Mustafa A, Arafa M, Morsi M. The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats.
Eur. J. Pharmacol. 507: 291-299 (2005).
-
El-Rassi Z, Barcet S, Mechet I, Chahine K, Bernard P, Chane L, Sagnard P, Delafasse B, Bouffond Y, Boillot O. The outcome of 400 consecutive liver grafts using the aortic perfusion-only technique.
Transpl. Int. 17: 772-778 (2005).
-
El-Refaie AM, Burt AD. Mast cells and c-Kit expression in liver allograft rejection.
Histopathology 47: 375-381 (2005).
*
-
Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E. Inflammatory bowel disease and preterm delivery.
Int. J. Gynaecol. Obstet. 90: 193-197 (2005).
-
Elder JT. Psoriasis clinical registries, genetics, and genomics.
Ann. Rheum. Dis. 64 Suppl. 2: ii106-ii107 (2005).
*
-
Eldor R, Cohen IR, Raz I. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
Int. Rev. Immunol. 24: 327-339 (2005).
-
Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being.
Neuroimmunomodulation 12: 255-269 (2005).
-
Eletto D, Leone A, Bifulco M, Tecce MF. Effect of unsaturated fat intake from Mediterranean diet on rat liver mRNA expression profile: selective modulation of genes involved in lipid metabolism.
Nutr. Metab. Cardiovasc. Dis. 15: 13-23 (2005).
-
Elias E. Hepatology highlights.
Hepatology 42: 1241-1242 (2005).
*
-
Elinav E, Ben-Dov IZ, Ackerman E, Kiderman A, Glikberg F, Shapira Y, Ackerman Z. Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern.
Am. J. Gastroenterol. 100: 2201-2204 (2005).
*
-
Elitsur Y, Lawrence Z, Tolaymat N. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.
J. Clin. Gastroenterol. 39: 670-673 (2005).
-
Elitsur Y, Lawrence Z, Wang R, Durst PR. Treatment for NASH: the value of histology.
Am. J. Gastroenterol. 100: 250-251 (2005).
*
-
Elli L, Bardella MT. Motility disorders in patients with celiac disease.
Scand. J. Gastroenterol. 40: 743-749 (2005).
*
-
Elliott DE, Summers RW, Weinstock JV. Helminths and the modulation of mucosal inflammation.
Curr. Opin. Gastroenterol. 21: 51-58 (2005).
-
Elliott JI, McVey JH, Higgins CF. The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products.
Arthritis Res. Ther. 7: R468-R475 (2005).
*
-
Elliott PR, Moore GT, Bell SJ, Connell WR. Severe recurrent Crohn's disease of the ileocolonic anastomosis disappearing completely with antibacterial therapy.
Gut 54: 1818-1819 (2005).
*
-
Elliott R. Mechanisms of genomic and non-genomic actions of carotenoids.
Biochim. Biophys. Acta 1740: 147-154 (2005).
*
-
Ellis HJ, Ciclitira PJ. Natural variation in toxicity of wheat.
Gastroenterology 129: 2129 (2005).
*
-
Ellis HJ, Ciclitira PJ. In vitro is less challenging to celiac children.
J. Pediatr. Gastroenterol. Nutr. 40: 122-124 (2005).
*
-
Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease.
J. Immunol. 175: 5448-5456 (2005).
*
-
Ellmerich S, Mycko M, Takacs K, Waldner H, Wahid FN, Boyton RJ, King RH, Smith PA, Amor S, Herlihy AH, Hewitt RE, Jutton M, Price DA, Hafler DA, Kuchroo VK, Altmann DM. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.
J. Immunol. 174: 1938-1946 (2005).
*
-
Elloumi H, Ben Abdelaziz A, Derbel F, Jmaa A, Lassoued Y, Arfaoui D, Ben Ali A, Letaief R, Hamida RB, Ghannem H, Ajmi S. Predictive factors of glucocorticosteroid treatment failure in severe acute idiopathic colitis.
Acta Gastroenterol. Belg. 68: 226-229 (2005).
-
Ellul P, Vassallo M, Montefort S. Association of asthma and allergic rhinitis with celiac disease.
Indian J. Gastroenterol. 24: 270-271 (2005).
*
-
Elner SG, Petty HR, Elner VM, Yoshida A, Bian ZM, Yang D, Kindezelskii AL. TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression.
Trans. Am. Ophthalmol. Soc. 103: 126-137 (2005).
*
-
Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism.
Arch. Biochem. Biophys. 433: 397-412 (2005).
*
-
Eloranta JJ, Meier PJ, Kullak-Ublick GA. Coordinate transcriptional regulation of transport and metabolism.
Methods Enzymol. 400: 511-530 (2005).
-
Elphick DA, Mahida YR. Paneth cells: their role in innate immunity and inflammatory disease.
Gut 54: 1802-1809 (2005).
*
-
Elrick LJ, Leel V, Blaylock MG, Duncan L, Drever MR, Strachan G, Charlton KA, Koruth M, Porter AJ, Wright MC. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells - a potential mechanism for targeting liver anti-fibrotic therapeutics.
J. Hepatol. 42: 888-896 (2005).
*
-
Elrod JW, Laroux FS, Houghton J, Carpenter A, Ando T, Jennings MH, Grisham M, Walker N, Alexander JS. DSS-induced colitis is exacerbated in STAT-6 knockout mice.
Inflamm. Bowel Dis. 11: 883-889 (2005).
*
-
Elsenbruch S. Melatonin: a novel treatment for IBS?
Gut 54: 1353-1354 (2005).
*
-
Elsenbruch S, Langhorst J, Popkirowa K, Muller T, Luedtke R, Franken U, Paul A, Spahn G, Michalsen A, Janssen OE, Schedlowski M, Dobos G. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis.
Psychother. Psychosom. 74: 277-287 (2005).
-
Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.
Apoptosis 10: 927-939 (2005).
-
Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
Immunol. Rev. 206: 260-276 (2005).
*
-
Elsurer R, Tatar G, Simsek H, Balaban YH, Aydinli M, Sokmensuer C. Celiac disease in the Turkish population.
Dig. Dis. Sci. 50: 136-142 (2005).
*
-
Ely LK, Kjer-Nielsen L, McCluskey J, Rossjohn J. Structural studies on the alphabeta T-cell receptor.
IUBMB Life 57: 575-582 (2005).
*
-
Elzbieta R, Elzbieta W, Dariusz G, Langfort R, Ptak J. Lymphocytic interstitial pneumonia in primary Sjogren syndrome.
Pneumonol. Alergol. Pol. 73: 277-280 (2005).
-
Embree-Ku M, Gruppuso PA. The role of nuclear factor kappaB in late-gestation liver development in the rat.
Hepatology 42: 326-334 (2005).
*
-
Emens LA, Reilly RT, Jaffee EM. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.
Endocr. Relat. Cancer 12: 1-17 (2005).
*
-
Emmi L, Chatzipetrou A. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
Ann. Ital. Med. Int. 20: 205-208 (2005).
*
-
Emori A, Matsushima E, Aihara O, Ohta K, Koike R, Miyasaka N, Kato M. Cognitive dysfunction in systemic lupus erythematosus.
Psychiatry Clin. Neurosci. 59: 584-589 (2005).
-
Emregul E, David A, Balthasar JP, Yang VC. A GPIIb/IIIa bioreactor for specific treatment of immune thrombocytopenic purpura, an autoimmune disease. Preparation, in vitro characterization, and preliminary proof-of-concept animal studies.
J. Biomed. Mater. Res. A. 75: 648-655 (2005).
*
-
Enarsson K, Brisslert M, Backert S, Quiding-Jarbrink M. Helicobacter pylori induces transendothelial migration of activated memory T cells.
Infect. Immun. 73: 761-769 (2005).
*
-
Enck P, Klosterhalfen S. The placebo response in functional bowel disorders: perspectives and putative mechanisms.
Neurogastroenterol. Motil. 17: 325-331 (2005).
-
Endo H, Rees TD, Matsue M, Kuyama K, Nakadai M, Yamamoto H. Early detection and successful management of oral pemphigus vulgaris: a case report.
J. Periodontol. 76: 154-160 (2005).
-
Engelhardt B, Briskin MJ. Therapeutic targeting of alpha4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?
Eur. J. Immunol. 35: 2268-2273 (2005).
*
-
Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms.
Trends Immunol. 26: 485-495 (2005).
*
-
Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, Gridley G, Severson RK, Hartge P. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Am. J. Epidemiol. 162: 1153-1161 (2005).
*
-
Engin G, Balk E. Imaging findings of intestinal tuberculosis.
J. Comput. Assist. Tomogr. 29: 37-41 (2005).
-
Englert H, Joyner E, Bade R, Thompson M, Morris D, Chambers P, Carroll G, Manolios N. Systemic scleroderma: a spatiotemporal clustering.
Intern. Med. J. 35: 228-233 (2005).
*
-
Englmann A, Clarke LA, Christan S, Amaral MD, Schindelhauer D, Zink D. The replication timing of CFTR and adjacent genes.
Chromosome Res. 13: 183-194 (2005).
*
-
Enjoji M, Nakamuta M, Yamaguchi K, Ohta S, Kotoh K, Fukushima M, Kuniyoshi M, Yamada T, Tanaka M, Nawata H. Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.
World J. Gastroenterol. 11: 1167-1171 (2005).
*
-
Enne M, Pacheco-Moreira L, Balbi E, Cerqueira A, Santalucia G, Martinho JM. Liver transplantation with monosegments. Technical aspects and outcome: a meta-analysis.
Liver Transpl. 11: 564-569 (2005).
*
-
Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.
Clin. Exp. Nephrol. 9: 195-205 (2005).
*
-
Enomoto N, Takei Y, Kon K, Yamashina S, Suzuki S, Ikejima K, Sato N. Serine protease inhibitors prevent alcoholic liver injury.
Nihon Arukoru Yakubutsu Igakkai Zasshi 40: 213-218 (2005).
-
Ensari C, Ensari A, Tumer N, Ertug E. Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients.
Nephrol. Dial. Transplant. 20: 1721-1725 (2005).
*
-
Eny KM, El-Sohemy A, Cornelis MC, Sung YK, Bae SC. Catalase and PPARgamma2 genotype and risk of systemic lupus erythematosus in Koreans.
Lupus 14: 351-355 (2005).
-
Epaud R, Girodon E, Corvol H, Niel F, Guigonis V, Clement A, Feldmann D, Bensman A, Ulinski T. Mild cystic fibrosis revealed by persistent hyponatremia during the French 2003 heat wave, associated with the S1455X C-terminus CFTR mutation.
Clin. Genet. 68: 552-553 (2005).
*
-
Epstein MP, Veal CD, Trembath RC, Barker JN, Li C, Satten GA. Genetic association analysis using data from triads and unrelated subjects.
Am. J. Hum. Genet. 76: 592-608 (2005).
*
-
Eradi B, Sandhu BK, Spray C, Cusick E. Highly destructive perianal Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 41: 667-669 (2005).
*
-
Ercolini AM, Miller SD. Role of immunologic cross-reactivity in neurological diseases.
Neurol. Res. 27: 726-733 (2005).
-
Erdem H, Pay S, Serdar M, Simsek I, Dinc A, Musabak U, Pekel A, Turan M. Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behcet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis.
Rheumatol. Int. 26: 162-167 (2005).
*
-
Erdos M, Durandy A, Marodi L. Genetically acquired class-switch recombination defects: the multi-faced hyper-IgM syndrome.
Immunol. Lett. 97: 1-6 (2005).
-
Erdos M, Uzvolgyi E, Nemes Z, Torok O, Rakoczi E, Went-Sumegi N, Sumegi J, Marodi L. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Hum. Mutat. 25: 506 (2005).
*
-
Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ, Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis.
Inflamm. Bowel Dis. 11: 744-748 (2005).
*
-
Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
Aliment. Pharmacol. Ther. 22: 831-838 (2005).
*
-
Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
Scand. J. Gastroenterol. 40: 1058-1065 (2005).
*
-
Ericksen SS, Szklarz GD. Regiospecificity of human cytochrome P450 1A1-mediated oxidations: the role of steric effects.
J. Biomol. Struct. Dyn. 23: 243-256 (2005).
-
Erickson RP, Bhattacharyya A, Hunter RJ, Heidenreich RA, Cherrington NJ. Liver disease with altered bile acid transport in Niemann-Pick C mice on a high fat, 1% cholesterol diet.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G300-G307 (2005).
*
-
Eriksen KW, Lovato P, Skov L, Krejsgaard T, Kaltoft K, Geisler C, Odum N. Increased sensitivity to interferon-alpha in psoriatic T cells.
J. Invest. Dermatol. 125: 936-944 (2005).
*
-
Eriksson A, Heimtun E. Does daily fecal volume predict the clinical outcome of the acute flare of extensive ulcerative colitis in terms of need for acute colectomy?
Inflamm. Bowel Dis. 11: 418-419 (2005).
*
-
Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
J. Intern. Med. 257: 540-548 (2005).
*
-
Ernestam S, Af Klint E, Catrina AI, Sundberg E, Engstrom M, Klareskog L, Ulfgren AK. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Arthritis Res. Ther. 8: R18 (2005).
*
-
Ernst PB. Understanding immunity to Helicobacter pylori: unraveling the riddle, wrapped in a mystery, inside an enigma.
Gastroenterology 129: 380-383 (2005).
*
-
Ernst R, Klemm R, Schmitt L, Kuchler K. Yeast ATP-binding cassette transporters: cellular cleaning pumps.
Methods Enzymol. 400: 460-484 (2005).
-
Erol A. PPARalpha activators may be good candidates as antiaging agents.
Med. Hypotheses 65: 35-38 (2005).
-
Ershler WB, Chen K, Reyes EB, Dubois R. Economic burden of patients with anemia in selected diseases.
Value Health 8: 629-638 (2005).
-
Ersoz G, Gunsar F, Karasu Z, Akay S, Batur Y, Akarca US. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Turk. J. Gastroenterol. 16: 124-128 (2005).
*
-
Ertekin V, Selimoglu MA, Turkan Y, Akcay F. Serum nitric oxide levels in children with celiac disease.
J. Clin. Gastroenterol. 39: 782-785 (2005).
-
Ertunc D, Aban M, Tok EC, Tamer L, Arslan M, Dilek S. Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
Hum. Reprod. 20: 2157-2161 (2005).
-
Esaki M, Matsumoto T, Hizawa K, Nakamura S, Jo Y, Mibu R, Iida M. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy.
Scand. J. Gastroenterol. 40: 1431-1437 (2005).
*
-
Eschbach JW. Iron requirements in erythropoietin therapy.
Best Pract. Res. Clin. Haematol. 18: 347-361 (2005).
-
Esche C, Stellato C, Beck LA. Chemokines: key players in innate and adaptive immunity.
J. Invest. Dermatol. 125: 615-628 (2005).
*
-
Esmon C. Do-all receptor takes on coagulation, inflammation.
Nat. Med. 11: 475-477 (2005).
*
-
Esmon CT. The interactions between inflammation and coagulation.
Br. J. Haematol. 131: 417-430 (2005).
*
-
Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
Nature 433: 430-433 (2005).
*
-
Espejo C, Martinez-Caceres EM. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
Ann. N. Y. Acad. Sci. 1051: 88-96 (2005).
*
-
Espejo C, Penkowa M, Demestre M, Montalban X, Martinez-Caceres EM. Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis.
Neuroscience 132: 1135-1149 (2005).
-
Espinosa G, Arostegui JI, Plaza S, Rius J, Cervera R, Yague J, Font J. Behcet's disease and hereditary periodic fever syndromes: casual association or causal relationship?
Clin. Exp. Rheumatol. 23: S64-S66 (2005).
-
Esrefoglu M, Gul M, Emre MH, Polat A, Selimoglu MA. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats.
World J. Gastroenterol. 11: 1951-1956 (2005).
*
-
Esteban E, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Vona G, Harich N, Luna F, Saetta AA, Bissar N, Moral P. An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: data on the Mediterranean region.
Am. J. Hum. Biol. 17: 690-695 (2005).
-
Esteghamat F, Noorinayer B, Sanati MH, Hekmatdoost A, Zafarghandi M, Shalmani HM, Agah M, Zali MR. C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis.
Hepatol. Res. 32: 154-157 (2005).
-
Etienne-Manneville S, Manneville JB, Nicholls S, Ferenczi MA, Hall A. Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization.
J. Cell. Biol. 170: 895-901 (2005).
*
-
Eudes R, Lehn P, Ferec C, Mornon JP, Callebaut I. Nucleotide binding domains of human CFTR: a structural classification of critical residues and disease-causing mutations.
Cell. Mol. Life Sci. 62: 2112-2123 (2005).
*
-
Eun CS. Crohn's disease of the small bowel.
Korean J. Gastroenterol. 45: 75-77 (2005).
-
Evans CH. Gene therapy: what have we accomplished and where do we go from here?
J. Rheumatol. Suppl. 72: 17-20 (2005).
-
Evans CH, Ghivizzani SC, Gouze E, Rediske JJ, Schwarz EM, Robbins PD. The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics.
Arthritis Res. Ther. 7: 273-278 (2005).
*
-
Evans CH, Robbins PD, Ghivizzani SC, Wasko MC, Tomaino MM, Kang R, Muzzonigro TA, Vogt M, Elder EM, Whiteside TL, Watkins SC, Herndon JH. Gene transfer to human joints: progress toward a gene therapy of arthritis.
Proc. Natl. Acad. Sci. U.S.A. 102: 8698-8703 (2005).
*
-
Evans EJ, Esnouf RM, Manso-Sancho R, Gilbert RJ, James JR, Yu C, Fennelly JA, Vowles C, Hanke T, Walse B, Hunig T, Sorensen P, Stuart DI, Davis SJ. Crystal structure of a soluble CD28-Fab complex.
Nat. Immunol. 6: 271-279 (2005).
*
-
Evans HM, McKiernan PJ, Kelly DA. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.
Transplantation 79: 1575-1580 (2005).
-
Evans JA, Nishioka NS. Endoscopic confocal microscopy.
Curr. Opin. Gastroenterol. 21: 578-584 (2005).
-
Evans JL, Lin JJ, Goldfine ID. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
Curr. Diabetes Rev. 1: 299-307 (2005).
-
Evans T. Regulation of hematopoiesis by retinoid signaling.
Exp. Hematol. 33: 1055-1061 (2005).
*
-
Evelson P, Susemihl C, Villarreal I, Llesuy S, Rodriguez R, Peredo H, Lemberg A, Perazzo J, Filinger E. Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats.
Ann. Hepatol. 4: 115-120 (2005).
*
-
Evenepoel P, Bammens B, Nevens F, Wilmer A, Vanrenterghem Y. The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin-bound toxins.
Liver Transpl. 11: 853-854 (2005).
*
-
Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Detoxifying capacity and kinetics of Prometheus - a new extracorporeal system for the treatment of liver failure.
Blood Purif. 23: 349-358 (2005).
-
Eventov-Friedman S, Katchman H, Shezen E, Aronovich A, Tchorsh D, Dekel B, Freud E, Reisner Y. Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows.
Proc. Natl. Acad. Sci. U.S.A. 102: 2928-2933 (2005).
*
-
Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease.
Surv. Ophthalmol. 50: 297-350 (2005).
-
Evers AW, Lu Y, Duller P, van der Valk PG, Kraaimaat FW, van de Kerkhof PC. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis.
Br. J. Dermatol. 152: 1275-1281 (2005).
*
-
Everson GT, Taylor MR. Management of polycystic liver disease.
Curr. Gastroenterol. Rep. 7: 19-25 (2005).
-
Evert M, Seiler C, Dombrowski F. Aberrant acinar cell CA 19-9 expression and peri-insular acinar cell alterations in an adult human pancreas.
Virchows Arch. 446: 68-72 (2005).
*
-
Everts HB, Sundberg JP, Ong DE. Immunolocalization of retinoic acid biosynthesis systems in selected sites in rat.
Exp. Cell Res. 308: 309-319 (2005).
*
-
Ewald N, Toepler M, Akinci A, Kloer HU, Bretzel RG, Hardt PD. Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review.
Z. Gastroenterol. 43: 1313-1317 (2005).
-
Ewan S. Weeding out new drugs.
Drug Discov. Today 10: 1336-1337 (2005).
-
Eysenbach G, Kummervold PE. "Is Cybermedicine Killing You?" - The story of a Cochrane disaster.
J. Med. Internet Res. 7: e21 (2005).
-
Ezekowitz RA, Shi L, Fraser I, Takahashi K. The mannose-binding lectin: an infection susceptibility gene.
Adv. Exp. Med. Biol. 560: 99-103 (2005).
-
Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease.
J. Autoimmun. 24: 101-109 (2005).
-
Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
J. Pediatr. Gastroenterol. Nutr. 40: 450-455 (2005).
*
-
Fagoonee S, Gburek J, Hirsch E, Marro S, Moestrup SK, Laurberg JM, Christensen EI, Silengo L, Altruda F, Tolosano E. Plasma protein haptoglobin modulates renal iron loading.
Am. J. Pathol. 166: 973-983 (2005).
*
-
Fagundes ED, Roquete ML, Penna FJ, Reis FJ, Goulart EM, Duque CG. Risk factors for cystic fibrosis related liver disease.
J. Pediatr. (Rio J.) 81: 478-484 (2005).
*
-
Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, Powrie F. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells.
J. Exp. Med. 201: 737-746 (2005).
*
-
Fahling M, Steege A, Perlewitz A, Nafz B, Mrowka R, Persson PB, Thiele BJ. Role of nucleolin in posttranscriptional control of MMP-9 expression.
Biochim. Biophys. Acta 1731: 32-40 (2005).
*
-
Fahy RJ, Wewers MD. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
Immunol. Res. 31: 75-89 (2005).
*
-
Faideau B, Larger E, Lepault F, Carel JC, Boitard C. Role of beta-cells in type 1 diabetes pathogenesis.
Diabetes 54: S87-S96 (2005).
*
-
Fainaru O, Shseyov D, Hantisteanu S, Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease.
Proc. Natl. Acad. Sci. U.S.A. 102: 10598-10603 (2005).
*
-
Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines.
Lupus 14: 646-651 (2005).
-
Falasca L, Iadevaia V, Ciccosanti F, Melino G, Serafino A, Piacentini M. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
J. Immunol. 174: 7330-7340 (2005).
*
-
Fall N, Bove KE, Stringer K, Lovell DJ, Brunner HI, Weiss J, Higgins GC, Bowyer SL, Graham TB, Thornton S, Grom AA. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
Arthritis Rheum. 52: 3175-3180 (2005).
*
-
Fallarino F, Puccetti P. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism.
Eur. J. Immunol. 36: 8-11 (2005).
*
-
Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.
Am. J. Hum. Genet. 77: 918-936 (2005).
*
-
Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome.
J. Clin. Gastroenterol. 39: S138-S142 (2005).
-
Falta MT, Fontenot AP, Rosloniec EF, Crawford F, Roark CL, Bill J, Marrack P, Kappler J, Kotzin BL. Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4+ T cell response to a rheumatoid arthritis-associated antigen.
Arthritis Rheum. 52: 1885-1896 (2005).
*
-
Famularo G, De Simone C, Pandey V, Sahu AR, Minisola G. Probiotic lactobacilli: an innovative tool to correct the malabsorption syndrome of vegetarians?
Med. Hypotheses 65: 1132-1135 (2005).
-
Famularo G, Minisola G, Nicotra GC, De Simone C. Idiosyncratic pancreatitis associated with perindopril.
JOP 6: 605-607 (2005).
*
-
Famularo G, Minisola G, Nicotra GC, Simone CD. Mesenteric and portal vein thrombosis associated with hyperhomocysteinemia and heterozygosity for factor V Leiden mutation.
World J. Gastroenterol. 11: 7700-7701 (2005).
*
-
Fan H, Qiu MY, Mei JJ, Shen GX, Liu SL, Chen R. Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis.
World J. Gastroenterol. 11: 4800-4806 (2005).
*
-
Fan JG, Zhong L, Tia LY, Xu ZJ, Li MS, Wang GL. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.
World J. Gastroenterol. 11: 2346-2350 (2005).
*
-
Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, Stoecker W, Zhong R. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese.
J. Gastroenterol. Hepatol. 20: 249-255 (2005).
*
-
Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ. Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese.
World J. Gastroenterol. 11: 2768-2772 (2005).
*
-
Fan W, Yanase T, Morinaga H, Mu YM, Nomura M, Okabe T, Goto K, Harada N, Nawata H. Activation of peroxisome proliferator activated receptor gamma and retinoid X receptor inhibits aromatase transcription via NF-kappaB.
Endocrinology 146: 85-92 (2005).
*
-
Fan XY, Li JZ, Yao SQ, Yan JD, Li CL, Ma QK. Relationship between pneumoconiosis and the polymorphisms of HLA-DRB1*, DQB1* genes.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23: 278-281 (2005).
-
Fanciulli G, Tomasi PA, Caucci F, Lai E, Sanciu F, Delitala G. Screening for celiac disease in patients with autoimmune thyroid disease: from research studies to daily clinical practice.
Ann. Ital. Med. Int. 20: 39-44 (2005).
-
Fang HL, Strom SC, Cai H, Falany CN, Kocarek TA, Runge-Morris M. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.
Mol. Pharmacol. 67: 1257-1267 (2005).
*
-
Fang MC, Minichiello T, Auerbach AD. Cost considerations surrounding current and future anticoagulant therapies.
Cleve. Clin. J. Med. 72 Suppl. 1: S43-S49 (2005).
*
-
Fang P, Dong L, Zhang WJ, Luo JY. Relationship between entero-hepatic bile acid circulation and interdigestive migrating myoelectrical activity in rats.
World J. Gastroenterol. 11: 5377-5380 (2005).
*
-
Fang SH, Hou YC, Chao PD. Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin.
Toxicol. Appl. Pharmacol. 205: 65-70 (2005).
*
-
Fanni D, Pilloni L, Orru S, Coni P, Liguori C, Serra S, Lai ML, Uccheddu A, Contu L, Van Eyken P, Faa G. Expression of ATP7B in normal human liver.
Eur. J. Histochem. 49: 371-378 (2005).
-
Fantuzzi G, Sennello JA, Batra A, Fedke I, Lehr HA, Zeitz M, Siegmund B. Defining the role of T cell-derived leptin in the modulation of hepatic or intestinal inflammation in mice.
Clin. Exp. Immunol. 142: 31-38 (2005).
*
-
Faour WH, Alaaeddine N, Mancini A, He QW, Jovanovic D, Di Battista JA. Early growth response factor-1 mediates prostaglandin E2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor-alpha gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts.
J. Biol. Chem. 280: 9536-9546 (2005).
*
-
Farber DL. Control of adaptive immunity: from naive to memory.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S17-S19 (2005).
*
-
Fardel O, Jigorel E, Le Vee M, Payen L. Physiological, pharmacological and clinical features of the multidrug resistance protein 2.
Biomed. Pharmacother. 59: 104-114 (2005).
-
Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields JZ. Heightened responses to stressors in patients with inflammatory bowel disease.
Am. J. Gastroenterol. 100: 1796-1804 (2005).
*
-
Faria AM, Weiner HL. Oral tolerance.
Immunol. Rev. 206: 232-259 (2005).
*
-
Farias AQ, Goncalves LL, Cancado EL, Seguro AC, Campos SB, Abrantes-Lemos CP, Carrilho FJ. Bone disease in primary biliary cirrhosis: lack of association with distal renal tubular acidosis.
J. Gastroenterol. Hepatol. 20: 147-152 (2005).
*
-
Farinha CM, Amaral MD. Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin.
Mol. Cell. Biol. 25: 5242-5252 (2005).
*
-
Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma.
Gastroenterology 128: 1579-1605 (2005).
*
-
Farkas D, Tannenbaum SR. In vitro methods to study chemically-induced hepatotoxicity: a literature review.
Curr. Drug Metab. 6: 111-125 (2005).
-
Farkas SA, Hornung M, Sattler C, Steinbauer M, Anthuber M, Obermeier F, Herfarth H, Schlitt HJ, Geissler EK. Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis.
Eur. Surg. Res. 37: 115-122 (2005).
-
Farmen SL, Karp PH, Ng P, Palmer DJ, Koehler DR, Hu J, Beaudet AL, Zabner J, Welsh MJ. Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR.
Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L1123-L1130 (2005).
*
-
Farras R, Bossis G, Andermarcher E, Jariel-Encontre I, Piechaczyk M. Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy?
Crit. Rev. Oncol. Hematol. 54: 31-51 (2005).
-
Fartoux L, Serfaty L. Liver cirrhosis in adults: etiology and specific treatments.
Rev. Prat. 55: 1539-1548 (2005).
-
Fasano A. Clinical presentation of celiac disease in the pediatric population.
Gastroenterology 128: S68-S73 (2005).
*
-
Fasano A, Catassi C. Coeliac disease in children.
Best Pract. Res. Clin. Gastroenterol. 19: 467-478 (2005).
-
Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 416-422 (2005).
*
-
Fatehi-Hassanabad Z, Chan CB. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function.
Nutr. Metab. (Lond.) 2: 1 (2005).
*
-
Fathalla BM, Miller L, Brady S, Schaller JG. Cutaneous polyarteritis nodosa in children.
J. Am. Acad. Dermatol. 53: 724-728 (2005).
-
Fathman CG, Soares L, Chan SM, Utz PJ. An array of possibilities for the study of autoimmunity.
Nature 435: 605-611 (2005).
*
-
Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Immunology 116: 134-141 (2005).
*
-
Faubel S, Edelstein CL. Caspases as drug targets in ischemic organ injury.
Curr. Drug Targets Immune Endocr. Metabol. Disord. 5: 269-287 (2005).
-
Faubion WA Jr. Natural killer T cells: dogs of war or defenders of peace?
Inflamm. Bowel Dis. 11: 74-75 (2005).
*
-
Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush.
Nat. Rev. Immunol. 5: 835-843 (2005).
*
-
Faulkner MA, Ryan-Haddad AM, Lenz TL, Degner K. Osteoporosis in long-term care residents with multiple sclerosis.
Consult. Pharm. 20: 128-136 (2005).
-
Faure E. Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial Hepatitis B virus polymerase play a role through molecular mimicry?
Med. Hypotheses 65: 509-520 (2005).
-
Fauroux B, Clement A. Paediatric sarcoidosis.
Paediatr. Respir. Rev. 6: 128-133 (2005).
-
Fausto N, Riehle KJ. Mechanisms of liver regeneration and their clinical implications.
J. Hepatobiliary Pancreat. Surg. 12: 181-189 (2005).
*
-
Fautrel A, Andrieux L, Musso O, Boudjema K, Guillouzo A, Langouet S. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
J. Hepatol. 43: 288-293 (2005).
*
-
Fava G, Glaser S, Francis H, Alpini G. The immunophysiology of biliary epithelium.
Semin. Liver Dis. 25: 251-264 (2005).
-
Fava G, Marucci L, Glaser S, Francis H, De Morrow S, Benedetti A, Alvaro D, Venter J, Meininger C, Patel T, Taffetani S, Marzioni M, Summers R, Reichenbach R, Alpini G. gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway.
Cancer Res. 65: 11437-11446 (2005).
*
-
Favalli EG, Varenna M, Sinigaglia L. Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy.
Clin. Exp. Rheumatol. 23: 247-250 (2005).
-
Favaloro EJ. Learning from peer assessment: the role of the external quality assurance multilaboratory thrombophilia test process.
Semin. Thromb. Hemost. 31: 85-89 (2005).
-
Favaloro EJ. Diagnostic issues in thrombophilia: a laboratory scientist's view.
Semin. Thromb. Hemost. 31: 11-16 (2005).
-
Favaloro EJ, Bonar R, Sioufi J, Wheeler M, Low J, Aboud M, Duncan E, Smith J, Exner T, Lloyd J, Marsden K. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Semin. Thromb. Hemost. 31: 49-58 (2005).
-
Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S. Association between colonic screening, subject characteristics, and stage of colorectal cancer.
Am. J. Gastroenterol. 100: 2531-2539 (2005).
*
-
Fazle Akbar SM, Furukawa S, Nakanishi S, Abe M, Horiike N, Onji M. Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis.
J. Gastroenterol. 40: 157-163 (2005).
*
-
Feagan BG. Management of perianal and fistulizing disease.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 37 (2005). *
-
Feagan BG, Bala M, Yan S, Olson A, Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease.
J. Clin. Gastroenterol. 39: 390-395 (2005).
-
Feagan BG, Greenberg GR, Wild G, Fedorak RN, Pare P, McDonald JW, Dube R, Cohen A, Steinhart AH, Landau S, Aguzzi RA, Fox IH, Vandervoort MK. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin.
N. Engl. J. Med. 352: 2499-2507 (2005).
*
-
Feagan BG, Sandborn WJ, Baker JP, Cominelli F, Sutherland LR, Elson CO, Salzberg BA, Archambault A, Bernstein CN, Lichtenstein GR, Heath PK, Cameron S, Hanauer SB. A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Aliment. Pharmacol. Ther. 21: 373-384 (2005).
*
-
Feart C, Mingaud F, Enderlin V, Husson M, Alfos S, Higueret P, Pallet V. Differential effect of retinoic acid and triiodothyronine on the age-related hypo-expression of neurogranin in rat.
Neurobiol. Aging 26: 729-738 (2005).
-
Fedorak RN, Bistritz L. Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide.
Adv. Drug Deliv. Rev. 57: 303-316 (2005).
*
-
Fedwick JP, Lapointe TK, Meddings JB, Sherman PM, Buret AG. Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability.
Infect. Immun. 73: 7844-7852 (2005).
*
-
Fefferman DS, Farrell RJ. Immunogenicity of biological agents in inflammatory bowel disease.
Inflamm. Bowel Dis. 11: 497-503 (2005).
*
-
Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice.
Clin. Gastroenterol. Hepatol. 3: 11-24 (2005).
*
-
Fegan PG, Shore AC, Mawson D, Tooke JE, Macleod KM. Microvascular endothelial function in subjects with type 2 diabetes and the effect of lipid-lowering therapy.
Diabet. Med. 22: 1670-1676 (2005).
*
-
Feghali-Bostwick CA. Genetics and proteomics in scleroderma.
Curr. Rheumatol. Rep. 7: 129-134 (2005).
-
Feige JN, Gelman L, Tudor C, Engelborghs Y, Wahli W, Desvergne B. Fluorescence imaging reveals the nuclear behavior of PPAR/RXR heterodimers in the absence and presence of ligand.
J. Biol. Chem. 280: 17880-17890 (2005).
*
-
Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, Russo CD. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
Biochem. Pharmacol. 70: 177-188 (2005).
*
-
Feinstein J, Arroyo R. Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade.
J. Clin. Rheumatol. 11: 219-222 (2005).
-
Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
Hepatology 42: 53-62 (2005).
*
-
Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration?
Trends Neurosci. 28: 487-493 (2005).
*
-
Feldman SR, Evans C, Russell MW. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
J. Dermatolog. Treat. 16: 37-42 (2005).
-
Feldman SR, Kimball AB, Krueger GG, Woolley JM, Lalla D, Jahreis A. Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
J. Am. Acad. Dermatol. 53: 887-889 (2005).
-
Feldman SR, Koo JY, Menter A, Bagel J. Decision points for the initiation of systemic treatment for psoriasis.
J. Am. Acad. Dermatol. 53: 101-107 (2005).
-
Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials.
Ann. Rheum. Dis. 64 Suppl. 2: ii65-ii68 (2005).
*
-
Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN. Anti-TNF therapy: where have we got to in 2005?
J. Autoimmun. 25: S26-S28 (2005).
-
Feldmann M, Steinman L. Design of effective immunotherapy for human autoimmunity.
Nature 435: 612-619 (2005).
*
-
Feldstein AC, Elmer PJ, Nichols GA, Herson M. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
Osteoporos. Int. 16: 2168-2174 (2005).
*
-
Feldstein AE, Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis.
Front. Biosci. 10: 3093-3099 (2005).
-
Felice KJ, DiMario FJ, Conway SR. Postinfectious myasthenia gravis: report of two children.
J. Child. Neurol. 20: 441-444 (2005).
-
Felici E, Novarini C, Magni-Manzoni S, Pistorio A, Magnani A, Bozzola E, Buoncompagni A, Martini A, Ravelli A. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.
J. Rheumatol. 32: 1805-1810 (2005).
-
Fell JM. Control of systemic and local inflammation with transforming growth factor beta containing formulas.
JPEN J. Parenter. Enteral Nutr. 29: S126-S133 (2005).
*
-
Feller SE, Gawrisch K. Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin.
Curr. Opin. Struct. Biol. 15: 416-422 (2005).
*
-
Felley C, Guyot J, Hess J, Mottet C, Delarive J, Michetti P. Inflammatory bowel diseases.
Rev. Med. Suisse. 1: 218-220, 223-227 (2005).
-
Felley C, Mottet C, Juillerat P, Froehlich F, Burnand B, Vader JP, Michetti P, Gonvers JJ. Fistulizing Crohn's disease.
Digestion 71: 26-28 (2005).
-
Feng D, Imasawa T, Nagano T, Kikkawa M, Takayanagi K, Ohsawa T, Akiyama K, Ishigami A, Toda T, Mitarai T, Machida T, Maruyama N. Citrullination preferentially proceeds in glomerular Bowman's capsule and increases in obstructive nephropathy.
Kidney Int. 68: 84-95 (2005).
*
-
Feng J, Chen J, Yan J, Jones IR, Craddock N, Cook EH Jr, Goldman D, Heston LL, Sommer SS. Structural variants in the retinoid receptor genes in patients with schizophrenia and other psychiatric diseases.
Am. J. Med. Genet. B. Neuropsychiatr. Genet. 133B: 50-53 (2005).
*
-
Feng S, Ku K, Hodzic E, Lorenzana E, Freet K, Barthold SW. Differential detection of five mouse-infecting Helicobacter species by multiplex PCR.
Clin. Diagn. Lab. Immunol. 12: 531-536 (2005).
*
-
Fenniche S, Dhaoui A, Ben Ammar F, Benmously R, Marrak H, Mokhtar I. Acebutolol-induced subacute cutaneous lupus erythematosus.
Skin Pharmacol. Physiol. 18: 230-233 (2005).
-
Feranchak AP, Gralla J, King R, Ramirez RO, Corkill M, Narkewicz MR, Sokol RJ. Comparison of indices of vitamin A status in children with chronic liver disease.
Hepatology 42: 782-792 (2005).
*
-
Ferdinandusse S, Denis S, Overmars H, Van Eeckhoudt L, Van Veldhoven PP, Duran M, Wanders RJ, Baes M. Developmental changes of bile acid composition and conjugation in L-and D-bifunctional protein single and double knockout mice.
J. Biol. Chem. 280: 18658-18666 (2005).
*
-
Ferguson CA. Disease models of autoimmunity.
Trends Immunol. 26: 557-558 (2005).
*
-
Ferguson JW, Tripathi D, Redhead DN, Ireland H, Hayes PC. Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedure.
J. Hepatol. 42: 145 (2005).
*
-
Ferguson SS, Chen Y, Lecluyse EL, Negishi M, Goldstein JA. Human CYP2C8 is transcriptionally regulated by the nuclear receptors CAR, PXR, GR, and HNF4alpha.
Mol. Pharmacol. 68: 747-757 (2005).
*
-
Ferkolj I, Ihan A, Markovic S. CD19+ in intestinal mucosa predict the response to infliximab in Crohn's disease.
Hepatogastroenterology 52: 1128-1133 (2005).
-
Fernald GH, Yeh RF, Hauser SL, Oksenberg JR, Baranzini SE. Mapping gene activity in complex disorders: integration of expression and genomic scans for multiple sclerosis.
J. Neuroimmunol. 167: 157-169 (2005).
-
Fernandes AP, Pace AE, Zanetti ML, Foss MC, Donadi EA. Immunogenetic factors associated with type 1 diabetes mellitus.
Rev. Lat. Am. Enfermagem. 13: 743-749 (2005).
-
Fernandez E, Riestra S, Rodrigo L, Blanco C, Lopez-Vazquez A, Fuentes D, Moreno M, Lopez-Larrea C. Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population.
World J. Gastroenterol. 11: 3762-3766 (2005).
*
-
Fernandez Fernandez FJ, de la Fuente Aguado J, Perez Fernandez S, Sopena Perez-Arguelles B, Nodar Germinas A, Butron Vila M. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Contribution of two new cases.
An. Med. Interna 22: 136-138 (2005).
-
Fernandez L, Martinez A, Mendoza JL, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Diaz-Rubio M, de la Concha EG. Interleukin-10 polymorphisms in Spanish patients with IBD.
Inflamm. Bowel Dis. 11: 739-743 (2005).
*
-
Fernandez L, Nunez C, Mendoza JL, Urcelay E, Fernandez-Arquero M, Taxonera C, Diaz-Rubio M, de la Concha EG, Martinez A. A recombined haplotype in the major histocompatibility region contains a cluster of genes conferring high susceptibility to ulcerative colitis in the Spanish population.
Inflamm. Bowel Dis. 11: 785-791 (2005).
*
-
Fernandez LL, Scheibe RM. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?
Arq. Neuropsiquiatr. 63: 1-6 (2005).
-
Fernandez-Banares F, Esteve M, Farre C, Salas A, Alsina M, Casalots J, Espinos J, Forne M, Viver JM. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis.
Eur. J. Gastroenterol. Hepatol. 17: 1333-1338 (2005).
-
Fernandez-Banares F, Esteve-Comas M, Rosinach M. Screening for celiac disease in high risk groups.
Gastroenterol. Hepatol. 28: 561-566 (2005).
-
Fernandez-Miranda C, Martinez Prieto M, Casis Herce B, Sanchez Gomez F, Gomez Gonzalez P, Martinez Lopez J, Saenz-Lopez Perez S, Gomez de la Camara A. Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.
Rev. Esp. Enferm. Dig. 97: 497-504 (2005).
*
-
Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion.
Clin. Chem. 51: 1201-1205 (2005).
*
-
Fernandez-Ruiz J, Gonzales S. Cannabinoid control of motor function at the basal ganglia.
Handb. Exp. Pharmacol. 168: 479-507 (2005).
-
Fernandez-Suarez A, Cordero Fernandez C, Garcia Lozano R, Pizarro A, Garzon M, Nunez Roldan A. Clinical and ethical implications of genetic counselling in familial adenomatous polyposis.
Rev. Esp. Enferm. Dig. 97: 654-665 (2005).
-
Fernandez-Suarez A, Reneses S, Wichmann I, Criado R, Nunez A. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis.
Clin. Chem. Lab. Med. 43: 1234-1239 (2005).
*
-
Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, Pivonello R, Albertelli M, Bianchi F, Giusti M, Minuto F. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
J. Endocrinol. Invest. 28: S111-S117 (2005).
-
Ferraccioli G. Biologic therapy with anti-TNFalpha in rheumathoid atrhritis.
Reumatismo 57: S17-S21 (2005).
-
Ferraccioli GF, Tomietto P, DE Santis M. Rationale for T cell inhibition by cyclosporin a in major autoimmune diseases.
Ann. N. Y. Acad. Sci. 1051: 658-665 (2005).
*
-
Ferrante M, De Hertogh G, Penninckx F, Van Assche G. Protein-losing enteropathy in Crohn's disease.
Clin. Gastroenterol. Hepatol. 3: A25 (2005).
*
-
Ferrantelli A, Bono L, Tortorici C, Termini R, Giammarresi C, Rotolo U. Treatment of lupus nephritis.
G. Ital. Nefrol. 22: S27-33 (2005).
-
Ferrarese F, Cecere V, Fabiano G. Extensive small bowel resections.
Chir. Ital. 57: 631-634 (2005).
-
Ferrario F, Rastaldi MP. Histopathological atlas of renal diseases: ANCA-associated vasculitis (first part).
J. Nephrol. 18: 113-116 (2005).
-
Ferrario F, Rastaldi MP. Histopathological atlas of renal diseases: ANCA-associated vasculitis (second part).
J. Nephrol. 18: 217-220 (2005).
-
Ferraris A, Knafelz D, Torres B, Fortina P, Castro M, Dallapiccola B. Analysis of CARD15 gene variants in Italian pediatric patients with inflammatory bowel diseases.
J. Pediatr. 147: 272-273 (2005).
*
-
Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G, Figueiredo C, Trindade E, Seruca R, Carneiro F, Amil J, Machado JC, Tavarela-Veloso F. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease.
Inflamm. Bowel Dis. 11: 331-339 (2005).
*
-
Ferreira AR, Roquete ML, Penna FJ, Toppa NH, de Castro LP. Type 1 autoimmune hepatitis in children and adolescents: assessment of immunosuppressive treatment withdrawal.
J. Pediatr. (Rio J.) 81: 343-348 (2005).
-
Ferreira ZS, Fernandes PA, Duma D, Assreuy J, Avellar MC, Markus RP. Corticosterone modulates noradrenaline-induced melatonin synthesis through inhibition of nuclear factor kappa B.
J. Pineal Res. 38: 182-188 (2005).
*
-
Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska natives: a review of the literature.
Semin. Arthritis Rheum. 34: 662-667 (2005).
*
-
Festi D, Capodicasa S, Sandri L, Colaiocco-Ferrante L, Staniscia T, Vitacolonna E, Vestito A, Simoni P, Mazzella G, Portincasa P, Roda E, Colecchia A. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.
World J. Gastroenterol. 11: 142-148 (2005).
*
-
Fesus L, Szondy Z. Transglutaminase 2 in the balance of cell death and survival.
FEBS Lett. 579: 3297-3302 (2005).
*
-
Fevery J, Buchel O, Nevens F, Verslype C, Stroobants S, Steenbergen WV. Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
J. Hepatol. 43: 358-360 (2005).
*
-
Ficari F, Fazi M, Garcea A, Nesi G, Tonelli F. Anal carcinoma occurring in Crohn's disease patients with chronic anal fistula.
Suppl. Tumori. 4: S31 (2005).
-
Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
Dis. Colon Rectum 48: 963-969 (2005).
*
-
Fichtner-Feigl S, Fuss IJ, Preiss JC, Strober W, Kitani A. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappaB decoy oligonucleotides.
J. Clin. Invest. 115: 3057-3071 (2005).
*
-
Fickert P, Trauner M, Fuchsbichler A, Zollner G, Wagner M, Marschall HU, Zatloukal K, Denk H. Oncosis represents the main type of cell death in mouse models of cholestasis.
J. Hepatol. 42: 378-385 (2005).
*
-
Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, Bar-Meir S, Avidan B, Shinhar Y. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease.
Am. J. Gastroenterol. 100: 338-343 (2005).
*
-
Fidder HH, Figer A, Geva R, Flex D, Schayek H, Avidan B, Meir SB, Friedman E. Genetic analyses in consecutive Israeli Jewish colorectal cancer patients.
Am. J. Gastroenterol. 100: 1376-1380 (2005).
*
-
Fiedler A, Wichers-Rother M, Hoeft A, Putensen C, von Spiegel T, Schroeder S. Schmidt syndrome presenting as acute liver failure.
Exp. Clin. Endocrinol. Diabetes 113: 60-63 (2005).
-
Fiedorczyk M, Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis.
Przegl. Lek. 62: 1321-1324 (2005).
-
Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment.
Clin. Pharmacol. Ther. 78: 551-558 (2005).
*
-
Field J, Biondo M, Murphy K, Alderuccio F, Toh B. Experimental autoimmune gastritis: mouse models of human organ-specific autoimmune disease.
Int. Rev. Immunol. 24: 93-110 (2005).
-
Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
Diabetes 54: 1588-1591 (2005).
*
-
Field T, Anasetti C. Selection of unrelated donors for hematopoietic cell transplantation.
Curr. Hematol. Rep. 4: 270-275 (2005).
-
Fieschi C, Allez M, Casanova JL. High risk of infectious disease caused by salmonellae and mycobacteria infections in patients with Crohn disease treated with anti-interleukin-12 antibody.
Clin. Infect. Dis. 40: 1381 (2005).
*
-
Fife MS, Ogilvie EM, Kelberman D, Samuel J, Gutierrez A, Humphries SE, Woo P. Novel IL-6 haplotypes and disease association.
Genes Immun. 6: 367-370 (2005).
*
-
Figueroa CC, Quera PR, Valenzuela EJ, Jensen BC. Inflammatory bowel disease: experience of two Chilean centers.
Rev. Med. Chil. 133: 1295-1304 (2005).
-
Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, Harboe E, Omdal R, Aarsland D. Neuropsychiatric symptoms in patients with multiple sclerosis.
Acta Psychiatr. Scand. 112: 463-468 (2005).
*
-
Fijak M, Iosub R, Schneider E, Linder M, Respondek K, Klug J, Meinhardt A. Identification of immunodominant autoantigens in rat autoimmune orchitis.
J. Pathol. 207: 127-138 (2005).
*
-
Filippi C, Bresson D, Herrath M. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
Int. Rev. Immunol. 24: 341-360 (2005).
-
Filippi C, von Herrath M. How viral infections affect the autoimmune process leading to type 1 diabetes.
Cell. Immunol. 233: 125-132 (2005).
*
-
Filippi J, Mambrini P, Arab K, Schneider SM, Hebuterne X. Treatment of oesophageal Crohn's disease by infliximab.
Gastroenterol. Clin. Biol. 29: 84-85 (2005).
-
Filipski E, Innominato PF, Wu M, Li XM, Iacobelli S, Xian LJ, Levi F. Effects of light and food schedules on liver and tumor molecular clocks in mice.
J. Natl. Cancer Inst. 97: 507-517 (2005).
*
-
Filler SG, Yeaman MR, Sheppard DC. Tumor necrosis factor inhibition and invasive fungal infections.
Clin. Infect. Dis. 41 Suppl. 3: S208-S212 (2005).
*
-
Finch CE, Crimmins EM. Response to Comment on "Inflammatory Exposure and Historical Changes in Human Life-Spans".
Science 308: 1743b (2005).
*
-
Finch R, Moore HG, Lindor N, Jalal SM, Markowitz A, Jhanwar S, Offit K, Guillem JG. Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case.
Dis. Colon Rectum 48: 2148-2152 (2005).
*
-
Findlay DM, Haynes DR. Mechanisms of bone loss in rheumatoid arthritis.
Mod. Rheumatol. 15: 232-240 (2005).
-
Fine RN. Renal function following liver transplantation in children.
Pediatr. Transplant. 9: 680-684 (2005).
*
-
Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM. Liver transplant recipient selection: MELD vs. clinical judgment.
Liver Transpl. 11: 621-626 (2005).
*
-
Fiocchi C. The multiple components of inflammatory bowel disease pathogenesis: should we invest in all of them or should we pick and choose?
Curr. Opin. Gastroenterol. 21: 399-400 (2005).
-
Fiocchi C. Inflammatory bowel disease pathogenesis: therapeutic implications.
Chin. J. Dig. Dis. 6: 6-9 (2005).
-
Fiocchi C, Cucchiara S, Czinn SJ, Grand RJ, Levine AD, Seidman EG; The Organizing Committee. First International Symposium on: Pediatric Inflammatory Bowel Disease: September 16-18, 2003; Irvington, Virginia, U.S.A.
J. Pediatr. Gastroenterol. Nutr. 40: S1 (2005).
*
-
Fiorentino S, Chopin M, Dastot H, Boissel N, Reboul M, Legres L, Janin A, Aplan P, Sigaux F, Regnault A. Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lymphoblastic leukemia in mice.
Eur. Cytokine Netw. 16: 300-308 (2005).
-
Fiorillo MT, Ruckert C, Hulsmeyer M, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.
J. Biol. Chem. 280: 2962-2971 (2005).
*
-
Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R, Renga B, Di Sante M, Morelli A, Cirino G, Wallace JL. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.
Gastroenterology 129: 1210-1224 (2005).
*
-
Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour B, Sabatino G, Russo G, Castellani D, Willson TM, Pellicciari R, Morelli A. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor (FXR) ligand, in estrogen induced cholestasis.
J. Pharmacol. Exp. Ther. 313: 604-612 (2005).
*
-
Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Antonio M, Pruzanski M, Pelllicciari R. Cross-talk between farnesoid X-receptor (FXR) and peroxisome proliferator-activated receptor (PPAR) gamma contributes to the anti-fibrotic activity of FXR ligands in rodent models of liver cirrhosis.
J. Pharmacol. Exp. Ther. 315: 58-68 (2005).
*
-
Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pruzanski M, Morelli A, Pellicciari R. A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
J. Pharmacol. Exp. Ther. 314: 584-595 (2005).
*
-
Fiotti N, Altamura N, Fisicaro M, Carraro N, Adovasio R, Sarra VM, Uxa L, Guarnieri G, Baxter BT, Giansante C. MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques.
Atherosclerosis 182: 287-292 (2005).
-
Firestein GS, Corr M. Common mechanisms in immune-mediated inflammatory disease.
J. Rheumatol. Suppl. 73: 8-13 (2005).
*
-
Firpo MA, Rollins MD, Szabo A, Gull JD, Jackson JD, Shao Y, Glasgow RE, Mulvihill SJ. A conscious mouse model of gastric ileus using clinically relevant endpoints.
BMC Gastroenterol. 5: 18 (2005).
*
-
Firth MA, Shewen PE, Hodgins DC. Passive and active components of neonatal innate immune defenses.
Anim. Health Res. Rev. 6: 143-158 (2005).
-
Fischer R, Reinehr R, Lu TP, Schonicke A, Warskulat U, Dienes HP, Haussinger D. Intercellular communication via gap junctions in activated rat hepatic stellate cells.
Gastroenterology 128: 433-448 (2005).
*
-
Fischer U, Schulze-Osthoff K. New approaches and therapeutics targeting apoptosis in disease.
Pharmacol. Rev. 57: 187-215 (2005).
*
-
Fischer-Betz R, Herzer P, Schneider M. Systemic lupus erythematosus.
Dtsch. Med. Wochenschr. 130: 2451-2458 (2005).
-
Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications.
Am. J. Gastroenterol. 100: 2526-2530 (2005).
*
-
Fiume L, Bolondi L, Busi C, Chieco P, Kratz F, Lanza M, Mattioli A, Di Stefano G. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
J. Hepatol. 43: 645-652 (2005).
*
-
Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N, Ruzickova J, Sponarova J, Drahota Z, Vlcek C, Keijer J, Houstek J, Kopecky J. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat.
Diabetologia 48: 2365-2375 (2005).
*
-
Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE. Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.
Diabetes 54: 582-586 (2005).
*
-
Fleischmann RM, Stern RL, Iqbal I. Treatment of early rheumatoid arthritis.
Mod. Rheumatol. 15: 153-162 (2005).
-
Fleith M, Clandinin MT. Dietary PUFA for preterm and term infants: review of clinical studies.
Crit. Rev. Food Sci. Nutr. 45: 205-229 (2005).
*
-
Fleming RE. Advances in understanding the molecular basis for the regulation of dietary iron absorption.
Curr. Opin. Gastroenterol. 21: 201-206 (2005).
-
Fleming RE, Britton RS, Waheed A, Sly WS, Bacon BR. Pathophysiology of hereditary hemochromatosis.
Semin. Liver Dis. 25: 411-419 (2005).
-
Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
Arthritis Res. Ther. 7: R666-R676 (2005).
*
-
Fletcher JG, Booya F, Johnson CD, Ahlquist D. CT colonography: unraveling the twists and turns.
Curr. Opin. Gastroenterol. 21: 90-98 (2005).
-
Fletcher N, Wahlstrom D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, Hakansson H. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study.
Toxicol. Appl. Pharmacol. 207: 1-24 (2005).
*
-
Fliege H, Rose M, Arck P, Walter OB, Kocalevent RD, Weber C, Klapp BF. The perceived stress questionnaire (PSQ) reconsidered: validation and reference values from different clinical and healthy adult samples.
Psychosom. Med. 67: 78-88 (2005).
-
Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM. Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and MHC-mismatched allogeneic bone marrow transplantation.
Blood 105: 2991-2994 (2005).
*
-
Flisiak R, Pelszynska M, Prokopowicz D, Rogalska M, Grygoruk U. High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis.
World J. Gastroenterol. 11: 5706-5709 (2005).
*
-
Floer M, Hlouschek V, Krieglstein CF, Bettendorf O, Domschke W, Pohle T. "Pancreatic lesion" outside the pancreas: value of endoscopic ultrasound.
Scand. J. Gastroenterol. 40: 482-485 (2005).
*
-
Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?
Br. J. Dermatol. 152: 202-216 (2005).
*
-
Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G. Is osteoporosis a peculiar association with primary biliary cirrhosis?
World J. Gastroenterol. 11: 5347-5350 (2005).
*
-
Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, Baldo V. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
Am. J. Gastroenterol. 100: 1516-1522 (2005).
*
-
Flores-Calderon J, Gomez-Diaz RA, Rodriguez-Gomez G, Moran-Villota S. Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City.
Ann. Hepatol. 4: 279-283 (2005).
-
Flori L, Delahaye NF, Iraqi FA, Hernandez-Valladares M, Fumoux F, Rihet P. TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso.
Genes Immun. 6: 472-480 (2005).
*
-
Florie J, Horsthuis K, Hommes DW, Nio CY, Reitsma JB, van Deventer SJ, Stoker J. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease.
Clin. Gastroenterol. Hepatol. 3: 1221-1228 (2005).
-
Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, Macary PA, Rankin A, Lehner PJ, Ouwehand WH, Allen JM, Watkins NA, Smith KG. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts.
Nat. Med. 11: 1056-1058 (2005).
*
-
Flotte TR, Schwiebert EM, Zeitlin PL, Carter BJ, Guggino WB. Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy.
Hum. Gene Ther. 16: 921-928 (2005).
-
Flower RJ, Perretti M. Controlling inflammation: a fat chance?
J. Exp. Med. 201: 671-674 (2005).
*
-
Foerster J, Nolte I, Junge J, Bruinenberg M, Schweiger S, Spaar K, van der Steege G, Ehlert C, Mulder M, Kalscheuer V, Blumenthal-Barby E, Winter J, Seeman P, Stander M, Sterry W, Te Meerman G. Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis.
J. Invest. Dermatol. 124: 99-102 (2005).
*
-
Fogel EL, McHenry L, Sherman S, Watkins JL, Lehman GA. Therapeutic biliary endoscopy.
Endoscopy 37: 139-145 (2005).
-
Fogel WA, Wagner W, Sasiak K, Stasiak A. The role of histamine in experimental ulcerative colitis in rats.
Inflamm. Res. 54: S68-S69 (2005).
*
-
Foligne B, Grangette C, Pot B. Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.
Gut 54: 727-728 (2005).
*
-
Foltz M, Mertl M, Dietz V, Boll M, Kottra G, Daniel H. Kinetics of bidirectional H+ and substrate transport by the proton-dependent amino acid symporter PAT1.
Biochem. J. 386: 607-616 (2005).
*
-
Folwaczny C, Glas J, Folwaczny M, Torok HP. Autologous hematopoietic stem cell transplantation in refractory Crohn's disease: a feasible therapeutic approach?
Gastroenterology 128: 2180 (2005).
*
-
Fontana RJ, Shakil AO, Greenson JK, Boyd I, Lee WM. Acute liver failure due to amoxicillin and amoxicillin/clavulanate.
Dig. Dis. Sci. 50: 1785-1790 (2005).
*
-
Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects.
Eur. J. Clin. Invest. 35: 691-699 (2005).
*
-
Fontenot AP, Maier LA. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
Trends Immunol. 26: 543-549 (2005).
*
-
Fontenot JD, Dooley JL, Farr AG, Rudensky AY. Developmental regulation of Foxp3 expression during ontogeny.
J. Exp. Med. 202: 901-906 (2005).
*
-
Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3.
Immunity 22: 329-341 (2005).
*
-
Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.
Nat. Immunol. 6: 331-337 (2005).
*
-
Food and Drug Administration, HHS. Medical devices; immunology and microbiology devices; classification of cystic fibrosis transmembrane conductance regulator gene mutation detection system. Final rule.
Fed. Regist. 70: 61736-61738 (2005).
-
Forbes A. Parenteral nutrition.
Curr. Opin. Gastroenterol. 21: 192-196 (2005).
-
Forbes A. Crohn's or abdominal tuberculosis?
Gut 54: 1156 (2005).
*
-
Forbes A, Al-Damluji A, Ashworth S, Bramble M, Herbert K, Ho J, Kang JY, Przemioslo R, Shetty A. Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis.
Aliment. Pharmacol. Ther. 21: 1099-1104 (2005).
*
-
Forchielli ML, Walker WA. The role of gut-associated lymphoid tissues and mucosal defence.
Br. J. Nutr. 93 Suppl. 1: S41-S48 (2005).
*
-
Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, Logan RF, McColl KE, Myres P, Delaney BC. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.
Gastroenterology 128: 1838-1844 (2005).
*
-
Ford P, Rivarola V, Chara O, Blot-Chabaud M, Cluzeaud F, Farman N, Parisi M, Capurro C. Volume regulation in cortical collecting duct cells: role of AQP2.
Biol. Cell 97: 687-697 (2005).
*
-
Foreman JE, Blizard DA, Gerhard G, Mack HA, Lang DH, Van Nimwegen KL, Vogler GP, Stout JT, Shihabi ZK, Griffith JW, Lakoski JM, McClearn GE, Vandenbergh DJ. Serum alkaline phosphatase activity is regulated by a chromosomal region containing the alkaline phosphatase 2 (Akp2) gene in C57BL/6J and DBA/2J mice.
Physiol. Genomics 23: 295-303 (2005).
*
-
Forman D, Tian C, Iacomini J. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
Mol. Ther. 12: 353-359 (2005).
-
Fornai M, Blandizzi C, Colucci R, Antonioli L, Bernardini N, Segnani C, Baragatti B, Barogi S, Berti P, Spisni R, Del Tacca M. Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice.
Gut 54: 608-616 (2005).
*
-
Forouhar F, Yang Y, Kumar D, Chen Y, Fridman E, Park SW, Chiang Y, Acton TB, Montelione GT, Pichersky E, Klessig DF, Tong L. Structural and biochemical studies identify tobacco SABP2 as a methyl salicylate esterase and implicate it in plant innate immunity.
Proc. Natl. Acad. Sci. U.S.A. 102: 1773-1778 (2005).
*
-
Forrest EH. Prognostic evaluation of alcoholic hepatitis.
J. Hepatol. 43: 738-739 (2005).
*
-
Forshaw MJ, Guirguis O, Hennigan TW. IgA nephropathy in association with Crohn's disease.
Int. J. Colorectal Dis. 20: 463-465 (2005).
*
-
Fort MM, Mozaffarian A, Stover AG, Correia Jda S, Johnson DA, Crane RT, Ulevitch RJ, Persing DH, Bielefeldt-Ohmann H, Probst P, Jeffery E, Fling SP, Hershberg RM. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
J. Immunol. 174: 6416-6423 (2005).
*
-
Forton DM, Patel N, Oatridge A, Hamilton G, Hajnal JV, Thomas HC, Taylor-Robinson SD, Prince M, Goldblatt J, Bassendine M, Jones DE. Fatigue in primary biliary cirrhosis.
Gut 54: 438 (2005).
*
-
Fortun PJ, Hawkey CJ. Nonsteroidal antiinflammatory drugs and the small intestine.
Curr. Opin. Gastroenterol. 21: 169-175 (2005).
-
Fortunato JE, Darbari A, Mitchell SE, Thompson RE, Cuffari C. The limitations of gastro-jejunal (G-J) feeding tubes in children: a 9-year pediatric hospital database analysis.
Am. J. Gastroenterol. 100: 186-189 (2005).
*
-
Foruny Olcina JR, Moreira Vicente VF, Maiz Caro L, Carrera Alonso E, Casals T. Cystic fibrosis presenting as acute recurrent pancreatitis.
Gastroenterol. Hepatol. 28: 20-22 (2005).
-
Foster EN, Nguyen KK, Sheikh RA, Prindiville TP. Crohn's disease associated with Sweet's syndrome and Sjogren's syndrome treated with infliximab.
Clin. Dev. Immunol. 12: 145-149 (2005).
*
-
Fostieri E, Tzartos SJ, Berrih-Aknin S, Beeson D, Mamalaki A. Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies.
Eur. J. Immunol. 35: 632-643 (2005).
*
-
Fotheringham J, Jacobson S. Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease.
Herpes 12: 4-9 (2005).
-
Foti M, Ricciardi-Castagnoli P. Antigen sampling by mucosal dendritic cells.
Trends Mol. Med. 11: 394-396 (2005).
*
-
Fotiadis C, Tsekouras DK, Antonakis P, Sfiniadakis J, Genetzakis M, Zografos GC. Gardner's syndrome: a case report and review of the literature.
World J. Gastroenterol. 11: 5408-5411 (2005).
*
-
Fournie JJ, Gaits F, Bonneville M. Science and society: promoting the learning of immunology in developing countries.
Nat. Rev. Immunol. 5: 893-898 (2005).
*
-
Fournier C. Where do T cells stand in rheumatoid arthritis?
Joint Bone Spine 72: 527-532 (2005).
*
-
Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.
Semin. Vasc. Med. 5: 77-86 (2005).
-
Fowler EV, Eri R, Hume G, Johnstone S, Pandeya N, Lincoln D, Templeton D, Radford-Smith GL. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease.
J. Med. Genet. 42: 523-528 (2005).
*
-
Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response.
Nat. Rev. Immunol. 5: 844-852 (2005).
*
-
Fox LP, Pasternack FR, Geyer AS, Grossman ME. Perineal squamous cell cancer in a patient with fistulizing and ulcerating Crohn's disease.
Clin. Exp. Dermatol. 30: 718-719 (2005).
*
-
Fox RI. Sjogren's syndrome.
Lancet 366: 321-331 (2005).
*
-
Foy E, Li K, Sumpter R Jr, Loo YM, Johnson CL, Wang C, Fish PM, Yoneyama M, Fujita T, Lemon SM, Gale Jr M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.
Proc. Natl. Acad. Sci. U.S.A. 102: 2986-2991 (2005).
*
-
Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins.
Proc. Natl. Acad. Sci. U.S.A. 102: 10604-10609 (2005).
*
-
Frahm N, Adams S, Kiepiela P, Linde CH, Hewitt HS, Lichterfeld M, Sango K, Brown NV, Pae E, Wurcel AG, Altfeld M, Feeney ME, Allen TM, Roach T, St John MA, Daar ES, Rosenberg E, Korber B, Marincola F, Walker BD, Goulder PJ, Brander C. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.
J. Virol. 79: 10218-10225 (2005).
*
-
Francavilla R, Lionetti E, Castellaneta SP, Magista AM, Boscarelli G, Piscitelli D, Amoruso A, Di Leo A, Miniello VL, Francavilla A, Cavallo L, Ierardi E. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Gastroenterology 129: 1414-1419 (2005).
*
-
Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P, Roccarina D, Nista EC, Cazzato AI, Lupascu A, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature.
Dig. Liver Dis. 37: 301-308 (2005).
-
Franchimont D, Roland S, Gustot T, Quertinmont E, Toubouti Y, Gervy MC, Deviere J, Van Gossum A. Impact of infliximab on serum leptin levels in patients with Crohn's disease.
J. Clin. Endocrinol. Metab. 90: 3510-3516 (2005).
*
-
Franchimont N, Lambert C, Huynen P, Ribbens C, Relic B, Chariot A, Bours V, Piette J, Merville MP, Malaise M. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Arthritis Rheum. 52: 84-93 (2005).
*
-
Franchimont N, Reenaers C, Louis E. Infliximab and the bone in Crohn's disease.
Aliment. Pharmacol. Ther. 21: 918-919 (2005).
*
-
Franchini M, Veneri D. Recent advances in hereditary hemochromatosis.
Ann. Hematol. 84: 347-352 (2005).
*
-
Franchini M, Veneri D. Helicobacter pylori infection and idiopathic thrombocytopenic purpura.
Recenti Prog. Med. 96: 151-154 (2005).
-
Franco A, Vaughan KG, Vukcevic Z, Thomas S, Mazariegos GV. Gastric volvulus as a complication of liver transplant.
Pediatr. Radiol. 35: 327-329 (2005).
*
-
Franco-Lopez E, Gonzalez-Escribano MF, Aguilera I, Pascasio JM, Pareja F, Bernardos A, Nunez-Roldan A. Lack of association of recipient MCP-1 gene promoter polymorphism with acute graft rejection after orthotopic liver transplantation.
Transplant. Proc. 37: 1496-1498 (2005).
*
-
Francois M, Richette P, Corvol MT. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
Drug News Perspect. 18: 257-261 (2005).
-
Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
Gut 54: 691-697 (2005).
*
-
Frank C, Makkonen H, Dunlop TW, Matilainen M, Vaisanen S, Carlberg C. Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis.
J. Mol. Biol. 346: 505-519 (2005).
*
-
Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria.
Clin. Exp. Rheumatol. 23: S93-S99 (2005).
-
Fransson J, Ros AM. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy.
Photodermatol. Photoimmunol. Photomed. 21: 326-332 (2005).
*
-
Frantz S. Drug discovery: playing dirty.
Nature 437: 942-943 (2005).
*
-
Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, Duca P, Conte D. Role of US in detection of Crohn disease: meta-analysis.
Radiology 236: 95-101 (2005).
*
-
Frasco PE, Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status.
Anesth. Analg. 101: 30-37 (2005).
-
Frasnelli ME, Tarussio D, Chobaz-Peclat V, Busso N, So A. TLR2 modulates inflammation in zymosan-induced arthritis in mice.
Arthritis Res. Ther. 7: R370-R379 (2005).
*
-
Frattini M, Carnevali I, Signoroni S, Balestra D, Moiraghi ML, Radice P, Varesco L, Gismondi V, Ballardini G, Sala P, Pierotti MA, Pilotti S, Bertario L. Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
Cancer Epidemiol. Biomarkers Prev. 14: 2049-2052 (2005).
*
-
Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine.
Nature 435: 964-968 (2005).
*
-
Fredenrich A, Grimaldi P. PPAR delta: an uncompletely known nuclear receptor.
Diabetes Metab. 31: 23-27 (2005).
*
-
Fredin MF, Ulfhammer E, Rhedin M, Melgar S, Mellgard B, Peterson A. Anti-inflammatory effects of budesonide in intestinal epithelial cells.
Pharmacol. Res. 52: 422-428 (2005).
*
-
Freeman H. C-ANCA/PR-3 positive colitis may be a distinctive form of inflammatory bowel disease.
J. Pediatr. Gastroenterol. Nutr. 41: 135 (2005).
*
-
Freeman H, Noble M. Lack of evidence for Mycobacterium avium subspecies paratuberculosis in Crohn's disease.
Inflamm. Bowel Dis. 11: 782-783 (2005).
*
-
Freeman HJ. Crohn's disease defined in three elderly sisters.
Can. J. Gastroenterol. 19: 251-252 (2005).
*
-
Freeman HJ. Collagenous mucosal inflammatory diseases of the gastrointestinal tract.
Gastroenterology 129: 338-350 (2005).
*
-
Freeman HJ. Long-term clinical behavior of jejunoileal involvement in Crohn's disease.
Can. J. Gastroenterol. 19: 575-578 (2005).
*
-
Freeman HJ. Age-dependent phenotypic clinical expression of Crohn's disease.
J. Clin. Gastroenterol. 39: 774-777 (2005).
-
Freeman HJ. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease.
Can. J. Gastroenterol. 19: 603-606 (2005).
*
-
Freeman HJ. Lymphoproliferative disorders in collagenous colitis.
Inflamm. Bowel Dis. 11: 781-782 (2005).
*
-
Freeman HJ, Flak B. Demyelination-like syndrome in Crohn's disease after infliximab therapy.
Can. J. Gastroenterol. 19: 313-316 (2005).
*
-
Freeman JM. Rasmussen's syndrome: progressive autoimmune multi-focal encephalopathy.
Pediatr. Neurol. 32: 295-299 (2005).
-
Freeman RB. MELD: the holy grail of organ allocation?
J. Hepatol. 42: 16-20 (2005).
*
-
Frei P, Gao B, Hagenbuch B, Mate A, Biber J, Murer H, Meier PJ, Stieger B. Identification and localization of sodium/phosphate cotransporters in hepatocytes and cholangiocytes of rat liver.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G771-G778 (2005).
*
-
Freigang S, Probst HC, van den Broek M. DC infection promotes antiviral CTL priming: the 'Winkelried' strategy.
Trends Immunol. 26: 13-18 (2005).
*
-
Freimuth RR, Xiao M, Marsh S, Minton M, Addleman N, Van Booven DJ, McLeod HL, Kwok PY. Polymorphism discovery in 51 chemotherapy pathway genes.
Hum. Mol. Genet. 14: 3595-3603 (2005).
*
-
French JJ, Midwinter MJ, Bennett MK, Manas DM, Charnley RM. A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma.
HPB (Oxford) 7: 289-291 (2005).
*
-
Frenz MB, Dunckley P, Camporota L, Jewell DP, Travis SP. Comparison between prospective and retrospective evaluation of Crohn's disease activity index.
Am. J. Gastroenterol. 100: 1117-1120 (2005).
*
-
Fresko I, Ugurlu S, Ozbakir F, Celik A, Yurdakul S, Hamuryudan V, Yazici H. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome.
Clin. Exp. Rheumatol. 23: S67-S70 (2005).
-
Freudenberg F, Carey MC. Hepatobiliary manifestations in inflammatory bowel disease.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 56-57 (2005). *
-
Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells.
Arthritis Res. Ther. 7: R291-R301 (2005).
*
-
Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, Jockel KH, Siffert W, Schmid KW. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.
Clin. Cancer Res. 11: 5071-5077 (2005).
*
-
Fride E, Ponde D, Breuer A, Hanus L. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Neuropharmacology 48: 1117-1129 (2005).
*
-
Fridell JA, Vianna R, Kwo PY, Howenstine M, Sannuti A, Molleston JP, Pescovitz MD, Tector AJ. Simultaneous liver and pancreas transplantation in patients with cystic fibrosis.
Transplant. Proc. 37: 3567-3569 (2005).
*
-
Friedl P, den Boer AT, Gunzer M. Tuning immune responses: diversity and adaptation of the immunological synapse.
Nat. Rev. Immunol. 5: 532-545 (2005).
*
-
Friedmann PS, Cooper HL, Healy E. Peroxisome proliferator-activated receptors and their relevance to dermatology.
Acta Derm. Venereol. 85: 194-202 (2005).
*
-
Friend DR. New oral delivery systems for treatment of inflammatory bowel disease.
Adv. Drug Deliv. Rev. 57: 247-265 (2005).
*
-
Frieri G, Pimpo M, Galletti B, Palumbo G, Corrao G, Latella G, Chiaramonte M, Caprilli R. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.
Dig. Liver Dis. 37: 92-96 (2005).
-
Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L, Giofre MR, Maggio A, Mattaliano A, Macaluso A, Cottone M. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.
Am. J. Gastroenterol. 100: 2730-2736 (2005).
*
-
Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Brain 128: 1747-1763 (2005).
*
-
Friese MA, Jones EY, Fugger L. MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
Trends Immunol. 26: 559-561 (2005).
*
-
Friesema EC, Jansen J, Milici C, Visser TJ. Thyroid hormone transporters.
Vitam. Horm. 70: 137-167 (2005).
-
Frigoul A, Lefranc MP. MICA: standardized IMGT allele nomenclature, polymorphisms and diseases.
Recent Res. Devel. Human Genet. 3: 95-145 (2005). *
-
Frini S, Chaabouni L, Ben Hamida A, Kchir M, Zouari R. Arthritis of the hip in spondylarthorpathy: retrospective study about 126 cases.
Tunis. Med. 83: 739-741 (2005).
-
Frisch M, Rostgaard C. Appendectomy and ulcerative colitis.
Epidemiology 16: 131-132 (2005).
-
Friso S, Choi SW. Gene-nutrient interactions in one-carbon metabolism.
Curr. Drug Metab. 6: 37-46 (2005).
*
-
Friso S, Girelli D, Trabetti E, Olivieri O, Guarini P, Pignatti PF, Corrocher R, Choi SW. The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes.
Cancer Epidemiol. Biomarkers Prev. 14: 938-943 (2005).
*
-
Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.
Curr. Gastroenterol. Rep. 7: 264-271 (2005).
-
Fritz JH, Girardin SE. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals.
J. Endotoxin Res. 11: 390-394 (2005).
*
-
Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, Cavaillon JM, Philpott DJ, Adib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
Eur. J. Immunol. 35: 2459-2470 (2005).
*
-
Froehlich F, Juillerat P, Felley C, Mottet C, Vader JP, Burnand B, Michetti P, Gonvers JJ. Treatment of postoperative Crohn's disease.
Digestion 71: 49-53 (2005).
-
Froehlich F, Juillerat P, Mottet C, Felley C, Vader JP, Burnand B, Gonvers JJ, Michetti P. Obstructive fibrostenotic Crohn's disease.
Digestion 71: 29-30 (2005).
-
Frokjaer JB, Larsen E, Steffensen E, Nielsen AH, Drewes AM. Magnetic resonance imaging of the small bowel in Crohn's disease.
Scand. J. Gastroenterol. 40: 832-842 (2005).
*
-
Frossard JL. Conversion of biliary system to pancreatic tissue: complete plasticity or same organ?
J. Hepatol. 42: 782-783 (2005).
-
Frostegard J. SLE, atherosclerosis and cardiovascular disease.
J. Intern. Med. 257: 485-495 (2005).
*
-
Frostegard J. Atherosclerosis in patients with autoimmune disorders.
Arterioscler. Thromb. Vasc. Biol. 25: 1776-1785 (2005).
*
-
Fry LC, Rickes S, Monkemuller K, Malfertheiner P. Crohn's disease associated with Takayasu's arteritis.
Acta Gastroenterol. Latinoam. 35: 238-242 (2005).
-
Fryer JP. Intestinal transplantation: an update.
Curr. Opin. Gastroenterol. 21: 162-168 (2005).
-
Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Neuropharmacology 48: 1147-1153 (2005).
*
-
Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. A nuclear receptor atlas: 3T3-L1 adipogenesis.
Mol. Endocrinol. 19: 2437-2450 (2005).
*
-
Fuchtenbusch M, Larger E, Thebault K, Boitard C. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Horm. Metab. Res. 37: 63-67 (2005).
-
Fuenzalida KM, Aguilera MC, Piderit DG, Ramos PC, Contador D, Quinones V, Rigotti A, Bronfman FC, Bronfman M. Peroxisome proliferator-activated receptor gamma is a novel target of the nerve growth factor signaling pathway in PC12 cells.
J. Biol. Chem. 280: 9604-9609 (2005).
*
-
Fujii H. Anti-inflammatory action of PPARs.
Nippon Rinsho 63: 609-615 (2005).
-
Fujii H. PPARs-mediated intracellular signal transduction.
Nippon Rinsho 63: 565-571 (2005).
-
Fujii H. Nuclear receptor PPARs and magnesium.
Clin. Calcium 15: 1814-1826 (2005).
-
Fujii S. Application of natural killer T-cells to posttransplantation immunotherapy.
Int. J. Hematol. 81: 1-5 (2005).
-
Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, Ichikawa K, Tomita S, Ohkura Y, Ono Y, Imura J, Chiba T, Fujimori T. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in long-standing and extensive ulcerative colitis.
Gut 54: 1287-1292 (2005).
*
-
Fujimoto M, Sato S. B lymphocytes and systemic sclerosis.
Curr. Opin. Rheumatol. 17: 746-751 (2005).
-
Fujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K. Bullous systemic lupus erythematosus as an initial manifestation of SLE.
J. Dermatol. 32: 1021-1027 (2005).
-
Fujinami RS. A tax on luxury: HTLV-I infection of CD4(+)CD25(+) Tregs.
J. Clin. Invest. 115: 1144-1146 (2005).
*
-
Fujisawa M, Oguchi K, Yamaura T, Suzuki M, Cyong JC. Protective effect of hawthorn fruit on murine experimental colitis.
Am. J. Chin. Med. 33: 167-180 (2005).
-
Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, Miyawaki H, Kishimoto N, Ishida T. Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia".
Respir. Med. 99: 234-240 (2005).
-
Fukami-Kobayashi K, Shiina T, Anzai T, Sano K, Yamazaki M, Inoko H, Tateno Y. Genomic evolution of MHC class I region in primates.
Proc. Natl. Acad. Sci. U.S.A. 102: 9230-9234 (2005).
*
-
Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K, Nast CC, Lechago J, Xu R, Naiki Y, Soliman A, Arditi M, Abreu MT. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G1055-G1065 (2005).
*
-
Fukata S, Brent GA, Sugawara M. Resistance to thyroid hormone in Hashimoto's thyroiditis.
N. Engl. J. Med. 352: 517-518 (2005).
-
Fukaya E, Watanabe H, Kobayashi H, Yokota T, Yamaguchi O, Kasukawa R, Sato Y. A case of interstitial cystitis accompanying Sjogren's syndrome.
Mod. Rheumatol. 15: 73-76 (2005).
-
Fukazawa T, Kikuchi S, Miyagishi R, Niino M, Yabe I, Hamada T, Sasaki H. CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese.
J. Neuroimmunol. 159: 225-229 (2005).
-
Fukuchi J, Song C, Dai Q, Hiipakka RA, Liao S. 5beta-Cholane activators of the farnesol X receptor.
J. Steroid Biochem. Mol. Biol. 94: 311-318 (2005).
-
Fukuda A, Nakase H, Seno H, Nabeshima M, Sawada M, Chiba T. Refractory enterovesical and duodenocolic fistulas in Crohn's disease successfully managed with tacrolimus.
J. Gastroenterol. 40: 433-435 (2005).
*
-
Fukuda W, Yamazaki T, Akaogi T, Hayashi H, Kusakabe T, Tsubouchi Y, Kawahito Y, Inoue M, Yoshikawa T. Malnutrition and disease progression in patients with rheumatoid arthritis.
Mod. Rheumatol. 15: 104-107 (2005).
-
Fukuen S, Iwaki M, Yasui A, Makishima M, Matsuda M, Shimomura I. Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity.
J. Biol. Chem. 280: 23653-23659 (2005).
*
-
Fukui H. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure.
Alcohol Clin. Exp. Res. 29: 172S-179S (2005).
-
Fukui T, Okazaki K, Yoshizawa H, Ohashi S, Tamaki H, Kawasaki K, Matsuura M, Asada M, Nakase H, Nakashima Y, Nishio A, Chiba T. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren's syndrome.
Pancreatology 5: 86-91 (2005).
-
Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, Taniguchi H, Ishikawa S, Ito H, Yamamoto S, Iwanari H, Hironaka M, Ishikawa Y, Niki T, Sohara Y, Kodama T, Nishimura M, Fukayama M, Dosaka-Akita H, Aburatani H. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
Clin. Cancer Res. 11: 1776-1785 (2005).
*
-
Fukunaga A, Bito T, Tsuru K, Oohashi A, Yu X, Ichihashi M, Nishigori C, Horikawa T. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes.
J. Allergy Clin. Immunol. 116: 397-402 (2005).
*
-
Fukushima A, Ohta A, Sakai K, Sakuma K. Expression of calbindin-D9k, VDR and Cdx-2 messenger RNA in the process by which fructooligosaccharides increase calcium absorption in rats.
J. Nutr. Sci. Vitaminol. (Tokyo) 51: 426-432 (2005).
-
Fukushima A, Yamaguchi T, Ishida W, Fukata K, Udaka K, Ueno H. Mice lacking the IFN-gamma receptor or fyn develop severe experimental autoimmune uveoretinitis characterized by different immune responses.
Immunogenetics 57: 337-343 (2005).
*
-
Fukushima-Nakase Y, Naoe Y, Taniuchi I, Hosoi H, Sugimoto T, Okuda T. Shared and distinct roles mediated through C-terminal subdomains of Acute Myeloid Leukemia/Runt-related transcription factor molecules in murine development.
Blood 105: 4298-4307 (2005).
*
-
Fuller BJ. Liver preservation: clinical and research aspects of the Royal Fee Hospital programme.
Ann. Hepatol. 4: 215 (2005).
-
Fuller BJ, Balogun L, Green C, Motterlini R. The heme oxygenase system and organ preservation: studies towards protection in a kidney model.
Ann. Hepatol. 4: 227 (2005).
-
Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, Pawelec G. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications.
Drugs Aging 22: 589-603 (2005).
-
Funatake CJ, Marshall NB, Steppan LB, Mourich DV, Kerkvliet NI. Activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+CD25+ cells with characteristics of regulatory T cells.
J. Immunol. 175: 4184-4188 (2005).
*
-
Fung J, Kelly D, Kadry Z, Patel-Tom K, Eghtesad B. Immunosuppression in liver transplantation: beyond calcineurin inhibitors.
Liver Transpl. 11: 267-280 (2005).
*
-
Funk GC, Doberer D, Osterreicher C, Peck-Radosavljevic M, Schmid M, Schneeweiss B. Equilibrium of acidifying and alkalinizing metabolic acid-base disorders in cirrhosis.
Liver Int. 25: 505-512 (2005).
*
-
Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Wien. Klin. Wochenschr. 117: 707-710 (2005).
-
Furlan A, Podswiadek M, Cozzi F, Todesco S. Tenosynovitis of the ankles as onset of sarcoidosis in a patient with ulcerative colitis.
Reumatismo 57: 197-200 (2005).
-
Furlow B. Systemic lupus erythematosus.
Radiol. Technol. 76: 289-296 (2005).
-
Furmanczyk PS, Grieco VS, Agoff SN. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
Am. J. Clin. Pathol. 124: 355-360 (2005).
-
Furrie E. Probiotics and allergy.
Proc. Nutr. Soc. 64: 465-469 (2005).
*
-
Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.
Gut 54: 242-249 (2005).
*
-
Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.
Immunology 115: 565-574 (2005).
*
-
Furukawa F, Yoshimasu T. Animal models of spontaneous and drug-induced cutaneous lupus erythematosus.
Autoimmun. Rev. 4: 345-350 (2005).
-
Furukawa O, Hirokawa M, Zhang L, Takeuchi T, Bi LC, Guth PH, Engel E, Akiba Y, Kaunitz JD. Mechanism of augmented duodenal HCO(3)(-) secretion after elevation of luminal CO(2).
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G557-G563 (2005).
*
-
Furuta GT, Nieuwenhuis EE, Karhausen J, Gleich G, Blumberg RS, Lee JJ, Ackerman SJ. Eosinophils alter colonic epithelial barrier function: role for major basic protein.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G890-G897 (2005).
*
-
Furuta R, Kusugami K, Goto H. Enema therapy for ulcerative colitis patients.
Nippon Rinsho 63: 845-849 (2005).
-
Fusconi M, Vannini A, Dall'aglio AC, Pappas G, Cassani F, Ballardini G, Frisoni M, Grassi A, Bianchi FB, Zauli D. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis.
Aliment. Pharmacol. Ther. 22: 951-955 (2005).
*
-
Fuster J, Charco R, Llovet JM, Bruix J, Garcia-Valdecasas JC. Liver transplantation in hepatocellular carcinoma.
Transpl. Int. 18: 278-282 (2005).
*
-
Futami K, Arima S. Role of strictureplasty in surgical treatment of Crohn's disease.
J. Gastroenterol. 40 Suppl. 16: 35-39 (2005).
-
Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schurmeyer TH, Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
Psychoneuroendocrinology 30: 188-198 (2005).
-
Gabra HO, Roberts JP, Variend S, Shawis RN. Solitary rectal ulcer syndrome in children. A report of three cases.
Eur. J. Pediatr. Surg. 15: 213-216 (2005).
-
Gabrielli M, Candelli M, Cremonini F, Ojetti V, Santarelli L, Nista EC, Nucera E, Schiavino D, Patriarca G, Gasbarrini G, Pola P, Gasbarrini A. Idiopathic chronic urticaria and celiac disease.
Dig. Dis. Sci. 50: 1702-1704 (2005).
*
-
Gaczynska M, Osmulski PA. Small-molecule inhibitors of proteasome activity.
Methods Mol. Biol. 301: 3-22 (2005).
-
Gad M. Regulatory T cells in experimental colitis.
Curr. Top. Microbiol. Immunol. 293: 179-208 (2005).
-
Gadewar S, Fasano A. Celiac disease: is the atypical really typical? Summary of the recent national institutes of health consensus conference and latest advances.
Curr. Gastroenterol. Rep. 7: 455-461 (2005).
-
Gadowska-Cicha A, Latos W, Niepsuj KJ, Sieron A. The therapy of Lesniowski-Crohn disease of the upper part of the gastrointestinal tract.
Wiad. Lek. 58: 307-312 (2005).
-
Gagnon SJ, Borbulevych OY, Davis-Harrison RL, Baxter TK, Clemens JR, Armstrong KM, Turner RV, Damirjian M, Biddison WE, Baker BM. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
J. Mol. Biol. 353: 556-573 (2005).
*
-
Gaillard P, Jeanclaude-Etter I, Ardissone V, Arkinstall S, Cambet Y, Camps M, Chabert C, Church D, Cirillo R, Gretener D, Halazy S, Nichols A, Szyndralewiez C, Vitte PA, Gotteland JP. Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.
J. Med. Chem. 48: 4596-4607 (2005).
*
-
Gajewska J, Ambroszkiewicz J, Hozyasz KK. The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease.
Wiad. Lek. 58: 338-341 (2005).
-
Gajewska J, Ambroszkiewicz J, Hozyasz KK. Biochemical markers of bone turnover in children with celiac disease on gluten-free diet.
Med. Wieku. Rozwoj. IX: 675-683 (2005).
-
Gal I, Bajnok E, Szanto S, Sarraj B, Glant TT, Mikecz K. Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a systemic murine model of rheumatoid arthritis.
Arthritis Rheum. 52: 3269-3278 (2005).
*
-
Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ. Perianal Crohn disease: predictors of need for permanent diversion.
Ann. Surg. 241: 796-802 (2005).
*
-
Galbraith SS, Drolet BA, Kugathasan S, Paller AS, Esterly NB. Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings.
Pediatrics 116: e439-e444 (2005).
*
-
Galindo M, Cabello A, Joven B, Alonso A, Carreira P, Porta J, Ricoy JR, Mateo I, Pablos JL. Mycophenolate mofetil induced myopathy in a patient with lupus nephritis.
J. Rheumatol. 32: 188-190 (2005).
-
Gallegos-Orozco JF, E Yurk C, Wang N, Rakela J, Charlton MR, Cutting GR, Balan V. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Am. J. Gastroenterol. 100: 874-878 (2005).
*
-
Gallelli B, De Angelis V, Ventura D, Meroni PL, Moroni G. SLE: extra-renal clinical manifestations and lupus nephritis.
G. Ital. Nefrol. 22: S3-S10 (2005).
-
Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, Surrenti C, Casini A. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism.
Hepatology 41: 1074-1084 (2005).
*
-
Galli M, Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests.
Semin. Thromb. Hemost. 31: 17-24 (2005).
-
Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances.
Annu. Rev. Immunol. 23: 749-786 (2005).
*
-
Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses.
Nat. Immunol. 6: 135-142 (2005).
*
-
Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis.
Gastroenterology 129: 1445-1453 (2005).
*
-
Galvani AP, Novembre J. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
Microbes Infect. 7: 302-309 (2005).
*
-
Galvez J, Rodriguez-Cabezas ME, Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease.
Mol. Nutr. Food Res. 49: 601-608 (2005).
*
-
Gambelunghe G, Gerli R, Bartoloni Bocci E, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Rheumatology (Oxford) 44: 287-292 (2005).
*
-
Gambelunghe G, Kockum I, Bini V, Giorgi GD, Celi F, Betterle C, Giordano R, Libe R, Falorni A. Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease.
Diabetes 54: 900-905 (2005).
*
-
Gan HT, Chen YQ, Ouyang Q. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
J. Gastroenterol. Hepatol. 20: 1016-1024 (2005).
*
-
Gan JH, Zhou XQ, Qin AL, Luo EP, Zhao WF, Yu H, Xu J. Hybrid artificial liver support system for treatment of severe liver failure.
World J. Gastroenterol. 11: 890-894 (2005).
*
-
Gangloff M, Weber AN, Gay NJ. Conserved mechanisms of signal transduction by Toll and Toll-like receptors.
J. Endotoxin Res. 11: 294-298 (2005).
*
-
Gannot G, Tangrea MA, Gillespie JW, Erickson HS, Wallis BS, Leakan RA, Knezevic V, Hartmann DP, Chuaqui RF, Emmert-Buck MR. Layered peptide arrays: high-throughput antibody screening of clinical samples.
J. Mol. Diagn. 7: 427-436 (2005).
*
-
Ganor Y, Freilinger M, Dulac O, Levite M. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
Autoimmunity 38: 139-150 (2005).
-
Ganor Y, Goldberg-Stern H, Blank M, Shoenfeld Y, Dobrynina LA, Kalashnikova L, Levite M. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
Autoimmunity 38: 417-424 (2005).
-
Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages.
Best Pract. Res. Clin. Haematol. 18: 171-182 (2005).
-
Gao B. Cytokines, STATs and liver disease.
Cell. Mol. Immunol. 2: 92-100 (2005).
*
-
Gao D, Wagner AH, Fankhaenel S, Stojanovic T, Schweyer S, Panzner S, Hecker M. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis.
Gut 54: 70-77 (2005).
*
-
Gao IK, Haas-Wohrle A, Mueller KG, Lorenz HM, Fiehn C. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?
Ann. Rheum. Dis. 64: 1516-1517 (2005).
*
-
Gao LH, Zheng SS, Zhu YF, Wang YL, Wei GQ, Qian SQ, Jiang WJ. A rat model of chronic allograft liver rejection.
Transplant. Proc. 37: 2327-2332 (2005).
*
-
Gao M, Cao Q, Luo LH, Wu ML, Hu WL, Si JM. NOD2/CARD15 gene polymorphisms and susceptibility to Crohn's disease in Chinese Han population.
Zhonghua Nei Ke Za Zhi 44: 210-212 (2005).
-
Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.
Development 132: 3431-3443 (2005).
*
-
Gao PS, Mathias RA, Plunkett B, Togias A, Barnes KC, Beaty TH, Huang SK. Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population.
J. Allergy Clin. Immunol. 115: 982-988 (2005).
*
-
Gao Q, Meijer MJ, Kubben FJ, Sier CF, Kruidenier L, van Duijn W, van den Berg M, van Hogezand RA, Lamers CB, Verspaget HW. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.
Dig. Liver Dis. 37: 584-592 (2005).
-
Gao X, Hu PJ, He Y, Liao SY, Peng S, Chen MH. Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Zhonghua Nei Ke Za Zhi 44: 428-430 (2005).
-
Gao XH, Barnardo MC, Winsey S, Ahmad T, Cook J, Agudelo JD, Zhai N, Powell JJ, Fuggle SV, Wojnarowska F. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated …
J. Invest. Dermatol. 125: 895-899 (2005).
*
-
Gao Y, Ye H, Yu F, Guo XH, Zhao MH. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
Clin. Immunol. 117: 87-93 (2005).
*
-
Garberg H, Jonsson R, Brokstad KA. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjogren's syndrome patients and healthy controls.
Scand. J. Rheumatol. 34: 49-55 (2005).
*
-
Garcea A, Fazi M, Ficari F, Valanzano R, Tonelli F. Are the preoperative histological findings accurate for the choice of the surgical approach in ulcerative colitis associated with colorectal cancer/dysplasia?
Suppl. Tumori. 4: S3 (2005).
-
Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
J. Proteome Res. 4: 2032-2042 (2005).
*
-
Garcia Callejo FJ, Laporta Marin P, Velert Vila MM, Orts Alborch MH, de Paula Vernetta C, Marco Algarra J. Hearing loss associated to ulcerative colitis.
Acta Otorrinolaringol. Esp. 56: 68-73 (2005).
-
Garcia MA, Margarita R, Mirta C, Hugo C, Pablo L, Estela A, de Davila MT. Alagille syndrome: cutaneous manifestations in 38 children.
Pediatr. Dermatol. 22: 11-14 (2005).
-
Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in the general population.
Aliment. Pharmacol. Ther. 22: 309-315 (2005).
*
-
Garcia-Botello SA, Garcia-Armengol J, Garcia-Granero E, Espi A, Juan C, Lopez-Mozos F, Lledo S. A prospective audit of the complications of loop ileostomy construction and takedown.
Dig. Surg. 21: 440-446 (2005).
-
Garcia-Careaga M Jr, Kerner JA Jr. Gastrointestinal manifestations of food allergies in pediatric patients.
Nutr. Clin. Pract. 20: 526-535 (2005).
*
-
Garcia-Garcia AB, Gonzalez C, Real JT, Martin de Llano JJ, Gonzalez-Albert V, Civera M, Chaves FJ, Ascaso JF, Carmena R. Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia.
Pharmacogenet. Genomics 15: 211-218 (2005).
-
Garcia-Lazaro JF, Thieringer F, Luth S, Czochra P, Meyer E, Renteria IB, Galle PR, Lohse AW, Herkel J, Kanzler S. Hepatic over-expression of TGF-beta1 promotes LPS-induced inflammatory cytokine secretion by liver cells and endotoxemic shock.
Immunol. Lett. 101: 217-222 (2005).
-
Garcia-Lopez S, Gomollon-Garcia F, Perez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review.
Gastroenterol. Hepatol. 28: 607-614 (2005).
-
Garcia-Morales I, Herrera-Saval A, Camacho F. Pyoderma gangrenosum over a saphenectomy scar in a cANCA-positive patient with diverticulitis.
Actas. Dermosifiliogr. 96: 258-260 (2005).
-
Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation.
Dis. Colon Rectum 48: 1416-1423 (2005).
*
-
Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis.
J. Hepatol. 42 Suppl. 1: S85-S92 (2005).
*
-
Garcia-Tsao G. Portal hypertension.
Curr. Opin. Gastroenterol. 21: 313-322 (2005).
-
Gardikis S, Antypas S, Kambouri K, Lainakis N, Panagidis A, Deftereos S, Polychronidis A, Dolatzas T, Simopoulos C. The Roux-en-Y procedure in congenital hepato-biliary disorders.
Rom. J. Gastroenterol. 14: 135-140 (2005).
*
-
Gardlik R, Palffy R, Hodosy J, Lukacs J, Turna J, Celec P. Vectors and delivery systems in gene therapy.
Med. Sci. Monit. 11: RA110-RA121 (2005).
*
-
Gardmo C, Kotokorpi P, Helander H, Mode A. Transfection of adult primary rat hepatocytes in culture.
Biochem. Pharmacol. 69: 1805-1813 (2005).
*
-
Gardner OS, Dewar BJ, Graves LM. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of non-genomic signaling.
Mol. Pharmacol. 68: 933-941 (2005).
*
-
Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition and female fertility.
Annu. Rev. Immunol. 23: 337-366 (2005).
*
-
Garrote J, Arranz E, Gomez-Gonzalez E, Leon A, Farre C, Calvo C, Bernardo D, Fernandez-Salazar L, Blanco-Quiros A. IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients.
Allergol. Immunopathol. (Madr.) 33: 245-249 (2005).
-
Gary A, Modeste AB, Richard C, Jubert C, Majour F, Nouvet G, Remond B, Joly P. Methotrexate for the treatment of patients with chronic cutaneous sarcoidosis: 4 cases.
Ann. Dermatol. Venereol. 132: 659-662 (2005).
-
Gasbarrini A, Franceschi F. Does H. pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases?
Am. J. Gastroenterol. 100: 1271-1273 (2005).
*
-
Gasche C, Goel A, Natarajan L, Boland CR. Mesalazine improves replication fidelity in cultured colorectal cells.
Cancer Res. 65: 3993-3997 (2005).
*
-
Gasche C, Grundtner P. Genotypes and phenotypes in Crohn’s disease: do they help in clinical management?
Gut 54: 162-167 (2005).
*
-
Gasche C, Turetschek K. Value of MR colonography for assessment of inflammatory bowel disease? Believe what you see - see what you believe.
Gut 54: 181-182 (2005).
*
-
Gassull MA, Mane J, Pedrosa E, Cabre E. Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease?
JPEN J. Parenter. Enteral Nutr. 29: S179-S183 (2005).
*
-
Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study.
World J. Gastroenterol. 11: 482-487 (2005).
*
-
Gaudier E, Michel C, Segain JP, Cherbut C, Hoebler C. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice.
J. Nutr. 135: 2753-2761 (2005).
*
-
Gaudio E, Onori P, Franchitto A, Pannarale L, Alpini G, Alvaro D. Hepatic microcirculation and cholangiocyte physiopathology.
Ital. J. Anat. Embryol. 110: 71S-75S (2005).
-
Gauthier-Villars M, Franchi S, Gauthier F, Fabre M, Pariente D, Bernard O. Cholestasis in children with portal vein obstruction.
J. Pediatr. 146: 568-573 (2005).
*
-
Gavin J, Anderson CE, Bremner AR, Beattie RM. Energy intakes of children with Crohn's disease treated with enteral nutrition as primary therapy.
J. Hum. Nutr. Diet. 18: 337-342 (2005).
*
-
Gawronska-Szklarz B, Wrzesniewska J, Starzynska T, Pawlik A, Safranow K, Ferenc K, Drozdzik M. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
Eur. J. Clin. Pharmacol. 61: 375-379 (2005).
*
-
Gay G, Delvaux M, Laurent V, Reibel N, Regent D, Grosdidier G, Roche JF. Temporary intestinal occlusion induced by a "patency capsule" in a patient with Crohn's disease.
Endoscopy 37: 174-177 (2005).
-
Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, Liddell C, Stanley AJ, Morris AJ, Mackenzie JF. Faecal calprotectin in the assessment of Crohn's disease activity.
QJM 98: 435-441 (2005).
*
-
Gaya DR, Oien KA, Stanley AJ, Morris AJ. Bleeding gastric varices and antiphospholipid syndrome.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 156-159 (2005).
*
-
Gazit E, Loewenthal R. The immunogenetics of pemphigus vulgaris.
Autoimmun. Rev. 4: 16-20 (2005).
*
-
Gazouli M, Mantzaris G, Archimandritis AJ, Nasioulas G, Anagnou NP. Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.
World J. Gastroenterol. 11: 7525-7530 (2005).
*
-
Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
World J. Gastroenterol. 11: 681-685 (2005).
*
-
Gazulla J, Benavente I, Ricoy J, Madero P. Myopathy with trabecular fibers associated with familiar autoinmune polyglandular syndrome type 1.
Neurologia 20: 702-708 (2005).
-
Ge X, Uzunel M, Ericzon BG, Sumitran-Holgersson S. Biliary epithelial cell antibodies induce expression of Toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis?
Liver Transpl. 11: 911-921 (2005).
*
-
Ge Z, Feng Y, Whary MT, Nambiar PR, Xu S, Ng V, Taylor NS, Fox JG. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice.
Infect. Immun. 73: 3559-3567 (2005).
*
-
Gearry RB, Aitken J, Roberts R, Ismail S, Keenan J, Barclay M. Mycobacterium avium paratuberculosis and Crohn's disease.
J. Gastroenterol. Hepatol. 20: 1943 (2005).
*
-
Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
J. Gastroenterol. Hepatol. 20: 1149-1157 (2005).
*
-
Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Intern. Med. J. 35: 580-585 (2005).
*
-
Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.
Gut 54: 928-934 (2005).
*
-
Geboes K. Appendiceal function and dysfunction: what are the implications for inflammatory bowel disease?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 338-339 (2005).
*
-
Geboes K, Rutgeerts P, Opdenakker G, Olson A, Patel K, Wagner CL, Marano CW. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
Curr. Med. Res. Opin. 21: 1741-1754 (2005).
-
Geddes D. Translational research - from gene to treatment: lessons from cystic fibrosis.
Clin. Med. 5: 258-263 (2005).
-
Geeraerts B, Vandenberghe J, Van Oudenhove L, Gregory LJ, Aziz Q, Dupont P, Demyttenaere K, Janssens J, Tack J. Influence of experimentally induced anxiety on gastric sensorimotor function in humans.
Gastroenterology 129: 1437-1444 (2005).
*
-
Geetha A, Surendran R. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein.
Pharmazie 60: 609-613 (2005).
-
Geha RS. Role of APRIL in the mucosal Iga antibody response.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S27 (2005).
*
-
Gehling UM, Willems M, Dandri M, Petersen J, Berna M, Thill M, Wulf T, Muller L, Pollok JM, Schlagner K, Faltz C, Hossfeld DK, Rogiers X. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors.
J. Hepatol. 43: 845-853 (2005).
*
-
Gehrig-Burger K, Kohout L, Gimpl G. CHAPSTEROL. A novel cholesterol-based detergent.
FEBS J. 272: 800-812 (2005).
*
-
Gehrke S, Pietrangelo A, Kascak M, Braner A, Eisold M, Kulaksiz H, Herrmann T, Hebling U, Bents K, Gugler R, Stremmel W. HJV gene mutations in European patients with juvenile hemochromatosis.
Clin. Genet. 67: 425-428 (2005).
*
-
Geier A, Dietrich CG, Grote T, Beuers U, Prufer T, Fraunberger P, Matern S, Gartung C, Gerbes AL, Bilzer M. Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat.
J. Hepatol. 43: 1021-1030 (2005).
*
-
Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, Suchy FJ, Matern S, Gartung C. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G831-G841 (2005).
*
-
Geier A, Gartung C, Theurl I, Weiss G, Lammert F, Dietrich CG, Weiskirchen R, Zoller H, Hermanns B, Matern S. Occult celiac disease prevents penetrance of hemochromatosis.
World J. Gastroenterol. 11: 3323-3326 (2005).
*
-
Geier A, Zollner G, Dietrich CG, Wagner M, Fickert P, Denk H, van Rooijen N, Matern S, Gartung C, Trauner M. Cytokine-independent repression of rodent Ntcp in obstructive cholestasis.
Hepatology 41: 470-477 (2005).
*
-
Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization.
Autoimmunity 38: 295-301 (2005).
-
Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA. HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome.
Neurology 64: 44-49 (2005).
-
Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States.
J. Am. Acad. Dermatol. 53: 573 (2005).
-
Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. The prevalence of psoriasis in African Americans: results from a population-based study.
J. Am. Acad. Dermatol. 52: 23-26 (2005).
-
Gelinas DS, McLaurin J. PPAR-alpha expression inversely correlates with inflammatory cytokines IL-1beta and TNF-alpha in aging rats.
Neurochem. Res. 30: 1369-1375 (2005).
*
-
Gellert K, Bottger J, Martin T, Werner J, Mangler C, Martin H. Thoracoscopic thymectomy in the treatment concept for myasthenia gravis.
Surg. Technol. Int. 14: 99-104 (2005).
-
Gelman L, Michalik L, Desvergne B, Wahli W. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.
Curr. Opin. Cell Biol. 17: 216-222 (2005).
*
-
Genovese MC, Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J, Birbara C, Box J, Natarajan K, Nuamah I, Li T, Aranda R, Hagerty DT, Dougados M. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
N. Engl. J. Med. 353: 1114-1123 (2005).
*
-
Genovese T, Mazzon E, Di Paola R, Muia C, Crisafulli C, Caputi AP, Cuzzocrea S. Role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor-alpha in the development of bleomycin-induced lung injury.
Shock 24: 547-555 (2005).
*
-
Gensch K, Gudowius S, Niehues T, Kuhn A. Connective tissue diseases in childhood.
Hautarzt. 56: 925-936 (2005).
-
Gentili C, Tutolo G, Pianezzi A, Cancedda R, Descalzi Cancedda F. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression.
Matrix Biol. 24: 35-44 (2005).
-
Gentilucci UV, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.
Aliment. Pharmacol. Ther. 21: 1063-1071 (2005).
*
-
Genton L, Kudsk KA, Reese SR, Ikeda S. Enteral feeding preserves gut Th-2 cytokines despite mucosal cellular adhesion molecule-1 blockade.
JPEN J. Parenter. Enteral Nutr. 29: 44-47 (2005).
*
-
George AJ, Stark J, Chan C. Understanding specificity and sensitivity of T-cell recognition.
Trends Immunol. 26: 653-659 (2005).
*
-
Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B. A Toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria.
Infect. Immun. 73: 4512-4521 (2005).
*
-
Geppert J, Kraft V, Demmelmair H, Koletzko B. Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial.
Lipids 40: 807-814 (2005).
-
Gerard L, Garey KW, Dupont HL. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.
Expert Rev. Anti. Infect. Ther. 3: 201-211 (2005).
-
Gergely P Jr, Pullmann R, Stancato C, Otvos L Jr, Koncz A, Blazsek A, Poor G, Brown KE, Phillips PE, Perl A. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
Clin. Immunol. 116: 124-134 (2005).
*
-
Gerhard M, Schmees C, Voland P, Endres N, Sander M, Reindl W, Rad R, Oelsner M, Decker T, Mempel M, Hengst L, Prinz C. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells.
Gastroenterology 128: 1327-1339 (2005).
*
-
Gerhardt T, Wolff M, Fischer HP, Sauerbruch T, Reichel C. Pitfalls in the diagnosis of intestinal tuberculosis: a case report.
Scand. J. Gastroenterol. 40: 240-243 (2005).
*
-
Gerk PM, Vore M. The ileocyte basolateral organic solute transporter (OSTalpha-OSTbeta) complex: finding the missing link in enterohepatic circulation.
Mol. Interv. 5: 8-10 (2005).
*
-
Gerl V, Hostmann B, Johnen C, Waka A, Gerl M, Schumann F, Klein R, Radbruch A, Hiepe F. The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I.
Arthritis Rheum. 52: 531-538 (2005).
*
-
Gerli G, Vanelli C, Turri O, Erario M, Gardellini A, Pugliano M, Biondi ML. SDF1-3'A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events.
Clin. Chem. 51: 2411-2414 (2005).
*
-
Gerli R, Goodson NJ. Cardiovascular involvement in rheumatoid arthritis.
Lupus 14: 679-682 (2005).
-
German V, Vassiloyanakopoulos A, Sampaziotis D, Giannakos G. Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy.
Scand. J. Infect. Dis. 37: 148-151 (2005).
*
-
Germano V, Picchianti Diamanti A, Baccano G, Natale E, Onetti Muda A, Priori R, Valesini G. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis.
Ann. Rheum. Dis. 64: 1519-1520 (2005).
*
-
Germenis AE, Yiannaki EE, Zachou K, Roka V, Barbanis S, Liaskos C, Adam K, Kapsoritakis AN, Potamianos S, Dalekos GN. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.
Clin. Diagn. Lab. Immunol. 12: 941-948 (2005).
*
-
Gerritsen ME. Genetic variations in vascular endothelial growth factor and endothelial nitric oxide synthase and their contributions to human disease.
Microcirculation 12: 129-140 (2005).
-
Gershon MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome.
J. Clin. Gastroenterol. 39: S184-S193 (2005).
-
Gershwin ME. The immunopathology of primary biliary cirrhosis: unraveling the mystery of etiology.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 61 (2005). *
-
Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM, USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.
Hepatology 42: 1194-1202 (2005).
*
-
Gershwin ME, Vierling JM. Primary biliary cirrhosis.
Semin. Liver Dis. 25: 237 (2005).
-
Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations.
Ther. Drug Monit. 27: 819-821 (2005).
-
Gescuk B, Wu AJ, Whitcher JP, Daniels TE, Lund S, Fye K, Davis Jr JC. Lamivudine is not effective in primary Sjogren's syndrome.
Ann. Rheum. Dis. 64: 1326-1330 (2005).
*
-
Getliffe KM, Al Dulaimi D, Martin-Ruiz C, Holder RL, von Zglinicki T, Morris A, Nwokolo CU. Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
Aliment. Pharmacol. Ther. 21: 121-131 (2005).
*
-
Getz GS. Thematic review series: the immune system and atherogenesis. Bridging the innate and adaptive immune systems.
J. Lipid Res. 46: 619-622 (2005).
*
-
Geuken E, Buis CI, Visser DS, Blokzijl H, Moshage H, Nemes B, Leuvenink HG, de Jong KP, Peeters PM, Slooff MJ, Porte RJ. Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation.
Am. J. Transplant. 5: 1875-1885 (2005).
*
-
Geuken E, Visser DS, Leuvenink HG, de Jong KP, Peeters PM, Slooff MJ, Kuipers F, Porte RJ. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
Hepatology 42: 1166-1174 (2005).
*
-
Geurts P, Fillet M, de Seny D, Meuwis MA, Malaise M, Merville MP, Wehenkel L. Proteomic mass spectra classification using decision tree based ensemble methods.
Bioinformatics 21: 3138-3145 (2005).
*
-
Gewirtz A. Lipoxin analogs: novel anti-inflammatory mediators.
Curr. Opin. Investig. Drugs 6: 1112-1115 (2005).
-
Gewirtz AT, Sitaraman SV. Technology evaluation: alicaforsen (Isis).
Curr. Opin. Mol. Ther. 7: 273-281 (2005).
-
Geyer J, Doring B, Godoy JR, Leidolf R, Moritz A, Petzinger E. Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany.
J. Vet. Pharmacol. Ther. 28: 545-551 (2005).
*
-
Ghafoorunissa, Ibrahim A, Rajkumar L, Acharya V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats.
J. Nutr. 135: 2634-2638 (2005).
*
-
Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleau D, Peltekian K, Metrakos P, Deschenes M. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.
Liver Transpl. 11: 1412-1416 (2005).
*
-
Ghandil P, Chelala C, Dubois-Laforgue D, Senee V, Caillat-Zucman S, Kockum I, Luthman H, Nerup J, Pociot F, Timsit J, Julier C. Crohn's disease associated CARD15 (NOD2) variants are not involved in the susceptibility to type 1 diabetes.
Mol. Genet. Metab. 86: 379-383 (2005).
*
-
Ghanem E, Robaye B, Leal T, Leipziger J, Van Driessche W, Beauwens R, Boeynaems JM. The role of epithelial P2Y(2) and P2Y(4) receptors in the regulation of intestinal chloride secretion.
Br. J. Pharmacol. 146: 364-369 (2005).
*
-
Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, Ghaderi A. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Immunol. Lett. 96: 277-281 (2005).
-
Ghavami S, Hashemi M, Kadkhoda K, Alavian SM, Bay GH, Los M. Apoptosis in liver diseases - detection and therapeutic applications.
Med. Sci. Monit. 11: RA337-RA345 (2005).
*
-
Gheorghe E, Adumitresi C, Botnarciuc M, Manea M. Histochemical study of the skin affected by certain autoimmune diseases.
Rom. J. Morphol. Embryol. 46: 73-78 (2005).
-
Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target.
Mol. Biotechnol. 31: 239-244 (2005).
-
Ghirardo S, Sauter B, Levy G, Fiel IM, Schiano T, Gondolesi G. Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction.
Gut 54: 1206-1207 (2005).
*
-
Ghisletti S, Meda C, Maggi A, Vegeto E. 17beta-Estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization.
Mol. Cell. Biol. 25: 2957-2968 (2005).
*
-
Ghonaim M, Al-Ghamdi A, El-Bana H, Bakr A, Ghoneim E, El-Edel R, Hassona M, Shoeib S, Allam H. Autoantibodies in chronic liver disease.
Egypt. J. Immunol. 12: 101-111 (2005).
-
Ghose R. Vitamin D deficiency and chronic autoimmune disease.
N. Z. Med. J. 118: U1275 (2005).
-
Ghosh JB, Gupta D. Chorea and microphonia as presenting feature of SLE.
Indian J. Pediatr. 72: 85 (2005).
*
-
Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
BMC Med. Genet. 6: 11 (2005).
*
-
Giaccone L, Martin P, Carpenter P, Moravec C, Hooper H, Funke VA, Storb R, Flowers ME. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease.
Bone Marrow Transplant. 36: 337-341 (2005).
*
-
Giacconi R, Cipriano C, Muti E, Costarelli L, Maurizio C, Saba V, Gasparini N, Malavolta M, Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc.
Biogerontology 6: 407-413 (2005).
*
-
Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin.
Circ. Res. 96: 717-722 (2005).
*
-
Giagounidis AA, Haase S, Germing U, Heinsch M, Aul C. Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.
Acta Haematol. 113: 146-149 (2005).
-
Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005.
Immunol. Rev. 204: 232-249 (2005).
*
-
Gianfrani C, Auricchio S, Troncone R. Adaptive and innate immune responses in celiac disease.
Immunol. Lett. 99: 141-145 (2005).
-
Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, Margaritis G, Christofilakis C. Stauffer's syndrome variant associated with renal cell carcinoma.
Int. J. Urol. 12: 757-759 (2005).
-
Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
Gastroenterology 129: 1375-1383 (2005).
*
-
Giannini EG, Kane SV, Testa R, Savarino V. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
Dig. Liver Dis. 37: 723-731 (2005).
-
Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians.
CMAJ 172: 367-379 (2005).
*
-
Giannoukakis N, Trucco M. Gene therapy for type 1 diabetes.
Am. J. Ther. 12: 512-528 (2005).
-
Giannoukakis N, Trucco M. Gene therapy for type 1 diabetes: a proposal to move to the next level.
Curr. Opin. Mol. Ther. 7: 467-475 (2005).
-
Gibbons LJ, Thomson W, Zeggini E, Worthington J, Barton A, Eyre S, Donn R, Hinks A. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis.
Rheumatology (Oxford) 44: 1390-1393 (2005).
*
-
Giboney PT. Mildly elevated liver transaminase levels in the asymptomatic patient.
Am. Fam. Physician 71: 1105-1110 (2005).
*
-
Gibson PR, Iser J. Flammatory bowel disease.
Aust. Fam. Physician 34: 233-237 (2005).
-
Gibson PR, Muir JG. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?
Gut 54: 900-903 (2005).
*
-
Gibson PR, Shepherd SJ. Personal view: food for thought - western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis.
Aliment. Pharmacol. Ther. 21: 1399-1409 (2005).
*
-
Gijsbers K, Geboes K, Van Damme J. Chemokines in gastrointestinal disorders.
Curr. Drug Targets 6: 47-64 (2005).
-
Giles JT, Fernandes V, Lima JA, Bathon JM. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.
Arthritis Res. Ther. 7: 195-207 (2005).
*
-
Giliani S, Mella P, Savoldi G, Mazzolari E. Cytokine-mediated signalling and early defects in lymphoid development.
Curr. Opin. Allergy Clin. Immunol. 5: 519-524 (2005).
-
Gilissen LP, Bierau J, Derijks LJ, Bos LP, Hooymans PM, Gennip A, Stockbrugger RW, Engels LG. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
Aliment. Pharmacol. Ther. 22: 605-611 (2005).
*
-
Gill KR, Mahadevan U. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
Inflamm. Bowel Dis. 11: 210-212 (2005).
*
-
Gill RK, Saksena S, Tyagi S, Alrefai WA, Malakooti J, Sarwar Z, Turner JR, Ramaswamy K, Dudeja PK. Serotonin inhibits Na+/H+ exchange activity via 5-HT4 receptors and activation of PKCalpha in human intestinal epithelial cells.
Gastroenterology 128: 962-974 (2005).
*
-
Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Semin. Oncol. 32: 24-34 (2005).
*
-
Gillard SE, Finlay AY. Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care.
Int. J. Clin. Pract. 59: 1260-1267 (2005).
*
-
Gillett CD, Langefeld CD, Williams AH, Ortmann WA, Graham RR, Rodine PR, Selby SA, Gaffney PM, Behrens TW, Moser KL. Fine mapping chromosome 16q12 in a collection of 231 systemic lupus erythematosus sibpair and multiplex families.
Genes Immun. 6: 19-23 (2005).
*
-
Gilmore S. Modelling skin disease: lessons from the worlds of mathematics, physics and computer science.
Australas. J. Dermatol. 46: 61-69 (2005).
-
Ginaldi L, De Martinis M, Monti D, Franceschi C. Chronic antigenic load and apoptosis in immunosenescence.
Trends Immunol. 26: 79-84 (2005).
*
-
Ginn SL, Curtin JA, Kramer B, Smyth CM, Wong M, Kakakios A, McCowage GB, Watson D, Alexander SI, Latham M, Cunningham SC, Zheng M, Hobson L, Rowe PB, Fischer A, Cavazzana-Calvo M, Hacein-Bey-Abina S, Alexander IE. Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia.
Med. J. Aust. 182: 458-463 (2005).
-
Ginsburg PM, Bayless TM. Managing functional disturbances in patients with inflammatory bowel disease.
Curr. Treat. Options Gastroenterol. 8: 211-221 (2005).
-
Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management.
Liver Transpl. 11: 881-890 (2005).
*
-
Gionchetti P, D'arienzo A, Rizzello F, Manguso F, Maieron R, Lecis PE, Valpiani D, Iaquinto G, Annese V, Balzano A, Varoli G, Campieri M; and the Italian BDP Study Group. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
J. Clin. Gastroenterol. 39: 291-297 (2005).
-
Gionchetti P, Lammers KM, Rizzello F, Campieri M. Probiotics and barrier function in colitis.
Gut 54: 898-900 (2005).
*
-
Gionchetti P, Lammers KM, Rizzello F, Campieri M. VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.
Gastroenterol. Clin. North Am. 34: 499-513, ix-x (2005).
-
Gionchetti P, Rizzello F, Morselli C, Romagnoli R, Campieri M. Management of inflammatory bowel disease: does rifaximin offer any promise?
Chemotherapy 51 Suppl. 1: 96-102 (2005).
-
Giordano N, Amendola A, Papakostas P, Cipolli F, Agate VM, Battisti E, Marchi B, Nuti R. Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature.
New Microbiol. 28: 311-317 (2005).
-
Giordano RJ, Anobom CD, Cardo-Vila M, Kalil J, Valente AP, Pasqualini R, Almeida FC, Arap W. Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors.
Chem. Biol. 12: 1075-1083 (2005).
*
-
Giorgini A, Selmi C, Invernizzi P, Podda M, Zuin M, Gershwin ME. Primary biliary cirrhosis: solving the enigma.
Ann. N. Y. Acad. Sci. 1051: 185-193 (2005).
*
-
Giraldo A, Gomez A, Salguero G, Garcia H, Aristizabal F, Gutierrez O, Angel LA, Padron J, Martinez C, Martinez H, Malaver O, Florez L, Barvo R. MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome) - description of four novel mutations.
Fam. Cancer 4: 285-290 (2005).
*
-
Girard H, Thibaudeau J, Court MH, Fortier LC, Villeneuve L, Caron P, Hao Q, von Moltke LL, Greenblatt DJ, Guillemette C. UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver.
Hepatology 42: 448-457 (2005).
*
-
Girard M. Autoimmune hazards of hepatitis B vaccine.
Autoimmun. Rev. 4: 96-100 (2005).
-
Girardin SE, Jehanno M, Mengin-Lecreulx D, Sansonetti PJ, Alzari PM, Philpott DJ. Identification of the critical residues involved in peptidoglycan detection by Nod1.
J. Biol. Chem. 280: 38648-38656 (2005).
*
-
Girlanda R, Rela M, Williams R, O'Grady JG, Heaton ND. Long-term outcome of immunosuppression withdrawal after liver transplantation.
Transplant. Proc. 37: 1708-1709 (2005).
*
-
Girlanda R, Vilca-Melendez H, Srinivasan P, Muiesan P, O'Grady JG, Rela M, Heaton ND. Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure.
Transplant. Proc. 37: 1720-1721 (2005).
*
-
Gironella M, Iovanna JL, Sans M, Gil F, Penalva M, Closa D, Miquel R, Pique JM, Panes J. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gut 54: 1244-1253 (2005).
*
-
Girones N, Cuervo H, Fresno M. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
Curr. Top. Microbiol. Immunol. 296: 89-123 (2005).
-
Girouard J, Reyes-Moreno C, Darveau A, Akoum A, Mourad W. Requirement of the extracellular cysteine at position six for CD40/CD40 dimer formation and CD40-induced IL-8 expression.
Mol. Immunol. 42: 773-780 (2005).
*
-
Giruadi PJ, Rodriguez JV. What is the meaning of cellular viability.
Ann. Hepatol. 4: 227-229 (2005).
-
Gisbert JP, Gomollon F, Cara C, Luna M, Gonzalez-Lama Y, Pajares JM, Mate J, Guijarro LG. Thiopurine methyltransferase activity in the inflammatory bowel disease. A study on 7046 Spanish patients.
Med. Clin. (Barc.) 125: 281-285 (2005).
-
Gisondi P, Ellis CN, Girolomoni G. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Int. J. Clin. Pract. 59: 969-974 (2005).
*
-
Giuliante F, Gauzolino R, Vellone M, Ardito F, Murazio M, Nuzzo G. Liver resection for intrahepatic cholangiocarcinoma.
Tumori. 91: 487-492 (2005).
*
-
Giuly E, Pesenti C, N Pernoud, Bories E, Francon D. Air embolism: an unusual complication of endoscopic retrogradecholangiopancreatography.
Ann. Fr. Anesth. Reanim. 24: 1400-1403 (2005).
-
Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, Percevault F, Sevestre H, Krimpenfort P, Corsini A, Rochette J, Glineur C, Fruchart JC, Torpier G, Staels B. PPARalpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16.
J. Clin. Invest. 115: 3228-3238 (2005).
*
-
Gladman DD. Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.
Drugs 65: 1223-1238 (2005).
-
Gladman DD. Consensus exercise on domains in psoriatic arthritis.
Ann. Rheum. Dis. 64 Suppl. 2: ii113-ii114 (2005).
*
-
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
Ann. Rheum. Dis. 64 Suppl. 2: ii14-ii17 (2005).
*
-
Gladman DD, Farewell VT. Longitudinal cohort studies.
J. Rheumatol. Suppl. 72: 30-32 (2005).
-
Gladman DD, Ritchlin C, Helliwell PS. Psoriatic arthritis clinical registries and genomics.
Ann. Rheum. Dis. 64 Suppl. 2: ii103-ii105 (2005).
*
-
Gladman DD, Strand V, Mease PJ, Antoni C, Nash P, Kavanaugh A. OMERACT 7 psoriatic arthritis workshop: synopsis.
Ann. Rheum. Dis. 64 Suppl. 2: ii115-ii116 (2005).
*
-
Gladman MA, Dvorkin LS, Lunniss PJ, Williams NS, Scott SM. Rectal hyposensitivity: a disorder of the rectal wall or the afferent pathway? An assessment using the barostat.
Am. J. Gastroenterol. 100: 106-114 (2005).
*
-
Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
Hepatology 42: 1399-1405 (2005).
*
-
Glas J, Torok HP, Daczo J, Tonenchi L, Folwaczny M, Folwaczny C. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
Eur. J. Med. Res. 10: 535-538 (2005).
-
Glas J, Torok HP, Tonenchi L, Kapser J, Schiemann U, Muller-Myhsok B, Folwaczny M, Folwaczny C. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype.
Inflamm. Bowel Dis. 11: 1031-1037 (2005).
*
-
Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health.
Nat. Rev. Immunol. 5: 243-251 (2005).
*
-
Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.
Nature 434: 644-648 (2005).
*
-
Glastras SJ, Craig ME, Verge CF, Chan AK, Cusumano JM, Donaghue KC. The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications.
Diabetes Care 28: 2170-2175 (2005).
*
-
Glastras SJ, Mohsin F, Donaghue KC. Complications of diabetes mellitus in childhood.
Pediatr. Clin. North Am. 52: 1735-1753 (2005).
-
Glazier KD, Palance AL, Griffel LH, Das KM. The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
J. Clin. Gastroenterol. 39: 21-26 (2005).
-
Glazier RH, Badley EM, Lineker SC, Wilkins AL, Bell MJ. Getting a grip on arthritis: an educational intervention for the diagnosis and treatment of arthritis in primary care.
J. Rheumatol. 32: 137-142 (2005).
-
Gleeson F, Clarke E, Kelly S, Hargadan G, Kenny E, Macmathuna P, Lennon J. Diagnosis by EUS trucut biopsy of extrapulmonary tuberculosis in a patient with Crohn's disease treated with infliximab.
Gastrointest. Endosc. 61: 489-492 (2005).
*
-
Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, Salame E, Piquet MA, Dao T. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea.
Eur. J. Gastroenterol. Hepatol. 17: 1135-1137 (2005).
-
Glossop JR, Dawes PT, Hassell AB, Mattey DL. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
J. Rheumatol. 32: 1673-1678 (2005).
-
Glossop JR, Dawes PT, Nixon NB, Mattey DL. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Arthritis Res. Ther. 7: R1227-R1234 (2005).
*
-
Glover DJ, Lipps HJ, Jans DA. Towards safe, non-viral therapeutic gene expression in humans.
Nat. Rev. Genet. 6: 299-310 (2005).
*
-
Gluck T, Kiefmann B, Grohmann M, Falk W, Straub RH, Scholmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy.
J. Rheumatol. 32: 1473-1480 (2005).
-
Glueck CJ, Pranikoff J, Aregawi D, Haque M, Zhu B, Tracy T, Wang P. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.
Metabolism 54: 1345-1349 (2005).
-
Gluud C. Mortality from cirrhosis: lack of progress over the last 35 years.
Gut 54: 1523-1526 (2005).
*
-
Gluud LL, Sorensen TI, Gotzsche PC, Gluud C. The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials.
Am. J. Gastroenterol. 100: 2431-2435 (2005).
*
-
Gnerre C, Schuster GU, Roth A, Handschin C, Johansson L, Looser R, Parini P, Podvinec M, Robertsson K, Gustafsson JA, Meyer UA. LXR deficiency and cholesterol feeding affect expression and phenobarbital mediated induction of cytochromes P450 in mouse liver.
J. Lipid Res. 46: 1633-1642 (2005).
*
-
Go EK, Jung KJ, Kim JY, Yu BP, Chung HY. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases.
J. Gerontol. A. Biol. Sci. Med. Sci. 60: 1252-1264 (2005).
-
Godde R, Rohde K, Becker C, Toliat MR, Entz P, Suk A, Muller N, Sindern E, Haupts M, Schimrigk S, Nurnberg P, Epplen JT. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.
J. Mol. Med. 83: 486-494 (2005).
*
-
Godefroy C, Pilleul F, Dugougeat F, Yzebe D, Lachaux A, Pracros J, Valette P. Value of contrast-enhanced MR enterography in pediatric Crohn's disease: preliminary study.
J. Radiol. 86: 1685-1692 (2005).
-
Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.
Hepatology 41: 1383-1390 (2005).
*
-
Goeb V, Dieude P, Vittecoq O, Mejjad O, Menard JF, Thomas M, Gilbert D, Boumier P, Pouplin S, Daragon A, Fardellone P, Tron F, Cornelis F, Le Loet X. Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis.
Arthritis Res. Ther. 7: R1056-R1062 (2005).
*
-
Goek ON, Stone JH. Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.
Curr. Opin. Rheumatol. 17: 257-264 (2005).
-
Goel NK, McBane RD, Kamath PS. Cardiomyopathy associated with celiac disease.
Mayo Clin. Proc. 80: 674-676 (2005).
*
-
Goessling W, Friedman LS. Increased liver chemistry in an asymptomatic patient.
Clin. Gastroenterol. Hepatol. 3: 852-858 (2005).
*
-
Goetzman ES, Tian L, Wood PA. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
Mol. Genet. Metab. 84: 39-47 (2005).
*
-
Goffe B, Papp K, Gratton D, Krueger GG, Darif M, Lee S, Bozic C, Sweetser MT, Ticho B. An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy.
Clin. Ther. 27: 1912-1921 (2005).
*
-
Gogalniceanu D, Trandafir V, Chiriac R, Gogalniceanu P. Temporomandibular joint ankylosis. A possible complication in juvenile psoriatic rheumatism.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 109: 652-659 (2005).
-
Gogolauri M, Antelava N. Effect of heptral and folic acid on the hepatic functions during toxic hepatitis.
Georgian Med. News 6: 57-60 (2005).
-
Goh BK. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.
Gastroenterology 128: 1529 (2005).
*
-
Goh KL, Quek KF, Yeo GT, Hilmi IN, Lee CK, Hasnida N, Aznan M, Kwan KL, Ong KT. Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy.
Aliment. Pharmacol. Ther. 22: 859-864 (2005)..
*
-
Goichot B, Vinzio S. Diagnostic accuracy in systemic autoimmune diseases.
Arch. Intern. Med. 165: 1438-1439 (2005).
*
-
Gokhale NR, Belgaumkar VA, Pandit DP, Deshpande S, Damle DK. A study of serum nitric oxide levels in psoriasis.
Indian J. Dermatol. Venereol. Leprol. 71: 175-178 (2005).
*
-
Golczak M, Kuksa V, Maeda T, Moise AR, Palczewski K. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle.
Proc. Natl. Acad. Sci. U.S.A. 102: 8162-8167 (2005).
*
-
Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C. The role of stress-response systems for the pathogenesis and progression of MS.
Trends Immunol. 26: 644-652 (2005).
*
-
Goldblatt F, Isenberg DA. New therapies for systemic lupus erythematosus.
Clin. Exp. Immunol. 140: 205-212 (2005).
*
-
Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.
J. Clin. Endocrinol. Metab. 90: 4904-4911 (2005).
*
-
Goldenberg G, Jorizzo JL. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.
J. Dermatolog. Treat. 16: 347-349 (2005).
-
Goldsmith DR, Wagstaff AJ. Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritis.
Am. J. Clin. Dermatol. 6: 121-136 (2005).
-
Goldsmith DR, Wagstaff AJ. Spotlight on etanercept in plaque psoriasis and psoriatic arthritis.
BioDrugs 19: 401-403 (2005).
-
Gomariz RP, Arranz A, Abad C, Torroba M, Martinez C, Rosignoli F, Garcia-Gomez M, Leceta J, Juarranz Y. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.
J. Leukoc. Biol. 78: 491-502 (2005).
*
-
Gombert M, Dieu-Nosjean MC, Winterberg F, Bunemann E, Kubitza RC, Da Cunha L, Haahtela A, Lehtimaki S, Muller A, Rieker J, Meller S, Pivarcsi A, Koreck A, Fridman WH, Zentgraf HW, Pavenstadt H, Amara A, Caux C, Kemeny L, Alenius H, Lauerma A, et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
J. Immunol. 174: 5082-5091 (2005).
*
-
Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions.
Curr. Opin. Allergy Clin. Immunol. 5: 309-316 (2005).
-
Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A, Martin J. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases.
Genes Immun. 6: 628-631 (2005).
*
-
Gomez LM, Anaya JM, Martin J. Genetic influence of PTPN22 R620W polymorphism in tuberculosis.
Hum. Immunol. 66: 1242-1247 (2005).
-
Gomez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
Medicine (Baltimore) 84: 225-230 (2005).
-
Gondim FA, Brannagan TH 3rd, Sander HW, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease.
Brain 128: 867-879 (2005).
*
-
Gong H, Sinz MW, Feng Y, Chen T, Venkataramanan R, Xie W. Animal models of xenobiotic receptors in drug metabolism and diseases.
Methods Enzymol. 400: 598-618 (2005).
-
Gong Q, Ou Q, Ye S, Lee WP, Cornelius J, Diehl L, Lin WY, Hu Z, Lu Y, Chen Y, Wu Y, Meng YG, Gribling P, Lin Z, Nguyen K, Tran T, Zhang Y, Rosen H, Martin F, Chan AC. Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy.
J. Immunol. 174: 817-826 (2005).
*
-
Gong Y, Christensen E, Gluud C. Primary biliary cirrhosis.
N. Engl. J. Med. 353: 2719-2720 (2005).
*
-
Gong Y, Gluud C. Methotrexate for primary biliary cirrhosis.
Cochrane Database Syst. Rev. 3: CD004385 (2005).
*
-
Gong Y, Gluud C. Colchicine for primary biliary cirrhosis: a Cochrane hepato-biliary group systematic review of randomized clinical trials.
Am. J. Gastroenterol. 100: 1-10 (2005).
*
-
Gong YL, Xie DW, Deng ZL, Bostick RM, Miao XJ, Zhang JH, Gong ZH. Vitamin D receptor gene Tru9I polymorphism and risk for incidental sporadic colorectal adenomas.
World J. Gastroenterol. 11: 4794-4799 (2005).
*
-
Gong Z, Jin Y, Zhang Y. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes.
J. Biotechnol. 119: 93-105 (2005).
*
-
Gong Z, Xie D, Deng Z, Bostick RM, Muga SJ, Hurley TG, Hebert JR. The PPARgamma Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
Carcinogenesis 26: 579-585 (2005).
*
-
Gong ZH, Jin HQ, Jin YF, Zhang YZ. Expression of cholera toxin B subunit and assembly as functional oligomers in silkworm.
J. Biochem. Mol. Biol. 38: 717-724 (2005).
*
-
Gonvers JJ, Juillerat P, Mottet C, Felley C, Burnand B, Vader JP, Michetti P, Froehlich F. Maintenance of remission in Crohn's disease.
Digestion 71: 41-48 (2005).
-
Gonwa TA. Combined kidney liver transplant in the MELD era: where are we going?
Liver Transpl. 11: 1022-1025 (2005).
*
-
Gonzalez C, Garcia-Berrocal B, Perez M, Navajo JA, Herraez O, Gonzalez-Buitrago JM. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
Clin. Chim. Acta 359: 109-114 (2005).
*
-
Gonzalez MG, Madrazo CP, Rodriguez AB, Gutierrez MG, Herrero JI, Pallardo JM, Ortiz de Urbina J, Paricio PP. An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: a comparison of dual vs. triple drug therapy.
Liver Transpl. 11: 515-524 (2005).
*
-
Gonzalez-Amaro R, Mittelbrunn M, Sanchez-Madrid F. Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords?
Immunology 116: 289-296 (2005).
*
-
Gonzalez-Gay MA, Oliver J, Orozco G, Garcia-Porrua C, Lopez-Nevot MA, Martin J. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis.
J. Rheumatol. 32: 1510-1512 (2005).
-
Gonzalez-Hevilla M, de Salamanca RE, Morales P, Martinez-Laso J, Fontanellas A, Castro MJ, Rojo R, Moscoso J, Zamora J, Serrano-Vela JI, Arnaiz-Villena A. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
J. Gastroenterol. Hepatol. 20: 456-462 (2005).
*
-
Gonzalez-Lama Y, Abreu L, Vera MI, Pastrana M, Tabernero S, Revilla J, Duran JG, Escartin P. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
Inflamm. Bowel Dis. 11: 8-15 (2005).
*
-
Gonzalez-Rey E, Delgado M. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
Curr. Opin. Investig. Drugs 6: 1116-1123 (2005).
-
Gonzalez-Roldan N, Ferat-Osorio E, Aduna-Vicente R, Wong-Baeza I, Esquivel-Callejas N, Astudillo-de la Vega H, Sanchez-Fernandez P, Arriaga-Pizano L, Villasis-Keever MA, Lopez-Macias C, Isibasi A. Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery.
World J. Gastroenterol. 11: 7473-7479 (2005).
*
-
Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS.
Nat. Rev. Immunol. 5: 69-81 (2005).
*
-
Good MF. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Trends Immunol. 26: 295-297 (2005).
*
-
Goode EL, Badzioch MD, Jarvik GP. Bias of allele-sharing linkage statistics in the presence of intermarker linkage disequilibrium.
BMC Genet. 6 Suppl. 1: S82 (2005).
*
-
Goodman BE, Percy WH. CFTR in cystic fibrosis and cholera: from membrane transport to clinical practice.
Adv. Physiol. Educ. 29: 75-82 (2005).
*
-
Goodman D, Morrissey S, Graham D, Bossingham D. Illness representations of systemic lupus erythematosus.
Qual. Health Res. 15: 606-619 (2005).
*
-
Goodman J, Glasgow SC, Schnitzler M, Lowell JA, Shenoy S, Jendrisak MD, Desai N, Lisker-Melman M, Crippin J, Chapman WC. Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease.
Arch. Surg. 140: 459-464 (2005).
*
-
Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S, Harris CC. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis.
Int. J. Cancer 118: 1790-1797 (2005).
*
-
Goodnow CC, Sprent J, de St Groth BF, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity.
Nature 435: 590-597 (2005).
*
-
Goodsell DS. The molecular perspective: major histocompatibility complex.
Oncologist 10: 80-81 (2005).
*
-
Goodyear CS, Silverman GJ. B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.
Springer Semin. Immunopathol. 26: 463-484 (2005).
*
-
Gorczynski RM. Modulation of auxiliary signals to T cells as a mechanism to induce transplant tolerance.
Arch. Immunol. Ther. Exp. (Warsz.) 53: 91-101 (2005).
-
Gordon JI. A genomic view of our symbiosis with members of the gut microbiota.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S28 (2005).
*
-
Gordon JN, Macdonald TT. Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease.
Gut 54: 1213-1215 (2005).
*
-
Gordon JN, Sabatino AD, Macdonald TT. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
Curr. Opin. Gastroenterol. 21: 431-437 (2005).
-
Gordon S, Taylor PR. Monocyte and macrophage heterogeneity.
Nat. Rev. Immunol. 5: 953-964 (2005).
*
-
Gordon YJ, Huang LC, Romanowski EG, Yates KA, Proske RJ, McDermott AM. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.
Curr. Eye Res. 30: 385-394 (2005).
-
Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger D. Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat.
Hepatology 41: 1065-1073 (2005).
*
-
Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger D. LPS-induced tyrosine nitration of hepatic glutamine synthetase.
Hepatology 42: 499 (2005).
*
-
Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Surgery 138: 631-637 (2005).
*
-
Gorgun E, Remzi FH, Montague DK, Connor JT, O'Brien K, Loparo B, Fazio VW. Male sexual function improves after ileal pouch anal anastomosis.
Colorectal Dis. 7: 545-550 (2005).
*
-
Gorman JD. Smoking and rheumatoid arthritis: another reason to just say no.
Arthritis Rheum. 54: 10-13 (2005).
*
-
Goronzy JJ, Henel G, Sawai H, Singh K, Lee EB, Pryshchep S, Weyand CM. Costimulatory pathways in rheumatoid synovitis and T-cell senescence.
Ann. N. Y. Acad. Sci. 1062: 182-194 (2005).
*
-
Gortz B, Hayer S, Tuerck B, Zwerina J, Smolen JS, Schett G. Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo.
Arthritis Res. Ther. 7: R1140-R1147 (2005).
*
-
Goss JA, Seu P, Gao FQ, Wyllie S. Ischemia-reperfusion of rat liver modulates hepcidin in vivo expression.
Liver Transpl. 11: 800-806 (2005).
*
-
Gossard AA, Angulo P, Lindor KD. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.
Am. J. Gastroenterol. 100: 1330-1333 (2005).
*
-
Goswami R, Gupta N, Ray D, Rani R, Tomar N, Sarin R, Vupputuri MR. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism.
Int. J. Immunogenet. 32: 393-400 (2005).
*
-
Goto A, Mukai M, Notoya A, Kohno M. Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report.
Mod. Rheumatol. 15: 118-122 (2005).
-
Goto T, Shibata A, Sasaki D, Suzuki N, Hishinuma T, Kakiyama G, Iida T, Mano N, Goto J. Identification of a novel conjugate in human urine: bile acid acyl galactosides.
Steroids 70: 185-192 (2005).
-
Goto T, Takahashi N, Kato S, Egawa K, Ebisu S, Moriyama T, Fushiki T, Kawada T. Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytes.
Biochem. Biophys. Res. Commun. 337: 440-445 (2005).
*
-
Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, Goto H, Hamajima N. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
Int. J. Cancer 118: 203-208 (2005).
*
-
Goto Y, Ando TU, Nishio K, Ishida Y, Kawai S, Goto H, Hamajima N. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis.
Asian Pac. J. Cancer Prev. 6: 464-467 (2005).
-
Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Anaya JM, Sibilia J, Mariette X. Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Ann. Rheum. Dis. 64: 913-920 (2005).
*
-
Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. CD4 CD25(high) regulatory T cells are not impaired in patients with primary Sjogren's syndrome.
J. Autoimmun. 24: 235-242 (2005).
-
Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome.
Ann. Rheum. Dis. 64: 114-117 (2005).
*
-
Gottlieb AB. Alefacept for psoriasis and psoriatic arthritis.
Ann. Rheum. Dis. 64 Suppl. 4: iv58-iv60 (2005).
*
-
Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA, Chen F, Magliocco M, Krueger JG. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
J. Immunol. 175: 2721-2729 (2005).
*
-
Gottlieb AB, Griffiths CE, Ho VC, Lahfa M, Mrowietz U, Murrell DF, Ortonne JP, Todd G, Cherill R, Marks I, Emady-Azar S, Paul CF; the Multi-Centre Investigator Group. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
Br. J. Dermatol. 152: 1219-1227 (2005).
*
-
Gotto AM Jr. Should patients with combined hyperlipidemia receive statin-fibrate combination therapy?
Nat. Clin. Pract. Cardiovasc. Med. 2: 284-285 (2005).
*
-
Goudy KS, Tisch R. Immunotherapy for the prevention and treatment of type 1 diabetes.
Int. Rev. Immunol. 24: 307-326 (2005).
-
Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity.
Immunol. Rev. 204: 102-115 (2005).
*
-
Goulvestre C, Chereau C, Nicco C, Mouthon L, Weill B, Batteux F. A mimic of p21WAF1/CIP1 ameliorates murine lupus.
J. Immunol. 175: 6959-6967 (2005).
*
-
Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
Atherosclerosis 183: 336-341 (2005).
-
Gouni-Berthold I, Giannakidou E, Muller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W. The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population.
J. Intern. Med. 257: 272-280 (2005).
*
-
Gouni-Berthold I, Krone W. Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.
Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 513-523 (2005).
-
Gourtsoyiannis NC, Papanikolaou N. Magnetic resonance enteroclysis.
Semin. Ultrasound CT MR 26: 237-246 (2005).
-
Goverdhana S, Puntel M, Xiong W, Zirger JM, Barcia C, Curtin JF, Soffer EB, Mondkar S, King GD, Hu J, Sciascia SA, Candolfi M, Greengold DS, Lowenstein PR, Castro MG. Regulatable gene expression systems for gene therapy applications: progress and future challenges.
Mol. Ther. 12: 189-211 (2005).
-
Goytain A, Quamme GA. Functional characterization of the human solute carrier, SLC41A2.
Biochem. Biophys. Res. Commun. 330: 701-705 (2005).
*
-
Goytain A, Quamme GA. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters.
Physiol. Genomics 21: 337-342 (2005).
*
-
Gozdzik J, Majka-Sumner L, Cofta S, Nowicka A, Piorunek T, Batura-Gabryel H. Challenges in care of adult CF patients - the specialist cystic fibrosis team.
Rocz. Akad. Med. Bialymst. 50 Suppl. 1: 42-45 (2005).
-
Graca L, Chen TC, Le Moine A, Cobbold SP, Howie D, Waldmann H. Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells.
Trends Immunol. 26: 130-135 (2005).
*
-
Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A, Schobel A, Madhok R, Pons-Kuhnemann J, McInnes IB, Moller B. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients.
Genes Immun. 6: 211-216 (2005).
*
-
Gradilone SA, Tietz PS, Splinter PL, Marinelli RA, LaRusso NF. Expression and subcellular localization of aquaporin water channels in the polarized hepatocyte cell line, WIF-B.
BMC Physiol. 5: 13 (2005).
*
-
Grady WM. Molecular basis for subdividing hereditary colon cancer?
Gut 54: 1676-1678 (2005).
*
-
Graepler F, Verbeek B, Graeter T, Smirnow I, Kong HL, Schuppan D, Bauer M, Vonthein R, Gregor M, Lauer UM. Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC.
Hepatology 41: 879-886 (2005).
*
-
Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population.
Arthritis Rheum. 54: 292-300 (2005).
*
-
Graff-Guerrero A, De la Fuente-Sandoval C, Camarena B, Gomez-Martin D, Apiquian R, Fresan A, Aguilar A, Mendez-Nunez JC, Escalona-Huerta C, Drucker-Colin R, Nicolini H. Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism.
Neuroimage 25: 1197-1204 (2005).
-
Graham KL, Thibault DL, Steinman JB, Okeke L, Kao PN, Utz PJ. Granzyme B is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus.
Arthritis Rheum. 52: 1684-1693 (2005).
*
-
Gralnek IM. Obscure-overt gastrointestinal bleeding.
Gastroenterology 128: 1424-1430 (2005).
*
-
Grand RJ. Inverting the therapeutic triangle.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S50-S52 (2005).
*
-
Grandbois L, Lomasney LM, Demos TC, Tehrani R. Radiologic case study. Seronegative spondyloarthropathy associated with Crohn's disease.
Orthopedics 28: 1296, 1375-1379 (2005).
-
Grandjean P. Contaminants in fish oil.
Am. J. Clin. Nutr. 82: 1354 (2005).
*
-
Granero F, Revert F, Revert-Ros F, Lainez S, Martinez-Martinez P, Saus J. A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein.
FEBS J. 272: 5291-5305 (2005).
*
-
Grangeia A, Carvalho F, Fernandes S, Silva J, Sousa M, Barros A. A novel missense mutation P1290S at exon-20 of the CFTR gene in a Portuguese patient with congenital bilateral absence of the vas deferens.
Fertil. Steril. 83: 448-451 (2005).
*
-
Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, Lenzi M, Bianchi FB. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.
Aliment. Pharmacol. Ther. 21: 1273-1277 (2005).
*
-
Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
Aliment. Pharmacol. Ther. 21: 881-887 (2005).
*
-
Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review.
Altern. Med. Rev. 10: 94-111 (2005).
*
-
Grateau G. Hereditary recurrent fever syndromes.
Bull. Acad. Natl. Med. 189: 1235-1246 (2005).
-
Grateau G. Auto-inflammatory syndromes.
Rev. Prat. 55: 353-359 (2005).
-
Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flow.
Curr. Drug Targets Immune Endocr. Metabol. Disord. 5: 153-161 (2005).
-
Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A. Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Bone Marrow Transplant. 35: 869-879 (2005).
-
Grau de Castro JJ. COX-2 inhibitors in cancer prevention.
Rev. Clin. Esp. 205: 446-456 (2005).
-
Gravanis A, Margioris AN. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications.
Curr. Med. Chem. 12: 1503-1512 (2005).
-
Gravholt CH. Clinical practice in Turner syndrome.
Nat. Clin. Pract. Endocrinol. Metab. 1: 41-52 (2005).
*
-
Gray SL, Dalla Nora E, Vidal-Puig AJ. Mouse models of PPAR-gamma deficiency: dissecting PPAR-gamma's role in metabolic homoeostasis.
Biochem. Soc. Trans. 33: 1053-1058 (2005).
*
-
Grazi GL, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Lauro A, Ramacciato G, Pinna AD. Using elderly donors in liver transplantation.
Transplant. Proc. 37: 2582-2583 (2005).
*
-
Graziani G, D'Argenio G, Tuccillo C, Loguercio C, Ritieni A, Morisco F, Del Vecchio Blanco C, Fogliano V, Romano M. Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo.
Gut 54: 193-200 (2005).
*
-
Grbovic L, Radenkovic M. Therapeutic use of glucocorticoids and immunosuppressive agents.
Srp. Arh. Celok. Lek. 133 Suppl. 1: 67-73 (2005).
-
Greaves MW. Itch in systemic disease: therapeutic options.
Dermatol. Ther. 18: 323-327 (2005).
*
-
Greaves MW. Antihistamines in dermatology.
Skin Pharmacol. Physiol. 18: 220-229 (2005).
-
Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population.
Gastroenterology 128: S74-S78 (2005).
*
-
Green PH, Alaedini A, Sander HW, Brannagan TH 3rd, Latov N, Chin RL. Mechanisms underlying celiac disease and its neurologic manifestations.
Cell. Mol. Life Sci. 62: 791-799 (2005).
*
-
Green PH, Rostami K, Marsh MN. Diagnosis of coeliac disease.
Best Pract. Res. Clin. Gastroenterol. 19: 389-400 (2005).
-
Green PH, Rubin M. Capsule endoscopy in celiac disease.
Gastrointest. Endosc. 62: 797-799 (2005).
-
Greenberg DA, Zhang J, Shmulewitz D, Strug LJ, Zimmerman R, Singh V, Marathe S. Construction of the model for the Genetic Analysis Workshop 14 simulated data: genotype-phenotype relationships, gene interaction, linkage, association, disequilibrium, and ascertainment effects for a complex phenotype.
BMC Genet. 6 Suppl. 1: S3 (2005).
*
-
Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
Ann. Neurol. 57: 664-678 (2005).
-
Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited.
Annu. Rev. Immunol. 23: 515-548 (2005).
*
-
Gregersen PK. Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond.
Immunol. Rev. 204: 74-86 (2005).
*
-
Gregersen PK. Gaining insight into PTPN22 and autoimmunity.
Nat. Genet. 37: 1300-1302 (2005).
*
-
Gregersen PK, Batliwalla F. PTPN22 and rheumatoid arthritis: gratifying replication.
Arthritis Rheum. 52: 1952-1955 (2005).
*
-
Gregg RK, Bell JJ, Lee HH, Jain R, Schoenleber SJ, Divekar R, Zaghouani H. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
J. Immunol. 174: 662-670 (2005).
*
-
Gregory GD, Bickford A, Robbie-Ryan M, Tanzola M, Brown MA. MASTering the immune response: mast cells in autoimmunity.
Novartis Found. Symp. 271: 215-225 (2005).
-
Greiner A, Plischke H, Kellner H, Gruber R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Ann. N. Y. Acad. Sci. 1050: 295-303 (2005).
*
-
Gremlich S, Nolan C, Roduit R, Burcelin R, Peyot ML, Delghingaro-Augusto V, Desvergne B, Michalik L, Prentki M, Wahli W. Pancreatic islet adaptation to fasting is dependent on PPARalpha transcriptional up-regulation of fatty acid oxidation.
Endocrinology 146: 375-382 (2005).
*
-
Grempler R, Gunther S, Steffensen KR, Nilsson M, Barthel A, Schmoll D, Walther R. Evidence for an indirect transcriptional regulation of glucose-6-phosphatase gene expression by liver X receptors.
Biochem. Biophys. Res. Commun. 338: 981-986 (2005).
*
-
Greten TF, Manns MP, Reinisch I, Kaatsch P. Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiation.
Gut 54: 732 (2005).
*
-
Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.
Nat. Med. 11: 328-334 (2005).
*
-
Greupink R, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Kok RJ, Meijer DK, Beljaars L, Poelstra K. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.
J. Hepatol. 43: 884-892 (2005).
*
-
Gribetz CH, Blum R, Brady C, Cohen S, Lebwohl M. An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis.
J. Am. Acad. Dermatol. 53: 73-75 (2005).
-
Grieco A, Forgione A, Miele L, Vero V, Greco AV, Gasbarrini A, Gasbarrini G. Fatty liver and drugs.
Eur. Rev. Med. Pharmacol. Sci. 9: 261-263 (2005).
-
Grieco A, Pompili M, Caminiti G, Miele L, Covino M, Alfei B, Rapaccini GL, Gasbarrini G. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
Gut 54: 411-418 (2005).
*
-
Griesenbach U, Boyd AC; On behalf of the UK Cystic Fibrosis Gene Therapy Consortium. Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy.
J. Cyst. Fibros. 4: 89-100 (2005).
-
Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, Gratwohl A, van Laar JM, Mayes MD, Martin R, McSweeney PA, Muraro PA, Openshaw H, Saccardi R, Sandmaier BM, Forman SJ, Nash RA; workshop participants. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-sponsored international workshop, Bethesda, MD.
Biol. Blood Marrow Transplant. 11: 862-870 (2005).
-
Griffiths AM. Enteral nutrition in the management of Crohn's disease.
JPEN J. Parenter. Enteral Nutr. 29: S108-S117 (2005).
*
-
Griffiths AM. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
Inflamm. Bowel Dis. 11: 200-202 (2005).
*
-
Griffiths AM, Otley AR, Hyams J, Quiros AR, Grand RJ, Bousvaros A, Feagan BG, Ferry GR. A review of activity indices and end points for clinical trials in children with Crohn's disease.
Inflamm. Bowel Dis. 11: 185-196 (2005).
*
-
Griffiths HR. ROS as signalling molecules in T cells - evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis.
Redox Rep. 10: 273-280 (2005).
-
Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
Hepatogastroenterology 52: 808-811 (2005).
-
Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
Eur. J. Med. Res. 10: 183-186 (2005).
-
Grigor'eva GA, Meshalkina Niu. Algorithm of diagnosis and treatment of complicated forms of nonspecific ulcerative colitis and Crohn's disease.
Ter. Arkh. 77: 48-55 (2005).
-
Grigoriadis N, Tselios T, Deraos S, Orologas A, Deraos G, Matsoukas J, Mavromatis I, Milonas I. Animal models of central nervous system immune-mediated diseases: therapeutic interventions with bioactive peptides and mimetics.
Curr. Med. Chem. 12: 1513-1519 (2005).
-
Grimaldi CM, Hicks R, Diamond B. B cell selection and susceptibility to autoimmunity.
J. Immunol. 174: 1775-1781 (2005).
*
-
Grimaudo S, Craxi A, Gentile S, Di Paolantonio T, Vaccaro A, Venezia G, Lo Coco L, Savella R, Usticano A, Capone F, Mariani G. Prolonged prothrombin time, factor VII and activated FVII levels in chronic liver disease are partly dependent on factor VII gene polymorphisms.
Dig. Liver Dis. 37: 446-450 (2005).
-
Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo.
Am. J. Pathol. 167: 835-848 (2005).
*
-
Grimble RF. Immunonutrition.
Curr. Opin. Gastroenterol. 21: 216-222 (2005).
-
Grindlay D, Boulos MN, Williams HC. Introducing the National Library for Health Skin Conditions Specialist Library.
BMC Dermatol. 5: 4 (2005).
*
-
Griseri T, Beaudoin L, Novak J, Mars LT, Lepault F, Liblau R, Lehuen A. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.
J. Immunol. 175: 2091-2101 (2005).
*
-
Grishin A, Ford H, Wang J, Li H, Salvador-Recatala V, Levitan E, Zaks-Makhina E. Attenuation of apoptosis in enterocytes by blocking potassium channels.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G815-G821 (2005).
*
-
Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Forster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils; protective and deleterious effects.
Immunity 22: 93-104 (2005).
*
-
Groen AK, Oude Elferink RP. Lipid transport into bile and role in bile formation.
Curr. Drug Targets Immune Endocr. Metabol. Disord. 5: 131-135 (2005).
-
Groman JD, Karczeski B, Sheridan M, Robinson TE, Fallin MD, Cutting GR. Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis.
J. Pediatr. 146: 675-680 (2005).
*
-
Grompe M. The origin of hepatocytes.
Gastroenterology 128: 2158-2160 (2005).
*
-
Gross TS, King KA, Rabaia NA, Pathare P, Srinivasan S. Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen.
J. Bone Miner. Res. 20: 250-256 (2005).
*
-
Grossmayer GE, Munoz LE, Gaipl US, Franz S, Sheriff A, Voll RE, Kalden JR, Herrmann M. Removal of dying cells and systemic lupus erythematosus.
Mod. Rheumatol. 15: 383-390 (2005).
-
Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
N. Engl. J. Med. 353: 2254-2261 (2005).
*
-
Grucela AL, Steinhagen RM. Restorative proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis after liver transplant for primary sclerosing cholangitis: case report and review of literature.
Am. Surg. 71: 362-365 (2005).
-
Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ, Wuerch A, Ludwig Y, Fukuyama H, Wardemann H, Waldschuetz R, Moroy T, Taniuchi I, Steimle V, Littman DR, Ehlers M. Runx3 regulates integrin alphaE/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
J. Immunol. 175: 1694-1705 (2005).
*
-
Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma.
Pathology 37: 409-419 (2005).
-
Grumbach IM, Chen W, Mertens SA, Harrison DG. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
J. Mol. Cell. Cardiol. 39: 595-603 (2005).
*
-
Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Schomig E. Discovery of the ergothioneine transporter.
Proc. Natl. Acad. Sci. U.S.A. 102: 5256-5261 (2005).
*
-
Grundmann S, Hoefer IE, Ulusans S, van Royen N, Schirmer SH, Ozaki CK, Bode C, Piek JJ, Buschmann IR. Anti-tumor necrosis factor-alpha therapies attenuate adaptive arteriogenesis in the rabbit.
Am. J. Physiol. Heart Circ. Physiol. 289: H1497-H1505 (2005).
*
-
Grundy D, Schemann M. Enteric nervous system.
Curr. Opin. Gastroenterol. 21: 176-182 (2005).
-
Grungreiff K, Reinhold D. Liver cirrhosis and "liver" diabetes mellitus are linked by zinc deficiency.
Med. Hypotheses 64: 316-317 (2005).
-
Gruttadauria S, Cintorino D, Mandala' L, Musumeci A, Volpes R, Vizzini GB, Palazzo U, Spada M, Verzaro R, Gridelli B. Acceptance of marginal liver donors increases the volume of liver transplant: early results of a single-center experience.
Transplant. Proc. 37: 2567-2568 (2005).
*
-
Gruttadauria S, Marsh JW, Bartlett DL, Gridelli B, Marcos A. Ex situ resection techniques and liver autotransplantation: last resource for otherwise unresectable malignancy.
Dig. Dis. Sci. 50: 1829-1835 (2005).
*
-
Gruttadauria S, Vasta F, Mandala L, Cintorino D, Piazza T, Spada M, Verzaro R, Gridelli B. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
Transplant. Proc. 37: 2611-2613 (2005).
*
-
Grutters JC, du Bois RM. Genetics of fibrosing lung diseases.
Eur. Respir. J. 25: 915-927 (2005).
*
-
Grygorczuk S, Zajkowska J, Kondrusik M, Pancewicz S, Hermanowska-Szpakowicz T. Guillain-Barre Syndrome and its association with infectious factors.
Neurol. Neurochir. Pol. 39: 230-236 (2005).
-
Gu P, Goodwin B, Chung AC, Xu X, Wheeler DA, Price RR, Galardi C, Peng L, Latour AM, Koller BH, Gossen J, Kliewer SA, Cooney AJ. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development.
Mol. Cell. Biol. 25: 3492-3505 (2005).
*
-
Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M, Reiter RE. Reg IV: a promising marker of hormone refractory metastatic prostate cancer.
Clin. Cancer Res. 11: 2237-2243 (2005).
*
-
Guadagni MG, Cocchi S, Tagariello T, Piana G. Case report: Alagille syndrome.
Minerva Stomatol. 54: 593-600 (2005).
-
Gualdrini UA, Sambuelli A, Barugel M, Gutierrez A, Avila KC. Prevention of colorectal cancer.
Acta Gastroenterol. Latinoam. 35: 104-140 (2005).
-
Guan YZ, Cui LY, Li YF, Zhang JB. Tumor necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
Chin. Med. Sci. J. 20: 104-107 (2005).
-
Guan Z, Basi D, Li Q, Mariash A, Xia YF, Geng J, Kao E, Hall JL. Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis.
Arterioscler. Thromb. Vasc. Biol. 25: 96-101 (2005).
*
-
Guanabens N, Pares A, Ros I, Caballeria L, Pons F, Vidal S, Monegal A, Peris P, Rodes J. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
J. Hepatol. 42: 573-577 (2005).
*
-
Guandalini S. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease.
J. Pediatr. Gastroenterol. Nutr. 41: 366-367 (2005).
*
-
Guardiano M, Vaz LG. Cystic fibrosis - clinical features of a sample of Portuguese patients.
Rev. Port. Pneumol. 11: 381-406 (2005).
-
Guardigli M, Marangi M, Casanova S, Grigioni WF, Roda E, Roda A. Chemiluminescence quantitative immunohistochemical determination of MRP2 in liver biopsies.
J. Histochem. Cytochem. 53: 1451-1457 (2005).
*
-
Guarino MP, Carotti S, Sarzano M, Alloni R, Vanni M, Grosso M, Sironi G, Maffettone PL, Cicala M. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.
Neurogastroenterol. Motil. 17: 680-686 (2005).
-
Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis.
Eur. J. Gastroenterol. Hepatol. 17: 27-31 (2005).
-
Guarner F. Inulin and oligofructose: impact on intestinal diseases and disorders.
Br. J. Nutr. 93 Suppl. 1: S61-S65 (2005).
-
Guarner F. The intestinal flora in inflammatory bowel disease: normal or abnormal?
Curr. Opin. Gastroenterol. 21: 414-418 (2005).
-
Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?
J. Cell. Mol. Med. 9: 741-744 (2005).
*
-
Gubbels MR, Jorgensen TN, Metzger TE, Menze K, Steele H, Flannery SA, Rozzo SJ, Kotzin BL. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice.
J. Immunol. 175: 6190-6196 (2005).
*
-
Guckelberger O, Stange B, Glanemann M, Lopez-Hanninen E, Heidenhain C, Jonas S, Klupp J, Neuhaus P, Langrehr JM. Hepatic resection in liver transplant recipients: single center experience and review of the literature.
Am. J. Transplant. 5: 2403-2409 (2005).
*
-
Guejes L, Zurgil N, Stambler I, Deutsch M, Gilburd B, Shoenfeld Y. The influence of different cultivating conditions on polymorphonuclear leukocyte apoptotic process in vitro, II: ultrastructural characteristics of PMN populations incubated with proteinase 3 anti-neutrophil autoantibodies.
Ultrastruct. Pathol. 29: 37-51 (2005).
-
Guenin LM. Stem cells, cloning, and regulation.
Mayo Clin. Proc. 80: 241-250 (2005).
*
-
Guerrero Hernandez I, Weimersheimer Sandoval M, Lopez Mendez E, Hernandez Calleros J, Tapia AR, Uribe M. Biliary stricture caused by portal biliopathy: case report and literature review.
Ann. Hepatol. 4: 286-288 (2005).
*
-
Guettier C. Which stem cells for adult liver?
Ann. Pathol. 25: 33-44 (2005).
-
Guettier C, Sebagh M, Buard J, Feneux D, Ortin-Serrano M, Gigou M, Tricottet V, Reynes M, Samuel D, Feray C. Male cell microchimerism in normal and diseased female livers from fetal life to adulthood.
Hepatology 42: 35-43 (2005).
*
-
Guex-Crosier Y, Zografos L. New therapies in ophthalmology: inhibitors of TNF-alpha.
Rev. Med. Suisse. 1: 140-141 (2005).
-
Guglielmi A, Fior F, Halmos O, Veraldi GF, Rossaro L, Ruzzenente A, Cordiano C. Transhepatic fibrinolysis of mesenteric and portal vein thrombosis in a patient with ulcerative colitis: aA case report.
World J. Gastroenterol. 11: 2035-2038 (2005).
*
-
Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury.
Gut 54: 1024-1033 (2005).
*
-
Guicciardi ME, Gores GJ. Cholestatic hepatocellular injury: what do we know and how should we proceed.
J. Hepatol. 42: 297-300 (2005).
*
-
Guida M, Mandato VD, Di Spiezio Sardo A, Di Carlo C, Giordano E, Nappi C. Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels.
J. Endocrinol. Invest. 28: 827-830 (2005).
-
Guidi L, Costanzo M, Ciarniello M, De Vitis I, Pioli C, Gatta L, Pace L, Tricerri A, Bartoloni C, Coppola L, Balistreri P, Doria G, Fedeli G, Gasbarrini GB. Increased levels of NF-kB inhibitors (IeBalpha and IeBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.
Int. J. Immunopathol. Pharmacol. 18: 155-164 (2005).
-
Guidry PA, Stroynowski I. The murine family of gut-restricted class Ib MHC includes alternatively spliced isoforms of the proposed HLA-G homolog, "blastocyst MHC".
J. Immunol. 175: 5248-5259 (2005).
*
-
Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
Lab. Anim. 39: 336-352 (2005).
-
Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.
Am. J. Gastroenterol. 100: 1174-1184 (2005).
*
-
Guilford WJ, Parkinson JF. Second-generation beta-oxidation resistant 3-oxa-lipoxin A(4) analogs.
Prostaglandins Leukot. Essent. Fatty Acids 73: 245-250 (2005).
*
-
Guilherme L, Fae K, Oshiro SE, Kalil J. Molecular pathogenesis of rheumatic fever and rheumatic heart disease.
Expert Rev. Mol. Med. 7: 1-15 (2005).
-
Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions.
Ann. N. Y. Acad. Sci. 1051: 132-140 (2005).
*
-
Guilhon de Araujo Sant'anna AM, Dubois J, Miron MC, Seidman EG. Wireless capsule endoscopy for obscure small-bowel disorders: final results of the first pediatric controlled trial.
Clin. Gastroenterol. Hepatol. 3: 264-270 (2005).
*
-
Guill CL, Hoang MP, Carder KR. Primary annular plaque-type psoriasis.
Pediatr. Dermatol. 22: 15-18 (2005).
-
Guillaumond F, Dardente H, Giguere V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors.
J. Biol. Rhythms 20: 391-403 (2005).
-
Guilpain P, Chanseaud Y, Tamby MC, Mahr A, Servettaz A, Guillevin L, Mouthon L. Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides.
Presse. Med. 34: 1013-1022 (2005).
-
Gul A. Behcet's disease as an autoinflammatory disorder.
Curr. Drug Targets Inflamm. Allergy 4: 81-83 (2005).
-
Guler ML, Ligons DL, Wang Y, Bianco M, Broman KW, Rose NR. Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis.
J. Immunol. 174: 2167-2173 (2005).
*
-
Gullo L, Mantovani V, Manca M, Migliori M, Bastagli L, Pezzilli R. Mutations of the CFTR gene in idiopathic pancreatic hyperenzymemia.
Pancreas 31: 350-352 (2005).
-
Gullu S, Emral R, Bastemir M, Parkes AB, Lazarus JH. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis.
Eur. J. Endocrinol. 153: 41-48 (2005).
*
-
Gumbs AA, Kim J, Kiehna E, Brink JA, Salem RR. Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder.
JOP 6: 455-459 (2005).
*
-
Gummadi SN, Kumar KS. The mystery of phospholipid flip-flop in biogenic membranes.
Cell. Mol. Biol. Lett. 10: 101-121 (2005).
*
-
Gumpricht E, Dahl R, Devereaux MW, Sokol RJ. Licorice compounds, glycyrrhizin and 18beta -glycyrrhetinic acid, are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes.
J. Biol. Chem. 280: 10556-10563 (2005).
*
-
Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology.
Nat. Genet. 37: 549-554 (2005).
*
-
Gundling F, Tillmann HL, Schmidt O, Brennenstuhl M, Nerlich A, Schepp W. Severe intrahepatic cholestasis in a 66-year old male with atrial fibrillation recieving antiarryhthmic drug-therapy.
Internist (Berl.) 46: 1038-1042 (2005).
-
Gunning PW, Schevzov G, Kee AJ, Hardeman EC. Tropomyosin isoforms: divining rods for actin cytoskeleton function.
Trends Cell Biol. 15: 333-341 (2005).
*
-
Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, Andrews NC. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver.
J. Clin. Invest. 115: 1258-1266 (2005).
*
-
Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management.
Crit. Care Med. 33: S332-S339 (2005).
-
Guo C, Ding J, Yao L, Sun L, Lin T, Song Y, Sun L, Fan D. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1.
Int. J. Cancer 116: 155-160 (2005).
*
-
Guo J, Fu YC, Becerra CR. Dissecting role of regulatory factors in NF-kappaB pathway with siRNA.
Acta Pharmacol. Sin. 26: 780-788 (2005).
-
Guo LH, Schluesener HJ. Lesional accumulation of P2X(4) receptor(+) macrophages in rat CNS during experimental autoimmune encephalomyelitis.
Neuroscience 134: 199-205 (2005).
-
Guo QS, Xia B, Jiang Y, Morre SA, Cheng L, Li J, Crusius JB, Pena AS. Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients.
Postgrad. Med. J. 81: 526-529 (2005).
*
-
Guo RF, Ward PA. Role of C5a in inflammatory responses.
Annu. Rev. Immunol. 23: 821-852 (2005).
*
-
Guo W, Smith D, Guth A, Aviszus K, Wysocki LJ. T cell tolerance to germline-encoded antibody sequences in a lupus-prone mouse.
J. Immunol. 175: 2184-2190 (2005).
*
-
Guo W, Xie W, Lei T, Hamilton JA. Eicosapentaenoic acid, but not oleic acid, stimulates beta-oxidation in adipocytes.
Lipids 40: 815-821 (2005).
-
Guo YF, Tan JM, Li RY, Liu SZ, Li Y, Ying K, Xie Y, Mao YM. Application of oligoneucleotide array in single nucleotide polymorphism typing of cytokines and cytokine receptors.
Zhonghua Yi Xue Za Zhi 85: 1757-1761 (2005).
-
Gupta A, Derbes C, Sellin J. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an academic medical center.
Inflamm. Bowel Dis. 11: 898-902 (2005).
*
-
Gupta B, Agrawal C, Raghav SK, Das SK, Das RH, Chaturvedi VP, Das HR. Association of mannose-binding lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an Indian cohort of case-control samples.
J. Hum. Genet. 50: 583-591 (2005).
*
-
Gupta C, Mazzara PF. High-grade pancreatic intraepithelial neoplasia in a patient with familial adenomatous polyposis.
Arch. Pathol. Lab. Med. 129: 1398-1400 (2005).
*
-
Gupta G, Gelfand JM, Lewis JD. Increased risk of demyelinating diseases in patients with inflammatory bowel disease.
Gastroenterology 129: 819-826 (2005).
*
-
Gupta L, Hamid B. Histological value of duodenal biopsies.
ScientificWorldJournal 5: 396-400 (2005).
-
Gupta S, McQuaid K. Management of nonsteroidal, anti-inflammatory, drug-associated dyspepsia.
Gastroenterology 129: 1711-1719 (2005).
*
-
Gupta V, Kumar M, Bhatia BD. Benign recurrent intrahepatic cholestasis.
Indian J. Pediatr. 72: 793-794 (2005).
*
-
Gupta V, Sarin BC, Changotra H, Sehajpal PK. Association of G-308A TNF-alpha polymorphism with bronchial asthma in a North Indian population.
J. Asthma 42: 839-841 (2005).
-
Gurel S, Kiyici M. Ulcerative colitis activity index: a useful prognostic factor for predicting ulcerative colitis outcome.
J. Int. Med. Res. 33: 103-110 (2005).
-
Gurevich VS, Shovman O, Slutzky L, Meroni PL, Shoenfeld Y. Statins and autoimmune diseases.
Autoimmun. Rev. 4: 123-129 (2005).
-
Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
Clin. Pharmacol. Ther. 77: 415-426 (2005).
*
-
Gursoy S, Guven K, Kula M, Canoz O, Yurci A, Unluhizarci K, Ozbakir O, Yucesoy M. Subclinical alveolar involvement in ulcerative colitis.
Inflamm. Bowel Dis. 11: 372-375 (2005).
*
-
Gursoy S, Guven K, Simsek T, Yurci A, Torun E, Koc N, Patroglu TE, Ozbakir O, Yucesoy M. The prevalence of unrecognized adult celiac disease in Central Anatolia.
J. Clin. Gastroenterol. 39: 508-511 (2005).
-
Gurusamy KS, Farouk M, Tweedie JH. UK guidelines for management of acute pancreatitis: is it time to change?
Gut 54: 1344-1345 (2005).
*
-
Guslandi M. Manipulation of enteric flora in ulcerative colitis.
World J. Gastroenterol. 11: 3327 (2005).
*
-
Guslandi M. Antibiotics for inflammatory bowel disease: do they work?
Eur. J. Gastroenterol. Hepatol. 17: 145-147 (2005).
-
Gustafsson JA. Steroids and the scientist.
Mol. Endocrinol. 19: 1412-1417 (2005).
*
-
Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery.
Hepatology 41: 1322-1328 (2005).
*
-
Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Deviere J, Franchimont D. Profile of soluble cytokine receptors in Crohn's disease.
Gut 54: 488-495 (2005).
*
-
Gutierrez-Macias A, Lizarralde-Palacios E, Martinez-Odriozola P, Miguel-De la Villa F. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.
BMJ 331: 623-624 (2005).
*
-
Gutjahr C, Murphy D, Lueking A, Koenig A, Janitz M, O'Brien J, Korn B, Horn S, Lehrach H, Cahill DJ. Mouse protein arrays from a T(H)1 cell cDNA library for antibody screening and serum profiling.
Genomics 85: 285-296 (2005).
*
-
Gutmann H, Hruz P, Zimmermann C, Beglinger C, Drewe J. Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract.
Biochem. Pharmacol. 70: 605-609 (2005).
*
-
Guy JE, Qian P, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.
Liver Transpl. 11: 1252-1257 (2005).
*
-
Guzman VB, Morgun A, Shulzhenko N, Mine KL, Goncalves-Primo A, Musatti CC, Gerbase-Delima M. Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups.
Hum. Immunol. 66: 773-776 (2005).
-
Gvozdjakova A, Kucharska J, Bartkovjakova M, Gazdikova K, Gazdik FE. Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma.
Biofactors 25: 235-240 (2005).
-
Gysemans CA, Cardozo AK, Giulietti A, Hulshagen L, Bouillon R, Eizirik DL, Mathieu C. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in NOD mice.
Endocrinology 146: 1956-1964 (2005).
*
-
Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Park HK, Yim SV, Chung JH, Bae HS, Nam M, Baik HH, Hong SJ. Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population.
J. Pineal Res. 39: 201-205 (2005).
*
-
Ha EM, Oh CT, Bae YS, Lee WJ. A direct role for dual oxidase in Drosophila gut immunity.
Science 310: 847-850 (2005).
*
-
Haas J, Hug A, Viehover A, Fritzsching B, Falk CS, Filser A, Vetter T, Milkova L, Korporal M, Fritz B, Storch-Hagenlocher B, Krammer PH, Suri-Payer E, Wildemann B. Reduced suppressive effect of CD4(+)CD25(high) regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Eur. J. Immunol. 35: 3343-3352 (2005).
*
-
Haas S, Bindl L, Fischer HP. Autoimmune enteric leiomyositis: a rare cause of chronic intestinal pseudo-obstruction with specific morphological features.
Hum. Pathol. 36: 576-580 (2005).
*
-
Haas SL, Andreas Koch W, Schreiber S, Reinhard I, Koyama N, Singer MV, Bocker U. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
Scand. J. Gastroenterol. 40: 1438-1443 (2005).
*
-
Haas U, Podda M, Behne M, Gurrieri S, Alonso A, Furstenberger G, Pfeilschifter J, Lambeau G, Gelb MH, Kaszkin M. Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skin.
J. Invest. Dermatol. 124: 204-211 (2005).
*
-
Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts.
Nat. Rev. Immunol. 5: 783-792 (2005).
*
-
Haase C, Ejrnaes M, Juedes AE, Wolfe T, Markholst H, von Herrath MG. Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo.
Blood 106: 4225-4233 (2005).
*
-
Habermehl D, Kempna P, Azzi A, Zingg JM. Recombinant SEC14-like proteins (TAP) possess GTPase activity.
Biochem. Biophys. Res. Commun. 326: 254-259 (2005).
*
-
Habib EE, Aziz M, Kotb M. Genetic polymorphism of folate and methionine metabolizing enzymes and their susceptibility to malignant lymphoma.
J. Egypt. Natl. Canc. Inst. 17: 184-192 (2005).
-
Habib Z, Arnaud B, Pascal de L, Caroline F, Yves A, Jean-Pierre C, Michel P, Jean-Pierre H, Dominique B. CARD15/NOD2 is not a predisposing factor for necrotizing enterocolitis.
Dig. Dis. Sci. 50: 1684-1687 (2005).
*
-
Haboubi NY, Jones S. Influence of dietary factors on the clinical course of inflammatory bowel disease.
Gut 54: 567 (2005).
*
-
Habtemariam B, Anisimov VM, MacKerell AD Jr. Cooperative binding of DNA and CBFbeta to the Runt domain of the CBFalpha studied via MD simulations.
Nucleic Acids Res. 33: 4212-4222 (2005).
*
-
Habtezion A, Toivola DM, Butcher EC, Omary MB. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment.
J. Cell Sci. 118: 1971-1980 (2005).
*
-
Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, Lambert D, Visvikis S. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort.
Eur. J. Hum. Genet. 13: 109-117 (2005).
*
-
Haeryfar SM. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?
Trends Immunol. 26: 311-317 (2005).
*
-
Hafkamp AM, Havinga R, Sinaasappel M, Verkade HJ. Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats.
Hepatology 41: 526-534 (2005).
*
-
Hafler DA, De Jager PL. Applying a new generation of genetic maps to understand human inflammatory disease.
Nat. Rev. Immunol. 5: 83-91 (2005).
*
-
Hafler DA, Kent SC, Chen Y, Bregoli L, Clemmings SM, Hering B, Kenyon NS, Ricordi C. Immunology: insulin auto-antigenicity in type 1 diabetes (Reply).
Nature 438: E5-E6 (2005).
*
-
Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C. Multiple sclerosis.
Immunol. Rev. 204: 208-231 (2005).
*
-
Hafner C, Meyer S, Langmann T, Schmitz G, Bataille F, Hagen I, Becker B, Roesch A, Rogler G, Landthaler M, Vogt T. Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro.
World J. Gastroenterol. 11: 4024-4031 (2005).
*
-
Haga HJ, Gjesdal CG, Irgens LM, Ostensen M. Reproduction and gynaecological manifestations in women with primary Sjogren's syndrome: a case-control study.
Scand. J. Rheumatol. 34: 45-48 (2005).
-
Haga HJ, Gjesdal CG, Koksvik HS, Skomsvoll JF, Irgens LM, Ostensen M. Pregnancy outcome in patients with primary Sjogren's syndrome. A case-control study.
J. Rheumatol. 32: 1734-1736 (2005).
-
Haga S, Ogawa W, Inoue H, Terui K, Ogino T, Igarashi R, Takeda K, Akira S, Enosawa S, Furukawa H, Todo S, Ozaki M. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice.
J. Hepatol. 43: 799-807 (2005).
*
-
Hagerman EM, Chao SH, Dunn JC, Wu BM. Surface modification and initial adhesion events for intestinal epithelial cells.
J. Biomed. Mater. Res. A. 76A: 272-278 (2005).
-
Hagfors L, Nilsson I, Skoldstam L, Johansson G. Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis.
Nutr. Metab. (Lond.) 2: 26 (2005).
*
-
Haggqvist B, Hultman P. Interleukin-10 in murine metal-induced systemic autoimmunity.
Clin. Exp. Immunol. 141: 422-431 (2005).
*
-
Hagman J, Lukin K. Early B-cell factor 'pioneers' the way for B-cell development.
Trends Immunol. 26: 455-461 (2005).
*
-
Hagymasi K, Tulassay Z. Pharmacogenetics of inflammatory bowel disease.
Orv. Hetil. 146: 1143-1150 (2005).
-
Hagymasi K, Tulassay Z. Genetics of primary biliary cirrhosis.
Orv. Hetil. 146: 2151-2155 (2005).
-
Hagymasi K, Tulassay Z. Genotype-phenotype associations in inflammatory bowel disease.
Orv. Hetil. 146: 1767-1773 (2005).
-
Hahn BH, Ebling F, Singh RR, Singh RP, Karpouzas G, La Cava A. Cellular and molecular mechanisms of regulation of autoantibody production in lupus.
Ann. N. Y. Acad. Sci. 1051: 433-441 (2005).
*
-
Hahn JS. Regulation of Nod1 by Hsp90 chaperone complex.
FEBS Lett. 579: 4513-4519 (2005).
*
-
Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.
Nat. Immunol. 6: 490-496 (2005).
*
-
Haigh B. Thrombosis in autoimmune disease: MBL2 genotyping identifies at-risk people.
Clin. Genet. 67: 297-298 (2005).
-
Hait L, Bousvaros A, Grand R. Pediatric inflammatory bowel disease: what children can teach adults.
Inflamm. Bowel Dis. 11: 519-527 (2005).
*
-
Hajeer AH, Issa S, Alaskar A, Abdullah K, Awad M, Tbakhi A, Alabdulkareem A. Neutrophils and lymphoid chimerism after adult living-related liver transplantation from a homozygous donor.
Transplant. Proc. 37: 4386-4388 (2005).
*
-
Hajj-Ali RA, Lowder C, Mandell BF. Uveitis in the internist's office: are a patient's eye symptoms serious?
Cleve. Clin. J. Med. 72: 329-339 (2005).
*
-
Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, Ebrahimi F, Shafaroodi H, Mirkhani SH, Amanpour S, Dehpour AR. Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides.
J. Hepatol. 43: 491-498 (2005).
*
-
Hakem D, Berrah A, Berkane S, Asselah H, Ait-Younes S, Asselah F, Salah S, Merriche S, Abbadi MC. Autoimmune chronic active hepatitis: anatomoclinic's study of 50 patients.
Rev. Med. Interne. 26: 858-865 (2005).
-
Hakonarson H, Bjornsdottir US, Halapi E, Bradfield J, Zink F, Mouy M, Helgadottir H, Gudmundsdottir AS, Andrason H, Adalsteinsdottir AE, Kristjansson K, Birkisson I, Arnason T, Andresdottir M, Gislason D, Gislason T, Gulcher JR, Stefansson K. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.
Proc. Natl. Acad. Sci. U.S.A. 102: 14789-14794 (2005).
*
-
Hale LP, Gottfried MR, Swidsinski A. Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria.
Inflamm. Bowel Dis. 11: 1060-1069 (2005).
*
-
Hale LP, Greer PK, Trinh CT, Gottfried MR. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.
Clin. Immunol. 116: 135-142 (2005).
*
-
Hale LP, Greer PK, Trinh CT, James CL. Proteinase activity and stability of natural bromelain preparations.
Int. Immunopharmacol. 5: 783-793 (2005).
-
Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I. O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.
Gut 54: 797-802 (2005).
*
-
Halfvarson J, Bresso F, D'Amato M, Jarnerot G, Pettersson S, Tysk C. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
Dig. Liver Dis. 37: 768-772 (2005).
-
Halfvarson J, Standaert-Vitse A, Jarnerot G, Sendid B, Jouault T, Bodin L, Duhamel A, Colombel JF, Tysk C, Poulain D. ASCA in twins with inflammatory bowel disease.
Gut 54: 1237-1243 (2005).
*
-
Hall EA, Ren S, Hylemon PB, Redford K, del Castillo A, Gil G, Pandak WM. Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia.
Lipids 40: 1237-1244 (2005).
-
Hall EA, Ren S, Hylemon PB, Rodriguez-Agudo D, Redford K, Marques D, Kang D, Gil G, Pandak WM. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells.
Biochim. Biophys. Acta 1733: 111-119 (2005).
*
-
Hall JF, Hodin R. Restorative proctocolectomy: fertile ground for technical improvements?
Inflamm. Bowel Dis. 11: 207-208 (2005).
*
-
Hall KE, Proctor DD, Fisher L, Rose S. American gastroenterological association future trends committee report: effects of aging of the population on gastroenterology practice, education, and research.
Gastroenterology 129: 1305-1338 (2005).
*
-
Hall NJ, Rubin GP, Dougall A, Hungin AP, Neely J. The fight for 'health-related normality': a qualitative study of the experiences of individuals living with established inflammatory bowel disease (IBD).
J. Health Psychol. 10: 443-455 (2005).
-
Hallasm J, Gaist D, Sorensen HT. Appendectomy and ulcerative colitis.
Epidemiology 16: 132-133 (2005).
-
Hallberg H, Stahlberg D, Akerlund JE. Ileal pouch-anal anastomosis (IPAA): functional outcome after postoperative pelvic sepsis. A prospective study of 100 patients.
Int. J. Colorectal Dis. 20: 529-533 (2005).
*
-
Hallenbeck JM, Hansson GK, Becker KJ. Immunology of ischemic vascular disease: plaque to attack.
Trends Immunol. 26: 550-556 (2005).
*
-
Haller MJ, Schatz DA, Schwartz ID, Keymeulen B, Pipeleers D, Chatenoud L. CD3-antibody therapy in new-onset type 1 diabetes mellitus.
N. Engl. J. Med. 353: 2086-2087 (2005).
*
-
Hallows KR. Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism.
Curr. Opin. Nephrol. Hypertens. 14: 464-471 (2005).
-
Halsall JA, Osborne JE, Pringle JH, Hutchinson PE. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis.
Pharmacogenet. Genomics 15: 349-355 (2005).
-
Haluszka O. Palliative gastroenterology.
Semin. Oncol. 32: 174-178 (2005).
-
Hamada D, Takata Y, Osabe D, Nomura K, Shinohara S, Egawa H, Nakano S, Shinomiya F, Scafe CR, Reeve VM, Miyamoto T, Moritani M, Kunika K, Inoue H, Yasui N, Itakura M. Association between single-nucleotide polymorphisms in the SEC8L1 gene, which encodes a subunit of the exocyst complex, and rheumatoid arthritis in a Japanese population.
Arthritis Rheum. 52: 1371-1380 (2005).
*
-
Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
J. Immunol. 174: 4389-4399 (2005).
*
-
Hamann L, Alexander C, Stamme C, Zahringer U, Schumann RR. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
Infect. Immun. 73: 193-200 (2005).
*
-
Hamann L, Gomma A, Schroder NW, Stamme C, Glaeser C, Schulz S, Gross M, Anker SD, Fox K, Schumann RR. A frequent Toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.
J. Mol. Med. 83: 478-485 (2005).
*
-
Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, Muraki T, Umino J, Kiyosawa K, Miyagawa S. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?
Gastrointest. Endosc. 62: 152-157 (2005).
*
-
Hamasaki T, Hashiguchi S, Ito Y, Kato Z, Nakanishi K, Nakashima T, Sugimura K. Human anti-human IL-18 antibody recognizing the IL-18-binding site 3 with IL-18 signaling blocking activity.
J. Biochem. (Tokyo) 138: 433-442 (2005).
*
-
Hamdan-Khalil R, Gala JL, Allorge D, Lo-Guidice JM, Horsmans Y, Houdret N, Broly F. Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19.
Biochem. Pharmacol. 69: 525-529 (2005).
*
-
Hamer RJ. Coeliac disease: background and biochemical aspects.
Biotechnol. Adv. 23: 401-408 (2005).
*
-
Hamilton TK. Clinical considerations of efalizumab therapy in patients with psoriasis.
Semin. Cutan. Med. Surg. 24: 19-27 (2005).
-
Hammarstedt A, Andersson CX, Rotter Sopasakis V, Smith U. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
Prostaglandins Leukot. Essent. Fatty Acids 73: 65-75 (2005).
*
-
Hamzaoglu I, Hodin RA. Perianal problems in patients with ulcerative colitis.
Inflamm. Bowel Dis. 11: 856-859 (2005).
*
-
Han C, Wu T. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.
J. Biol. Chem. 280: 24053-24063 (2005).
*
-
Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity.
Nat. Immunol. 6: 1198-1205 (2005).
*
-
Han S, Li Y, Mao Y, Xie Y. Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.
Hum. Genet. 118: 123-132 (2005).
*
-
Han S, Shang Y, Li J, Geng L, Zhai N, Cao K, Song F. High resolution DNA typing for HLA-A, B, Cw genes by polymerase chain reaction-sequence specific oligonucleotide probes method in the Shenyang Han population.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22: 665-667 (2005).
-
Han S, Zhang X, Marinova E, Ozen Z, Bheekha-Escura R, Guo L, Wansley D, Booth G, Fu YX, Zheng B. Blockade of lymphotoxin pathway exacerbates autoimmune arthritis by enhancing the Th1 response.
Arthritis Rheum. 52: 3202-3209 (2005).
*
-
Han SH, Ki CS, Lee JE, Hong YJ, Son BK, Lee KH, Choe YH, Lee SY, Kim JW. A novel mutation (A148V) in the glucose 6-phosphate translocase (SLC37A4) gene in a Korean patient with glycogen storage disease type 1b.
J. Korean Med. Sci. 20: 499-501 (2005).
*
-
Han SH, Quon MJ, Koh KK. Beneficial vascular and mtabolic effects of peroxisome proliferator-activated receptor-alpha activators.
Hypertension 46: 1086-1092 (2005).
-
Han SW, Kim GW, Lee J, Kim YJ, Kang YM. Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behcet's disease.
Rheumatol. Int. 25: 234-237 (2005).
*
-
Han SW, McColl E, Barton JR, James P, Steen IN, Welfare MR. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations.
Inflamm. Bowel Dis. 11: 24-34 (2005).
*
-
Han X, Sosnowska D, Bonkowski EL, Denson LA. Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis.
Gastroenterology 129: 185-203 (2005).
*
-
Han XY, Ji LN. Contribution of MODY2 gene to the pathogenesis of Chinese early onset familial type 2 diabetes.
Beijing Da Xue Xue Bao 37: 591-594 (2005).
-
Han YN, Yang JL, Zheng SG, Tang Q, Zhu W. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients.
World J. Gastroenterol. 11: 5721-5724 (2005).
*
-
Hanabata N, Sasaki Y, Tanaka M, Tsuji T, Hatada Y, Hada R, Munakata A. Vascular endothelial growth factor expression and microvessel parameters of colonic mucosa correlate with sensitivity to steroid in patients with ulcerative colitis.
Scand. J. Gastroenterol. 40: 188-193 (2005).
*
-
Hanada K. Sphingolipids in infectious diseases.
Jpn. J. Infect. Dis. 58: 131-148 (2005).
-
Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, Tanaka T, Kondo K, Tanaka K, Takai K. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
World J. Gastroenterol. 11: 3085-3090 (2005).
*
-
Hanauer S, Sandborn WJ, Persson A, Persson T. Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Aliment. Pharmacol. Ther. 21: 363-371 (2005).
*
-
Hanauer SB. The case for using 5-aminosalicyclates in Crohn's disease: pro.
Inflamm. Bowel Dis. 11: 609-612 (2005).
*
-
Hanauer SB. A BALANCING VIEW: lifetime channeling of infliximab for Crohn's disease.
Am. J. Gastroenterol. 100: 1438-1439 (2005).
*
-
Hanauer SB. Infliximab as rescue therapy in ulcerative colitis.
Curr. Gastroenterol. Rep. 7: 465-466 (2005).
-
Hanauer SB. Infliximab or cyclosporine for severe ulcerative colitis.
Gastroenterology 129: 1358-1359 (2005).
*
-
Hanauer SB. Assessment, prevention and treatment of osteoporosis in inflammatory bowel disease patients: a bone of contention.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 199 (2005).
*
-
Hanauer SB. Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 493 (2005).
*
-
Hanauer SB, Sandborn WJ, Kornbluth A, Katz S, Safdi M, Woogen S, Regalli G, Yeh C, Smith-Hall N, Ajayi F. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Am. J. Gastroenterol. 100: 2478-2485 (2005).
*
-
Hanauer SB, Thisted RA. Treatment of Crohn's disease: the "long" of it.
Gastroenterology 128: 2164-2166 (2005).
*
-
Hanaway P, Roseth A. Inflammatory biomarkers predict relapse in IBD.
Gut 54: 1346-1347 (2005).
*
-
Hand CE, Honek JF. Biological chemistry of naturally occurring thiols of microbial and marine origin.
J. Nat. Prod. 68: 293-308 (2005).
*
-
Handa T, Nagai S, Ito I, Tabuena R, Shigematsu M, Hamada K, Kitaichi M, Izumi T, Aoyama T, Toguchida J, Mishima M. Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis.
Respiration 72: 243-248 (2005).
*
-
Handschin AE, Weber M, Renner E, Clavien PA. Abdominal compartment syndrome after liver transplantation.
Liver Transpl. 11: 98-100 (2005).
*
-
Handschin C, Gnerre C, Fraser DJ, Martinez-Jimenez C, Jover R, Meyer UA. Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids.
Arch. Biochem. Biophys. 434: 75-85 (2005).
*
-
Handschin C, Meyer UA. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.
Arch. Biochem. Biophys. 433: 387-396 (2005).
*
-
Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
J. Rheumatol. 32: 1459-1466 (2005).
-
Hanniman EA, Lambert G, McCarthy TC, Sinal CJ. Loss of functional farnesoid X-receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.
J. Lipid Res. 46: 2595-2604 (2005).
*
-
Hanninen ML, Karenlampi RI, Koort JM, Mikkonen T, Bjorkroth KJ. Extension of the species Helicobacter bilis to include the reference strains of Helicobacter sp. flexispira taxa 2, 3 and 8 and Finnish canine and feline flexispira strains.
Int. J. Syst. Evol. Microbiol. 55: 891-898 (2005).
*
-
Hannuksela J, Leppilampi M, Peuhkurinen K, Karkkainen S, Saastamoinen E, Helio T, Kaartinen M, Nieminen MS, Nieminen P, Parkkila S. Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy.
Eur. J. Heart Fail. 7: 103-108 (2005).
-
Hansen A, Reiter K, Ziprian T, Jacobi A, Hoffmann A, Gosemann M, Scholze J, Lipsky PE, Dorner T. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjogren's syndrome.
Arthritis Rheum. 52: 2109-2119 (2005).
*
-
Hansen SK, Rose CS, Glumer C, Drivsholm T, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T. Variation near the hepatocyte nuclear factor (HNF)-4alpha gene associates with type 2 diabetes in the Danish population.
Diabetologia 48: 452-458 (2005).
*
-
Hansen TK. Mannose-binding lectin (MBL) and vascular complications in diabetes.
Horm. Metab. Res. 37 Suppl. 1: 95-98 (2005).
-
Hansen W, Saft C, Andrich J, Muller T, Wieczorek S, Epplen JT, Arning L. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
J. Negat. Results Biomed. 4: 12 (2005).
*
-
Hanson CA, Miller JR. Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein.
Gene 361: 1-12 (2005).
*
-
Hanson CV, Nishiyama Y, Paul S. Catalytic antibodies and their applications.
Curr. Opin. Biotechnol. 16: 631-636 (2005).
*
-
Hanson DR, Gottesman II. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.
BMC Med. Genet. 6: 7 (2005).
*
-
Hanson K. Urinary stones and Crohn's disease.
Urol. Nurs. 25: 466-468 (2005).
-
Hansson M, Djerbi M, Rabbani H, Mellstedt H, Gharibdoost F, Hassan M, Depierre JW, Abedi-Valugerdi M. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice.
Immunology 114: 428-437 (2005).
*
-
Hansson T, Dahlbom I, Rogberg S, Nyberg BI, Dahlstrom J, Anneren G, Klareskog L, Dannaeus A. Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.
J. Pediatr. Gastroenterol. Nutr. 40: 170-174 (2005).
*
-
Hanto DW, Fishbein TM, Pinson CW, Olthoff KM, Shiffman ML, Punch JD, Goodrich NP. Liver and intestine transplantation: summary analysis, 1994-2003.
Am. J. Transplant. 5: 916-933 (2005).
-
Hao CY, Moore DH, Wong P, Bennington JL, Lee NM, Chen LC. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer.
Clin. Cancer Res. 11: 1400-1407 (2005).
*
-
Hao K, Liu S, Niu T. A sparse marker extension tree algorithm for selecting the best set of haplotype tagging single nucleotide polymorphisms.
Genet. Epidemiol. 29: 336-352 (2005).
-
Haq SM, Dayal HH. Chronic liver disease and consumption of raw oysters: a potentially lethal combination - a review of Vibrio vulnificus septicemia.
Am. J. Gastroenterol. 100: 1195-1199 (2005).
*
-
Haque S, Bruce IN. Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease.
Nat. Clin. Pract. Cardiovasc. Med. 2: 423-430 (2005).
-
Harada K, Isse K, Kamihira T, Shimoda S, Nakanuma Y. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis.
Hepatology 41: 1329-1338 (2005).
*
-
Harada M, Kumemura H, Fujita A, Yanagimoto C, Harada R, Hashimoto O, Sakamoto M, Yoshida H, Okamura T, Sata M. A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis.
Hepatol. Res. 31: 116-119 (2005)
(2005).
-
Harada T, Koyama I, Matsunaga T, Kikuno A, Kasahara T, Hassimoto M, Alpers DH, Komoda T. Characterization of structural and catalytic differences in rat intestinal alkaline phosphatase isozymes.
FEBS J. 272: 2477-2486 (2005).
*
-
Harangi M, Kaminski WE, Fleck M, Orso E, Zeher M, Kiss E, Szekanecz Z, Zilahi E, Marienhagen J, Aslanidis C, Paragh G, Bolstad AI, Jonsson R, Schmitz G. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome.
Eur. J. Immunol. 35: 305-317 (2005).
*
-
Haraoui B. Differentiating the efficacy of the tumor necrosis factor inhibitors.
Semin. Arthritis Rheum. 34: 7-11 (2005).
*
-
Haraoui B. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
J. Rheumatol. Suppl. 72: 46-47 (2005).
*
-
Haraoui B. Differentiating the efficacy of tumor necrosis factor inhibitors.
J. Rheumatol. Suppl. 74: 3-7 (2005).
-
Harboe E, Goransson L, Wildhagen K, Omdal R. Mycophenolate mofetil: a new therapeutic agent for chronic autoimmune diseases.
Tidsskr. Nor. Laegeforen. 125: 1650-1652 (2005).
-
Harder J, Schroder JM. Antimicrobial peptides in human skin.
Chem. Immunol. Allergy 86: 22-41 (2005).
-
Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity.
Immunobiology 210: 743-747 (2005).
*
-
Harewood GC. What is the most sensitive screening method for the detection of colon cancer?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 134-135 (2005).
*
-
Harewood GC, Mattek NC, Holub JL, Peters D, Lieberman DA. Variation in practice of ileal intubation among diverse endoscopy settings: results from a national endoscopic database.
Aliment. Pharmacol. Ther. 22: 571-578 (2005).
*
-
Harewood GC, Topazian M. Post-ERCP pancreatitis: is allopurinol the Holy Grail?
Gastrointest. Endosc. 62: 251-252 (2005).
-
Harimoto N, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Giona T, Tanaka S, Shirabe K, Shimada M, Maehara Y. The newly established human hepatocyte cell line: application for the bioartificial liver.
J. Hepatol. 42: 557-564 (2005).
*
-
Harisinghani MG. MRI colonography for IBD: do magnets spin a tale of the inflamed colon?
Inflamm. Bowel Dis. 11: 778 (2005).
*
-
Harizi H, Gualde N. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
Tissue Antigens 65: 507-514 (2005).
*
-
Harle L, Brown T, Laheru D, Dobs AS. Omega-3 fatty acids for the treatment of cancer cachexia: issues in designing clinical trials of dietary supplements.
J. Altern. Complement. Med. 11: 1039-1046 (2005).
-
Harney SM, Meisel C, Sims AM, Woon PY, Wordsworth BP, Brown MA. Genetic and genomic studies of PADI4 in rheumatoid arthritis.
Rheumatology (Oxford) 44: 869-872 (2005).
*
-
Harpavat M, Greenspan SL, O'Brien C, Chang CC, Bowen A, Keljo DJ. Altered bone mass in children at diagnosis of Crohn disease: a pilot study.
J. Pediatr. Gastroenterol. Nutr. 40: 295-300 (2005).
*
-
Harpaz N, Schiano T, Ruf AE, Shukla D, Tao Y, Fishbein TM, Sauter BV, Gondolesi GE. Early and frequent histological recurrence of Crohn's disease in small intestinal allografts.
Transplantation 80: 1667-1670 (2005).
-
Harrigan GG, Brackett DJ, Boros LG. Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics.
Mini. Rev. Med. Chem. 5: 13-20 (2005).
-
Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
Nat. Immunol. 6: 1123-1132 (2005).
*
-
Harris G, Ghazallah RA, Nascene D, Wuertz B, Ondrey FG. PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR.
Otolaryngol. Head Neck Surg. 133: 695-701 (2005).
-
Harris HA, Bruner-Tran KL, Zhang X, Osteen KG, Richard Lyttle C. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.
Hum. Reprod. 20: 936-941 (2005).
-
Harris M, Smith B, Veale A. Printed patient education interventions to facilitate shared management of chronic disease: a literature review.
Intern. Med. J. 35: 711-716 (2005).
*
-
Harris MJ, LE Couteur DG, Arias IM. Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters.
J. Gastroenterol. Hepatol. 20: 807-817 (2005).
*
-
Harris NR, Whatley JR, Carter PR, Specian RD. Venular constriction of submucosal arterioles induced by dextran sodium sulfate.
Inflamm. Bowel Dis. 11: 806-813 (2005).
*
-
Harrison LC. The prospect of vaccination to prevent type 1 diabetes.
Hum. Vaccin. 1: 143-150 (2005).
-
Harrison N, Abhyankar B. The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction.
Curr. Med. Res. Opin. 21: 95-100 (2005).
-
Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, Kamm MA, Stagg AJ. Characteristics of intestinal dendritic cells in inflammatory bowel diseases.
Gastroenterology 129: 50-65 (2005).
*
-
Hart JW, Bremner AR, Wootton SA, Beattie RM. Measured versus predicted energy expenditure in children with inactive Crohn's disease.
Clin. Nutr. 24: 1047-1055 (2005).
-
Hart MA, Konstan MW, Darrah RJ, Schluchter MD, Storfer-Isser A, Xue L, Londono D, Goddard KA, Drumm ML. Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.
Pediatr. Pulmonol. 39: 544-550 (2005).
-
Harth V, Bruning T, Bolt HM. Renal carcinogenicity of trichloroethylene: update, mode of action, and fundamentals for occupational standard setting.
Rev. Environ. Health 20: 103-118 (2005).
-
Hartmann D, Bassler B, Schilling D, Pfeiffer B, Jakobs R, Eickhoff A, Riemann JF, Layer G. Incomplete conventional colonoscopy: magnetic resonance colonography in the evaluation of the proximal colon.
Endoscopy 37: 816-820 (2005).
-
Hartmann M, Enk A. Mycophenolate mofetil and skin diseases.
Lupus 14 Suppl. 1: s58-s63 (2005).
-
Hartung HP, Kieseier BC, Hemmer B. Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis.
J. Neurol. 252 Suppl. 5: v30-v37 (2005).
-
Harty MW, Huddleston HM, Papa EF, Puthawala T, Tracy AP, Ramm GA, Gehring S, Gregory SH, Tracy TF Jr. Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity.
Surgery 138: 313-320 (2005).
*
-
Harty S, Fleming P, Rowland M, Crushell E, McDermott M, Drumm B, Bourke B. A prospective study of the oral manifestations of Crohn's disease.
Clin. Gastroenterol. Hepatol. 3: 886-891 (2005).
-
Hasdemir C, Sagcan A, Sekuri C, Ildizli M, Ulucan C, Ceylan C. Isotretinoin (13-cis-retinoic acid) associated atrial tachycardia.
Pacing Clin. Electrophysiol. 28: 348-349 (2005).
-
Hasegawa H, Yokomori H, Tsuji T, Hirose R. Hemorrhagic cerebral sinus thrombosis in a case of controlled ulcerative colitis.
Intern. Med. 44: 155 (2005).
*
-
Hasegawa K, Sugawara Y, Imamura H, Ikeda M, Kokudo N, Makuuchi M. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
Transpl. Int. 18: 794-799 (2005).
*
-
Hasegawa M. B lymphocyte.
Nihon Rinsho Meneki Gakkai Kaishi 28: 300-308 (2005).
-
Hasegawa M, Imamura R, Kinoshita T, Matsumoto N, Masumoto J, Inohara N, Suda T. ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP.
J. Biol. Chem. 280: 15122-15130 (2005).
*
-
Hashimoto H. Evaluation and improvement of QOL among IBD patients.
Nippon Rinsho 63: 881-884 (2005).
-
Hashimoto K, Maruyama H, Nishiyama M, Asaba K, Ikeda Y, Takao T, Iwasaki Y, Kumon Y, Suehiro T, Tanimoto N, Mizobuchi M, Nakamura T. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Horm. Res. 64: 253-260 (2005).
-
Hashimoto K, Sheller JR, Morrow JD, Collins RD, Goleniewska K, O'Neal J, Zhou W, Ji S, Mitchell DB, Graham BS, Peebles RS Jr. Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms.
J. Immunol. 174: 525-532 (2005).
*
-
Hashimoto S, Nakamura K, Oyama N, Kaneko F, Fujita T, Tsunemi Y, Saeki H, Tamaki K. Mannose-binding lectin (MBL) single nucleotide polymorphism is not associated with atopic dermatitis in Japanese patients.
J. Dermatol. 32: 1038-1040 (2005).
-
Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects.
Int. Arch. Allergy Immunol. 137 Suppl. 1: 51-54 (2005).
-
Hashimoto Y, Miyachi H. Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesis.
Bioorg. Med. Chem. 13: 5080-5093 (2005).
*
-
Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis.
JAMA 294: 1671-1684 (2005).
*
-
Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse.
Adv. Immunol. 87: 123-162 (2005).
-
Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity.
Cell. Immunol. 233: 102-108 (2005).
*
-
Hassan AB, Paraskeva C. Colorectal cancer prognosis: is it all mutation, mutation, mutation?
Gut 54: 1209-1211 (2005).
*
-
Hasson E, Slovatizky Y, Shimoni Y, Falk H, Panet A, Mitrani E. Solid tissues can be manipulated ex vivo and used as vehicles for gene therapy.
J. Gene Med. 7: 926-935 (2005).
-
Haston CK, Hudson TJ. Finding genetic modifiers of cystic fibrosis.
N. Engl. J. Med. 353: 1509-1511 (2005).
*
-
Hasuike S, Ido A, Uto H, Moriuchi A, Tahara Y, Numata M, Nagata K, Hori T, Hayashi K, Tsubouchi H. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
J. Gastroenterol. Hepatol. 20: 1753-1761 (2005).
*
-
Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y, Uemoto S, Yamada S, Maruyama I. Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.
Thromb. Haemost. 94: 975-979 (2005).
-
Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology.
Inflamm. Bowel Dis. 11: 304-313 (2005).
*
-
Hatoum OA, Binion DG, Gutterman DD. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease.
Eur. J. Clin. Invest. 35: 599-609 (2005).
-
Hatoum OA, Gauthier KM, Binion DG, Miura H, Telford G, Otterson MF, Campbell WB, Gutterman DD. Novel mechanism of vasodilation in inflammatory bowel disease.
Arterioscler. Thromb. Vasc. Biol. 25: 2355-2361 (2005).
*
-
Hatoum OA, Spinelli KS, Abu-Hajir M, Attila T, Franco J, Otterson MF, Telford GL, Binion DG. Mesenteric venous thrombosis in inflammatory bowel disease.
J. Clin. Gastroenterol. 39: 27-31 (2005).
-
Hattar K, van Burck S, Bickenbach A, Grandel U, Maus U, Lohmeyer J, Csernok E, Hartung T, Seeger W, Grimminger F, Sibelius U. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.
J. Leukoc. Biol. 78: 992-1000 (2005).
*
-
Hattori N, Niimi T, Sato S, Achiwa H, Maeda H, Oguri T, Bessho Y, Ito H, Shimizu S, Ueda R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients.
Sarcoidosis Vasc. Diffuse Lung Dis. 22: 27-32 (2005).
-
Hattori T, Von Der Mark K, Kawaki H, Yutani Y, Kubota S, Nakanishi T, Eberspaecher H, De Crombrugghe B, Takigawa M. Downregulation of rheumatoid arthritis-related antigen RA-A47 (HSP47/colligin-2) in chondrocytic cell lines induces apoptosis and cell-surface expression of RA-A47 in association with CD9.
J. Cell. Physiol. 202: 191-204 (2005).
*
-
Hauache OM, Reis AF, Oliveira CS, Vieira JG, Sjoroos M, Ilonen J. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes.
Dis. Markers 21: 139-145 (2005).
-
Hauben E, Roncarolo MG, Nevo U, Schwartz M. Beneficial autoimmunity in type 1 diabetes mellitus.
Trends Immunol. 26: 248-253 (2005).
*
-
Haubrich WS. Yersin of Yersinia infection.
Gastroenterology 128: 23 (2005).
*
-
Hauer J, Puschner S, Ramakrishnan P, Simon U, Bongers M, Federle C, Engelmann H. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Proc. Natl. Acad. Sci. U.S.A. 102: 2874-2879 (2005).
*
-
Hauff K, Zamzow C, Law WJ, De Melo J, Kennedy K, Los M. Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system.
Arch. Immunol. Ther. Exp. (Warsz.) 53: 308-320 (2005).
-
Haug S, Braun-Falco M. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Arch. Dermatol. Res. 296: 568-572 (2005).
*
-
Hauser IA, Schaeffeler E, Gauer S, Scheuermann EH, Wegner B, Gossmann J, Ackermann H, Seidl C, Hocher B, Zanger UM, Geiger H, Eichelbaum M, Schwab M. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
J. Am. Soc. Nephrol. 16: 1501-1511 (2005).
*
-
Hauser W, Janke KH, Stallmach A. Mental disorder and psychologic distress in patients with ulcerative colitis after ileal pouch-anal anastomosis.
Dis. Colon Rectum 48: 952-962 (2005).
*
-
Haussinger D, Gorg B, Reinehr R, Schliess F. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy.
Metab. Brain Dis. 20: 285-294 (2005).
-
Havrdova E. Aggressive multiple sclerosis - is there a role for stem cell transplantation?
J. Neurol. 252 Suppl. 3: iii34-iii37 (2005).
*
-
Havrdova E, Horakova D, Kovarova I, Krasulova E. Future possibilities of the multiple sclerosis treatment.
Cas. Lek. Cesk. 144: 663-665 (2005).
-
Hawk E, Viner JL. Statins and cancer - beyond the "one drug, one disease" model.
N. Engl. J. Med. 352: 2238-2239 (2005).
*
-
Hawn TR, Ozinsky A, Williams LM, Rodrigues S, Clark A, Pham U, Hill HR, Ochs H, Aderem A, Liles WC. Hyper-IgE syndrome is not associated with defects in several candidate Toll-like receptor pathway genes.
Hum. Immunol. 66: 842-847 (2005).
-
Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease.
Proc. Natl. Acad. Sci. U.S.A. 102: 2487-2489 (2005).
*
-
Hawn TR, Wu H, Grossman JM, Hahn BH, Tsao BP, Aderem A. A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus.
Proc. Natl. Acad. Sci. U.S.A. 102: 10593-10597 (2005).
*
-
Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.
Nat. Rev. Immunol. 5: 271-283 (2005).
*
-
Hayase H, Ishizu A, Ikeda H, Miyatake Y, Baba T, Higuchi M, Abe A, Tomaru U, Yoshiki T. Aberrant gene expression by CD25+CD4+ immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-I gene.
Int. Immunol. 17: 677-684 (2005).
*
-
Hayase Y, Iwasaki S, Akisawa N, Saibara T, Kadokawa Y, Omagari K, Maeda T, Onishi S. Similar anti-mitochondrial antibody reactivity profiles in familial primary biliary cirrhosis.
Hepatol. Res. 33: 33-38 (2005).
-
Hayashi H, Shimizu K, Tani T, Takamura H, Takeshita M, Funaki K, Kitagawa H, Kayahara M, Ota T, Miwa K. Multiple organ failure caused by end-stage liver disease successfully treated with living donor liver transplantation using perioperative percutaneous cardiopulmonary support: a case report.
Transplant. Proc. 37: 1101-1103 (2005).
-
Hayashi H, Takada T, Suzuki H, Akita H, Sugiyama Y. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.
Hepatology 41: 916-924 (2005).
*
-
Hayashi H, Takada T, Suzuki H, Onuki R, Hofmann AF, Sugiyama Y. Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep.
Biochim. Biophys. Acta 1738: 54-62 (2005).
*
-
Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T. Clinical characteristics of anti-glucose-6-phosphate isomerase antibody-positive Japanese patients with rheumatoid arthritis.
Mod. Rheumatol. 15: 258-263 (2005).
-
Hayee BH, Harris AW. Methotrexate for Crohn's disease: experience in a district general hospital.
Eur. J. Gastroenterol. Hepatol. 17: 893-898 (2005).
-
Hayee BH, Harris AW. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Gastroenterology 128: 249 (2005).
*
-
Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases.
Annu. Rev. Pharmacol. Toxicol. 45: 51-88 (2005).
*
-
Hayes VM, Severi G, Eggleton SA, Padilla EJ, Southey MC, Sutherland RL, Hopper JL, Giles GG. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
Cancer Epidemiol. Biomarkers Prev. 14: 993-996 (2005).
*
-
Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG. Genetic variants in the vitamin D receptor gene and prostate cancer risk.
Cancer Epidemiol. Biomarkers Prev. 14: 997-999 (2005).
*
-
Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Carcinogenesis 26: 219-227 (2005).
*
-
Hazzan D, Eckstein JG, Steinhagen R. Carcinoid tumor and Crohn's ileitis.
Isr. Med. Assoc. J. 7: 674 (2005).
-
He LJ, Yu YM, Qiao F, Liu JS, Sun XF, Jiang LL. Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk.
World J. Gastroenterol. 11: 4268-4271 (2005).
*
-
He MM, Smith AS, Oslob JD, Flanagan WM, Braisted AC, Whitty A, Cancilla MT, Wang J, Lugovskoy AA, Yoburn JC, Fung AD, Farrington G, Eldredge JK, Day ES, Cruz LA, Cachero TG, Miller SK, Friedman JE, Choong IC, Cunningham BC. Small-molecule inhibition of TNF-alpha.
Science 310: 1022-1025 (2005).
*
-
He SH, Xie H, Fu YL. Inhibition of tryptase release from human colon mast cells by histamine receptor antagonists.
Asian Pac. J. Allergy Immunol. 23: 35-39 (2005).
-
He X, Lu Y, Saha N, Yang H, Heng CK. Acyl-CoA: cholesterol acyltransferase-2 gene polymorphisms and their association with plasma lipids and coronary artery disease risks.
Hum. Genet. 118: 393-403 (2005).
*
-
Healy KD, Vanhooke JL, Prahl JM, Deluca HF. Parathyroid hormone decreases renal vitamin D receptor expression in vivo.
Proc. Natl. Acad. Sci. U.S.A. 102: 4724-4728 (2005).
*
-
Healy PJ, Helliwell PS. Classification of the spondyloarthropathies.
Curr. Opin. Rheumatol. 17: 395-399 (2005).
-
Heazell AE, Sinha A, Bhatti NR. A case of gestational diabetes arising following treatment with glucocorticosteroids for pemphigoid gestationis.
J. Matern. Fetal Neonatal Med. 18: 353-355 (2005).
-
Hecht GA. Early enterocyte responses to enteropathogenic E. coli.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S32 (2005).
*
-
Heckmann MI, Mendes-Junior CT, Tada MS, Santos MG, Cabello GM, Salzano FM, Simoes AL, Engracia V. CFTR haplotype distribution in the Brazilian Western Amazonian region.
Hum. Biol. 77: 499-508 (2005).
-
Heczko PB, Strus M, Jawien M, Szymanski H. Medical applications of probiotics.
Wiad. Lek. 58: 640-646 (2005).
-
Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport.
Physiology (Bethesda) 20: 125-133 (2005).
*
-
Heeringa P, Huugen D, Tervaert JW. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
Trends Immunol. 26: 561-564 (2005).
*
-
Heffernan C, Jenkinson C. Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions.
Chronic Illn. 1: 131-142 (2005).
-
Heffeter P, Pongratz M, Steiner E, Chiba P, Jakupec MA, Elbling L, Marian B, Korner W, Sevelda F, Micksche M, Keppler BK, Berger W. Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).
J. Pharmacol. Exp. Ther. 312: 281-289 (2005).
*
-
Hegab AE, Sakamoto T, Saitoh W, Nomura A, Ishii Y, Morishima Y, Iizuka T, Kiwamoto T, Matsuno Y, Massoud HH, Massoud HM, Hassanein KM, Sekizawa K. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease.
Biochem. Biophys. Res. Commun. 329: 1246-1252 (2005).
*
-
Hegarty BD, Bobard A, Hainault I, Ferre P, Bossard P, Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c.
Proc. Natl. Acad. Sci. U.S.A. 102: 791-796 (2005).
*
-
Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway.
J. Exp. Med. 202: 1703-1713 (2005).
*
-
Hegde N, Gayomali C, Rich MW. Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum?
South Med. J. 98: 564-566 (2005).
-
Hegele RA. Retinoid X receptor heterodimers in the metabolic syndrome.
N. Engl. J. Med. 353: 2088 (2005).
*
-
Hegele RA, Pollex RL. Genetic and physiological insights into the metabolic syndrome.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R663-R669 (2005).
*
-
Hegele RA, Robinson JF. ABC transporters and sterol absorption.
Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 31-37 (2005).
-
Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.
Immunology 115: 1-20 (2005).
*
-
Heidemann J, Kucharzik T. Adalimumab in infliximab refractory Crohn's disease - the next generation of anti-TNF-alpha-therapy?
Z. Gastroenterol. 43: 689-690 (2005).
-
Heier A, Sonne C, Grone A, Leifsson PS, Dietz R, Born EW, Bacciarini LN. An immunohistochemical study of retinol-binding protein (RBP) in livers of free-living polar bears (Ursus maritimus) from east Greenland.
J. Zoo. Wildl. Med. 36: 440-446 (2005).
-
Heijerman H. Infection and inflammation in cystic fibrosis: a short review.
J. Cyst. Fibros. 4 Suppl. 2: S3-S5 (2005).
-
Heil PM, Volc-Platzer B, Karlhofer F, Gebhart W, Huber WD, Benesch T, Vogelsang H, Stingl G. Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity.
J. Dtsch. Dermatol. Ges. 3: 974-978 (2005).
-
Heiligenhaus A, Niewerth M, Mingels A, Ganser G, Thon A, Pleyer U, Greiner K, Minden K. Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database.
Klin. Monatsbl. Augenheilkd. 222: 993-1001 (2005).
-
Heimbach JK, Menon KV, Ishitani MB, Nyberg SL, Jankowski CJ, Lindor KD, Rosen CB. Living donor liver transplantation using a right lobe graft in an adult with situs inversus.
Liver Transpl. 11: 111-113 (2005).
*
-
Heinsbroek SE, Brown GD, Gordon S. Dectin-1 escape by fungal dimorphism.
Trends Immunol. 26: 352-354 (2005).
*
-
Heinz C, Plentz A, Bauer D, Heiligenhaus A, Modrow S. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
Graefes Arch. Clin. Exp. Ophthalmol. 243: 999-1004 (2005).
-
Heird WC, Lapillonne A. The role of essential fatty acids in development.
Annu. Rev. Nutr. 25: 549-571 (2005).
*
-
Heissmeyer V, Macian F, Varma R, Im SH, Garcia-Cozar F, Horton HF, Byrne MC, Feske S, Venuprasad K, Gu H, Liu YC, Dustin ML, Rao A. A molecular dissection of lymphocyte unresponsiveness induced by sustained calcium signalling.
Novartis Found. Symp. 267: 165-174 (2005).
-
Hela S, Nihel M, Faten L, Monia F, Jalel B, Azza F, Slaheddine S. Osteoporosis and Crohn's disease.
Joint Bone Spine 72: 403-407 (2005).
*
-
Helal TE, Ahmed NS, El Fotoh OA. Lymphocytic colitis: a clue to bacterial etiology.
World J. Gastroenterol. 11: 7266-7271 (2005).
*
-
Held MA, Cosme-Blanco W, Difedele LM, Bonkowski EL, Menon RK, Denson LA. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
Am. J. Physiol. Gastrointest. Liver Physiol. 288: G986-G993 (2005).
*
-
Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C. Oral and salivary parameters in patients with rheumatic diseases.
Acta Odontol. Scand. 63: 284-293 (2005).
-
Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Gastroenterology 129: 550-564 (2005).
*
-
Heller M. Behcet disease (incomplete) and cutaneous polyarteritis nosa.
Dermatol. Online J. 11: 25 (2005).
*
-
Heller T, Saito S, Auerbach J, Williams T, Moreen TR, Jazwinski A, Cruz B, Jeurkar N, Sapp R, Luo G, Liang TJ. An in vitro model of hepatitis C virion production.
Proc. Natl. Acad. Sci. U.S.A. 102: 2579-2583 (2005).
*
-
Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Liver Transpl. 11: 656-662 (2005).
*
-
Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis.
Ann. Rheum. Dis. 64 Suppl. 2: ii3-ii8 (2005).
*
-
Hellmich B, Csernok E, Gross WL. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Ann. N. Y. Acad. Sci. 1051: 121-131 (2005).
*
-
Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Leuk. Lymphoma 46: 869-872 (2005).
-
Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-cell lymphoma.
Am. J. Gastroenterol. 100: 2644-2649 (2005).
*
-
Hellmig S, Hampe J, Folsch UR, Schreiber S. Role of IL-10 promoter haplotypes in Helicobacter pylori associated gastric inflammation.
Gut 54: 888 (2005).
*
-
Hellmig S, Mascheretti S, Folsch U, Schreiber S. Functional promotor polymorphism in RANTES gene does not influence the clinical course of Helicobacter pylori infection.
J. Gastroenterol. Hepatol. 20: 405-408 (2005).
*
-
Helmberger H, Kammer B. Inflammatory diseases of the gall bladder and biliary system. Part II. Acute and chronic inflammation of the biliary system - primary biliary cirrhosis.
Radiologe 45: 569-580 (2005).
-
Helms C, Saccone NL, Cao L, Daw JA, Cao K, Hsu TM, Taillon-Miller P, Duan S, Gordon D, Pierce B, Ott J, Rice J, Fernandez-Vina MA, Kwok PY, Menter A, Bowcock AM. Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR.
Hum. Genet. 118: 466-476 (2005).
*
-
Helms S. Celiac disease and gluten-associated diseases.
Altern. Med. Rev. 10: 172-192 (2005).
*
-
Helpman L, Pauzner D, Lessing JB, Kupferminc MJ, Gutman G. Chorioamnionitis associated with Crohn's disease and azathioprine treatment: a case report.
J. Med. Microbiol. 54: 803-804 (2005).
*
-
Heltianu C, Costache G, Gafencu A, Diaconu M, Bodeanu M, Cristea C, Azibi K, Poenaru L, Simionescu M. Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction.
J. Cell. Mol. Med. 9: 135-142 (2005).
*
-
Helwig U, Schrezenmeir J, Folsch UR. Conjugated linoleic acid protects from inflammatory bowel disease in mice.
Z. Gastroenterol. 43: 1091-1092 (2005).
-
Helyes Z. Role of peripheral mu-opioid receptors in arthritis: are they potential targets for therapy?
Arthritis Rheum. 52: 2955-2959 (2005).
*
-
Hempel N, Negishi M, McManus ME. Human SULT1A genes: cloning and activity assays of the SULT1A promoters.
Methods Enzymol. 400: 147-165 (2005).
-
Henderson JM. Liver transplantation for severe intrahepatic non-cirrhotic portal hypertension.
Liver Transpl. 11: 610-611 (2005).
-
Henderson JM, Yang Y. Is there still a role for surgery in bleeding portal hypertension?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 246-247 (2005).
*
-
Hendig D, Schulz V, Eichgrun J, Szliska C, Gotting C, Kleesiek K. New ABCC6 gene mutations in German pseudoxanthoma elasticum patients.
J. Mol. Med. 83: 140-147 (2005).
*
-
Hendrie PC, Russell DW. Gene targeting with viral vectors.
Mol. Ther. 12: 9-17 (2005).
-
Heneghan MA, McFarlane IG. Of mice and women: toward a mouse model of autoimmune hepatitis.
Hepatology 42: 17-20 (2005).
*
-
Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: new insights into IFN networks.
Trends Immunol. 26: 396-401 (2005).
*
-
Henke MO, Shah SA, Rubin BK. The role of airway secretions in COPD - clinical applications.
COPD 2: 377-390 (2005).
-
Henneken M, Dorner T, Burmester GR, Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Arthritis Res. Ther. 7: R1001-R1013 (2005).
*
-
Hennig B, Reiterer G, Majkova Z, Oesterling E, Meerarani P, Toborek M. Modification of environmental toxicity by nutrients: implications in atherosclerosis.
Cardiovasc. Toxicol. 5: 153-160 (2005).
-
Hennig J, Ottosson L, Andresen C, Horvath L, Kuchroo VK, Broo K, Wahren-Herlenius M, Sunnerhagen M. Structural organization and Zn2+ dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-Coiled-Coil (RBCC) region of Ro52.
J. Biol. Chem. 280: 33250-33261 (2005).
*
-
Hennuyer N, Tailleux A, Torpier G, Mezdour H, Fruchart JC, Staels B, Fievet C. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
Arterioscler. Thromb. Vasc. Biol. 25: 1897-1902 (2005).
*
-
Henry T, Mohan C. Systemic lupus erythematosus - recent clues from congenic strains.
Arch. Immunol. Ther. Exp. (Warsz.) 53: 207-212 (2005).
-
Henson PM. Dampening inflammation.
Nat. Immunol. 6: 1179-1181 (2005).
*
-
Henson SM, Snelgrove R, Hussell T, Wells DJ, Aspinall R. An IL-7 fusion protein that shows increased thymopoietic ability.
J. Immunol. 175: 4112-4118 (2005).
*
-
Hentgen V, Despert V, Lepretre AC, Cuisset L, Chevrant-Breton J, Jego P, Chales G, Gall EL, Delpech M, Grateau G. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome.
J. Rheumatol. 32: 747-751 (2005).
-
Herath KB, Jayasuriya H, Guan Z, Schulman M, Ruby C, Sharma N, Macnaul K, Menke JG, Kodali S, Galgoci A, Wang J, Singh SB. Anthrabenzoxocinones from Streptomyces sp. as liver X receptor ligands and antibacterial agents.
J. Nat. Prod. 68: 1437-1440 (2005).
*
-
Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Politis J, Richecoeur M, Robaszkiewicz M, Seyrig JA. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.
Gut 54: 215-222 (2005).
*
-
Herfarth H. Can OCT be used to distinguish accurately between patients with ulcerative colitis and those with Crohn's disease?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 172-173 (2005).
*
-
Herfarth H, Rogler G. Inflammatory bowel disease.
Endoscopy 37: 42-47 (2005).
-
Herias MV, Koninkx JF, Vos JG, Huis In't Veld JH, van Dijk JE. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice.
Int. J. Food Microbiol. 103: 143-155 (2005).
*
-
Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DE. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
JAMA 293: 830-835 (2005).
*
-
Heriot AG, Tekkis PP, Smith JJ, Bona R, Cohen RG, Nicholls RJ. Management and outcome of pouch-vaginal fistulas following restorative proctocolectomy.
Dis. Colon Rectum 48: 451-458 (2005).
*
-
Herkel J, Schuchmann M, Tiegs G, Lohse AW. Immune-mediated liver injury.
J. Hepatol. 42: 920-923 (2005).
*
-
Hermann C, Krikovszky D, Fust G, Kovacs M, Korner A, Szabo A, Vannay A, Madacsy L. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.
Eur. Cytokine Netw. 16: 277-281 (2005).
-
Hermann J, Demel U, Stunzner D, Daghofer E, Tilz G, Graninger W. Clinical interpretation of antineutrophil cytoplasmatic antibodies: parvovirus B19 infection as a pitfall.
Ann. Rheum. Dis. 64: 641-643 (2005).
*
-
Hermans PW, Hazelzet JA. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.
Clin. Infect. Dis. 41 Suppl. 7: S453-S458 (2005).
*
-
Hermoye L, Laamari-Azjal I, Cao Z, Annet L, Lerut J, Dawant BM, Van Beers BE. Liver segmentation in living liver transplant donors: comparison of semiautomatic and manual methods.
Radiology 234: 171-178 (2005).
*
-
Hernandez Guerrero A, Sobrino Cossio S. Therapuetic colonoscopy.
Rev. Gastroenterol. Mex. 70 Suppl. 1: 149-157 (2005).
-
Hernandez-Boluda JC, Lis MJ, Goterris R, Arbona C, Terol MJ, Tormo M, Solano C. Guillain-Barre syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Transpl. Infect. Dis. 7: 93-96 (2005).
-
Herrera JL. Recent advances in the treatment of liver disorders.
Clin. Liver Dis. 9: xi-xii (2005).
*
-
Herrera-Esparza R, Aguilar JL, Saucedo A, Gonzalez I, Lopez-Robles E, Avalos-Diaz E. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
J. Eur. Acad. Dermatol. Venereol. 19: 617-620 (2005).
-
Herrero JI, Espana A, Quiroga J, Sangro B, Pardo F, Alvarez-Cienfuegos J, Prieto J. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Liver Transpl. 11: 1100-1106 (2005).
*
-
Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J, Prieto J. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival.
Liver Transpl. 11: 89-97 (2005).
*
-
Herrlinger KR, Cummings JR, Barnardo MC, Schwab M, Ahmad T, Jewell DP. The pharmacogenetics of methotrexate in inflammatory bowel disease.
Pharmacogenet. Genomics 15: 705-711 (2005).
-
Herrmann MM, Gaertner S, Stadelmann C, van den Brandt J, Boscke R, Budach W, Reichardt HM, Weissert R. Tolerance induction by bone marrow transplantation in a multiple sclerosis model.
Blood 106: 1875-1883 (2005).
*
-
Herrmann W, Schorr H, Obeid R, Makowski J, Fowler B, Kuhlmann MK. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Clin. Chem. 51: 891-897 (2005).
*
-
Hershfield NB. Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey.
Can. J. Gastroenterol. 19: 231-234 (2005).
*
-
Hershko AY, Naparstek Y. Removal of pathogenic autoantibodies by immunoadsorption.
Ann. N. Y. Acad. Sci. 1051: 635-646 (2005).
*
-
Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, Lahad A. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Haematologica 90: 585-595 (2005).
*
-
Herzer K, Ganten TM, Schulze-Bergkamen H, Grosse-Wilde A, Koschny R, Krammer PH, Walczak H. Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells.
Hepatology 42: 183-192 (2005).
*
-
Heselmans M, Reid G, Akkermans LM, Savelkoul H, Timmerman H, Rombouts FM. Gut flora in health and disease: potential role of probiotics.
Curr. Issues Intest. Microbiol. 6: 1-7 (2005).
-
Hess J, Thorens J, Pache I, Troillet FX, Moradpour D, Gonvers JJ. Auto-immune liver diseases and their treatment.
Rev. Med. Suisse. 1: 242, 245-247 (2005).
-
Hetland ML. DANBIO: a nationwide registry of biological therapies in Denmark.
Clin. Exp. Rheumatol. 23: S205-S207 (2005).
-
Hetz H, Bauer M, Lahner D, Faybik P, Winning J, Ankersmit HJ, Bacher A, Krenn CG. Endothelin activation and postoperative renal failure after human liver transplantation.
Liver Transpl. 11: 1201-1206 (2005).
*
-
Heuschkel R. Synergy between immunosuppressive therapy and enteral nutrition in the management of childhood Crohn's disease.
JPEN J. Parenter. Enteral Nutr. 29: S160-S165 (2005).
*
-
Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, Hehir M. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored.
Arthritis Rheum. 53: 697-702 (2005).
*
-
Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver.
J. Immunol. 174: 1055-1062 (2005).
*
-
Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T, El-Serag HB. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.
J. Pediatr. 146: 35-40 (2005).
-
Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation? - no, never.
J. Hepatol. 43: 573-577 (2005).
*
-
Hibi T, Sakuraba A. Is there a role for apheresis in gastrointestinal disorders?
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 200-201 (2005).
*
-
Hickman SP, Turka LA. Homeostatic T cell proliferation as a barrier to T cell tolerance.
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360: 1713-1721 (2005).
*
-
Hida S, Miura NN, Adachi Y, Ohno N. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
J. Autoimmun. 25: 93-101 (2005).
-
Hidaka Y, Hagiwara T, Yamada M. Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV.
FEBS Lett. 579: 4088-4092 (2005).
*
-
Hider SL, Bruce IN, Silman AJ, Symmons DP. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
J. Rheumatol. 32: 6-10 (2005).
-
Hider SL, Hoggard P, Khoo S, Back D, Bruce IN. Drug efflux transporters in rheumatoid arthritis: comment on the article by Kremer.
Arthritis Rheum. 52: 670 (2005).
*
-
Hiepe F, Dorner T. Autoantibodies and antibody-secreting cells.
Z. Rheumatol. 64: 389-395 (2005).
-
Hierro L, Jara P. Childhood cholestasis and bile transporters.
Gastroenterol. Hepatol. 28: 388-395 (2005).
-
Higashi N, Kawana S. Atopic eczema complicated by systemic lupus erythematosus.
Eur. J. Dermatol. 15: 500-502 (2005).
-
Higashi N, Sato M, Kojima N, Irie T, Kawamura K, Mabuchi A, Senoo H. Vitamin A storage in hepatic stellate cells in the regenerating rat liver: with special reference to zonal heterogeneity.
Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 286: 899-907 (2005).
-
Higenbottam T. Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment.
Proc. Am. Thorac. Soc. 2: 12-19 (2005).
*
-
Higgins PD, Schwartz M, Mapili J, Krokos I, Leung J, Zimmermann EM. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis.
Gut 54: 782-788 (2005).
*
-
Higgins PD, Schwartz M, Mapili J, Zimmermann EM. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?
Am. J. Gastroenterol. 100: 355-361 (2005).
*
-
Highsmith WE Jr, Friedman KJ, Burch LH, Spock A, Silverman LM, Boucher RC, Knowles MR. A CFTR mutation (D1152H) in a family with mild lung disease and normal sweat chlorides.
Clin. Genet. 68: 88-90 (2005).
*
-
Hijova E. Matrix metalloproteinases: their biological functions and clinical implications.
Bratisl. Lek. Listy. 106: 127-132 (2005).
-
Hildebrand F, Pape HC, Griensven MV, Meier S, Hasenkamp S, Krettek C, Stuhrmann M. Genetic predisposition for a compromised immune system after multiple trauma.
Shock 24: 518-522 (2005).
*
-
Hildebrand F, Pape HC, Krettek C. The importance of cytokines in the posttraumatic inflammatory reaction.
Unfallchirurg. 108: 793-794, 796-803 (2005).
-
Hill AM, Buckley JD, Murphy KJ, Saint DA, Morris AM, Howe PR. Combined effects of omega-3 supplementation and regular exercise on body composition and cardiovascular risk factors.
Asia Pac. J. Clin. Nutr. 14: S57 (2005).
-
Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?
Gastroenterology 128: S25-S32 (2005).
*
-
Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
J. Pediatr. Gastroenterol. Nutr. 40: 1-19 (2005).
*
-
Hill M, Havlikova H, Vrbikova J, Kancheva R, Kancheva L, Pouzar V, Cerny I, Starka L. The identification and simultaneous quantification of 7-hydroxylated metabolites of pregnenolone, dehydroepiandrosterone, 3beta,17beta-androstenediol, and testosterone in human serum using gas chromatography-mass spectrometry.
J. Steroid Biochem. Mol. Biol. 96: 187-200 (2005).
-
Hillemann A, Brandenburg B, Schmidt U, Roos M, Smirnow I, Lemken ML, Lauer UM, Hildt E. Protein transduction with bacterial cytosine deaminase fused to the TLM intercellular transport motif induces profound chemosensitivity to 5-fluorocytosine in human hepatoma cells.
J. Hepatol. 43: 442-450 (2005).
*
-
Hillion S, Rochas C, Youinou P, Jamin C. Expression and reexpression of recombination activating genes: relevance to the development of autoimmune states.
Ann. N. Y. Acad. Sci. 1050: 10-18 (2005).
*
-
Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF, Flaquer A, Freudenberg-Hua Y, Jamra RA, Metzen C, Heyn U, Schweiger N, Betz RC, Blaumeiser B, Hampe J, Schreiber S, Schulze TG, Hennies HC, Schumacher J, Propping P, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.
Am. J. Hum. Genet. 77: 140-148 (2005).
*
-
Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat.
Hepatology 42: 1349-1354 (2005).
*
-
Himes SR, Cronau S, Mulford C, Hume DA. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages.
Oncogene 24: 5278-5286 (2005).
*
-
Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR. Whole-genome patterns of common DNA variation in three human populations.
Science 307: 1072-1079 (2005).
*
-
Hinks A, Barton A, John S, Bruce I, Hawkins C, Griffiths CE, Donn R, Thomson W, Silman A, Worthington J. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.
Arthritis Rheum. 52: 1694-1699 (2005).
*
-
Hinoi T, Gesina G, Akyol A, Kuick R, Hanash S, Giordano TJ, Gruber SB, Fearon ER. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium.
Gastroenterology 128: 946-961 (2005).
*
-
Hinrichs AL, Bertelsen S, Bierut LJ, Dunn G, Jin CH, Kauwe JS, Suarez BK. Multipoint identity-by-descent computations for single-point polymorphism and microsatellite maps.
BMC Genet. 6 Suppl. 1: S34 (2005).
*
-
Hinrichs JW, Klappe K, van Riezen M, Kok JW. Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains.
J. Lipid Res. 46: 2367-2376 (2005).
*
-
Hirai H, Samokhvalov IM, Fujimoto T, Nishikawa S, Imanishi J, Nishikawa SI. Involvement of Runx1 in the downregulation of fetal liver kinase-1 (Flk-1) expression during transition of endothelial cells to hematopoietic cells.
Blood 106: 1948-1955 (2005).
*
-
Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima, H, Fukai K, Suzuki Y, Hata A, Saisho H. Fas polymorphisms influence susceptibility to autoimmune hepatitis.
Am. J. Gastroenterol. 100: 1322-1329 (2005).
*
-
Hiramatsu K, Matsumoto Y, Miyazaki M, Tsubouchi H, Yamamoto I, Gohda E. Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid.
Biol. Pharm. Bull. 28: 619-624 (2005).
*
-
Hirano M, Ma BY, Kawasaki N, Okimura K, Baba M, Nakagawa T, Miwa K, Kawasaki N, Oka S, Kawasaki T. Mannan-binding protein blocks the activation of metalloproteases Meprin alpha and beta.
J. Immunol. 175: 3177-3185 (2005).
*
-
Hirano M, Maeda K, Hayashi H, Kusuhara H, Sugiyama Y. Bile salt export pump (BSEP/ABCB11) can transport a non-bile acid substrate, pravastatin.
J. Pharmacol. Exp. Ther. 314: 876-882 (2005).
*
-
Hirano M, Maeda K, Matsushima S, Nozaki Y, Kusuhara H, Sugiyama Y. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin.
Mol. Pharmacol. 68: 800-807 (2005).
*
-
Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease.
J. Clin. Endocrinol. Metab. 90: 2898-2903 (2005).
*
-
Hirayama I, Ide M, Shoji H, Nakamura J, Fujita K, Iizuka H, Oshimoto K, Hisada T, Sato T, Mori M, Asao T, Kuwano H. Laparoscopic-assisted partial ileectomy for Crohn's disease associated with chronic anemia due to frequent hemorrhage.
Hepatogastroenterology 52: 823-825 (2005).
-
Hirayama T, Dai S, Abbas S, Yamanaka Y, Abu-Amer Y. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
Arthritis Rheum. 52: 2719-2729 (2005).
*
-
Hirche TO, Loitsch S, Smaczny C, Wagner TO. New concepts of pathophysiology and therapy in cystic fibrosis.
Pneumologie 59: 811-818 (2005).
-
Hiromatsu Y, Fukutani T, Ichimura M, Mukai T, Kaku H, Nakayama H, Miyake I, Shoji S, Koda Y, Bednarkzuk T. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease.
J. Clin. Endocrinol. Metab. 90: 296-301 (2005).
*
-
Hirota T, Lipp JJ, Toh BH, Peters JM. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin.
Nature 438: 1176-1180 (2005).
*
-
Hirota T, Suzuki Y, Hasegawa K, Obara K, Matsuda A, Akahoshi M, Nakashima K, Cheng L, Takahashi N, Shimizu M, Doi S, Fujita K, Enomoto T, Ebisawa M, Yoshihara S, Nakamura Y, Kishi F, Shirakawa T, Tamari M. Functional haplotypes of IL-12B are associated with childhood atopic asthma.
J. Allergy Clin. Immunol. 116: 789-795 (2005).
*
-
Hirota Y, Kasuga M. Search for type 2 diabetes susceptibility genes.
Tanpakushitsu Kakusan Koso 50: S2084-S2089 (2005).
-
Hirouchi M, Suzuki H, Sugiyama Y. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Pharm. Res. 22: 661-666 (2005).
*
-
Hirsch HH. BK virus: opportunity makes a pathogen.
Clin. Infect. Dis. 41: 354-360 (2005).
*
-
Hirschhorn JN. Genetic approaches to studying common diseases and complex traits.
Pediatr. Res. 57: 74R-77R (2005).
*
-
Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits.
Nat. Rev. Genet. 6: 95-108 (2005).
*
-
Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds.
J. Pediatr. 147: 263-266 (2005).
*
-
Hisajima T, Kojima Y, Yamaguchi A, Goris RC, Funakoshi K. Morphological analysis of the relation between immunoglobulin A production in the small intestine and the enteric nervous system.
Neurosci. Lett. 381: 242-246 (2005).
*
-
Hisamatsu T, Hibi T. Immunosuppressant.
Nippon Rinsho 63: 831-835 (2005).
-
Hitchins M, Williams R, Cheong K, Halani N, Lin VA, Packham D, Ku S, Buckle A, Hawkins N, Burn J, Gallinger S, Goldblatt J, Kirk J, Tomlinson I, Scott R, Spigelman A, Suter C, Martin D, Suthers G, Ward R. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.
Gastroenterology 129: 1392-1399 (2005).
*
-
Hitoshi S. Lipid synthetic transcription factor, SREBP.
Nippon Rinsho 63: 897-907 (2005).
-
Hivroz C. Everything you ever wanted to know about ZAP-70.
Med. Sci. (Paris) 21: 150-155 (2005).
-
Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects.
Arthritis Rheum. 52: 1534-1544 (2005).
*
-
Hla T. Immunology. Dietary factors and immunological consequences.
Science 309: 1682-1683 (2005).
*
-
Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, Schuerbeek N, Noman M, Rutgeerts P, Vermeire S. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
Aliment. Pharmacol. Ther. 22: 613-626 (2005).
*
-
Ho CH, Kuo BI, Kong CW, Chau WK, Hsu HC, Gau JP, Yu YB. Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese.
J. Chin. Med. Assoc. 68: 560-565 (2005).
-
Ho GT, Gaya DR, Satsangi J. Multidrug resistance (MDR1) gene in inflammatory bowel disease: a key player?
Inflamm. Bowel Dis. 11: 1013-1019 (2005).
*
-
Ho GT, Nimmo ER, Tenesa A, Fennell J, Drummond H, Mowat C, Arnott ID, Satsangi J. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis.
Gastroenterology 128: 288-296 (2005).
*
-
Ho GT, Seddon AJ, Therapondos G, Satsangi J, Hayes PC. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation.
Eur. J. Gastroenterol. Hepatol. 17: 1379-1385 (2005).
-
Ho LJ, Lin LC, Hung LF, Wang SJ, Lee CH, Chang DM, Lai JH, Tai TY. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes.
Biochem. Pharmacol. 70: 200-208 (2005).
*
-
Ho LP, Merlin F, Gaber K, Davies RJ, McMichael AJ, Hugot JP. CARD 15 gene mutations in sarcoidosis.
Thorax 60: 354-355 (2005).
*
-
Ho P, Bruce IN, Silman A, Symmons D, Newman B, Young H, Griffiths CE, John S, Worthington J, Barton A. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis.
Arthritis Rheum. 52: 3596-3602 (2005).
*
-
Ho PK, Hawkins CJ. Mammalian initiator apoptotic caspases.
FEBS J. 272: 5436-5453 (2005).
*
-
Ho PP, Fontoura P, Platten M, Sobel RA, Devoss JJ, Lee LY, Kidd BA, Tomooka BH, Capers J, Agrawal A, Gupta R, Zernik J, Yee MK, Lee BJ, Garren H, Robinson WH, Steinman L. A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease.
J. Immunol. 175: 6226-6234 (2005).
*
-
Ho RH, Kim RB. Transporters and drug therapy: implications for drug disposition and disease.
Clin. Pharmacol. Ther. 78: 260-277 (2005).
*
-
Hobbs K. Chronic sarcoid arthritis treated with intraarticular etanercept.
Arthritis Rheum. 52: 987-988 (2005).
*
-
Hobson-Webb LD, Donofrio PD. Inflammatory neuropathies: an update on evaluation and treatment.
Curr. Rheumatol. Rep. 7: 348-355 (2005).
-
Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.
Semin. Arthritis Rheum. 34: 819-836 (2005).
*
-
Hodanova K, Majewski J, Kublova M, Vyletal P, Kalbacova M, Stiburkova B, Hulkova H, Chagnon YC, Lanouette CM, Marinaki A, Fryns JP, Venkat-Raman G, Kmoch S. Mapping of a new candidate locus for uromodulin-associated kidney disease (UAKD) to chromosome 1q41.
Kidney Int. 68: 1472-1482 (2005).
*
-
Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J. Multiple costimulatory modalities enhance CTL avidity.
J. Immunol. 174: 5994-6004 (2005).
*
-
Hodge W, Barnes D, Schachter HM, Pan Y, Lowcock EC, Zhang L, Sampson M, Morrison A, Tran K, Miguelez M, Lewin G. Effects of omega-3 fatty acids on eye health.
Evid. Rep. Technol. Assess. 117: 1-6 (2005).
*
-
Hodgkinson AD, Page T, Millward BA, Demaine AG. A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with type 1 diabetes mellitus.
J. Diabetes Complications 19: 65-69 (2005).
-
Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GF, Vimalachandra D, Webster AC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Cochrane Database Syst. Rev. 4: CD003774 (2005).
*
-
Hoekstra M, Out R, Kar Kruijt J, Van Eck M, Van Berkel TJ. Diet induced regulation of genes involved in cholesterol metabolism in rat liver parenchymal and Kupffer cells.
J. Hepatol. 42: 400-407 (2005).
*
-
Hoentjen F, Sartor RB, Ozaki M, Jobin C. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells.
Blood 105: 689-696 (2005).
*
-
Hoentjen F, Welling GW, Harmsen HJ, Zhang X, Snart J, Tannock GW, Lien K, Churchill TA, Lupicki M, Dieleman LA. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation.
Inflamm. Bowel Dis. 11: 977-985 (2005).
*
-
Hof D, Cheung K, de Rooij DJ, van den Hoogen FH, Pruijn GJ, van Venrooij WJ, Raats JM. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease.
Arthritis Res. Ther. 7: R302-R309 (2005).
*
-
Hof D, Raats JM, Pruijn GJ. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
Autoimmun. Rev. 4: 380-388 (2005).
-
Hofer H, Neufeld JB, Oesterreicher C, Grundtner P, Wrba F, Gangl A, Ferenci P, Gasche C. Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection.
Genes Immun. 6: 242-247 (2005).
*
-
Hoff S, Seiler H, Heinrich J, Kompauer I, Nieters A, Becker N, Nagel G, Gedrich K, Karg G, Wolfram G, Linseisen J. Allergic sensitisation and allergic rhinitis are associated with n-3 polyunsaturated fatty acids in the diet and in red blood cell membranes.
Eur. J. Clin. Nutr. 59: 1071-1080 (2005).
*
-
Hoffenberg EJ. Should all children be screened for celiac disease?
Gastroenterology 128: S98-S103 (2005).
*
-
Hoffjan S, Epplen JT. The genetics of atopic dermatitis: recent findings and future options.
J. Mol. Med. 83: 682-692 (2005).
*
-
Hoffjan S, Stemmler S, Parwez Q, Petrasch-Parwez E, Arinir U, Rhode G, Reinitz-Rademacher K, Schultze-Werninghaus G, Bufe A, Epplen JT. Evaluation of the Toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease.
BMC Med. Genet. 6: 34 (2005).
*
-
Hoffman GS. Determinants of vessel targeting in vasculitis.
Ann. N. Y. Acad. Sci. 1051: 332-339 (2005).
*
-
Hoffmann F, Lohse P, Stojanov S, Shin YS, Renner ED, Kery A, Zellerer S, Belohradsky BH. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
Eur. J. Hum. Genet. 13: 510-512 (2005).
*
-
Hoffmann RM, Schwarz G, Pohl C, Ziegenhagen DJ, Kruis W. Bile acid-independent effect of hymecromone on bile secretion and common bile duct motility.
Dtsch. Med. Wochenschr. 130: 1938-1943 (2005).
-
Hofman M, Princen H, Zwinderman A, Jukema J. Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events.
Clin. Sci. (Lond.) 108: 539-545 (2005).
-
Hofmann AF. Helicobacter and cholesterol gallstones: do findings in the mouse apply to man?
Gastroenterology 128: 1126-1129 (2005).
*
-
Hofmann AF. Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones.
Gut 54: 575-578 (2005).
*
-
Hofmann AF, Zakko SF, Lira M, Clerici C, Hagey LR, Lambert KK, Steinbach JH, Schteingart CD, Olinga P, Groothuis GM. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans.
Hepatology 42: 1391-1398 (2005).
*
-
Hofmann S, Gluckmann M, Kausche S, Schmidt A, Corvey C, Lichtenfels R, Huber C, Albrecht C, Karas M, Herr W. Rapid and sensitive identification of major histocompatibility complex class-I associated tumor peptides by nanoLC MALDI MS/MS.
Mol. Cell. Proteomics 4: 1888-1897 (2005).
*
-
Hofstaedter F. Granuloma formation in the different phenotypes of Crohn's disease.
Gut 54: 180-181 (2005).
*
-
Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Cell. Immunol. 237: 123-130 (2005).
*
-
Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF. Aspergillus and asthma - any link?
Med. Mycol. 43 Suppl. 1: S197-S202 (2005).
-
Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
Ann. Intern. Med. 143: 621-631 (2005).
-
Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus.
Nat. Rev. Immunol. 5: 772-782 (2005).
*
-
Hohl C, Haage P, Krombach GA, Schmidt T, Ahaus M, Gunther RW, Staatz G. Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-fisp as new gold standard?
Rofo. 177: 856-863 (2005).
-
Hohlfeld R, Wekerle H. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
Nat. Clin. Pract. Neurol. 1: 34-44 (2005).
*
-
Hokama A, Kinjo F, Tomiyama R, Kishimoto K, Maeda K, Miyagi S, Nakama M, Saito A. Mesenteric abscess in Crohn's disease.
Gastrointest. Endosc. 62: 306 (2005).
*
-
Hokama A, Kinjo F, Tomiyama R, Maeda K, Saito A, Matayoshi M. Progression of diverticular colitis to ulcerative colitis.
Inflamm. Bowel Dis. 11: 618 (2005).
*
-
Hokama A, Tomiyama R, Kishimoto K, Kinjo F, Saito A, Matayoshi M. Chronic intermittent vomiting after scoliosis surgery.
Gut 54: 222 (2005).
*
-
Hokari R, Lee H, Crawley SC, Yang SC, Gum JR Jr, Miura S, Kim YS. Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1.
Am. J. Physiol. Gastrointest. Liver Physiol. 289: G949-G959 (2005).
*
-
Holden C. Stem cells. California institute: most systems go.
Science 309: 241 (2005).
*
-
Holderbaum D, Malvitz T, Ciesielski CJ, Carson D, Corr MP, Moskowitz RW. A newly described hereditary cartilage debonding syndrome.
Arthritis Rheum. 52: 3300-3304 (2005).
*
-
Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers.
South. Med. J. 98: 1024-1027 (2005).
-
Holick MF. Vitamin D for health and in chronic kidney disease.
Semin. Dial. 18: 266-275 (2005).
-
Holick MF. The vitamin D epidemic and its health consequences.
J. Nutr. 135: 2739S-2748S (2005).
*
-
Holick MF. Stay tuned to PXR: an orphan actor that may not be D-structive only to bone.
J. Clin. Invest. 115: 32-34 (2005).
*
-
Holland KA, Holland IB. Adventures with ABC-proteins: highly conserved ATP-dependent transporters.
Acta Microbiol. Immunol. Hung. 52: 309-322 (2005).
-
Hollande E, Salvador-Cartier C, Alvarez L, Fanjul M. Expression of a wild-type CFTR maintains the integrity of the biosynthetic-secretory pathway in human cystic fibrosis pancreatic duct cells.
J. Histochem. Cytochem. 53: 1539-1552 (2005).
*
-
Hollander G. Thymic functions related to the pathogenesis of IBD.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S10-S12 (2005).
*
-
Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P, Naumann M. Inhibition of RICK/nuclear factor-kappa B- and p38 signaling attenuates the inflammatory response in a murine model of Crohn's disease.
J. Biol. Chem. 280: 14981-14988 (2005).
*
-
Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.
J. Nutr. 135: 317-322 (2005).
*
-
Hollis BW, Wagner CL. Normal serum vitamin D levels.
N. Engl. J. Med. 352: 515-516 (2005).
-
Holloway JW, Yang IA, Ye S. Variation in the Toll-like receptor 4 gene and susceptibility to myocardial infarction.
Pharmacogenet. Genomics 15: 15-21 (2005).
-
Holloway RH. Capsule pH monitoring: is wireless more?
Gut 54: 1672-1681 (2005).
*
-
Hollox EJ, Davies J, Griesenbach U, Burgess J, Alton EW, Armour JA. Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis.
J. Negat. Results Biomed. 4: 9 (2005).
*
-
Holm AM, Aukrust P, Damas JK, Muller F, Halvorsen B, Froland SS. Abnormal interleukin-7 function in common variable immunodeficiency.
Blood 105: 2887-2890 (2005).
*
-
Holm SJ, Sakuraba K, Mallbris L, Wolk K, Stahle M, Sanchez FO. Distinct HLA-C/KIR genotype profile associates with guttate psoriasis.
J. Invest. Dermatol. 125: 721-730 (2005).
*
-
Holm SJ, Sanchez F, Carlen LM, Mallbris L, Stahle M, O'Brien KP. HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3.
Acta Derm. Venereol. 85: 2-8 (2005).
-
Holmberg D, Cilio CM, Lundholm M, Motta V. CTLA-4 (CD152) and its involvement in autoimmune disease.
Autoimmunity 38: 225-233 (2005).
-
Holmes S, Siebold C, Jones EY, Friese MA, Fugger L, Bell J. Multiple sclerosis: MHC associations and therapeutic implications.
Expert Rev. Mol. Med. 7: 1-17 (2005).
-
Holmgren G, Hellman U, Jonasson J, Lundgren HE, Westermark P, Suhr OB. A Swedish family with the rare Phe33Leu transthyretin mutation.
Amyloid 12: 189-192 (2005).
-
Holmgren J, Czerkinsky C. Mucosal immunity and vaccines.
Nat. Med. 10 Suppl. 1: S45-S53 (2005).
*
-
Holmkvist J, Almgren P, Parikh H, Zucchelli M, Kere J, Groop L, Lindgren CM. Haplotype construction of the FRDA gene and evaluation of its role in type II diabetes.
Eur. J. Hum. Genet. 13: 849-855 (2005).
*
-
Holmoy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells.
Eur. J. Immunol. 35: 1786-1794 (2005).
*
-
Holmqvist B, Olsson CF, Svensson ML, Svanborg C, Forsell J, Alm P. Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4.
J. Mol. Histol. 36: 499-516 (2005).
*
-
Holscher C. Targeting IL-23 in autoimmunity.
Curr. Opin. Investig. Drugs 6: 489-495 (2005).
-
Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study.
Dig. Dis. Sci. 50: 2191-2193 (2005).
*
-
Holtmann MH, Neurath MF. Anti-TNF strategies in stenosing and fistulizing Crohn's disease.
Int. J. Colorectal Dis. 20: 1-8 (2005).
*
-
Holtmeier W. Diagnosis of celiac disease.
Z. Gastroenterol. 43: 1243-1252 (2005).
-
Holtmeier W, Henker J, Riecken EO, Zimmer KP. Definitions of celiac disease - statement of an expert group from the German Society for Celiac Disease.
Z. Gastroenterol. 43: 751-754 (2005).
-
Holub M, Bodamer OA, Item C, Muhl A, Pollak A, Stockler-Ipsiroglu S. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
Acta Paediatr. 94: 48-52 (2005).
-
Homan M, Baldassano RN, Mamula P. Managing complicated Crohn's disease in children and adolescents.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 572-579 (2005).
*
-
Homann N, Klarmann U, Fellermann K, Bruning A, Klingenberg-Noftz R, Witthoft T, Stange EF, Ludwig D. Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease.
Inflamm. Bowel Dis. 11: 126-132 (2005).
*
-
Homey B. Chemokines and inflammatory skin diseases.
Adv. Dermatol. 21: 251-277 (2005).
-
Hommes D, Baert F, Van Assche G, Caenepeel F, Vergauwe P, Tuynman H, De Vos M, Van Deventer S, Stitt L, Rutgeerts P, Feagan B, D'haens G. Management of recent onset Crohn's disease: a controlled, randomized trial comparing step-up and top-down therapy.
Gastroenterology 129: 371 (2005).
*
-
Hon C, Ho SL, Ma E, Trendell-Smith N, Au W. High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome.
Leuk. Lymphoma 46: 289-292 (2005).
-
Honda A, Salen G, Matsuzaki Y, Batta AK, Xu G, Hirayama T, Tint GS, Doy M, Shefer S. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
J. Lipid Res. 46: 287-296 (2005).
*
-
Honda K, Nakamura K, Matsui N, Takahashi M, Kitamura Y, Mizutani T, Harada N, Nawata H, Hamano S, Yoshida H. T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis.
Inflamm. Bowel Dis. 11: 1044-1052 (2005).
*
-
Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, Ino Y, Ono M, Hirohashi S. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer.
Gastroenterology 128: 51-62 (2005).
*
-
Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
Nature 434: 772-777 (2005).
*
-
Honda M, Kawai H, Shirota Y, Yamashita T, Kaneko S. Differential gene expression profiles in stage I primary biliary cirrhosis.
Am. J. Gastroenterol. 100: 2019-2030 (2005).
*
-
Honda M, Kawai H, Shirota Y, Yamashita T, Takamura T, Kaneko S. cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation.
J. Autoimmun. 25: 133-140 (2005).
-
Honda W, Kawashima S, Kanehisa M. Autoimmune diseases and peptide variations.
Genome Inform. 16: 272-280 (2005).
*
-
Hong CH, Lee JS, Lee HS, Bae SC, Yoo DH. The association between FcgammaRIIIB polymorphisms and systemic lupus erythematosus in Korea.
Lupus 14: 346-350 (2005).
-
Hong J, Li N, Zhang X, Zheng B, Zhang JZ. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.
Proc. Natl. Acad. Sci. U.S.A. 102: 6449-6454 (2005).
*
-
Hong MY, Bancroft LK, Turner ND, Davidson LA, Murphy ME, Carroll RJ, Chapkin RS, Lupton JR. Fish oil decreases oxidative DNA damage by enhancing apoptosis in rat colon.
Nutr. Cancer 52: 166-175 (2005).
*
-
Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.
Biochem. Biophys. Res. Commun. 330: 1153-1161 (2005).
*
-
Honko AN, Mizel SB. Effects of flagellin on innate and adaptive immunity.
Immunol. Res. 33: 83-102 (2005).
*
-
Honma K, Udono H, Kohno T, Yamamoto K, Ogawa A, Takemori T, Kumatori A, Suzuki S, Matsuyama T, Yui K. Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS.
Proc. Natl. Acad. Sci. U.S.A. 102: 16001-16006 (2005).
*
-
Honma T, Sugimura K, Asakura H, Matsuzawa J, Suzuki K, Kobayashi M, Aoyagi Y. Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis.
J. Clin. Gastroenterol. 39: 886-890 (2005).
-
Honorio KM, Garratt RC, Andricopulo AD. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.
Bioorg. Med. Chem. Lett. 15: 3119-3125 (2005).
*
-
Hoofnagle JH. Primary sclerosing cholangitis.
Hepatology 41: 955 (2005).
*
-
Hoofnagle JH. Milk thistle and chronic liver disease.
Hepatology 42: 4 (2005).
*
-
Hookey LC, Le Moine O, Deviere J. Use of a temporary plastic stent to facilitate the placement of multiple self-expanding metal stents in malignant biliary hilar strictures.
Gastrointest. Endosc. 62: 605-609 (2005).
-
Hoon Lee J, Joe EH, Jou I. PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia.
Neuroreport 16: 829-833 (2005).
-
Hopf U. The elder patient with advanced liver disease.
Schweiz. Rundsch. Med. Prax. 94: 743-750 (2005).
-
Hopkins LM, Davis JM, Buchli R, Vangundy RS, Schwartz KA, Gerlach JA. MHC class I-associated peptides identified from normal platelets and from individuals with idiopathic thrombocytopenic purpura.
Hum. Immunol. 66: 874-883 (2005).
-
Hopkins PA, Fraser JD, Pridmore AC, Russell HH, Read RC, Sriskandan S. Superantigen recognition by HLA class II on monocytes up-regulates Toll-like receptor 4 and enhances proinflammatory responses to endotoxin.
Blood 105: 3655-3662 (2005).
*
-
Hopkins PA, Sriskandan S. Mammalian Toll-like receptors: to immunity and beyond.
Clin. Exp. Immunol. 140: 395-407 (2005).
*
-
Hopper AD, Horoldt BS, Stephenson TJ, Sanders DS. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy-what are the implications for diagnosing adult celiac disease?
Am. J. Gastroenterol. 100: 2128 (2005).
*
-
Hopper AD, Leeds JS, Hurlstone DP, Hadjivassiliou M, Drew K, Sanders DS. Are lower gastrointestinal investigations necessary in patients with coeliac disease?
Eur. J. Gastroenterol. Hepatol. 17: 617-621 (2005).
-
Hopper JL. Application of genetics to the prevention of colorectal cancer.
Recent Results Cancer Res. 166: 17-33 (2005).
-
Hora M, Klecka J Jr, Hes O, Ferda J, Urge T. Miniinvasive laparoscopic or retroperitoneoscopic radical nephrectomy for the parenchymal tumor.
Rozhl. Chir. 84: 246-252 (2005).
-
Horikawa N, Suzuki T, Uchiumi T, Minamimura T, Tsukada K, Takeguchi N, Sakai H. Cyclic AMP-dependent Cl- secretion induced by thromboxane A2 in isolated human colon.
J. Physiol. 562: 885-897 (2005).
*
-
Horiuchi T, Gondo H, Miyagawa H, Otsuka J, Inaba S, Nagafuji K, Takase K, Tsukamoto H, Koyama T, Mitoma H, Tamimoto Y, Miyagi Y, Tahira T, Hayashi K, Hashimura C, Okamura S, Harada M. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT.
Genes Immun. 6: 162-166 (2005).
*
-
Horiya M, Kakizaki S, Teshigaw ara K, Kikuchi Y, Hashida T, Tomizawa Y, Iida T, Masuo T, Takagi H, Mori M. Concordance of ulcerative colitis in monozygotic twin sisters.
World J. Gastroenterol. 11: 7547-7549 (2005).
*
-
Hornef MW, Bogdan C. The role of epithelial Toll-like receptor expression in host defense and microbial tolerance.
J. Endotoxin Res. 11: 124-128 (2005).
*
-
Horneff G. Treatment of juvenile idiopathic arthritis.
Z. Rheumatol. 64: 317-326 (2005).
-
Hornell A. Effects of a gluten-free diet on gastrointestinal symptoms in celiac disease.
Am. J. Clin. Nutr. 81: 1452-1453 (2005).
*
-
Horst-Sikorska W, Wawrzyniak A, Celczynska-Bajew L, Marcinkowska M, Dabrowski S, Kalak R, Slomski R. Polymorphism of VDR gene - the most effective molecular marker of osteoporotic bone fractures risk within postmenopausal women from Wielkopolska region of Poland.
Endokrynol. Pol. 56: 233-239 (2005).
-
Horsthuis K, Lavini Mphil C, Stoker J. MRI in Crohn's disease.
J. Magn. Reson. Imaging 22: 1-12 (2005).
*
-
Horwitz B. NF-kappa B, an inhibitor of microflora-induced colitis.
J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1: S22-S23 (2005).
*
-
Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocana A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
J. Bone Miner. Res. 20: 1792-1803 (2005).
*
-
Hoshida Y, Hongyo T, Xu JX, Sasaki T, Tomita Y, Nomura T, Aozasa K. TP53 gene mutation, an unfavorable prognostic factor for malignant lymphomas in autoimmune diseases.
Oncology 69: 175-183 (2005).
-
Hosomi N, Fukai K, Oiso N, Kato A, Fukui M, Ishii M. No association between atopic dermatitis and the SLC9A3R1-NAT9 RUNX1 binding site polymorphism in Japanese patients.
Clin. Exp. Dermatol. 30: 192-193 (2005).
*
-
Hostetler HA, Petrescu AD, Kier AB, Schroeder F. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands.
J. Biol. Chem. 280: 18667-18682 (2005).
*
-
Hou W, Xia B, Yuan A, Li J, Yang Z, Mao L. CTLA-4 gene polymorphisms in Chinese patients with ulcerative colitis.
Inflamm. Bowel Dis. 11: 653-656 (2005).
*
-
Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective.
Br. J. Haematol. 128: 432-459 (2005).
*
-
Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.
Gastroenterology 128: 1567-1578 (2005).
*
-
Houghton KM, Cabral DA, Petty RE, Tucker LB. Primary Sjogren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia.
J. Rheumatol. 32: 1603-1606 (2005).
-
Houwing-Duistermaat JJ, Uh HW, Lebrec JJ, Putter H, Hsu L. Modeling the effect of an associated single-nucleotide polymorphism in linkage studies.
BMC Genet. 6 Suppl. 1: S46 (2005).
*
-
Hovingh GK, de Groot E, van der Steeg W, Boekholdt SM, Hutten BA, Kuivenhoven JA, Kastelein JJ. Inherited disorders of HDL metabolism and atherosclerosis.
Curr. Opin. Lipidol. 16: 139-145 (2005).
-
Howard LM, Kohm AP, Castaneda CL, Miller SD. Therapeutic blockade of TCR signal transduction and co-stimulation in autoimmune disease.
Curr. Drug Targets Inflamm. Allergy 4: 205-216 (2005).
-
Howarth PH, Babu KS, Arshad HS, Lau LC, Buckley MG, McConnell W, Beckett P, Ali MA, Chauhan A, Wilson SJ, Reynolds A, Davies DE, Holgate ST. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma.
Thorax 60: 1012-1018 (2005).
*
-
Howcroft TK, Weissman JD, Gegonne A, Singer DS. A T lymphocyte-specific transcription complex containing RUNX1 activates MHC class I expression.
J. Immunol. 174: 2106-2115 (2005).
*
-
Howe KL, Reardon C, Wang A, Nazli A, McKay DM. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability.
Am. J. Pathol. 167: 1587-1597 (2005).
*
-
Howell MD, Novak N, Bieber T, Pastore S, Girolomoni G, Boguniewi
| |
